head,tail,relation,note
rs5760410,"[['methotrexate', '(PA450428)']]",increased risk of,
rs5760410,"[['ADORA2A', '(PA24584)'], ['SPECC1L', '(PA164718673)']]",belongs to,
rs1042522,"[['fluorouracil', '(PA128406956)']]",decreased overall survival when treated with fluorouracil in people with Stomach Neoplasms as compared to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs2814707,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs2814707,"[['MOB3B', '(PA134886513)']]",belongs to,
rs3849942,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs3849942,"[['C9orf72', '(PA134908144)']]",belongs to,
rs437943,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs437943,"[['ARAP2', '(PA164715938)']]",belongs to,
rs6138150,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs6138150,"[['CST5', '(PA26978)']]",belongs to,
rs7046653,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs7046653,"[['MOB3B', '(PA134886513)']]",belongs to,
rs854555,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs854555,"[['PON1', '(PA33529)']]",belongs to,
rs854548,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs854548,"[['PON1', '(PA33529)']]",belongs to,
rs6028945,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs6028945,"[['MAFB', '(PA30535)']]",belongs to,
rs6071980,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs6071980,"[['MAFB', '(PA30535)']]",belongs to,
rs1799931,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs983332,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs983332,"[['CSRP3', '(PA26971)']]",belongs to,
rs12050217,"[['perindopril', '(PA450877)']]",decreased risk of,
rs12050217,"[['BDKRB1', '(PA79)']]",belongs to,
rs275651,"[['perindopril', '(PA450877)']]",decreased risk of,
rs275651,"[['AGTR1', '(PA43)']]",belongs to,
rs5182,"[['perindopril', '(PA450877)']]",decreased risk of,
rs5182,"[['AGTR1', '(PA43)']]",belongs to,
rs10836235,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs10836235,"[['CAT', '(PA26099)']]",belongs to,
rs1056892,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs8133052,"[['doxorubicin', '(PA449412)']]",decreased tumor response when treated with doxorubicin in people with Breast Neoplasms as compared to,
rs8133052,"[['CBR3', '(PA26122)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs7569963,"[['citalopram', '(PA449015)']]",decreased likelihood of,
rs7569963,"[['CREB1', '(PA26864)'], ['METTL21A', '(PA145008433)']]",belongs to,
rs7569963,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs7569963,"[['CREB1', '(PA26864)'], ['METTL21A', '(PA145008433)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs774359,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs774359,"[['C9orf72', '(PA134908144)']]",belongs to,
rs868856,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs868856,"[['MOB3B', '(PA134886513)']]",belongs to,
rs928655,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs928655,"[['GBP6', '(PA134964409)']]",belongs to,
rs2032582,"[['platinum', '(PA150595617)'], ['taxanes', '(PA150481189)']]",decreased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2075252,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2075252,"[['LRP2', '(PA30452)']]",belongs to,
rs316019,"[['cisplatin', '(PA449014)']]",decreased risk of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs1695,"[['oxaliplatin', '(PA131285527)']]",increased severity of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['oxaliplatin', '(PA131285527)']]",increased severity of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['Platinum', 'compounds', '(PA164713176)'], ['taxanes', '(PA150481189)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['Platinum', 'compounds', '(PA164713176)']]",decreased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased progression free survival when treated with cisplatin and cyclophosphamide in people with Ovarian Neoplasms as compared to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs712829,"[['erlotinib', '(PA134687924)']]",increased sensitivity when exposed to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs712829,"[['topoisomerase', 'I', 'inhibitors', '(PA150481186)']]",decreased sensitivity when treated with topoisomerase I inhibitors as compared to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs712829,"[['geldanamycin', '(PA152031327)']]",decreased sensitivity when exposed to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs712829,"[['Alkylating', 'Agents', '(PA164712331)']]",decreased sensitivity when exposed to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs712829,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs1954787,"[['citalopram', '(PA449015)']]",decreased likelihood of,
rs1954787,"[['GRIK4', '(PA28976)']]",belongs to,
rs1954787,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs1954787,"[['GRIK4', '(PA28976)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP1A2*1A, CYP1A2*1C","[['CYP1A2', '(PA27093)']]",belongs to,
rs7997012,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['antidepressants', '(PA452229)']]","increased resistance when treated with antidepressants in people with Depressive Disorder, Major as compared to",
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs717620,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",decreased likelihood of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs750332,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs750332,"[['BAG6', '(PA25264)'], ['PRRC2A', '(PA25263)']]",belongs to,
rs2227956,"[['carbamazepine', '(PA448785)']]",decreased severity of,
rs2227956,"[['HSPA1L', '(PA29500)']]",belongs to,
rs2236196,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs2236196,"[['CHRNA4', '(PA26490)']]",belongs to,
rs1042714,"[['carvedilol', '(PA448817)']]",decreased likelihood of,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs730012,"[['aspirin', '(PA448497)']]",increased risk of,
rs730012,"[['LTC4S', '(PA235)']]",belongs to,
rs2236196,"[['nicotine', '(PA450626)']]",increased risk of,
rs2236196,"[['CHRNA4', '(PA26490)']]",belongs to,
rs12720441,"[['amiodarone', '(PA448383)']]",increased risk of,
rs12720441,"[['KCNH2', '(PA212)']]",belongs to,
rs9937,"[['gemcitabine', '(PA449748)']]",increased likelihood of,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
rs9937,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
rs2032583,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2032583,"[['ABCB1', '(PA267)']]",belongs to,
rs2235015,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2235015,"[['ABCB1', '(PA267)']]",belongs to,
rs11572080,"[['amodiaquine', '(PA448404)']]",decreased risk of,
rs11572080,"[['CYP2C8', '(PA125)']]",belongs to,
rs10509681,"[['amodiaquine', '(PA448404)']]",decreased risk of,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs25531,"[['fluoxetine', '(PA449673)']]",increased risk of,
rs25531,"[['SLC6A4', '(PA312)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs104894540,"[['warfarin', '(PA451906)']]","severe warfarin resistance, may require a higher dose (INR never reached) when treated with warfarin as compared to",
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs5065,"[['amlodipine', '(PA448388)']]",decreased major adverse cardiac events (mace) when treated with amlodipine in people with Hypertension as compared to,
rs5065,"[['NPPA', '(PA256)']]",belongs to,
rs5065,"[['chlorthalidone', '(PA448970)']]",decreased major adverse cardiac events (mace) when treated with chlorthalidone in people with Hypertension as compared to,
rs5065,"[['NPPA', '(PA256)']]",belongs to,
rs5065,"[['NPPA', '(PA256)']]",belongs to,
rs6295,"[['paroxetine', '(PA450801)'], ['sertraline', '(PA451333)']]",increased likelihood of,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
rs6295,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
rs4253778,"[['atenolol', '(PA448499)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['carvedilol', '(PA448817)'], ['metoprolol', '(PA450480)']]","decreased cardiac rehospitalization when treated with atenolol, Beta Blocking Agents, carvedilol or metoprolol in people with Acute coronary syndrome as compared to",
rs4253778,"[['PPARA', '(PA280)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['omeprazole', '(PA450704)']]",decreased AUC of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799722,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased risk of,
rs1799722,"[['BDKRB2', '(PA80)']]",belongs to,
rs1799722,"[['BDKRB2', '(PA80)']]",belongs to,
rs1799722,"[['BDKRB2', '(PA80)']]",belongs to,
rs1799722,"[['enalapril', '(PA449456)'], ['imidapril', '(PA452640)'], ['lisinopril', '(PA450242)']]",increased risk of,
rs1799722,"[['BDKRB2', '(PA80)']]",belongs to,
rs2306283,"[['pravastatin', '(PA451089)']]",decreased plasma AUC of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2472677,"[['rifampin', '(PA451250)']]",decreased CYP3A4 acitvity when exposed to,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs2854117,"[['ritonavir', '(PA451260)']]",increased risk of,
rs2854117,"[['APOC3', '(PA53)']]",belongs to,
rs5128,"[['protease', 'inhibitors', '(PA451159)']]",decreased Hypertriglyceridemia when treated with protease inhibitors as compared to,
rs5128,"[['APOC3', '(PA53)']]",belongs to,
rs3846662,"[['HMGCR', '(PA189)']]",belongs to,
rs2273697,"[['talinolol', '(PA146123005)']]",increased residual clearance of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs4986938,"[['tamoxifen', '(PA451581)']]",increased triglycerides in postmenopausal woman when treated with tamoxifen as compared to,
rs4986938,"[['ESR2', '(PA27886)']]",belongs to,
rs9340799,"[['tamoxifen', '(PA451581)']]",decreased in total cholesterol in postmenopausal woman and increase in triglycerides and decrease in high density lipoprotein in premenopausal women when treated with tamoxifen as compared to,
rs9340799,"[['ESR1', '(PA156)']]",belongs to,
rs1751034,"[['tenofovir', '(PA10204)']]",increased intracellular tenofovir diphosphate (TFV-DP) concentrations when treated with tenofovir in people with HIV as compared to,
rs1751034,"[['ABCC4', '(PA397)']]",belongs to,
rs1751034,"[['tenofovir', '(PA10204)']]","increased tenofovir renal clearance, and lower AUC when treated with tenofovir as compared to",
rs1751034,"[['ABCC4', '(PA397)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs119774,"[['montelukast', '(PA450546)']]",increased changes in FEV1 when treated with montelukast in people with Asthma as compared to,
rs119774,"[['ABCC1', '(PA244)']]",belongs to,
rs2368564,"[['muraglitazar', '(PA162356187)']]",decreased risk of,
rs2368564,"[['REN', '(PA297)']]",belongs to,
rs2278293,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1799971,"[['naloxone', '(PA450586)']]",increased cortisol response when treated with naloxone as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['naloxone', '(PA450586)']]",increased peak cortisol response when treated with naloxone as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs246240,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs246240,"[['ABCC1', '(PA244)']]",belongs to,
rs2238476,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2238476,"[['ABCC1', '(PA244)']]",belongs to,
rs2372536,"[['methotrexate', '(PA450428)']]","decreased disease activity as assessed by the physician when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['atomoxetine', '(PA134688071)']]",increased risk of,
"CYP2D6*1, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs622342,"[['SLC22A1', '(PA329)']]",belongs to,
rs1801253,"[['muraglitazar', '(PA162356187)']]",increased risk of,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs5370,"[['muraglitazar', '(PA162356187)']]",decreased risk of,
rs5370,"[['EDN1', '(PA27614)']]",belongs to,
rs11572080,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs11572080,"[['CYP2C8', '(PA125)']]",belongs to,
rs1045642,"[['nortriptyline', '(PA450657)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4933824,"[['iloperidone', '(PA161199368)']]",the highest mean increased QT when treated with iloperidone in people with Schizophrenia as compared to,
rs4933824,"[['NRG3', '(PA31778)']]",belongs to,
rs7142881,"[['iloperidone', '(PA161199368)']]",the lowest mean increased QT when treated with iloperidone in people with Schizophrenia as compared to,
rs7142881,"[['NUBPL', '(PA134907818)']]",belongs to,
rs4799915,"[['CELF4', '(PA25428)']]",belongs to,
rs993648,"[['iloperidone', '(PA161199368)']]",the lowest mean increased QT when treated with iloperidone in people with Schizophrenia as compared to,
rs993648,"[['CERKL', '(PA134984780)']]",belongs to,
rs10918594,"[['verapamil', '(PA451868)']]",increased risk of,
rs10918594,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs10494366,"[['verapamil', '(PA451868)']]",increased risk of,
rs10494366,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs762551,"[['leflunomide', '(PA450192)']]",increased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs3213422,"[['leflunomide', '(PA450192)']]",increased likelihood of,
rs3213422,"[['DHODH', '(PA27327)']]",belongs to,
rs4646,"[['letrozole', '(PA450196)']]",increased treatment efficacy when treated with letrozole in people with Breast Neoplasms as compared to,
rs4646,"[['CYP19A1', '(PA27091)']]",belongs to,
rs2076369,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs2076369,"[['PICK1', '(PA33760)']]",belongs to,
rs3213207,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs3213207,"[['DTNBP1', '(PA27512)']]",belongs to,
rs2619538,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs2619538,"[['DTNBP1', '(PA27512)']]",belongs to,
rs2115819,"[['montelukast', '(PA450546)']]",increased FEV1 response when treated with montelukast in people with Asthma as compared to,
rs2115819,"[['ALOX5', '(PA46)']]",belongs to,
rs2660845,"[['montelukast', '(PA450546)']]",increased risk of,
rs2660845,"[['LTA4H', '(PA24345)']]",belongs to,
rs730012,"[['montelukast', '(PA450546)']]",decreased risk of,
rs730012,"[['LTC4S', '(PA235)']]",belongs to,
rs5443,"[['olanzapine', '(PA450688)']]",increased risk of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs6313,"[['olanzapine', '(PA450688)']]",decreased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs6313,"[['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs6318,"[['olanzapine', '(PA450688)']]",increased severity of,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs4994,"[['olanzapine', '(PA450688)']]",increased risk of,
rs4994,"[['ADRB3', '(PA24598)']]",belongs to,
rs6280,"[['olanzapine', '(PA450688)']]",greater positive symptom improvement and positive symptom remission when treated with olanzapine in people with Schizophrenia as compared to,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs3813929,"[['olanzapine', '(PA450688)']]",decreased risk of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['olanzapine', '(PA450688)']]",decreased risk of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['olanzapine', '(PA450688)']]",decreased risk of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs4731426,"[['olanzapine', '(PA450688)']]",increased risk of,
rs4731426,"[['LEP', '(PA228)']]",belongs to,
rs1123617,"[['nifedipine', '(PA450631)']]",larger mean changes in systolic and diastolic blood pressure when treated with nifedipine as compared to,
rs1123617,"[['SLC14A2', '(PA35811)']]",belongs to,
rs1123617,"[['nifedipine', '(PA450631)']]",larger mean changes in systolic and diastolic blood pressure when treated with nifedipine as compared to,
rs1123617,"[['SLC14A2', '(PA35811)']]",belongs to,
rs3745009,"[['nifedipine', '(PA450631)']]",smaller mean changes in systolic and diastolic blood pressure when treated with nifedipine as compared to,
rs3745009,"[['SLC14A2', '(PA35811)']]",belongs to,
rs3745009,"[['nifedipine', '(PA450631)']]",smaller mean changes in systolic and diastolic blood pressure when treated with nifedipine as compared to,
rs3745009,"[['SLC14A2', '(PA35811)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4880,"[['cyclophosphamide', '(PA449165)']]",decreased survival when treated with cyclophosphamide in people with Breast Neoplasms as compared to,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs2032582,"[['cyclosporine', '(PA449167)']]",increased trough blood concentration of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cyclosporine', '(PA449167)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['cyclosporine', '(PA449167)']]",increased trough blood concentration of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs10932125,"[['daunorubicin', '(PA449212)']]",increased IC50 of,
rs10932125,"[['NRP2', '(PA31784)']]",belongs to,
rs1056836,"[['paclitaxel', '(PA450761)']]",increased progression-free survival when treated with paclitaxel in people with Breast Neoplasms as compared to,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs1056836,"[['docetaxel', '(PA449383)']]",decreased overall survival when treated with docetaxel in people with Prostatic Neoplasms as compared to,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs11045819,"[['fluvastatin', '(PA449688)']]",decreased LDL-C reduction when treated with fluvastatin in people with Hypercholesterolemia as compared to,
rs11045819,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1934951,"[['Bisphosphonates', '(PA164712563)']]",increased risk of,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
rs951439,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs951439,"[['RGS4', '(PA34375)']]",belongs to,
rs951439,"[['olanzapine', '(PA450688)'], ['perphenazine', '(PA450882)']]",increased likelihood of,
rs951439,"[['RGS4', '(PA34375)']]",belongs to,
rs951439,"[['olanzapine', '(PA450688)']]",increased likelihood of,
rs951439,"[['RGS4', '(PA34375)']]",belongs to,
rs17244841,"[['simvastatin', '(PA451363)']]",increased reduction of,
rs17244841,"[['HMGCR', '(PA189)']]",belongs to,
rs17244841,"[['pravastatin', '(PA451089)']]",decreased reduction in LDL when treated with pravastatin as compared to,
rs17244841,"[['HMGCR', '(PA189)']]",belongs to,
rs17238540,"[['pravastatin', '(PA451089)']]",decreased reduction in LDL when exposed to,
rs17238540,"[['HMGCR', '(PA189)']]",belongs to,
rs17238540,"[['simvastatin', '(PA451363)']]",increased reduction of,
rs17238540,"[['HMGCR', '(PA189)']]",belongs to,
rs17238540,"[['atorvastatin', '(PA448500)'], ['cerivastatin', '(PA448897)'], ['fluvastatin', '(PA449688)'], ['pravastatin', '(PA451089)'], ['rosuvastatin', '(PA134308647)'], ['simvastatin', '(PA451363)']]",decreased likelihood of,
rs17238540,"[['HMGCR', '(PA189)']]",belongs to,
rs20455,"[['pravastatin', '(PA451089)']]",decreased risk of,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs20455,"[['pravastatin', '(PA451089)']]",decreased risk of,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs20455,"[['atorvastatin', '(PA448500)']]",increased benefit when treated with atorvastatin in people with Acute coronary syndrome as compared to,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs4149015,"[['pravastatin', '(PA451089)']]",increased AUC0-12 when exposed to,
rs4149015,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs58597806,"[['propofol', '(PA451141)']]",decreased UGT1A9 activity for propofol when exposed to,
rs58597806,"[['UGT1A9', '(PA419)']]",belongs to,
rs4149056,"[['repaglinide', '(PA451234)']]",increased mean plasma AUC of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs7412,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['ritonavir', '(PA451260)']]",increased risk of,
rs7412,"[['APOE', '(PA55)']]",belongs to,
rs7412,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)']]",increased risk of,
rs7412,"[['APOE', '(PA55)']]",belongs to,
rs396991,"[['rituximab', '(PA451261)']]",decreased levels of,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs396991,"[['rituximab', '(PA451261)']]","increased complete response rate when treated with rituximab in people with Lymphoma, Large B-Cell, Diffuse as compared to",
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs396991,"[['rituximab', '(PA451261)']]","response rate when treated with rituximab in people with Lymphoma, Non-Hodgkin as compared to",
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs20417,"[['rofecoxib', '(PA451268)']]",increased pain relief when treated with rofecoxib as compared to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['ibuprofen', '(PA449957)']]",increased pain relief when treated with ibuprofen as compared to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",decreased AUC of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]","increased reduction in low-density lipoprotein cholesterol (LDL-C) level, in a gene-dose-dependent manner, when treated with rosuvastatin in people with Hypercholesterolemia as compared to",
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",increased AUC of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs4343,"[['sildenafil', '(PA451346)']]",decreased chance of,
rs4343,"[['ACE', '(PA139)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",decreased event-free survival when treated with tamoxifen in people with Breast Neoplasms as compared to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",decreased relapse free time when treated with tamoxifen in people with Breast Neoplasms as compared to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",decreased disease free survival when treated with tamoxifen in people with Breast Neoplasms as compared to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",decreased severity of,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",increased disease free survival when treated with tamoxifen in people with Breast Neoplasms as compared to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)'], ['tamoxifen', '(PA451581)']]",decreased progression-free survival when treated with anthracyclines and related substances and tamoxifen in people with Breast Neoplasms as compared to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs10811661,"[['troglitazone', '(PA451799)']]",increased beta cell function when treated with troglitazone in people with high risk for type 2 diabetes as compared to,
rs5030655,"[['venlafaxine', '(PA451866)']]","impaired metabolic activity and more side effects when treated with venlafaxine in people with Depressive Disorder, Major as compared to",
rs5030655,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['venlafaxine', '(PA451866)']]","impaired metabolic activity and more side effects when treated with venlafaxine in people with Depressive Disorder, Major as compared to",
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['acenocoumarol', '(PA452632)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs11080344,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs11080344,"[['NOS2', '(PA164724093)']]",belongs to,
rs12960,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs12960,"[['RPL13', '(PA34670)'], ['SNORD68', '(PA145007789)'], ['SPG7', '(PA36067)']]",belongs to,
rs2070995,"[['opioids', '(PA452618)']]",increased frequency of,
rs2070995,"[['KCNJ6', '(PA30049)']]",belongs to,
rs1045642,"[['nevirapine', '(PA450616)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs870995,"[['docetaxel', '(PA449383)']]",increased clearance of,
rs870995,"[['PIK3CA', '(PA33308)']]",belongs to,
rs518329,"[['docetaxel', '(PA449383)']]",decreased clearance of,
rs518329,"[['PRDX4', '(PA33725)']]",belongs to,
rs2234922,"[['docetaxel', '(PA449383)']]",increased clearance of,
rs2234922,"[['EPHX1', '(PA27829)']]",belongs to,
rs1382368,"[['docetaxel', '(PA449383)']]",increased clearance of,
rs1382368,"[['XRCC4', '(PA37423)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]","decreased disease activity as assessed by the physician, less patient-assessed difficulty with physical tasks, and fewer swollen joints when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased response base on Disease Activity Score in 44 joints improvement at 6 months of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1801133,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
rs1142345,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs4646316,"[['cisplatin', '(PA449014)']]",increased risk of,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs12201199,"[['cisplatin', '(PA449014)']]",increased risk of,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs1800460,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs9332377,"[['cisplatin', '(PA449014)']]",increased risk of,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs2228001,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs1042522,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased severity of,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs11615,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1799735,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1799735,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1799735,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1799793,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased severity of,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs25487,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased severity of,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs3212986,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs3212986,"[['Platinum', 'compounds', '(PA164713176)']]",increased when treated with Platinum compounds in people with Ovarian Neoplasms as compared to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs3957357,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased overall survival when treated with cisplatin and cyclophosphamide in people with Ovarian Neoplasms as compared to,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
rs60369023,"[['gemcitabine', '(PA449748)']]",increased severity of,
rs60369023,"[['CDA', '(PA98)']]",belongs to,
rs60369023,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",increased severity of,
rs60369023,"[['CDA', '(PA98)']]",belongs to,
rs1544410,"[['clodronate', '(PA10239)']]",increased likelihood of,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['alendronate', '(PA448082)'], ['raloxifene', '(PA451221)']]","increased improvement in bone mineral density when treated with alendronate and raloxifene in people with Osteoporosis, Postmenopausal as compared to",
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['calcium', '(PA164712582)'], ['etidronic', 'acid', '(PA449548)']]","increased Mean spinal bone mineral density changes when treated with Calcium and etidronic acid in people with Osteoporosis, Postmenopausal as compared to",
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs731236,"[['clodronate', '(PA10239)']]",increased likelihood of,
rs731236,"[['VDR', '(PA37301)']]",belongs to,
rs16944,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",decreased rates of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",decreased ADP-induced platelet aggregation when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs9345389,"[['methotrexate', '(PA450428)']]",end-of-induction minimal risidual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) and is also associated with greater methotrexate clearance. when treated with methotrexate as compared to,
rs4888024,"[['methotrexate', '(PA450428)']]",end-of-induction minimal risidual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) and is also associated with greater methotrexate clearance when treated with methotrexate as compared to,
rs5030655,"[['metoprolol', '(PA450480)']]",increased plasma concentrations of,
rs5030655,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['metoprolol', '(PA450480)']]",increased plasma concentrations of,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs1044396,"[['nicotine', '(PA450626)']]",increased risk of,
rs1044396,"[['CHRNA4', '(PA26490)']]",belongs to,
rs2276307,"[['atorvastatin', '(PA448500)'], ['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",increased risk of,
rs2276307,"[['HTR3B', '(PA29556)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2031920,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs5443,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs9934438,"[['acenocoumarol', '(PA452632)']]",decreased dose requirement of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)']]",decreased dosage requirement when treated with acenocoumarol in people with Atrial Fibrillation as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1801252,"[['verapamil', '(PA451868)']]",increased risk of,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1800497,"[['bupropion', '(PA448687)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1800497,"[['bupropion', '(PA448687)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1935349,"[['atorvastatin', '(PA448500)'], ['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",increased risk of,
rs1935349,"[['HTR7', '(PA29561)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs7992226,"[['methotrexate', '(PA450428)']]",increased clearance of,
rs7992226,"[['NALCN', '(PA162396840)']]",belongs to,
rs1800497,"[['olanzapine', '(PA450688)']]",increased gastrointestinal toxicity when treated with olanzapine in healthy individuals as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs10821936,"[['methotrexate', '(PA450428)']]",increased methotrexate polyglutamate accumulation when treated with methotrexate in people with B-hyperdiploid subtype of,
rs10821936,"[['ARID5B', '(PA134943193)']]",belongs to,
rs4846051,"[['MTHFR', '(PA245)']]",belongs to,
rs1800909,"[['methotrexate', '(PA450428)']]","decreased in the disease activity score when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs1800909,"[['GGH', '(PA432)']]",belongs to,
rs1079598,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased likelihood of,
rs1079598,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs6277,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased likelihood of,
rs6277,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['antipsychotics', '(PA452233)']]",increased prolactin level when treated with antipsychotics in people with Schizophrenia as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs2070744,"[['Antihypertensives', '(PA164712445)'], ['diuretics', '(PA151249535)']]",increased risk of,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs1800497,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs13181,"[['cisplatin', '(PA449014)']]",decreased event free survival when treated with cisplatin in people with Osteosarcoma as compared to,
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
rs13181,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
rs13181,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs762551,"[['olanzapine', '(PA450688)']]",decreased plasma concentrations when treated with olanzapine in people with psychiatric disorders as compared to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs7997012,"[['olanzapine', '(PA450688)']]",increased risk of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs1414334,"[['antipsychotics', '(PA452233)'], ['aripiprazole', '(PA10026)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs1414334,"[['clozapine', '(PA449061)'], ['risperidone', '(PA451257)']]",increased risk of,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)'], ['nelfinavir', '(PA450606)']]",increased rise in CD4-cell count when treated with efavirenz or nelfinavir in people with HIV as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)']]",increased CD4 T cell count when treated with efavirenz in people with HIV as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2074087,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",decreased severity of,
rs2074087,"[['ABCC1', '(PA244)']]",belongs to,
rs2273697,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs1800629,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
rs1800629,"[['LTA', '(PA30474)'], ['TNF', '(PA435)']]",belongs to,
rs2032582,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased drug-induced liver injury when treated with methotrexate in people with Psoriasis as compared to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs13058338,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs13058338,"[['RAC2', '(PA34163)']]",belongs to,
rs17222723,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
rs1883112,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs1883112,"[['NCF4', '(PA31465)']]",belongs to,
rs45511401,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs45511401,"[['ABCC1', '(PA244)']]",belongs to,
rs4673,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
rs1051740,"[['phenytoin', '(PA450947)']]",increased risk of,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
rs2234922,"[['phenytoin', '(PA450947)']]",increased risk of,
rs2234922,"[['EPHX1', '(PA27829)']]",belongs to,
rs2784917,"[['etoposide', '(PA449552)']]",decreased inhibitory concentration 50 when exposed to,
rs2784917,"[['SLIT1', '(PA35938)']]",belongs to,
rs6539870,"[['etoposide', '(PA449552)']]",increased sensitivity to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['fexofenadine', '(PA449621)']]",decreased plasma concentration of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)'], ['doxorubicin', '(PA449412)'], ['epirubicin', '(PA449476)']]",increased time to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8187710,"[['doxorubicin', '(PA449412)']]",increased risk of,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs714368,"[['doxorubicin', '(PA449412)']]",increased doxorubicin AUC when treated with doxorubicin in people with Breast Neoplasms as compared to,
rs714368,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs714368,"[['doxorubicin', '(PA449412)']]",increased doxorubicinol AUC when treated with doxorubicin in people with Breast Neoplasms as compared to,
rs714368,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs4646487,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs4646487,"[['CYP4B1', '(PA27119)']]",belongs to,
rs4148950,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs4148950,"[['CHST3', '(PA26503)']]",belongs to,
rs4148945,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs4148945,"[['CHST3', '(PA26503)']]",belongs to,
rs2301159,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs2301159,"[['SLC10A2', '(PA318)']]",belongs to,
rs2292954,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs2292954,"[['SPG7', '(PA36067)']]",belongs to,
rs2238472,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs2238472,"[['ABCC6', '(PA58)']]",belongs to,
rs2227291,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs2227291,"[['ATP7A', '(PA72)']]",belongs to,
rs1871450,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs1871450,"[['CHST3', '(PA26503)']]",belongs to,
rs1799931,"[['docetaxel', '(PA449383)'], ['thalidomide', '(PA451644)']]",increased risk of,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs1799794,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs1799794,"[['XRCC3', '(PA37422)']]",belongs to,
rs13306278,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",decreased likelihood of,
rs13306278,"[['COMT', '(PA117)'], ['TXNRD2', '(PA38302)']]",belongs to,
rs11123469,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs11123469,"[['INSIG2', '(PA134890284)']]",belongs to,
rs506770,"[['carbamazepine', '(PA448785)']]",decreased severity of,
rs506770,"[['HSPA1A', '(PA29498)']]",belongs to,
rs1043620,"[['carbamazepine', '(PA448785)']]",decreased severity of,
rs1043620,"[['HSPA1A', '(PA29498)']]",belongs to,
rs2372536,"[['methotrexate', '(PA450428)']]",severity of,
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs2273504,"[['CHRNA4', '(PA26490)']]",belongs to,
rs2229959,"[['CHRNA4', '(PA26490)']]",belongs to,
rs1044397,"[['CHRNA4', '(PA26490)']]",belongs to,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
rs6920220,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs6920220,"[['TNFAIP3', '(PA36593)']]",belongs to,
rs2476601,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2476601,"[['PTPN22', '(PA33995)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased overall survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['antineoplastic', 'agents', '(PA452621)']]","increased progression free survival when treated with antineoplastic agents in people with Leukemia, Lymphocytic, Chronic, B-Cell as compared to",
rs1801133,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2227684,"[['SERPINE1', '(PA261)']]",belongs to,
rs7242,"[['SERPINE1', '(PA261)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs11549467,"[['pazopanib', '(PA165291492)']]","decreased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs11549467,"[['HIF1A', '(PA29283)']]",belongs to,
rs2661319,"[['RGS4', '(PA34375)']]",belongs to,
rs11572080,"[['CYP2C8', '(PA125)']]",belongs to,
rs3740066,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs3211371,"[['bupropion', '(PA448687)']]",increased likelihood of,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['bupropion', '(PA448687)']]",increased likelihood of,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs77905,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs77905,"[['DBH', '(PA136)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs2072661,"[['CHRNB2', '(PA115)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs1001179,"[['CAT', '(PA26099)']]",belongs to,
rs3750518,"[['daunorubicin', '(PA449212)']]",increased IC50 of,
rs3750518,"[['MAN1B1', '(PA30572)']]",belongs to,
rs6603859,"[['daunorubicin', '(PA449212)']]",decreased IC50 of,
rs6603859,"[['SZRD1', '(PA142672461)']]",belongs to,
rs7929521,"[['daunorubicin', '(PA449212)']]",increased IC50 of,
rs3758149,"[['methotrexate', '(PA450428)']]","decreased methotrexate polyglutamate (MTXPG3-5) levels when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs3758149,"[['GGH', '(PA432)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]","increased methotrexate polyglutamate (MTXPG3-5) levels when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs4149117,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased dose-normalized Cmax and dose-normalized AUC0to12 h when treated with mycophenolate mofetil in people with kidney transplants as compared to,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs11188072,"[['CYP2C19', '(PA124)']]",belongs to,
rs11188072,"[['escitalopram', '(PA10074)']]",decreased serum concentration of,
rs11188072,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['escitalopram', '(PA10074)']]",increased serum concentration of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4444903,"[['cetuximab', '(PA10040)']]",increased survival when treated with cetuximab in people with Colorectal Neoplasms as compared to,
rs4444903,"[['EGF', '(PA27664)']]",belongs to,
rs1801394,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801394,"[['FASTKD3', '(PA145148868)'], ['MTRR', '(PA31277)']]",belongs to,
rs4444903,"[['cetuximab', '(PA10040)']]",decreased overall survival when treated with cetuximab in people with colorectal neoplasms as compared to,
rs4444903,"[['EGF', '(PA27664)']]",belongs to,
rs11615,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs12800734,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs12800734,"[['GRIK4', '(PA28976)']]",belongs to,
rs17288723,"[['antidepressants', '(PA452229)']]",increased likelihood of,
rs17288723,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs1928040,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased likelihood of,
rs1928040,"[['HTR2A', '(PA193)']]",belongs to,
rs1799752,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['calcium', 'channel', 'blockers', '(PA10407)'], ['digoxin', '(PA449319)'], ['diuretics', '(PA151249535)']]","increased mortality when treated with Ace Inhibitors, Plain, Beta Blocking Agents, calcium channel blockers, digoxin or diuretics in people with Heart Failure as compared to",
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs8176746,"[['ABO', '(PA24415)']]",belongs to,
rs8176746,"[['ABO', '(PA24415)']]",belongs to,
rs495828,"[['ABO', '(PA24415)']]",belongs to,
rs495828,"[['ABO', '(PA24415)']]",belongs to,
rs4343,"[['ACE', '(PA139)']]",belongs to,
rs1799971,"[['Drugs', 'used', 'in', 'nicotine', 'dependence', '(PA164712720)'], ['nicotine', '(PA450626)']]",increased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['olanzapine', '(PA450688)']]",positive relationship between olanzapine plasma levels and positive symptom reduction compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs70991108,"[['DHFR', '(PA143)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['digoxin', '(PA449319)']]",decreased duodenal absorption of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2069514,"[['theophylline', '(PA451647)']]",increased ratio of,
rs2069514,"[['CYP1A2', '(PA27093)']]",belongs to,
rs5186,"[['AGTR1', '(PA43)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs151264360,"[['methotrexate', '(PA450428)']]",increased risk of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs2032582,"[['fexofenadine', '(PA449621)']]",decreased plasma concentration of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs12721646,"[['nevirapine', '(PA450616)']]",increased plasma alanine aminotransferase level when treated with nevirapine in people with HIV as compared to,
rs12721646,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased plasma alanine aminotransferase level when treated with nevirapine in people with HIV as compared to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs58425034,"[['nevirapine', '(PA450616)']]",increased plasma alanine aminotransferase level when treated with nevirapine in people with HIV as compared to,
rs58425034,"[['CYP2B6', '(PA123)']]",belongs to,
rs776746,"[['nevirapine', '(PA450616)']]",increased plasma alanine aminotransferase level when treated with nevirapine in people with HIV as compared to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs6295,"[['antidepressants', '(PA452229)']]","decreased treatment response when treated with antidepressants in people with Depressive Disorder, Major as compared to",
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs4680,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs4680,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs4680,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs877087,"[['amlodipine', '(PA448388)']]",increased risk of,
rs877087,"[['RYR3', '(PA34897)']]",belongs to,
rs2031920,"[['theophylline', '(PA451647)']]",increased ratio of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs2298383,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2298383,"[['ADORA2A', '(PA24584)']]",belongs to,
rs3761422,"[['methotrexate', '(PA450428)']]",increased risk of,
rs3761422,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2267076,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2267076,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2236624,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2236624,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2279343,"[['cyclophosphamide', '(PA449165)']]",increased risk of,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs2740574,"[['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs8192709,"[['cyclophosphamide', '(PA449165)']]",increased risk of,
rs8192709,"[['CYP2B6', '(PA123)']]",belongs to,
rs9561778,"[['cyclophosphamide', '(PA449165)']]",increased risk of,
rs9561778,"[['ABCC4', '(PA397)']]",belongs to,
rs9561778,"[['cyclophosphamide', '(PA449165)']]",increased severity of,
rs9561778,"[['ABCC4', '(PA397)']]",belongs to,
rs9561778,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs9561778,"[['ABCC4', '(PA397)']]",belongs to,
rs1799983,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)'], ['methotrexate', '(PA450428)']]","increased disease free survival when treated with cyclophosphamide, doxorubicin, fluorouracil and methotrexate in people with Breast Neoplasms as compared to",
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs1799983,"[['cyclophosphamide', '(PA449165)']]",increased disease free survival in people not taking cyclophosphamide in women with Breast Neoplasms as compared to,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs2070744,"[['cyclophosphamide', '(PA449165)']]",increased disease free survival in people not taking cyclophosphamide in women with Breast Neoplasms as compared to,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs2072671,"[['cytarabine', '(PA449177)']]",decreased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs532545,"[['cytarabine', '(PA449177)']]","decreased 5 year survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs532545,"[['cytarabine', '(PA449177)']]",increased risk of,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs7799039,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs1799978,"[['risperidone', '(PA451257)']]",increased risk of,
rs1799978,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['risperidone', '(PA451257)']]",increased risk of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1800497,"[['nemonapride', '(PA151186253)']]",increased prolactin concentrations when exposed to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs12248560,"[['escitalopram', '(PA10074)']]",decreased serum concentration of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1902023,"[['oxazepam', '(PA450731)']]",decreased S-oxazepam glucuronidation in human liver microsomes when exposed to,
rs1902023,"[['UGT2B15', '(PA37188)']]",belongs to,
rs1902023,"[['oxazepam', '(PA450731)']]",decreased oxazepam oral clearance when exposed to,
rs1902023,"[['UGT2B15', '(PA37188)']]",belongs to,
rs1801133,"[['nitrous', 'oxide', '(PA450645)']]",increased plasma total homocysteine concentrations when exposed to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['nitrous', 'oxide', '(PA450645)']]",increased plasma total homocysteine concentrations when exposed to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs167771,"[['risperidone', '(PA451257)']]",increased risk of,
rs167771,"[['DRD3', '(PA27479)']]",belongs to,
rs70991108,"[['methotrexate', '(PA450428)']]",increased risk of,
rs70991108,"[['DHFR', '(PA143)']]",belongs to,
rs4149081,"[['methotrexate', '(PA450428)']]",increased clearance of,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149081,"[['methotrexate', '(PA450428)']]",increased risk of,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149081,"[['methotrexate', '(PA450428)']]",clearance of,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11045879,"[['methotrexate', '(PA450428)']]",increased clearance of,
rs11045879,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11045879,"[['methotrexate', '(PA450428)']]",increased clearance of,
rs11045879,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11045879,"[['methotrexate', '(PA450428)']]",increased risk of,
rs11045879,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['methotrexate', '(PA450428)']]",increased clearance of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2032582,"[['paclitaxel', '(PA450761)']]",increased chance of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['prednisone', '(PA451100)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799732,"[['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased time to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs776746,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1113129,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs1113129,"[['CYP2C8', '(PA125)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs3813867,"[['theophylline', '(PA451647)']]",increased ratio of,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs2016848,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased risk of,
rs2016848,"[['MME', '(PA30864)']]",belongs to,
rs11209716,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",decreased risk of,
rs11209716,"[['PTGER3', '(PA288)']]",belongs to,
rs8012552,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased risk of,
rs8012552,"[['BDKRB2', '(PA80)']]",belongs to,
rs4343,"[['spironolactone', '(PA451483)']]","improvement in left ventricular ejection fraction, end-systolic and end-diastolic volume when treated with spironolactone in people with chronic heart failure as compared to",
rs4343,"[['ACE', '(PA139)']]",belongs to,
rs1695,"[['fluorouracil', '(PA128406956)']]",decreased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs2236225,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs2236225,"[['MTHFD1', '(PA31236)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2848716,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs2848716,"[['MICA', '(PA30811)']]",belongs to,
rs3130690,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs2894342,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs2894342,"[['MLN', '(PA30856)']]",belongs to,
rs4673993,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs4673993,"[['ATIC', '(PA25094)']]",belongs to,
rs135561,"[['PPARA', '(PA280)']]",belongs to,
rs3136228,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs3136228,"[['MSH6', '(PA184)']]",belongs to,
rs4244285,"[['citalopram', '(PA449015)']]","increased intolerance when treated with citalopram in people with Depressive Disorder, Major as compared to",
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs11805303,"[['IL23R', '(PA134935109)']]",belongs to,
rs17221417,"[['NOD2', '(PA26074)']]",belongs to,
rs6897932,"[['IL7R', '(PA29840)']]",belongs to,
rs3135388,"[['HLA-DRA', '(PA35071)']]",belongs to,
rs2104286,"[['IL2RA', '(PA29828)']]",belongs to,
rs6679677,"[['PHTF1', '(PA33278)'], ['RSBN1', '(PA134869532)']]",belongs to,
rs2476601,"[['PTPN22', '(PA33995)']]",belongs to,
rs4402960,"[['IGF2BP2', '(PA128394577)']]",belongs to,
rs4506565,"[['TCF7L2', '(PA36394)']]",belongs to,
rs12243326,"[['TCF7L2', '(PA36394)']]",belongs to,
rs12255372,"[['TCF7L2', '(PA36394)']]",belongs to,
rs5215,"[['KCNJ11', '(PA217)']]",belongs to,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs8050136,"[['FTO', '(PA152208656)']]",belongs to,
rs10965219,"[['CDKN2B-AS1', '(PA164717802)']]",belongs to,
rs10965219,"[['CDKN2B-AS1', '(PA164717802)']]",belongs to,
rs4553808,"[['bortezomib', '(PA10252)'], ['melphalan', '(PA450354)'], ['prednisone', '(PA451100)']]",earlier onset of,
rs4553808,"[['CTLA4', '(PA27006)']]",belongs to,
rs4553808,"[['CTLA4', '(PA27006)']]",belongs to,
rs4149056,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased intracellular PBMC exposure of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased PBMC-associated drug concentrations of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased minimum plasma concentrations of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs3842,"[['efavirenz', '(PA449441)']]",increased accumulation of,
rs3842,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2235040,"[['citalopram', '(PA449015)'], ['fluvoxamine', '(PA449690)'], ['paroxetine', '(PA450801)'], ['sertraline', '(PA451333)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2235040,"[['ABCB1', '(PA267)']]",belongs to,
rs4986893,"[['escitalopram', '(PA10074)']]",increased serum concentration of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs11188072,"[['omeprazole', '(PA450704)']]",decreased AUC of,
rs11188072,"[['CYP2C19', '(PA124)']]",belongs to,
rs2500535,"[['nortriptyline', '(PA450657)']]",decreased improvement of,
rs2500535,"[['UST', '(PA38213)']]",belongs to,
rs1045642,"[['paclitaxel', '(PA450761)']]",decreased disease control rate and lower overall survival rate when treated with paclitaxel in people with metastatic breast cancer as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",worse prognoses when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1045642,"[['rhodamine', '123', '(PA165110729)']]",increased efflux of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)']]",decreased levels of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)']]",decreased levels of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2231142,"[['atorvastatin', '(PA448500)']]",increased AUC of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1799978,"[['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",decreased time until response when treated with olanzapine and risperidone in people with Schizophrenia as compared to,
rs1799978,"[['DRD2', '(PA27478)']]",belongs to,
rs4680,"[['antipsychotics', '(PA452233)']]",decreased risk of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs4680,"[['antipsychotics', '(PA452233)']]",increased methylation at sites 1 and 2 in the COMT promoter when treated with antipsychotics in people with Schizophrenia as compared to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs4343,"[['ACE', '(PA139)']]",belongs to,
rs72551372,"[['NR1I2', '(PA378)']]",belongs to,
rs72551374,"[['NR1I2', '(PA378)']]",belongs to,
rs1801260,"[['lithium', '(PA450243)']]",increased risk of,
rs1801260,"[['CLOCK', '(PA26609)']]",belongs to,
rs8133052,"[['doxorubicin', '(PA449412)']]",increased doxorubicinol AUC when treated with doxorubicin in people with Breast Neoplasms as compared to,
rs8133052,"[['CBR3', '(PA26122)']]",belongs to,
rs8133052,"[['doxorubicin', '(PA449412)']]",decreased severity of,
rs8133052,"[['CBR3', '(PA26122)']]",belongs to,
rs1056892,"[['doxorubicin', '(PA449412)']]",increased doxorubicinol AUC when treated with doxorubicin in people with Breast Neoplasms as compared to,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs1801133,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",graft vs host disease when treated with cyclosporine and methotrexate in people with recipients of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs3745274,"[['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4675690,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs3087243,"[['CTLA4', '(PA27006)']]",belongs to,
rs2278294,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1799971,"[['naloxone', '(PA450586)']]",increased cortisol response when treated with naloxone as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs2606345,"[['carbamazepine', '(PA448785)'], ['phenobarbital', '(PA450911)'], ['phenytoin', '(PA450947)'], ['valproic', 'acid', '(PA451846)']]",increased risk of,
rs2606345,"[['CYP1A1', '(PA27092)']]",belongs to,
rs776746,"[['CYP3A', '(PA27114)'], ['CYP3A5', '(PA131)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased severity of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",decreased severity of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs151264360,"[['methotrexate', '(PA450428)']]",increased severity of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['busulfan', '(PA448691)'], ['cyclophosphamide', '(PA449165)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2229109,"[['cytarabine', '(PA449177)']]","increased survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['cytarabine', '(PA449177)']]","decreased survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cytarabine', '(PA449177)']]","decreased survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['mitoxantrone', '(PA450526)']]",increased sensitivity in vitro when treated with mitoxantrone as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['etoposide', '(PA449552)']]",increased sensitivity in vitro when treated with etoposide as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2762939,"[['CYP24A1', '(PA27097)']]",belongs to,
rs121913459,"[['dasatinib', '(PA162372878)']]",decreased AUC 0-4 hours of,
rs121913459,"[['ABL1', '(PA24413)']]",belongs to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1256049,"[['alendronate', '(PA448082)']]",increased lumbar spine Bone Mineral Density when treated with alendronate in people with Osteoporosis as compared to,
rs1256049,"[['ESR2', '(PA27886)']]",belongs to,
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs3736228,"[['LRP5', '(PA30455)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3736228,"[['LRP5', '(PA30455)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3736228,"[['LRP5', '(PA30455)']]",belongs to,
rs2269577,"[['valproic', 'acid', '(PA451846)']]",increased likelihood of,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1544410,"[['conjugated', 'estrogens', '(PA164754789)'], ['medroxyprogesterone', '(PA450344)']]",increased spine Bone Mineral Density when treated with conjugated estrogens and medroxyprogesterone as compared to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs9340799,"[['conjugated', 'estrogens', '(PA164754789)'], ['medroxyprogesterone', '(PA450344)']]",increased spine Bone Mineral Density when treated with conjugated estrogens and medroxyprogesterone as compared to,
rs9340799,"[['ESR1', '(PA156)']]",belongs to,
rs2301339,"[['diuretics', '(PA151249535)']]",decreased risk of,
rs2301339,"[['CDCA3', '(PA26276)'], ['GNB3', '(PA176)'], ['USP5', '(PA37253)']]",belongs to,
rs2357928,"[['verapamil', '(PA451868)']]",increased risk of,
rs2357928,"[['CACNB2', '(PA88)']]",belongs to,
rs1045642,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)']]",increased survival when treated with fluorouracil in people with Colorectal Neoplasms as compared to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)']]",decreased severity of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs5030952,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs5030952,"[['CAPN10', '(PA26058)']]",belongs to,
rs7439366,"[['codeine', '(PA449088)']]",increased risk of,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs699,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",decreased risk of,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs2230345,"[['Beta', 'Blocking', 'Agents', '(PA164712535)']]",decreased risk of,
rs2230345,"[['GRK5', '(PA180)']]",belongs to,
rs6313,"[['paroxetine', '(PA450801)']]",increased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs12248560,"[['tamoxifen', '(PA451581)']]",decreased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs6314,"[['paroxetine', '(PA450801)']]",increased likelihood of,
rs6314,"[['HTR2A', '(PA193)']]",belongs to,
rs6314,"[['paroxetine', '(PA450801)']]",improved response when treated with paroxetine in people with Depression as compared to,
rs6314,"[['HTR2A', '(PA193)']]",belongs to,
rs1065852,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs28371725,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs28371725,"[['CYP2D6', '(PA128)']]",belongs to,
rs8034191,"[['HYKK', '(PA165478483)']]",belongs to,
rs57098334,"[['antidepressants', '(PA452229)']]",lack of,
rs57098334,"[['SLC6A4', '(PA312)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs57098334,"[['antidepressants', '(PA452229)']]",increased risk of,
rs57098334,"[['SLC6A4', '(PA312)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs699,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",decreased risk of,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs2357928,"[['CACNB2', '(PA88)']]",belongs to,
rs2357928,"[['CACNB2', '(PA88)']]",belongs to,
rs7439366,"[['valproic', 'acid', '(PA451846)']]",increased AUC of,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs7438284,"[['valproic', 'acid', '(PA451846)']]",increased AUC of,
rs7438284,"[['UGT2B7', '(PA361)']]",belongs to,
rs6759892,"[['valproic', 'acid', '(PA451846)']]",increased glucuronidation of,
rs6759892,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs2070959,"[['valproic', 'acid', '(PA451846)']]",increased glucuronidation of,
rs2070959,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs1105879,"[['valproic', 'acid', '(PA451846)']]",increased glucuronidation of,
rs1105879,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs2854744,"[['fluorouracil', '(PA128406956)']]",better survival outcome when treated with fluorouracil in people with Stomach Neoplasms as compared to,
rs2854744,"[['IGFBP3', '(PA29705)']]",belongs to,
rs2960436,"[['fluorouracil', '(PA128406956)']]",better survival outcome when treated with fluorouracil in people with Stomach Neoplasms as compared to,
rs11014166,"[['verapamil', '(PA451868)']]",increased risk of,
rs11014166,"[['CACNB2', '(PA88)']]",belongs to,
rs11014166,"[['CACNB2', '(PA88)']]",belongs to,
rs2283265,"[['cocaine', '(PA449072)']]",increased risk of,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
rs1076560,"[['cocaine', '(PA449072)']]",increased risk of,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs1125394,"[['cocaine', '(PA449072)']]",increased risk of,
rs1125394,"[['DRD2', '(PA27478)']]",belongs to,
HLA-A*33:03,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
rs806374,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs806374,"[['CNR1', '(PA26681)']]",belongs to,
rs806374,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs806374,"[['CNR1', '(PA26681)']]",belongs to,
rs2070744,"[['Antihypertensives', '(PA164712445)']]",increased likelihood of,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs1799983,"[['Antihypertensives', '(PA164712445)']]",increased likelihood of,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs1047891,"[['antiepileptics', '(PA143485705)'], ['valproic', 'acid', '(PA451846)']]",increased risk of,
rs1047891,"[['CPS1', '(PA26840)']]",belongs to,
rs1050828,"[['artesunate', '(PA165111697)'], ['chlorproguanil', '(PA165857067)'], ['dapsone', '(PA449211)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs2228001,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs1695,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]","increased progression free survival when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to",
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs13181,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]","increased progression-free survival when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to",
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs1801133,"[['carboplatin', '(PA448803)'], ['pemetrexed', '(PA10810)']]","increased progression-free survival when treated with carboplatin and pemetrexed in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['carboplatin', '(PA448803)'], ['pemetrexed', '(PA10810)']]","decreased progression free survival when treated with carboplatin and pemetrexed in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs151264360,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs861539,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","decreased progression free survival when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs861539,"[['KLC1', '(PA162393424)'], ['XRCC3', '(PA37422)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased severity of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs5442,"[['GNB3', '(PA176)'], ['USP5', '(PA37253)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma concentration (p<0.001) of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs8192726,"[['efavirenz', '(PA449441)']]",increased plasma concentration (p=0.028) of,
rs8192726,"[['CYP2A6', '(PA121)']]",belongs to,
rs28399454,"[['CYP2A6', '(PA121)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
rs7439366,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
rs762551,"[['clopidogrel', '(PA449053)']]",decreased on-treatment platelet reactivity when treated with clopidogrel in people with cigarette smokers as compared to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs16892645,"[['FGFBP1', '(PA134880558)']]",belongs to,
rs2245964,"[['FGFBP1', '(PA134880558)']]",belongs to,
rs4958381,"[['asparaginase', '(PA448492)']]",increased risk of,
rs4958381,"[['GRIA1', '(PA28966)']]",belongs to,
rs8192726,"[['CYP2A6', '(PA121)']]",belongs to,
rs28399454,"[['CYP2A6', '(PA121)']]",belongs to,
rs35303484,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased mid-dose plasma concentrations of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399454,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['nevirapine', '(PA450616)']]",increased likelihood of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased plasma exposure of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma exposure of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs8192726,"[['CYP2A6', '(PA121)']]",belongs to,
rs1544410,"[['alendronate', '(PA448082)']]",increased Bone Mineral Density when treated with alendronate in people with Osteoporosis as compared to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['alendronate', '(PA448082)']]",decreased urinary DPD/Cr levels when treated with alendronate in people with Osteoporosis as compared to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1265112,"[['nevirapine', '(PA450616)']]",increased risk of,
rs1265112,"[['CCHCR1', '(PA134942738)']]",belongs to,
rs2073724,"[['nevirapine', '(PA450616)']]",increased risk of,
rs2073724,"[['TCF19', '(PA36384)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",the largest mean blood pressure decrease in combination with the I allele of,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
CYP2A6 poor metabolizer genotype,"[['nicotine', '(PA450626)']]",increased ratio of,
CYP2A6 poor metabolizer genotype,"[['CYP2A6', '(PA121)']]",belongs to,
rs1045642,"[['methylprednisolone', '(PA450466)'], ['prednisolone', '(PA451096)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs4720833,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs4720833,"[['MAFK', '(PA30540)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",decreased severity of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs9344,"[['methotrexate', '(PA450428)']]",decreased severity of,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased plasma drug levels when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1695,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs1051266,"[['leucovorin', '(PA450198)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs11023197,"[['tamoxifen', '(PA451581)']]",increased frequency of,
rs11023197,"[['RRAS2', '(PA34862)']]",belongs to,
rs1051266,"[['leucovorin', '(PA450198)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['leucovorin', '(PA450198)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased plasma drug levels of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs2768759,"[['aspirin', '(PA448497)']]",increased residual platelet aggregation to,
rs2768759,"[['NTRK1', '(PA31817)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs8187710,"[['lopinavir', '(PA450264)']]",a higher accumulation of,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs1065852,"[['propranolol', '(PA451145)']]",increased area under plasma concentration of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs2518224,"[['citalopram', '(PA449015)']]",increased risk of,
rs2518224,"[['GRIK2', '(PA164741600)']]",belongs to,
rs4825476,"[['citalopram', '(PA449015)']]",increased risk of,
rs4825476,"[['GRIA3', '(PA28968)']]",belongs to,
rs7586110,"[['irinotecan', '(PA450085)']]",increased risk of,
rs7586110,"[['UGT1A9', '(PA419)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)'], ['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1800734,"[['dacarbazine', '(PA449197)'], ['procarbazine', '(PA451112)']]",increased likelihood of,
rs1800734,"[['EPM2AIP1', '(PA134917440)']]",belongs to,
rs1800734,"[['dacarbazine', '(PA449197)'], ['procarbazine', '(PA451112)']]",increased likelihood of,
rs1800734,"[['EPM2AIP1', '(PA134917440)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['vincristine', '(PA451879)']]","decreased survival when treated with dexamethasone, doxorubicin and vincristine in people with Multiple Myeloma as compared to",
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799971,"[['alfentanil', '(PA448084)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs5182,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",decreased risk of,
rs5182,"[['AGTR1', '(PA43)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs889299,"[['Farglitazar', '(PA165815771)'], ['glibenclamide', '(PA449782)']]","oedema when treated with Farglitazar and glibenclamide in people with Diabetes Mellitus, Type 2 as compared to",
rs889299,"[['SCNN1B', '(PA306)']]",belongs to,
rs34241435,"[['SCNN1B', '(PA306)']]",belongs to,
rs1902023,"[['lorazepam', '(PA450267)']]",increased area under the visual analog scale-time curve during the induced state when exposed to,
rs1902023,"[['UGT2B15', '(PA37188)']]",belongs to,
rs1801019,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",increased likelihood of,
rs1801019,"[['UMPS', '(PA363)']]",belongs to,
rs1801019,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",Diarrhea when treated with fluorouracil and leucovorin in people with Adenocarcinoma as compared to,
rs1801019,"[['UMPS', '(PA363)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",decreased peak plasma concentration (Cmax) and the total area under the plasma concentration-time curve (AUC) of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-C*08:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*08:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
CYP2D6 haplotype,"[['tetrabenazine', '(PA140222719)']]",longer titration to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs1800629,"[['etanercept', '(PA449515)'], ['infliximab', '(PA452639)']]",risk of,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1801159,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs1801159,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['nevirapine', '(PA450616)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)'], ['nevirapine', '(PA450616)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1457266,"[['NEFM', '(PA162397442)']]",belongs to,
rs1379357,"[['NEFM', '(PA162397442)']]",belongs to,
rs2232165,"[['ethanol', '(PA448073)']]",heavy consumption of,
rs2232165,"[['GHSR', '(PA28677)']]",belongs to,
rs4606,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs4606,"[['RGS2', '(PA34372)']]",belongs to,
rs70991108,"[['Multivitamins,', 'Plain', '(PA164712913)']]",increased risk of,
rs70991108,"[['DHFR', '(PA143)']]",belongs to,
rs70991108,"[['Multivitamins,', 'Plain', '(PA164712913)']]",increased risk of,
rs70991108,"[['DHFR', '(PA143)']]",belongs to,
rs324420,"[['cannabinoids', '(PA131890620)']]",decreased risk of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs1127354,"[['mercaptopurine', '(PA450379)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1051266,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801394,"[['methotrexate', '(PA450428)']]",increased speed of,
rs1801394,"[['FASTKD3', '(PA145148868)'], ['MTRR', '(PA31277)']]",belongs to,
CYP2E1*1A,"[['isoniazid', '(PA450112)'], ['pyridoxal', 'phosphate', '(PA164749650)']]",increased likelihood of,
CYP2E1*1A,"[['CYP2E1', '(PA129)']]",belongs to,
rs1979277,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs1979277,"[['SHMT1', '(PA35753)']]",belongs to,
rs45445694,"[['asparaginase', '(PA448492)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['etoposide', '(PA449552)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",increased risk of,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['asparaginase', '(PA448492)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['etoposide', '(PA449552)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased risk of,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased vomiting when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1042713,"[['salbutamol', '(PA448068)']]",increased morning peak expiratory flow rate during treatment with regularly scheduled albuterol compared with placebo when treated with salbutamol in people with Asthma as compared to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs1042713,"[['isoproterenol', '(PA450121)']]",increased isoproterenol-mediated desensitization in the vasculature when exposed to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs712829,"[['egfr', 'inhibitors', '(PA153561371)']]",cytotoxicity of,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs2227983,"[['egfr', 'inhibitors', '(PA153561371)']]",cytotoxicity of,
rs2227983,"[['EGFR', '(PA7360)']]",belongs to,
rs56256500,"[['CYP2A6', '(PA121)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)'], ['rifampin', '(PA451250)']]",a nearly tripled increased percentage of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4341,"[['Thiazides,', 'plain', '(PA164713347)']]",increased risk of,
rs4341,"[['ACE', '(PA139)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs560018,"[['cisplatin', '(PA449014)']]",increased IC-50 when exposed to,
rs560018,"[['GSTM4', '(PA29026)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)'], ['fluvastatin', '(PA449688)'], ['pravastatin', '(PA451089)'], ['rosuvastatin', '(PA134308647)'], ['simvastatin', '(PA451363)']]",increased cholesterol synthesis rate when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased subjective feelings of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]","increased alcohol response, consumption, and preference when exposed to",
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1076560,"[['ethanol', '(PA448073)']]",increased risk of,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs708272,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs5275,"[['capecitabine', '(PA448771)'], ['oxaliplatin', '(PA131285527)']]",increased progression-free survival and overall survival when treated with capecitabine and oxaliplatin in people with Colorectal Neoplasms as compared to,
rs5275,"[['PTGS2', '(PA293)']]",belongs to,
rs2304016,"[['carbamazepine', '(PA448785)'], ['lamotrigine', '(PA450164)'], ['oxcarbazepine', '(PA450732)'], ['phenytoin', '(PA450947)'], ['topiramate', '(PA451728)']]","drug resistance when treated with carbamazepine, lamotrigine, oxcarbazepine, phenytoin or topiramate in people with Epilepsy as compared to",
rs2304016,"[['SCN2A', '(PA35004)']]",belongs to,
rs1799732,"[['bromperidol', '(PA165282097)'], ['nemonapride', '(PA151186253)']]",increased improvement in Anxiety-Depression symptoms when treated with bromperidol and nemonapride in people with Schizophrenia as compared to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs2231142,"[['diflomotecan', '(PA134653756)']]",increased plasma concentrations of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs28933389,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs28933389,"[['BCHE', '(PA25294)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801394,"[['FASTKD3', '(PA145148868)'], ['MTRR', '(PA31277)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1105525,"[['methotrexate', '(PA450428)']]",decreased event free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1105525,"[['DHFR', '(PA143)']]",belongs to,
rs11545078,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs11545078,"[['GGH', '(PA432)']]",belongs to,
rs12654264,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs12654264,"[['HMGCR', '(PA189)']]",belongs to,
rs12654264,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs12654264,"[['HMGCR', '(PA189)']]",belongs to,
rs12654264,"[['HMGCR', '(PA189)']]",belongs to,
rs12654264,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased risk of,
rs12654264,"[['HMGCR', '(PA189)']]",belongs to,
rs12654264,"[['HMGCR', '(PA189)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1051375,"[['verapamil', '(PA451868)']]",decreased risk of,
rs1051375,"[['CACNA1C', '(PA83)']]",belongs to,
rs680244,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs680244,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1051375,"[['CACNA1C', '(PA83)']]",belongs to,
rs1051375,"[['verapamil', '(PA451868)']]",increased risk of,
rs1051375,"[['CACNA1C', '(PA83)']]",belongs to,
rs1805087,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['dactinomycin', '(PA151917012)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1801133,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['dactinomycin', '(PA151917012)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1805087,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1805087,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",decreased event free survuval when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['methotrexate', '(PA450428)']]",increased risk of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['omega-3', 'polyunsaturated', 'fatty', 'acids', '(PA450702)']]",increased risk of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs45445694,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs3212986,"[['platinum', '(PA150595617)']]","increased overall survival when treated with platinum in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['platinum', '(PA150595617)']]",increased likelihood of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs25487,"[['platinum', '(PA150595617)']]","worse overall survival outcome when treated with platinum in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs11188072,"[['imipramine', '(PA449969)']]",decreased dose-corrected plasma concentrations of,
rs11188072,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['imipramine', '(PA449969)']]",decreased dose-corrected plasma concentrations of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
APOE E4,"[['simvastatin', '(PA451363)']]",increased risk of,
APOE E4,"[['APOE', '(PA55)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs1800497,"[['ethanol', '(PA448073)']]",increased risk of,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['ethanol', '(PA448073)']]",increased risk of,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs35529209,"[['conjugated', 'estrogens', '(PA164754789)']]",decreased transport of,
rs35529209,"[['ABCC1', '(PA244)']]",belongs to,
rs2070995,"[['methadone', '(PA450401)']]",decreased risk of,
rs2070995,"[['KCNJ6', '(PA30049)']]",belongs to,
rs4148356,"[['conjugated', 'estrogens', '(PA164754789)']]",decreased transport of,
rs4148356,"[['ABCC1', '(PA244)']]",belongs to,
rs1045642,"[['folic', 'acid', '(PA449692)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4986790,"[['folic', 'acid', '(PA449692)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs4986790,"[['TLR4', '(PA36552)']]",belongs to,
rs4148396,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs4148396,"[['ABCC2', '(PA116)']]",belongs to,
rs4148396,"[['methotrexate', '(PA450428)']]",increased time to,
rs4148396,"[['ABCC2', '(PA116)']]",belongs to,
rs1128503,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2273697,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs17868323,"[['irinotecan', '(PA450085)']]",increased risk of,
rs17868323,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs17868323,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs17868323,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",increased risk of,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4436578,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
rs4436578,"[['DRD2', '(PA27478)']]",belongs to,
rs2274407,"[['antineoplastic', 'agents', '(PA452621)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]","decreased event free survival when treated with antineoplastic agents, mercaptopurine and methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to",
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs2274407,"[['antineoplastic', 'agents', '(PA452621)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased severity of,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs2372536,"[['folic', 'acid', '(PA449692)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs28933390,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs28933390,"[['BCHE', '(PA25294)']]",belongs to,
rs1799983,"[['cytarabine', '(PA449177)'], ['doxorubicin', '(PA449412)'], ['leucovorin', '(PA450198)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]","decreased IQ when treated with cytarabine, doxorubicin, leucovorin, methotrexate, prednisone and vincristine in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to",
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*4","[['atomoxetine', '(PA134688071)']]",dose reduction to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1799945,"[['epoetin', 'alfa', '(PA10072)'], ['iron', '(PA450087)']]",decreased risk of,
rs1799945,"[['HFE', '(PA29263)']]",belongs to,
rs1800562,"[['epoetin', 'alfa', '(PA10072)'], ['iron', '(PA450087)']]",decreased risk of,
rs1800562,"[['HFE', '(PA29263)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)']]",increased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)']]","increased aminotransferase activity when treated with methotrexate and prednisone in people with Arthritis, Rheumatoid as compared to",
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",decreased progression free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs9344,"[['methotrexate', '(PA450428)']]",decreased event free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1801394,"[['methotrexate', '(PA450428)']]","increased red blood cell folate when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs1801394,"[['FASTKD3', '(PA145148868)'], ['MTRR', '(PA31277)']]",belongs to,
rs2236225,"[['methotrexate', '(PA450428)']]","increased red blood cell folate when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs2236225,"[['MTHFD1', '(PA31236)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3789243,"[['antiepileptics', '(PA143485705)']]",increased risk of,
rs3789243,"[['ABCB1', '(PA267)']]",belongs to,
rs3789243,"[['antiepileptics', '(PA143485705)']]",increased risk of,
rs3789243,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['antiepileptics', '(PA143485705)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['antiepileptics', '(PA143485705)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs17602729,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs17602729,"[['AMPD1', '(PA24776)']]",belongs to,
rs2231142,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1801282,"[['olanzapine', '(PA450688)']]",increased Weight gain when treated with olanzapine in people with Schizophrenia as compared to,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs5443,"[['Thiazides,', 'plain', '(PA164713347)']]",increased risk of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs730012,"[['aspirin', '(PA448497)']]",increased risk of,
rs730012,"[['LTC4S', '(PA235)']]",belongs to,
rs5186,"[['Thiazides,', 'plain', '(PA164713347)']]",increased risk of,
rs5186,"[['AGTR1', '(PA43)']]",belongs to,
rs28364072,"[['budesonide', '(PA448681)']]",severe exacerbations with asthma when treated with budesonide in people with Asthma as compared to,
rs28364072,"[['FCER2', '(PA28058)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs2277869,"[['RAD52', '(PA34180)'], ['WNK1', '(PA33782)']]",belongs to,
rs4149601,"[['NEDD4L', '(PA31534)']]",belongs to,
rs2854117,"[['protease', 'inhibitors', '(PA451159)']]",decreased severity of,
rs2854117,"[['APOC3', '(PA53)']]",belongs to,
rs2854116,"[['protease', 'inhibitors', '(PA451159)']]",decreased severity of,
rs2854116,"[['APOC3', '(PA53)']]",belongs to,
rs2231142,"[['pazopanib', '(PA165291492)'], ['simvastatin', '(PA451363)']]",increased likelihood of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",decreased reduction in ambulatory SBP when treated with hydrochlorothiazide in men with Hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4961,"[['Thiazides,', 'plain', '(PA164713347)']]",decreased risk of,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in mean blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
CYP2D6*3,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*57:01:01,"[['pazopanib', '(PA165291492)']]",increased likelihood of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1126647,"[['pazopanib', '(PA165291492)']]","decreased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs1126647,"[['CXCL8', '(PA29841)']]",belongs to,
rs1109374,"[['AK4', '(PA165750325)']]",belongs to,
rs12126638,"[['USH2A', '(PA37228)']]",belongs to,
rs5128,"[['ritonavir', '(PA451260)']]",increased triglyceride levels when treated with ritonavir in people with HIV as compared to,
rs5128,"[['APOC3', '(PA53)']]",belongs to,
rs34116584,"[['AGXT', '(PA24633)']]",belongs to,
rs121913459,"[['dasatinib', '(PA162372878)']]",increased likelihood of,
rs121913459,"[['ABL1', '(PA24413)']]",belongs to,
rs1801131,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs659734,"[['HTR2A', '(PA193)']]",belongs to,
rs1050828,"[['artesunate', '(PA165111697)'], ['chlorproguanil', '(PA165857067)'], ['dapsone', '(PA449211)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs20417,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['aspirin', '(PA448497)']]",decreased risk of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs12208357,"[['metformin', '(PA450395)']]","increased bioavailability (AUC, CL & AUC/CL ratio) when exposed to",
rs12208357,"[['SLC22A1', '(PA329)']]",belongs to,
rs34059508,"[['metformin', '(PA450395)']]",increased bioavailability when exposed to,
rs34059508,"[['SLC22A1', '(PA329)']]",belongs to,
rs2296840,"[['PSMB4', '(PA33886)']]",belongs to,
rs17244587,"[['TBX21', '(PA36362)']]",belongs to,
rs2125739,"[['nevirapine', '(PA450616)']]",increased likelihood of,
rs2125739,"[['ABCC10', '(PA24392)']]",belongs to,
rs539748,"[['HTR2C', '(PA194)']]",belongs to,
rs1440451,"[['HTR5A', '(PA29558)']]",belongs to,
rs3800373,"[['FKBP5', '(PA28162)']]",belongs to,
rs1360780,"[['FKBP5', '(PA28162)']]",belongs to,
rs680244,"[['CHRNA5', '(PA26491)']]",belongs to,
rs569207,"[['CHRNA5', '(PA26491)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs578776,"[['CHRNA3', '(PA113)'], ['CHRNA5', '(PA26491)']]",belongs to,
HLA-C*03:02,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
rs7851395,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]","increased overall survival when treated with carboplatin or cisplatin in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs7851395,"[['SLC31A1', '(PA118)']]",belongs to,
rs2032583,"[['citalopram', '(PA449015)'], ['fluvoxamine', '(PA449690)'], ['paroxetine', '(PA450801)'], ['sertraline', '(PA451333)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2032583,"[['ABCB1', '(PA267)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1045642,"[['cyclosporine', '(PA449167)']]",increased severity of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3110697,"[['fluorouracil', '(PA128406956)']]",better survival outcome when treated with fluorouracil in people with Stomach Neoplasms as compared to,
rs3110697,"[['IGFBP3', '(PA29705)']]",belongs to,
rs2854746,"[['fluorouracil', '(PA128406956)']]",better survival outcome when treated with fluorouracil in people with Stomach Neoplasms as compared to,
rs2854746,"[['IGFBP3', '(PA29705)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs11240688,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in SBP when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs11240688,"[['REN', '(PA297)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2740574,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs12762549,"[['docetaxel', '(PA449383)']]",increased risk of,
rs12762549,"[['ABCC2', '(PA116)']]",belongs to,
rs11045585,"[['docetaxel', '(PA449383)']]",increased risk of,
rs11045585,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs3213207,"[['DTNBP1', '(PA27512)']]",belongs to,
rs135550,"[['fenofibrate', '(PA449594)']]",increased reduction in fasting LDL-C when treated with fenofibrate as compared to,
rs135550,"[['PPARA', '(PA280)']]",belongs to,
rs2619539,"[['DTNBP1', '(PA27512)']]",belongs to,
rs3213207,"[['DTNBP1', '(PA27512)']]",belongs to,
rs2619538,"[['DTNBP1', '(PA27512)']]",belongs to,
rs6721498,"[['nicotine', '(PA450626)']]","smoking quantity, heaviness of",
rs6721498,"[['NRXN1', '(PA31786)']]",belongs to,
rs2193225,"[['nicotine', '(PA450626)']]","smoking quantity, heaviness of",
rs2193225,"[['NRXN1', '(PA31786)']]",belongs to,
rs2193225,"[['nicotine', '(PA450626)']]",smoking quantity when exposed to,
rs2193225,"[['NRXN1', '(PA31786)']]",belongs to,
rs2948694,"[['ethanol', '(PA448073)']]",weight when exposed to,
rs2948694,"[['GHSR', '(PA28677)']]",belongs to,
rs4149056,"[['cerivastatin', '(PA448897)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2819742,"[['cerivastatin', '(PA448897)']]",decreased risk of,
rs2819742,"[['RYR2', '(PA300)']]",belongs to,
rs2237895,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs2237895,"[['KCNQ1', '(PA223)']]",belongs to,
rs1045642,"[['tacrolimus', '(PA451578)']]","increased success rate in achieving short-term remission when treated with tacrolimus in people with Colitis, Ulcerative as compared to",
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['tacrolimus', '(PA451578)']]","increased success rate in achieving short-term remission when treated with tacrolimus in people with Colitis, Ulcerative as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1451371,"[['DDC', '(PA140)']]",belongs to,
rs3735273,"[['DDC', '(PA140)']]",belongs to,
rs921451,"[['DDC', '(PA140)']]",belongs to,
rs4655226,"[['gemcitabine', '(PA449748)']]",increased elimination clearance of,
rs4655226,"[['CDA', '(PA98)']]",belongs to,
rs532545,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs3215400,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1801019,"[['leucovorin', '(PA450198)'], ['tegafur', '(PA452620)']]",increased severity of,
rs1801019,"[['UMPS', '(PA363)']]",belongs to,
rs1801019,"[['leucovorin', '(PA450198)'], ['tegafur', '(PA452620)']]",increased likelihood of,
rs1801019,"[['UMPS', '(PA363)']]",belongs to,
rs1801394,"[['leucovorin', '(PA450198)'], ['tegafur', '(PA452620)']]",increased severity of,
rs1801394,"[['FASTKD3', '(PA145148868)'], ['MTRR', '(PA31277)']]",belongs to,
rs1801133,"[['cyclophosphamide', '(PA449165)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1042522,"[['cyclophosphamide', '(PA449165)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs10497338,"[['STK39', '(PA38243)']]",belongs to,
rs2297595,"[['fluorouracil', '(PA128406956)']]",Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs301435,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased severity of,
rs301435,"[['SLC1A1', '(PA35826)']]",belongs to,
rs121434569,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased acquired resistance when treated with erlotinib or gefitinib in lung adenocarcinoma patients as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs852977,"[['antidepressants', '(PA452229)']]",increased antidepressant response when exposed to,
rs852977,"[['NR3C1', '(PA181)']]",belongs to,
rs1799853,"[['phenytoin', '(PA450947)']]",increased plasma free phenytoin concentration when treated with phenytoin in people with Epilepsy as compared to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs6545803,"[['nevirapine', '(PA450616)']]",increased risk of,
rs9461684,"[['nevirapine', '(PA450616)']]",increased risk of,
rs9461684,"[['HLA-C', '(PA35057)']]",belongs to,
rs1057910,"[['phenytoin', '(PA450947)']]",increased plasma free phenytoin concentration when treated with phenytoin in people with Epilepsy as compared to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs2229107,"[['phenytoin', '(PA450947)']]",increased plasma drug levels of,
rs2229107,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['phenytoin', '(PA450947)']]",increased plasma drug levels of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['phenytoin', '(PA450947)']]",increased plasma drug levels of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799853,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs9626730,"[['fenofibrate', '(PA449594)']]",decreased reduction in fasting IL-2 when treated with fenofibrate as compared to,
rs9626730,"[['PPARA', '(PA280)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs10482633,"[['NR3C1', '(PA181)']]",belongs to,
rs9316233,"[['escitalopram', '(PA10074)']]",increased antidepressant response when treated with escitalopram in people with Depressive Disorder as compared to,
rs9316233,"[['HTR2A', '(PA193)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased nortriptyline/(E)-10-OH-NT ratio when treated with amitriptyline as compared to,['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased amitriptyline/(E)-10- OH-AT ratio when treated with amitriptyline as compared to,['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
HLA-C*08:01,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1048977,"[['gemcitabine', '(PA449748)']]",increased elimination clearance of,
rs1048977,"[['CDA', '(PA98)']]",belongs to,
rs35694136,"[['theophylline', '(PA451647)']]",increased severity of,
rs35694136,"[['CYP1A2', '(PA27093)']]",belongs to,
rs35694136,"[['theophylline', '(PA451647)']]","decreased plasma drug levels when treated with theophylline in people with Pulmonary Disease, Chronic Obstructive as compared to",
rs35694136,"[['CYP1A2', '(PA27093)']]",belongs to,
rs35694136,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs1044457,"[['gemcitabine', '(PA449748)']]",decreased formation clearance of,
rs1044457,"[['CMPK1', '(PA162382539)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-DRB1*01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs3780126,"[['bevacizumab', '(PA130232992)'], ['pemetrexed', '(PA10810)']]",increased overall survival when treated with bevacizumab and pemetrexed in people with Lung Neoplasms as compared to,
rs3780126,"[['GGH', '(PA432)']]",belongs to,
rs11545077,"[['bevacizumab', '(PA130232992)'], ['pemetrexed', '(PA10810)']]",increased overall survival when treated with bevacizumab and pemetrexed in people with Lung Neoplasms as compared to,
rs11545077,"[['GGH', '(PA432)']]",belongs to,
rs762551,"[['chlorpromazine', '(PA448964)']]",increased QT interval when treated with chlorpromazine in people with Schizophrenia as compared to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['antipsychotics', '(PA452233)'], ['chlorpromazine', '(PA448964)'], ['fluphenazine', '(PA449676)'], ['thioridazine', '(PA451666)'], ['trifluoperazine', '(PA451771)']]","increased QT interval when treated with antipsychotics, chlorpromazine, fluphenazine, thioridazine and trifluoperazine in people with Schizophrenia as compared to",
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2069514,"[['CYP1A2', '(PA27093)']]",belongs to,
rs1051298,"[['bevacizumab', '(PA130232992)'], ['pemetrexed', '(PA10810)']]",increased progression-free survival when treated with bevacizumab and pemetrexed in people with Lung Neoplasms as compared to,
rs1051298,"[['SLC19A1', '(PA327)']]",belongs to,
rs5443,"[['diuretics', '(PA151249535)']]",increased reduction in SBP when treated with diuretics in people with Hypertension as compared to,
rs5443,"[['CDCA3', '(PA26276)'], ['GNB3', '(PA176)'], ['USP5', '(PA37253)']]",belongs to,
"SLCO1B1*15, SLCO1B1*1A, SLCO1B1*1B, SLCO1B1*5","[['repaglinide', '(PA451234)']]",decreased repaglinide exposure (decreased AUC and increased clearance) when exposed to,
"SLCO1B1*15, SLCO1B1*1A, SLCO1B1*1B, SLCO1B1*5","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs2228622,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
rs2228622,"[['SLC1A1', '(PA35826)']]",belongs to,
rs3780413,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
rs3780413,"[['SLC1A1', '(PA35826)']]",belongs to,
rs3780412,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
rs3780412,"[['SLC1A1', '(PA35826)']]",belongs to,
rs762551,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2069514,"[['clozapine', '(PA449061)']]",increased likelihood of,
rs2069514,"[['CYP1A2', '(PA27093)']]",belongs to,
rs35694136,"[['clozapine', '(PA449061)']]",increased likelihood of,
rs35694136,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
"CYP2B6*1, CYP2B6*18, CYP2B6*6","[['nevirapine', '(PA450616)']]",increased likelihood of,
"CYP2B6*1, CYP2B6*18, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs2562519,"[['nevirapine', '(PA450616)']]",increased risk of,
rs2562519,"[['POLR3G', '(PA134986024)']]",belongs to,
rs130072,"[['nevirapine', '(PA450616)']]",increased risk of,
rs130072,"[['CCHCR1', '(PA134942738)']]",belongs to,
rs1805054,"[['HTR6', '(PA29560)']]",belongs to,
rs1891311,"[['HTR7', '(PA29561)']]",belongs to,
CYP2D6 extensive metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs5996696,"[['ADORA2A', '(PA24584)']]",belongs to,
rs71651683,"[['ADORA2A', '(PA24584)']]",belongs to,
rs762551,"[['caffeine', '(PA448710)']]",decreased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2470890,"[['caffeine', '(PA448710)']]",decreased risk of,
rs2470890,"[['CYP1A2', '(PA27093)']]",belongs to,
rs1045642,"[['clozapine', '(PA449061)']]",increased plasma concentrations of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs4244285,"[['clozapine', '(PA449061)']]",increased plasma concentrations of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4646425,"[['paroxetine', '(PA450801)']]",decreased likelihood of,
rs4646425,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2472304,"[['paroxetine', '(PA450801)']]",increased likelihood of,
rs2472304,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2470890,"[['paroxetine', '(PA450801)']]",increased likelihood of,
rs2470890,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4646427,"[['paroxetine', '(PA450801)']]","slower response time when treated with paroxetine in people with Depressive Disorder, Major as compared to",
rs4646427,"[['CYP1A2', '(PA27093)']]",belongs to,
rs135543,"[['fenofibrate', '(PA449594)']]",increased reduction in fasting LDL-C when treated with fenofibrate as compared to,
rs135543,"[['PPARA', '(PA280)']]",belongs to,
rs762551,"[['paroxetine', '(PA450801)']]",increased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4244285,"[['leflunomide', '(PA450192)']]",increased oral clearance of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs3215133,"[['ARNT', '(PA24994)']]",belongs to,
rs2228099,"[['ARNT', '(PA24994)']]",belongs to,
rs12410394,"[['ARNT', '(PA24994)']]",belongs to,
rs2470890,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4886410,"[['CSK', '(PA26946)']]",belongs to,
rs2306719,"[['topiramate', '(PA451728)'], ['zonisamide', '(PA451978)']]",decreased serum bicarbonate levels when treated with topiramate and zonisamide as compared to,
rs2306719,"[['CA12', '(PA25987)']]",belongs to,
rs4984241,"[['topiramate', '(PA451728)'], ['zonisamide', '(PA451978)']]",decreased serum bicarbonate levels when treated with topiramate and zonisamide as compared to,
rs4984241,"[['CA12', '(PA25987)']]",belongs to,
rs3087879,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased severity of,
rs3087879,"[['SLC1A1', '(PA35826)']]",belongs to,
rs301434,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased severity of,
rs301434,"[['SLC1A1', '(PA35826)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs9340799,"[['ESR1', '(PA156)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs11568695,"[['indinavir', '(PA449977)'], ['lamivudine', '(PA450163)'], ['zidovudine', '(PA451954)']]","increased median zidovudine-triphosphate concentration at a marginally significance after gender adjustment when treated with indinavir, lamivudine and zidovudine in people with HIV as compared to",
rs11568695,"[['ABCC4', '(PA397)']]",belongs to,
rs4880,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased likelihood of,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs4880,"[['Analgesics', 'and', 'anesthetics', '(PA164712363)'], ['Antibiotics', '(PA164712406)'], ['antiepileptics', '(PA143485705)'], ['Antifungals', 'For', 'Systemic', 'Use', '(PA164712435)'], ['antiinflammatory', 'and', 'antirheumatic', 'products,', 'non-steroids', '(PA10384)'], ['Antimycobacterials', '(PA164712471)'], ['Antithyroid', 'Preparations', '(PA164712499)']]",increased risk of,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs2740574,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]","decreased disease free survival when treated with cyclophosphamide, doxorubicin and fluorouracil in people with Breast Neoplasms as compared to",
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]","decreased disease free survival when treated with cyclophosphamide, doxorubicin and fluorouracil in people with Breast Neoplasms as compared to",
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs13181,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]","increased progression-free survival when treated with fluorouracil, leucovorin and oxaliplatin in people with Colorectal Neoplasms as compared to",
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs10912675,"[['nicotine', '(PA450626)']]",increased risk of,
rs10912675,"[['FMO1', '(PA165)']]",belongs to,
rs7877,"[['nicotine', '(PA450626)']]",increased risk of,
rs7877,"[['FMO1', '(PA165)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",smoking cessation when treated with nicotine in people with Depression as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs518147,"[['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['iloperidone', '(PA161199368)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)'], ['ziprasidone', '(PA451974)']]",increased risk of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs6166,"[['follitropin', 'beta', '(PA449693)'], ['thyrotropin', 'alfa', '(PA164746560)'], ['urofollitropin', '(PA451835)']]",good response to,
rs6166,"[['FSHR', '(PA28386)']]",belongs to,
rs4149056,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs4149015,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs4149015,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149117,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1128503,"[['capecitabine', '(PA448771)']]",decreased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['fluorouracil', '(PA128406956)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['capecitabine', '(PA448771)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs5030868,"[['G6PD', '(PA28469)'], ['IKBKG', '(PA29777)']]",belongs to,
rs1059829,"[['SPARC', '(PA36055)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1050828,"[['chlorproguanil', '(PA165857067)'], ['dapsone', '(PA449211)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs6277,"[['DRD2', '(PA27478)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs10895256,"[['etoposide', '(PA449552)'], ['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs10895256,"[['YAP1', '(PA38103)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1065776,"[['P2RY1', '(PA32868)']]",belongs to,
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
rs6721961,"[['estradiol', '(PA449503)']]",increased risk of,
rs6721961,"[['NFE2L2', '(PA31588)']]",belongs to,
rs5030868,"[['G6PD', '(PA28469)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['primaquine', '(PA451103)']]",Hemolysis when exposed to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs2207396,"[['Alkylating', 'Agents', '(PA164712331)'], ['cisplatin', '(PA449014)']]",increased risk of,
rs2207396,"[['ESR1', '(PA156)']]",belongs to,
rs1045642,"[['antiepileptics', '(PA143485705)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['antiepileptics', '(PA143485705)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['antiepileptics', '(PA143485705)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['antiepileptics', '(PA143485705)'], ['carbamazepine', '(PA448785)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['antiepileptics', '(PA143485705)'], ['carbamazepine', '(PA448785)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3789243,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2235048,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1186746,"[['ABCB1', '(PA267)']]",belongs to,
rs1186745,"[['ABCB1', '(PA267)']]",belongs to,
rs1633021,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
rs4410790,"[['caffeine', '(PA448710)']]",habitual consumption of,
rs2470893,"[['caffeine', '(PA448710)']]",habitual consumption of,
rs2470893,"[['CYP1A1', '(PA27092)']]",belongs to,
rs9272105,"[['interferon', 'beta-1a', '(PA450037)'], ['interferon', 'beta-1b', '(PA450039)']]",increased anti-IFN-beta antibodies when treated with interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to,
rs9272105,"[['HLA-DQA1', '(PA35066)']]",belongs to,
rs4961252,"[['interferon', 'beta-1a', '(PA450037)'], ['interferon', 'beta-1b', '(PA450039)']]",increased anti-IFN-beta antibodies when treated with interferon beta-1a and interferon beta-1b in people with Multiple Sclerosis as compared to,
rs716274,"[['etoposide', '(PA449552)'], ['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs716274,"[['DYNC2H1', '(PA27433)']]",belongs to,
rs3812718,"[['lamotrigine', '(PA450164)']]",increased tonic block of,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
rs316019,"[['metformin', '(PA450395)'], ['trimethoprim', '(PA451788)']]",lack of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs1801131,"[['cisplatin', '(PA449014)'], ['pemetrexed', '(PA10810)']]",decreased overall survival when treated with cisplatin and pemetrexed in people with Stomach Neoplasms as compared to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['escitalopram', '(PA10074)']]",increased relative dose-adjusted serum concentrations of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs10929302,"[['irinotecan', '(PA450085)']]",increased risk of,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs4124874,"[['irinotecan', '(PA450085)']]",increased risk of,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs1800566,"[['benzene', '(PA451991)']]",increased risk of,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs762551,"[['caffeine', '(PA448710)']]",decreased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs34717272,"[['RGS2', '(PA34372)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",decreased absolute neutrophil count when treated with irinotecan in people with Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['tranilast', '(PA131890628)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1801030,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1801030,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs9282861,"[['conjugated', 'estrogens', '(PA164754789)']]",increased likelihood of,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1048943,"[['CYP1A1', '(PA27092)']]",belongs to,
rs3736599,"[['SULT1E1', '(PA340)']]",belongs to,
rs11039149,"[['atenolol', '(PA448499)'], ['verapamil', '(PA451868)']]",decreased risk of,
rs11039149,"[['NR1H3', '(PA31751)']]",belongs to,
rs12221497,"[['verapamil', '(PA451868)']]",decreased risk of,
rs12221497,"[['NR1H3', '(PA31751)']]",belongs to,
rs2279238,"[['verapamil', '(PA451868)']]",increased risk of,
rs2279238,"[['NR1H3', '(PA31751)']]",belongs to,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs1059829,"[['antineoplastic', 'agents', '(PA452621)'], ['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",increased time to,
rs1059829,"[['SPARC', '(PA36055)']]",belongs to,
rs2738466,"[['pravastatin', '(PA451089)']]",increased risk of,
rs2738466,"[['LDLR', '(PA227)']]",belongs to,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs2072671,"[['gemcitabine', '(PA449748)']]",increased severity of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs2032582,"[['atorvastatin', '(PA448500)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2066853,"[['AHR', '(PA24641)']]",belongs to,
CYP2A6 poor metabolizer genotype,"[['nicotine', '(PA450626)']]",decreased ratio of,
CYP2A6 poor metabolizer genotype,"[['CYP2A6', '(PA121)']]",belongs to,
rs2066853,"[['AHR', '(PA24641)']]",belongs to,
rs2066853,"[['AHR', '(PA24641)']]",belongs to,
rs1800566,"[['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]","decreased overall survival when treated with cisplatin and etoposide in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs7626962,"[['SCN5A', '(PA304)']]",belongs to,
rs7626962,"[['SCN5A', '(PA304)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs2072660,"[['varenicline', '(PA164781343)']]",increased severity of,
rs2072660,"[['CHRNB2', '(PA115)']]",belongs to,
rs2072661,"[['varenicline', '(PA164781343)']]",increased severity of,
rs2072661,"[['CHRNB2', '(PA115)']]",belongs to,
rs4292956,"[['varenicline', '(PA164781343)']]",increased severity of,
rs4292956,"[['CHRNB2', '(PA115)']]",belongs to,
rs2302764,"[['varenicline', '(PA164781343)']]",increased severity of,
rs2302764,"[['CHRNB1', '(PA26494)'], ['ZBTB4', '(PA134959224)']]",belongs to,
rs9895420,"[['methotrexate', '(PA450428)']]",decreased event free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs9895420,"[['ABCC3', '(PA376)']]",belongs to,
rs9895420,"[['methotrexate', '(PA450428)']]",increased plasma levels of,
rs9895420,"[['ABCC3', '(PA376)']]",belongs to,
rs9895420,"[['methotrexate', '(PA450428)']]",increased risk of,
rs9895420,"[['ABCC3', '(PA376)']]",belongs to,
rs9895420,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs9895420,"[['ABCC3', '(PA376)']]",belongs to,
rs1801253,"[['metoprolol', '(PA450480)']]",increased likelihood of,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs1801252,"[['metoprolol', '(PA450480)']]",increased likelihood of,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs757110,"[['ABCC8', '(PA24395)'], ['KCNJ11', '(PA217)']]",belongs to,
rs1805123,"[['KCNH2', '(PA212)']]",belongs to,
rs3807375,"[['KCNH2', '(PA212)']]",belongs to,
rs1805123,"[['KCNH2', '(PA212)']]",belongs to,
rs1805123,"[['KCNH2', '(PA212)']]",belongs to,
rs36210421,"[['KCNH2', '(PA212)']]",belongs to,
rs3815459,"[['KCNH2', '(PA212)']]",belongs to,
rs757092,"[['KCNQ1', '(PA223)']]",belongs to,
rs3815459,"[['KCNH2', '(PA212)']]",belongs to,
rs1805123,"[['KCNH2', '(PA212)']]",belongs to,
rs757092,"[['KCNQ1', '(PA223)']]",belongs to,
rs727957,"[['KCNE1', '(PA211)']]",belongs to,
rs1805123,"[['KCNH2', '(PA212)']]",belongs to,
rs3807375,"[['KCNH2', '(PA212)']]",belongs to,
rs72554665,"[['G6PD', '(PA28469)']]",belongs to,
rs3814055,"[['cyclosporine', '(PA449167)']]",decreased bioavailabilty of,
rs3814055,"[['NR1I2', '(PA378)']]",belongs to,
rs2276707,"[['cyclosporine', '(PA449167)']]",decreased bioavailability of,
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs2276707,"[['cyclosporine', '(PA449167)']]",increased bioavailability of,
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs3814055,"[['rifampin', '(PA451250)']]",increased erythromycin breath test when treated with rifampin as compared to,
rs3814055,"[['NR1I2', '(PA378)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",increased Anxiety Disorders when exposed to,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",increased likelihood of,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",increased likelihood of,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",decreased habitual consumption of,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",increased anxiety when exposed to,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2298383,"[['caffeine', '(PA448710)']]",increased anxiety when exposed to,
rs2298383,"[['ADORA2A', '(PA24584)']]",belongs to,
rs4822492,"[['caffeine', '(PA448710)']]",increased anxiety when exposed to,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs3032740,"[['ADORA2A', '(PA24584)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs35694136,"[['CYP1A2', '(PA27093)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs1110976,"[['caffeine', '(PA448710)']]",decreased anxiety when exposed to,
rs1110976,"[['DRD2', '(PA27478)']]",belongs to,
rs2472297,"[['CYP1A1', '(PA27092)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['itraconazole', '(PA450132)'], ['ketoconazole', '(PA450146)']]",decreased severity of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs5443,"[['Beta', 'Blocking', 'Agents', '(PA164712535)']]",decreased heart rate when treated with Beta Blocking Agents as compared to,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs5443,"[['Beta', 'Blocking', 'Agents', '(PA164712535)']]",decreased heart rate when treated with Beta Blocking Agents as compared to,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs5442,"[['GNB3', '(PA176)'], ['USP5', '(PA37253)']]",belongs to,
rs1544410,"[['alendronate', '(PA448082)']]",decreased serum osteocalcin when treated with alendronate in people with Osteoporosis as compared to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs2228001,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs2228001,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs2228001,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs4646425,"[['paroxetine', '(PA450801)']]","increased slower response time when treated with paroxetine in people with Depressive Disorder, Major as compared to",
rs4646425,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4646425,"[['paroxetine', '(PA450801)']]","increased slower response time when treated with paroxetine in people with Depressive Disorder, Major as compared to",
rs4646425,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4646427,"[['paroxetine', '(PA450801)']]","slower response time when treated with paroxetine in people with Depressive Disorder, Major as compared to",
rs4646427,"[['CYP1A2', '(PA27093)']]",belongs to,
HTR2C2--1--1,"[['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased risk of,
HTR2C2--1--1,"[['HTR2C', '(PA194)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs12208357,"[['tramadol', '(PA451735)']]",higher plasma concentrations of,
rs12208357,"[['SLC22A1', '(PA329)']]",belongs to,
rs34130495,"[['tramadol', '(PA451735)']]",increased plasma concentrations of,
rs34130495,"[['SLC22A1', '(PA329)']]",belongs to,
rs35167514,"[['tramadol', '(PA451735)']]",increased plasma concentrations of,
rs35167514,"[['SLC22A1', '(PA329)']]",belongs to,
rs4148977,"[['imatinib', '(PA10804)']]",increased imatinib clearance when treated with imatinib as compared to,
rs4148977,"[['SLCO1A2', '(PA328)']]",belongs to,
rs4148978,"[['imatinib', '(PA10804)']]",increased imatinib clearance when treated with imatinib as compared to,
rs4148978,"[['SLCO1A2', '(PA328)']]",belongs to,
rs3764043,"[['imatinib', '(PA10804)']]",decreased imatinib clearance when treated with imatinib as compared to,
rs3764043,"[['SLCO1A2', '(PA328)']]",belongs to,
rs4444903,"[['cetuximab', '(PA10040)']]",increased likelihood of,
rs4444903,"[['EGF', '(PA27664)']]",belongs to,
rs61764370,"[['ETFRF1', '(PA162394773)']]",belongs to,
rs1695,"[['doxorubicin', '(PA449412)']]",increased micronucleated binucleated cells when exposed to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased event-free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased event free survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs70991108,"[['methotrexate', '(PA450428)']]",increased risk of,
rs70991108,"[['DHFR', '(PA143)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased severity of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs10423928,"[['olanzapine', '(PA450688)']]",increased plasma insulin levels when treated with olanzapine in people with Schizophrenia as compared to,
rs10423928,"[['GIPR', '(PA28682)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased trough concentrations when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased trough levels of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased likelihood of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased glomerular filtration rate when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs6413432,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs676643,"[['HTR1D', '(PA29550)']]",belongs to,
rs3758987,"[['HTR3B', '(PA29556)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs28399433,"[['coumarin', '(PA134521193)'], ['nicotine', '(PA450626)']]",decreased expression of,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs28399434,"[['CYP2A6', '(PA121)']]",belongs to,
rs1799971,"[['alfentanil', '(PA448084)']]",increased plasma concentration when treated with alfentanil in people with Pain as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs6312,"[['HTR2A', '(PA193)']]",belongs to,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs28399435,"[['CYP2A6', '(PA121)']]",belongs to,
rs1065776,"[['aspirin', '(PA448497)']]",increased risk of,
rs1065776,"[['P2RY1', '(PA32868)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",increased area under the plasma concentration-time curve values when treated with atomoxetine in healthy individuals as compared to,"['*1/*1', '+', '*1/*10', '+', '*1/*2', '+', '*2/*10.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*10', '+', '*1/*2', '+', '*2/*10.']"
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs20417,"[['aspirin', '(PA448497)']]",increased risk of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['aspirin', '(PA448497)']]",decreased risk of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['aspirin', '(PA448497)']]",decreased risk of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs3782905,"[['VDR', '(PA37301)']]",belongs to,
rs1540339,"[['VDR', '(PA37301)']]",belongs to,
rs2239185,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs731236,"[['VDR', '(PA37301)']]",belongs to,
rs731236,"[['calcium', '(PA164712582)']]",increased risk of,
rs731236,"[['VDR', '(PA37301)']]",belongs to,
rs2228570,"[['calcitriol', '(PA448717)']]",increased risk of,
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs1057910,"[['valproic', 'acid', '(PA451846)']]",increased mean plasma drug concentrations of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased minimum plasma concentrations of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs7438284,"[['UGT2B7', '(PA361)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4244285,"[['nelfinavir', '(PA450606)']]",decreased likelihood of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['efavirenz', '(PA449441)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs776746,"[['CYP3A', '(PA27114)'], ['CYP3A5', '(PA131)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma exposure of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-B*35:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs4713916,"[['corticosteroids', '(PA10832)']]",increased likelihood of,
rs4713916,"[['FKBP5', '(PA28162)']]",belongs to,
rs4646421,"[['CYP1A1', '(PA27092)']]",belongs to,
rs2472299,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2070676,"[['CYP2E1', '(PA129)']]",belongs to,
rs8192766,"[['CYP2E1', '(PA129)']]",belongs to,
rs5751862,"[['SPECC1L', '(PA164718673)']]",belongs to,
rs5760405,"[['SPECC1L', '(PA164718673)']]",belongs to,
rs2298383,"[['caffeine', '(PA448710)']]",increased Anxiety Disorders when exposed to,
rs2298383,"[['ADORA2A', '(PA24584)']]",belongs to,
rs3761422,"[['caffeine', '(PA448710)']]",increased Anxiety Disorders when exposed to,
rs3761422,"[['ADORA2A', '(PA24584)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*17,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
rs562,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs562,"[['ABCC5', '(PA395)']]",belongs to,
rs425215,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs425215,"[['ABCG1', '(PA24408)']]",belongs to,
rs2306283,"[['irinotecan', '(PA450085)']]",decreased likelihood of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
HLA-C*03:02:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*03:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-A*33:03:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-A*33:03:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DRB1*01:02:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-B*58:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:10:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:10:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:02,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*58:02,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*02:10,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-C*02:10,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:02:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*13:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:19,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*15:19,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:27:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*15:27:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*27:09,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*27:09,"[['HLA-B', '(PA35056)']]",belongs to,
rs1126742,"[['CYP4A11', '(PA27118)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4693075,"[['atorvastatin', '(PA448500)'], ['rosuvastatin', '(PA134308647)']]",increased risk of,
rs4693075,"[['COQ2', '(PA142672084)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased ADP-stimulated platelet aggregation when treated with clopidogrel as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",High Platelet Reactivity (HPR) when treated with clopidogrel as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4426527,"[['AGXT', '(PA24633)']]",belongs to,
rs2267076,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2445142,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs2445142,"[['HSPG2', '(PA29537)']]",belongs to,
rs878949,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs878949,"[['HSPG2', '(PA29537)']]",belongs to,
rs2061051,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs2061051,"[['GABRG3', '(PA28502)']]",belongs to,
rs6702335,"[['bupropion', '(PA448687)'], ['nicotine', '(PA450626)']]",increased abstinence when treated with bupropion or nicotine in men with Tobacco Use Disorder as compared to,
rs6702335,"[['EPB41', '(PA27810)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs6311,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs1065852,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs762551,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2069514,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs2069514,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs6977820,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs2485914,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs2485914,"[['SMYD3', '(PA37972)']]",belongs to,
rs13181,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)'], ['ifosfamide', '(PA449964)'], ['methotrexate', '(PA450428)']]","increased event free survival when treated with cisplatin, doxorubicin, ifosfamide and methotrexate in people with Osteosarcoma as compared to",
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
"SLCO1B1*15, SLCO1B1*1A, SLCO1B1*1B, SLCO1B1*5","[['repaglinide', '(PA451234)']]",decreased repaglinide exposure (decreased AUC and increased clearance) when exposed to,
"SLCO1B1*15, SLCO1B1*1A, SLCO1B1*1B, SLCO1B1*5","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1799793,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)'], ['ifosfamide', '(PA449964)'], ['methotrexate', '(PA450428)']]","increased event free survival when treated with cisplatin, doxorubicin, ifosfamide and methotrexate in people with Osteosarcoma as compared to",
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs762551,"[['caffeine', '(PA448710)']]",increased likelihood of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['caffeine', '(PA448710)']]",increased likelihood of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs1695,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)']]",decreased severity of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
"CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A","[['docetaxel', '(PA449383)'], ['tegafur', '(PA452620)']]",decreased likelihood of,
"CYP2A6*1A, CYP2A6*4A","[['CYP2A6', '(PA121)']]",belongs to,
rs2273697,"[['antiepileptics', '(PA143485705)']]",increased probability of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2A6*1A, CYP2A6*1B1","[['nicotine', '(PA450626)']]",increased cigarettes per day due to,
"CYP2A6*1A, CYP2A6*1B1","[['CYP2A6', '(PA121)']]",belongs to,
rs1570360,"[['bevacizumab', '(PA130232992)'], ['irinotecan', '(PA450085)']]",decreased overall survival when treated with bevacizumab and irinotecan in people with Colorectal Neoplasms as compared to,
rs1570360,"[['VEGFA', '(PA37302)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
CYP2D6*3,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*6,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2A6*1A,"[['CYP2A6', '(PA121)']]",belongs to,
CYP2A6*1A,"[['CYP2A6', '(PA121)']]",belongs to,
"SLCO1B1*15, SLCO1B1*1A, SLCO1B1*1B, SLCO1B1*5","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs2472304,"[['caffeine', '(PA448710)']]",decreased risk of,
rs2472304,"[['CYP1A2', '(PA27093)']]",belongs to,
rs11125883,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
rs11125883,"[['XPO1', '(PA37418)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs3757241,"[['CYP39A1', '(PA38452)'], ['SLC25A27', '(PA134970102)']]",belongs to,
rs649446,"[['UCP2', '(PA37165)']]",belongs to,
rs5977250,"[['SLC25A14', '(PA35860)']]",belongs to,
rs130058,"[['clomipramine', '(PA449048)'], ['liothyronine', '(PA164778866)'], ['lithium', '(PA450243)'], ['nefazodone', '(PA450603)'], ['venlafaxine', '(PA451866)']]",decreased risk of,
rs130058,"[['HTR1B', '(PA29549)']]",belongs to,
rs1801133,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['gemcitabine', '(PA449748)'], ['paclitaxel', '(PA450761)'], ['vinorelbine', '(PA451881)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs9395206,"[['SLC25A27', '(PA134970102)']]",belongs to,
rs591758,"[['UCP2', '(PA37165)']]",belongs to,
rs1050828,"[['artesunate', '(PA165111697)'], ['primaquine', '(PA451103)'], ['pyrimethamine', '(PA451193)'], ['sulfadoxine', '(PA451540)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)'], ['IKBKG', '(PA29777)']]",belongs to,
rs532545,"[['cytarabine', '(PA449177)']]",increased Drug Toxicity when exposed to,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs2072671,"[['cytarabine', '(PA449177)']]",increased Drug Toxicity when treated with cytarabine as compared to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs9993633,"[['DCK', '(PA137)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs12145722,"[['gefitinib', '(PA131301952)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs2622604,"[['ABCG2', '(PA390)']]",belongs to,
rs2270450,"[['SLC25A27', '(PA134970102)'], ['TDRD6', '(PA134945900)']]",belongs to,
rs668514,"[['UCP3', '(PA37166)']]",belongs to,
rs6962291,"[['aspirin', '(PA448497)']]",decreased risk of,
rs6962291,"[['TBXAS1', '(PA349)']]",belongs to,
rs1360780,"[['clomipramine', '(PA449048)'], ['liothyronine', '(PA164778866)'], ['lithium', '(PA450243)'], ['nefazodone', '(PA450603)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased risk of,
rs1360780,"[['FKBP5', '(PA28162)']]",belongs to,
rs13181,"[['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",increased progression-free survival when treated with fluorouracil and oxaliplatin in people with Colorectal Neoplasms as compared to,
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
rs602950,"[['cytarabine', '(PA449177)']]",increased Drug Toxicity when treated with cytarabine as compared to,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs747199,"[['SLC29A1', '(PA154)']]",belongs to,
rs1056892,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs137852808,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased locomotor activity when treated with hmg coa reductase inhibitors as compared to,
rs137852808,"[['CHRNA1', '(PA26487)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2622604,"[['ABCG2', '(PA390)']]",belongs to,
rs2622604,"[['ABCG2', '(PA390)']]",belongs to,
rs10807344,"[['CYP39A1', '(PA38452)'], ['SLC25A27', '(PA134970102)']]",belongs to,
rs659366,"[['UCP2', '(PA37165)']]",belongs to,
rs586773,"[['UCP2', '(PA37165)']]",belongs to,
rs2235800,"[['SLC25A14', '(PA35860)']]",belongs to,
rs1050828,"[['artesunate', '(PA165111697)'], ['primaquine', '(PA451103)'], ['pyrimethamine', '(PA451193)'], ['sulfadoxine', '(PA451540)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)'], ['IKBKG', '(PA29777)']]",belongs to,
rs130058,"[['paroxetine', '(PA450801)']]",increased risk of,
rs130058,"[['HTR1B', '(PA29549)']]",belongs to,
rs660339,"[['UCP2', '(PA37165)']]",belongs to,
rs1010978,"[['SLC25A14', '(PA35860)']]",belongs to,
rs1360780,"[['paroxetine', '(PA450801)']]",increased risk of,
rs1360780,"[['FKBP5', '(PA28162)']]",belongs to,
rs1695,"[['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",increased overall survival when treated with fluorouracil and oxaliplatin in people with Colorectal Neoplasms as compared to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1048977,"[['CDA', '(PA98)']]",belongs to,
rs1042714,"[['carvedilol', '(PA448817)']]",increased reduction in resting blood pressure when treated with carvedilol in healthy individuals as compared to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs9024,"[['CBR1', '(PA26121)']]",belongs to,
rs2032582,"[['clomipramine', '(PA449048)'], ['liothyronine', '(PA164778866)'], ['lithium', '(PA450243)'], ['nefazodone', '(PA450603)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3215400,"[['cytarabine', '(PA449177)']]",increased Drug Toxicity when treated with cytarabine as compared to,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs9024,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs9024,"[['CBR1', '(PA26121)']]",belongs to,
rs1137101,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1137101,"[['LEPR', '(PA229)']]",belongs to,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs3813929,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs655717,"[['DNAJB13', '(PA142671972)'], ['UCP2', '(PA37165)']]",belongs to,
rs2239483,"[['SLC25A14', '(PA35860)']]",belongs to,
rs1137101,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs1137101,"[['LEPR', '(PA229)']]",belongs to,
rs9679162,"[['cisplatin', '(PA449014)'], ['fluorouracil', '(PA128406956)'], ['mitoxantrone', '(PA450526)']]",increased likelihood of,
rs9679162,"[['GALNT14', '(PA134920089)']]",belongs to,
rs9679162,"[['cisplatin', '(PA449014)'], ['fluorouracil', '(PA128406956)'], ['mitoxantrone', '(PA450526)']]","increased overall survival when treated with cisplatin, fluorouracil and mitoxantrone in people with Carcinoma, Hepatocellular as compared to",
rs9679162,"[['GALNT14', '(PA134920089)']]",belongs to,
rs27072,"[['SLC6A3', '(PA311)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",requirement for earlier dose reduction of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs3735451,"[['methadone', '(PA450401)']]",increased severity of,
rs3735451,"[['CYP3A4', '(PA130)']]",belongs to,
rs2242480,"[['methadone', '(PA450401)']]",increased severity of,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs4646437,"[['methadone', '(PA450401)']]",increased severity of,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs4834232,"[['LARP1B', '(PA165664174)']]",belongs to,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs1617640,"[['EPO', '(PA27833)']]",belongs to,
rs25489,"[['XRCC1', '(PA369)']]",belongs to,
rs1799782,"[['XRCC1', '(PA369)']]",belongs to,
"CYP1A2*1A, CYP1A2*1F","[['CYP1A2', '(PA27093)']]",belongs to,
rs2011425,"[['UGT1A4', '(PA37179)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1804645,"[['NCOA1', '(PA31470)']]",belongs to,
rs1804645,"[['tamoxifen', '(PA451581)']]",increased severity of,
rs1804645,"[['NCOA1', '(PA31470)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs4646440,"[['methadone', '(PA450401)']]",increased severity of,
rs4646440,"[['CYP3A4', '(PA130)']]",belongs to,
rs2246709,"[['methadone', '(PA450401)']]",increased severity of,
rs2246709,"[['CYP3A4', '(PA130)']]",belongs to,
rs4646440,"[['methadone', '(PA450401)']]",increased severity of,
rs4646440,"[['CYP3A4', '(PA130)']]",belongs to,
rs763780,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs763780,"[['IL17F', '(PA29800)']]",belongs to,
rs11062040,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs11062040,"[['DCP1B', '(PA134889143)']]",belongs to,
rs4785367,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs13181,"[['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['gemcitabine', '(PA449748)']]","decreased overall survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to",
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs12720067,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs12720067,"[['ABCB1', '(PA267)']]",belongs to,
rs1451371,"[['DDC', '(PA140)']]",belongs to,
rs490332,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs10736526,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs10736526,"[['UBASH3B', '(PA162407840)']]",belongs to,
rs179619,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs2246709,"[['methadone', '(PA450401)']]",decreased severity of,
rs2246709,"[['CYP3A4', '(PA130)']]",belongs to,
rs2242480,"[['methadone', '(PA450401)']]",increased severity of,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs3212986,"[['cisplatin', '(PA449014)']]",decreased likelihood of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs3735273,"[['DDC', '(PA140)']]",belongs to,
rs3744311,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs3735451,"[['methadone', '(PA450401)']]",increased severity of,
rs3735451,"[['CYP3A4', '(PA130)']]",belongs to,
rs13181,"[['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['gemcitabine', '(PA449748)']]","decreased progression-free survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to",
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs11615,"[['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['gemcitabine', '(PA449748)']]","decreased overall survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to",
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs3757472,"[['DDC', '(PA140)']]",belongs to,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs1804645,"[['tamoxifen', '(PA451581)']]",increased severity of,
rs1804645,"[['NCOA1', '(PA31470)']]",belongs to,
CYP2C19*2,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19*17,"[['clopidogrel', '(PA449053)']]",decreased likelihood of,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
rs814951,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs1808458,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs7712169,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs921451,"[['DDC', '(PA140)']]",belongs to,
rs10489997,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs10489997,"[['BAZ2B', '(PA25273)']]",belongs to,
rs1910236,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs306104,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs306104,"[['CAMK4', '(PA26050)']]",belongs to,
rs7771466,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs7771466,"[['IL17F', '(PA29800)']]",belongs to,
rs10883617,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs10883617,"[['BTRC', '(PA25465)']]",belongs to,
rs12361312,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs12361312,"[['MS4A2', '(PA31109)']]",belongs to,
rs2900174,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs2900174,"[['PRB2', '(PA33700)']]",belongs to,
rs2550731,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs2550731,"[['WWOX', '(PA37398)']]",belongs to,
rs7149097,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs11644322,"[['gemcitabine', '(PA449748)']]",decreased Median Overall Survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs11644322,"[['WWOX', '(PA37398)']]",belongs to,
rs10799754,"[['gefitinib', '(PA131301952)']]",increased risk of,
rs12718541,"[['DDC', '(PA140)']]",belongs to,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs1799732,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",increased likelihood of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs6280,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs10509373,"[['tamoxifen', '(PA451581)']]",decreased recurrence-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,
rs10509373,"[['LRMDA', '(PA134899373)']]",belongs to,
rs1045642,"[['oseltamivir', '(PA450721)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['oseltamivir', '(PA450721)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs11615,"[['cisplatin', '(PA449014)']]",decreased likelihood of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs7295250,"[['amiodarone', '(PA448383)'], ['Antibiotics', '(PA164712406)'], ['antipsychotics', '(PA452233)'], ['diuretics', '(PA151249535)'], ['quinidine', '(PA451209)'], ['sotalol', '(PA451457)']]",increased risk of,
rs7295250,"[['CACNA1C', '(PA83)']]",belongs to,
rs1801253,"[['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['carvedilol', '(PA448817)']]",significantly greater improvement in left ventricular ejection fraction (LVEF) when treated with Beta Blocking Agents and carvedilol in people with Heart Failure as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs1801253,"[['carvedilol', '(PA448817)']]",increased improvement in left ventricular function (LVEF) when treated with carvedilol in people with Heart Failure as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs12946454,"[['ACBD4', '(PA134897893)'], ['PLCD3', '(PA33389)']]",belongs to,
rs12946454,"[['diltiazem', '(PA449334)']]",increased reduction in blood pressure when treated with diltiazem in people with Hypertension as compared to,
rs12946454,"[['PLCD3', '(PA33389)']]",belongs to,
rs11191548,"[['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['Thiazides,', 'plain', '(PA164713347)']]","increased reduction in diastolic blood pressure when treated with Beta Blocking Agents or Thiazides, plain in people with Hypertension as compared to",
rs16998073,"[['FGF5', '(PA28122)']]",belongs to,
rs17367504,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
rs1530440,"[['CABCOCO1', '(PA134897916)']]",belongs to,
rs3184504,"[['SH2B3', '(PA145148124)']]",belongs to,
rs1378942,"[['CSK', '(PA26946)']]",belongs to,
rs16948048,"[['ZNF652', '(PA134896615)']]",belongs to,
rs1799998,"[['CYP11B2', '(PA134)']]",belongs to,
rs1799752,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in systolic blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs3745274,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2307424,"[['efavirenz', '(PA449441)']]",early (< 3 months) termination of,
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",early (< 3 months) termination of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4149081,"[['rosuvastatin', '(PA134308647)']]",increased LDL-C reduction when treated with rosuvastatin in people with Coronary Disease as compared to,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149081,"[['rosuvastatin', '(PA134308647)']]",increased LDL-C reduction when treated with rosuvastatin in people with Coronary Disease as compared to,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)']]",increased AUC when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1801253,"[['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['metoprolol', '(PA450480)']]",increased improvement in left ventricular(LV) remodeling and greater increase in LVEF (left ventricular ejection fraction) when treated with Beta Blocking Agents and metoprolol in people with Heart Failure as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs243865,"[['pamidronate', '(PA450767)'], ['zoledronate', '(PA10235)']]",increased likelihood of,
rs243865,"[['MMP2', '(PA30877)']]",belongs to,
rs242941,"[['fluticasone/salmeterol', '(PA165290926)']]","increased mean change in FEV when treated with fluticasone/salmeterol in people with Pulmonary Disease, Chronic Obstructive as compared to",
rs242941,"[['CRHR1', '(PA26874)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1799752,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in men with Essential hypertension as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2740574,"[['efavirenz', '(PA449441)']]",increased plasma efavirenz exposure when treated with efavirenz in people with HIV as compared to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs1045642,"[['dicloxacillin', '(PA164749649)'], ['probenecid', '(PA451106)']]",increased clearance of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs1800440,"[['CYP1B1', '(PA27094)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs12210538,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs12210538,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs17655,"[['platinum', '(PA150595617)']]",decreased survival when treated with platinum in women with Ovarian Neoplasms as compared to,
rs17655,"[['ERCC5', '(PA27851)']]",belongs to,
rs17091162,"[['antineoplastic', 'agents', '(PA452621)']]",decreased survival when treated with antineoplastic agents in people with Pancreatic Neoplasms as compared to,
rs17091162,"[['SERPINA3', '(PA35020)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",Death and Myelosuppression when treated with fluorouracil in people with Drug Toxicity as compared to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3215400,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs11075646,"[['capecitabine', '(PA448771)']]",increased time to,
rs11075646,"[['CES2', '(PA377)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs396991,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisolone', '(PA451096)'], ['rituximab', '(PA451261)'], ['vincristine', '(PA451879)']]","decreased progression free survival when treated with cyclophosphamide, doxorubicin, prednisolone, rituximab and vincristine in people with Lymphoma, B-Cell as compared to",
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs7311358,"[['docetaxel', '(PA449383)']]",increased AUC of,
rs7311358,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs2019604,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs2019604,"[['SPG7', '(PA36067)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",increased plasma nortriptyline when treated with amitriptyline in people with Mental Disorders as compared to,['*1.']
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs72552763,"[['metformin', '(PA450395)']]","decreased trough metformin steady-state concentration when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs72552763,"[['SLC22A1', '(PA329)']]",belongs to,
rs776746,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs37973,"[['glucocorticoids', '(PA452347)']]",increased likelihood of,
rs37973,"[['GLCCI1', '(PA38657)']]",belongs to,
rs307821,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs307821,"[['FLT4', '(PA28183)']]",belongs to,
rs2301149,"[['verapamil', '(PA451868)']]",decreased risk of,
rs2301149,"[['KCNIP1', '(PA30041)'], ['KCNMB1', '(PA221)']]",belongs to,
rs7997012,"[['venlafaxine', '(PA451866)']]",significantly better improvement (Clinical Global Impression of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased severity of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs11739136,"[['verapamil', '(PA451868)']]",earlier achievement of,
rs11739136,"[['KCNIP1', '(PA30041)'], ['KCNMB1', '(PA221)']]",belongs to,
rs7997012,"[['venlafaxine', '(PA451866)']]",increased significantly better response (Hamilton Anxiety Scale (HAM-A)) at 6 months of,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
rs307826,"[['sunitinib', '(PA162372840)']]","reduced progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs307826,"[['FLT4', '(PA28183)']]",belongs to,
rs3763980,"[['methotrexate', '(PA450428)']]",increased risk of,
rs3763980,"[['SLC16A7', '(PA35819)']]",belongs to,
rs5030655,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs5030655,"[['CYP2D6', '(PA128)']]",belongs to,
"UGT1A1*1, UGT1A1*27","[['irinotecan', '(PA450085)']]",increased severity of,
"UGT1A1*1, UGT1A1*27","[['UGT1A1', '(PA420)']]",belongs to,
"NAT2*7, NAT2*7A","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*7, NAT2*7A","[['NAT2', '(PA18)']]",belongs to,
rs1800566,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",worse outcome (overall survival and progression-free survival) when treated with cyclophosphamide and doxorubicin in people with Breast Neoplasms as compared to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs402007,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",the most benefit from statin treatment in reducing the risk of,
rs402007,"[['ADAMTS1', '(PA24536)']]",belongs to,
CYP2B6*1,"[['efavirenz', '(PA449441)']]",decreased plasma concentration of,
CYP2B6*1,"[['CYP2B6', '(PA123)']]",belongs to,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs6749447,"[['losartan', '(PA450268)']]",decreased reduction in ambulatory blood pressure when treated with losartan in men with Hypertension as compared to,
rs6749447,"[['STK39', '(PA38243)']]",belongs to,
rs4149081,"[['simvastatin', '(PA451363)']]",increased LDL-C reduction when treated with simvastatin in people with Coronary Disease as compared to,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149081,"[['simvastatin', '(PA451363)']]",increased LDL-C reduction when treated with simvastatin in people with Coronary Disease as compared to,
rs4149081,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs776746,"[['efavirenz', '(PA449441)']]",decreased plasma efavirenz exposure when treated with efavirenz in people with HIV as compared to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs746647,"[['nevirapine', '(PA450616)']]",increased risk of,
rs746647,"[['CCHCR1', '(PA134942738)']]",belongs to,
rs5723,"[['bumetanide', '(PA448682)'], ['furosemide', '(PA449719)'], ['torasemide', '(PA451733)']]",decreased 24-h excretion of,
rs5723,"[['SCNN1G', '(PA307)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs4516035,"[['VDR', '(PA37301)']]",belongs to,
rs4516035,"[['VDR', '(PA37301)']]",belongs to,
rs1885301,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs1885301,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['paclitaxel', '(PA450761)']]",increased severity of,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs1050450,"[['aspirin', '(PA448497)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['clopidogrel', '(PA449053)'], ['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs16890979,"[['SLC2A9', '(PA37771)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs7319981,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs7319981,"[['SLC10A2', '(PA318)']]",belongs to,
rs316019,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs17863783,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs17863783,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
"VKORC1*1, VKORC1*2","[['warfarin', '(PA451906)']]",decreased time to,
"VKORC1*1, VKORC1*2","[['VKORC1', '(PA133787052)']]",belongs to,
rs67376798,"[['tegafur', '(PA452620)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs714368,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs714368,"[['SLC22A16', '(PA134911502)']]",belongs to,
PIK3CA H4,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased likelihood of,
PIK3CA H4,"[['PIK3CA', '(PA33308)']]",belongs to,
PIK3CA H4,"[['PIK3CA', '(PA33308)']]",belongs to,
rs1799752,"[['enalapril', '(PA449456)']]",increased likelihood of,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs4149118,"[['docetaxel', '(PA449383)']]",increased AUC of,
rs4149118,"[['SLCO1B3', '(PA35844)']]",belongs to,
CYP2A6*27,"[['nicotine', '(PA450626)']]",decreased metabolism of,
CYP2A6*27,"[['CYP2A6', '(PA121)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs296766,"[['thiazolidinediones', '(PA452631)']]",increased risk of,
rs296766,"[['AQP2', '(PA24920)']]",belongs to,
rs12819210,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to,
rs12819210,"[['OASL', '(PA31879)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs7900194,"[['warfarin', '(PA451906)']]",warfarin variability when treated with warfarin as compared to,
rs7900194,"[['CYP2C9', '(PA126)']]",belongs to,
rs34399035,"[['metformin', '(PA450395)']]",decreased metformin uptake in HEK-293 cells and reduction in protein expression levels when exposed to,
rs34399035,"[['SLC47A2', '(PA162403847)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",non-remission when treated with antidepressants in people with Mood Disorders as compared to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele)', '+', 'HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'short', 'form', '(S', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele)', '+', 'HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'short', 'form', '(S', 'allele).']"
rs2298826,"[['haloperidol', '(PA449841)']]",motor side effects when treated with haloperidol in people with Schizophrenia as compared to,
rs2298826,"[['SLC6A5', '(PA35911)']]",belongs to,
rs2306168,"[['fexofenadine', '(PA449621)']]",decreased area under the plasma concentration-time curve when treated with fexofenadine in healthy individuals as compared to,
rs2306168,"[['SLCO2B1', '(PA35845)']]",belongs to,
rs3808607,"[['atorvastatin', '(PA448500)']]",increased mean percentage reduction of,
rs3808607,"[['CYP7A1', '(PA132)']]",belongs to,
rs9657182,"[['IDO1', '(PA29869)']]",belongs to,
rs9349256,"[['tenofovir', '(PA10204)']]",increased kidney tubular dysfunction when exposed to,
rs9349256,"[['ABCC10', '(PA24392)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs5729,"[['hydrochlorothiazide', '(PA449899)']]",decreased reduction in office diastolic blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs5729,"[['SCNN1G', '(PA307)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma efavirenz exposure (AUC) during the first 24 weeks of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs1042636,"[['CASR', '(PA26097)']]",belongs to,
rs2032582,"[['cyclosporine', '(PA449167)'], ['dicloxacillin', '(PA164749649)']]",increased clearance of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1517114,"[['irinotecan', '(PA450085)']]",increased severity of,
rs1517114,"[['C8orf34', '(PA142672353)']]",belongs to,
rs2745761,"[['irinotecan', '(PA450085)']]",increased severity of,
rs2745761,"[['PLCB1', '(PA33384)']]",belongs to,
rs11746641,"[['bupropion', '(PA448687)'], ['nicotine', '(PA450626)']]",increased likelihood of,
rs11746641,"[['DRD1', '(PA147)']]",belongs to,
NAT2*5D,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*5D,"[['NAT2', '(PA18)']]",belongs to,
rs1799983,"[['aspirin', '(PA448497)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['clopidogrel', '(PA449053)'], ['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs4713916,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs4713916,"[['FKBP5', '(PA28162)']]",belongs to,
rs4244285,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased survival when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
PIK3CA H5,"[['egfr', 'inhibitors', '(PA153561371)']]",increased likelihood of,
PIK3CA H5,"[['PIK3CA', '(PA33308)']]",belongs to,
rs2286455,"[['PROM1', '(PA33807)']]",belongs to,
rs729147,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs729147,"[['ADH7', '(PA24577)']]",belongs to,
rs1799971,"[['naltrexone', '(PA450588)']]",increased blunting of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)'], ['naltrexone', '(PA450588)']]",increased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
CYP2A6*1A,"[['CYP2A6', '(PA121)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1801131,"[['bevacizumab', '(PA130232992)'], ['cyanocobalamin', '(PA451892)'], ['folic', 'acid', '(PA449692)'], ['pemetrexed', '(PA10810)']]","increased overall survival when treated with bevacizumab, cyanocobalamin, folic acid and pemetrexed in people with Head and Neck Neoplasms as compared to",
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs2622604,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs2622604,"[['ABCG2', '(PA390)']]",belongs to,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
rs13273672,"[['Drugs', 'used', 'in', 'alcohol', 'dependence', '(PA164712718)']]",decreased time to,
rs13273672,"[['GATA4', '(PA28587)']]",belongs to,
rs4630,"[['GSTT1', '(PA183)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased plasma concentrations of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1127354,"[['interferon', 'alfa-2b,', 'recombinant', '(PA164783990)'], ['ribavirin', '(PA451241)']]","decreased hemoglobin levels when treated with interferon alfa-2b, recombinant and ribavirin in people with Hepatitis C, Chronic as compared to",
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs10494366,"[['dolasetron', '(PA449390)'], ['granisetron', '(PA449809)']]",increased risk of,
rs10494366,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs2228479,"[['desipramine', '(PA449233)']]",increased likelihood of,
rs2228479,"[['MC1R', '(PA30673)']]",belongs to,
rs1042173,"[['ondansetron', '(PA450705)']]",increased treatment response among patients carrying the SLC6A4 promoter length polymorphism long/long genotype when treated with ondansetron in people with Alcoholism as compared to,
rs1042173,"[['SLC6A4', '(PA312)']]",belongs to,
rs1057868,"[['midazolam', '(PA450496)']]",increased metabolic ratio of,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs9657182,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)']]","increased Depression when treated with peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis C, Chronic as compared to",
rs9657182,"[['IDO1', '(PA29869)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs1979277,"[['bevacizumab', '(PA130232992)'], ['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","increased progression-free survival (PFS) (P=0.00004) and overall survival (OS) (P=0.034) when treated with bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs1979277,"[['SHMT1', '(PA35753)']]",belongs to,
rs6318,"[['escitalopram', '(PA10074)']]",decreased Pain when treated with escitalopram in men with neuropathic pain as compared to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs12806698,"[['gemcitabine', '(PA449748)'], ['Platinum', 'compounds', '(PA164713176)']]",decreased likelihood of,
rs12806698,"[['RRM1', '(PA298)']]",belongs to,
rs2242480,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs1127354,"[['methotrexate', '(PA450428)']]",response to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1799963,"[['F2', '(PA157)']]",belongs to,
rs5186,"[['irbesartan', '(PA450084)']]",blood pressure response when treated with irbesartan in people with Hypertension as compared to,
rs5186,"[['AGTR1', '(PA43)']]",belongs to,
"CYP2A6*1A, CYP2A6*7","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*7","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*9A","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*9A","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*20","[['nicotine', '(PA450626)']]",decreased metabolism of,
"CYP2A6*1A, CYP2A6*20","[['CYP2A6', '(PA121)']]",belongs to,
CYP2A6*26,"[['nicotine', '(PA450626)']]",decreased metabolism of,
CYP2A6*26,"[['CYP2A6', '(PA121)']]",belongs to,
rs3957357,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased likelihood of,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2168631,"[['bupropion', '(PA448687)'], ['nicotine', '(PA450626)']]",increased likelihood of,
rs2168631,"[['DRD1', '(PA147)']]",belongs to,
rs6600879,"[['methadone', '(PA450401)']]",increased severity of,
rs6600879,"[['UGT2B7', '(PA361)']]",belongs to,
rs6600880,"[['methadone', '(PA450401)']]",increased severity of,
rs6600880,"[['UGT2B7', '(PA361)']]",belongs to,
rs4554144,"[['methadone', '(PA450401)']]",increased severity of,
rs4554144,"[['UGT2B7', '(PA361)']]",belongs to,
rs11940316,"[['methadone', '(PA450401)']]",increased severity of,
rs11940316,"[['UGT2B7', '(PA361)']]",belongs to,
rs7438135,"[['methadone', '(PA450401)']]",increased severity of,
rs7438135,"[['UGT2B7', '(PA361)']]",belongs to,
rs7662029,"[['methadone', '(PA450401)']]",increased severity of,
rs7662029,"[['UGT2B7', '(PA361)']]",belongs to,
rs7668258,"[['methadone', '(PA450401)']]",increased severity of,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
rs12233719,"[['UGT2B7', '(PA361)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
rs4149056,"[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) and Cmax when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs5219,"[['metformin', '(PA450395)'], ['sulfonamides,', 'urea', 'derivatives', '(PA10390)']]",increased likelihood of,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
CYP2A6*9A,"[['nicotine', '(PA450626)']]",decreased metabolism of,
CYP2A6*9A,"[['CYP2A6', '(PA121)']]",belongs to,
rs28493229,"[['Immunoglobulins', '(PA164712817)']]",increased likelihood of,
rs28493229,"[['COQ8B', '(PA134988974)'], ['ITPKC', '(PA29977)']]",belongs to,
rs5751876,"[['caffeine', '(PA448710)']]",increased anxiety when exposed to,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
SLCO1B1*15,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['antiepileptics', '(PA143485705)']]",decreased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs151264360,"[['carboplatin', '(PA448803)'], ['gemcitabine', '(PA449748)']]",increased likelihood of,
rs174541,"[['FADS1', '(PA27973)'], ['FEN1', '(PA28090)'], ['MIR611', '(PA164722907)'], ['TMEM258', '(PA25478)']]",belongs to,
rs1149222,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs1149222,"[['ABCB4', '(PA268)']]",belongs to,
rs10426377,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs10426377,"[['SULT2B1', '(PA36249)']]",belongs to,
CYP3A4*1B,"[['erlotinib', '(PA134687924)']]",decreased likelihood of,
CYP3A4*1B,"[['CYP3A4', '(PA130)']]",belongs to,
rs1128503,"[['digoxin', '(PA449319)']]",increased serum concentrations of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['atorvastatin', '(PA448500)']]",increased AUC of,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2032582,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased survival when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2847153,"[['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs2847153,"[['TYMS', '(PA359)']]",belongs to,
"CYP3A4*1, CYP3A4*18B","[['cyclosporine', '(PA449167)']]",increased risk of,
"CYP3A4*1, CYP3A4*18B","[['CYP3A4', '(PA130)']]",belongs to,
rs2072671,"[['gemcitabine', '(PA449748)'], ['Platinum', 'compounds', '(PA164713176)']]",increased likelihood of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased tacrolimus concentration to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2740574,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs13181,"[['cisplatin', '(PA449014)']]",increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs3212986,"[['cisplatin', '(PA449014)']]",increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs2281617,"[['amphetamine', '(PA448408)']]",increased Euphoric and Energetic after amphetamine (10 mg) when exposed to,
rs2281617,"[['OPRM1', '(PA31945)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs510769,"[['amphetamine', '(PA448408)']]",decreased Stimulation and Euphoria scores after amphetamine when exposed to,
rs510769,"[['OPRM1', '(PA31945)']]",belongs to,
rs13266634,"[['SLC30A8', '(PA134915546)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1143684,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",worse prognosis (overall survival and progression-free survival) in patients who were ER-ve/PR-ve negative when treated with cyclophosphamide and doxorubicin in people with Breast Neoplasms as compared to,
rs1143684,"[['NQO2', '(PA31745)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",decreased on-clopidogrel platelet reactivity (PR) at 1 month and at 6 months after percutaneous coronary intervention (PCI) when treated with clopidogrel in people with Myocardial Ischemia as compared to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs1736557,"[['rosuvastatin', '(PA134308647)']]",severity of,
rs1736557,"[['FMO3', '(PA166)']]",belongs to,
rs8016905,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","Cough when treated with Ace Inhibitors, Plain as compared to",
rs8016905,"[['BDKRB2', '(PA80)']]",belongs to,
rs4149056,"[['lopinavir', '(PA450264)']]",increased median plasma lopinavir Cmin and C2-6 when treated with lopinavir as compared to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11706052,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased inosine monophosphate dehydrogenase activity when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs2400707,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in whole day ambulatory blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs2400707,"[['ADRB2', '(PA39)']]",belongs to,
rs1159744,"[['hydrochlorothiazide', '(PA449899)']]",increased urinary potassium excretion when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs1159744,"[['WNK1', '(PA33782)']]",belongs to,
rs7439366,"[['methadone', '(PA450401)']]",increased severity of,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs6600893,"[['methadone', '(PA450401)']]",increased severity of,
rs6600893,"[['UGT2B7', '(PA361)']]",belongs to,
rs242941,"[['fluoxetine', '(PA449673)']]",increased response when treated with fluoxetine in people with major depression and high anxiety as compared to,
rs242941,"[['CRHR1', '(PA26874)']]",belongs to,
rs3815583,"[['methylphenidate', '(PA450464)']]",increased risk of,
rs3815583,"[['CES1', '(PA107)']]",belongs to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in mean arterial pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
"UGT1A3*1, UGT1A3*2","[['atorvastatin', '(PA448500)']]",increased atorvastatin lactonization when exposed to,
"UGT1A3*1, UGT1A3*2","[['UGT1A3', '(PA37178)']]",belongs to,
"UGT1A3*1, UGT1A3*2","[['atorvastatin', '(PA448500)']]",decreased total and the low-density lipoprotein cholesterol maximum percent decreases from baseline when exposed to,
"UGT1A3*1, UGT1A3*2","[['UGT1A3', '(PA37178)']]",belongs to,
rs13306673,"[['Thiazides,', 'plain', '(PA164713347)']]","increased reduction in mean blood pressure when treated with Thiazides, plain in people with Essential hypertension as compared to",
rs13306673,"[['SLC12A3', '(PA321)']]",belongs to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs880054,"[['hydrochlorothiazide', '(PA449899)']]",decreased reduction in SBP when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs880054,"[['WNK1', '(PA33782)']]",belongs to,
rs4961,"[['diuretics', '(PA151249535)']]",decreased likelihood of,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs2717162,"[['bupropion', '(PA448687)']]",increased risk of,
rs2717162,"[['GALR1', '(PA28545)']]",belongs to,
rs2717162,"[['GALR1', '(PA28545)']]",belongs to,
rs2717162,"[['bupropion', '(PA448687)']]",decreased likelihood of,
rs2717162,"[['GALR1', '(PA28545)']]",belongs to,
rs12350051,"[['MLLT3', '(PA30852)']]",belongs to,
rs11045879,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased GI toxicity when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs11045879,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs7483,"[['GSTM3', '(PA29024)']]",belongs to,
rs892940,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (BDR) when treated with salbutamol in children with Asthma as compared to,
rs892940,"[['THRB', '(PA36508)']]",belongs to,
rs12478318,"[['SCN9A', '(PA35010)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs735482,"[['CD3EAP', '(PA142672156)'], ['ERCC1', '(PA155)'], ['PPP1R13L', '(PA34195)']]",belongs to,
rs1127354,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs1127354,"[['DDRGK1', '(PA164718734)'], ['ITPA', '(PA29973)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs4244285,"[['amitriptyline', '(PA448385)']]",increased log metabolic ratio of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs12721655,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased survival when treated with cyclophosphamide and doxorubicin in women with Breast Neoplasms as compared to,
rs12721655,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs445925,"[['APOC1', '(PA51)'], ['APOE', '(PA55)']]",belongs to,
rs7853758,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs7853758,"[['SLC28A3', '(PA426)']]",belongs to,
rs2622604,"[['erlotinib', '(PA134687924)']]",decreased mean AUC of,
rs2622604,"[['ABCG2', '(PA390)']]",belongs to,
rs1045642,"[['cyclosporine', '(PA449167)']]",decreased intracellular and blood concentration of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs4459610,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","same protective properties against angiotensin-converting enzyme inhibitors-induced cough when treated with Ace Inhibitors, Plain in people with homozygous GG genotype for rs4343 as compared to",
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1800544,"[['dexmedetomidine', '(PA449256)']]","increased Bispectral Index and Ramsay Sedation Scores, indicating a longer period for falling asleep when exposed to",
rs1800544,"[['ADRA2A', '(PA35)']]",belongs to,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs7787082,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs7787082,"[['ABCB1', '(PA267)']]",belongs to,
rs3842787,"[['celecoxib', '(PA448871)']]",reduction in COX-1 inhibition when exposed to,
rs3842787,"[['PTGS1', '(PA24346)']]",belongs to,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs2070676,"[['CYP2E1', '(PA129)']]",belongs to,
rs25489,"[['XRCC1', '(PA369)']]",belongs to,
rs717620,"[['tenofovir', '(PA10204)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2071230,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs2071230,"[['MMP1', '(PA30867)'], ['MMP10', '(PA30868)']]",belongs to,
rs17626122,"[['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",increased likelihood of,
rs17626122,"[['PARD3B', '(PA162398721)']]",belongs to,
rs4243761,"[['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",decreased likelihood of,
rs1054774,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1054774,"[['CDK9', '(PA26316)'], ['FPGS', '(PA167)']]",belongs to,
rs4451422,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs4451422,"[['ENG', '(PA27785)'], ['FPGS', '(PA167)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in mean blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs4994,"[['Thiazides,', 'plain', '(PA164713347)']]","increased reduction in mean blood pressure when treated with Thiazides, plain in people with Essential hypertension as compared to",
rs4994,"[['ADRB3', '(PA24598)']]",belongs to,
CYP2D6*3,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*5,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*9,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*17,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A4*1, CYP3A4*18B","[['cyclosporine', '(PA449167)']]",increased trough concentrations of,
"CYP3A4*1, CYP3A4*18B","[['CYP3A4', '(PA130)']]",belongs to,
rs1050828,"[['amodiaquine', '(PA448404)'], ['pyrimethamine', '(PA451193)'], ['sulfadoxine', '(PA451540)']]",increased risk of,
rs1050828,"[['G6PD', '(PA28469)']]",belongs to,
rs1142345,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased GI toxicity when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs2413739,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased GI toxicity when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs2413739,"[['PACSIN2', '(PA32897)']]",belongs to,
rs10306114,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs10306114,"[['PTGS1', '(PA24346)']]",belongs to,
rs1901440,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs1057910,"[['celecoxib', '(PA448871)']]",decreased metabolism of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['celecoxib', '(PA448871)']]",decreased metabolism of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased plasma concentration of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['digoxin', '(PA449319)']]",increased serum concentrations of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3918290,"[['tegafur', '(PA452620)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs723685,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs723685,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs1801133,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",decreased severity of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs4970722,"[['DPYD', '(PA145)']]",belongs to,
rs1801274,"[['trastuzumab', '(PA451743)']]",increased progression free survival when treated with trastuzumab in women with Breast Neoplasms as compared to,
rs1801274,"[['FCGR2A', '(PA28063)']]",belongs to,
rs7325568,"[['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",increased likelihood of,
rs699,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased likelihood of,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs396991,"[['cetuximab', '(PA10040)']]",increased overall survival and progression-free survival when treated with cetuximab in people with Colorectal Neoplasms as compared to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs429358,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['ritonavir', '(PA451260)']]",increased non-HDL cholesterol when treated with Antivirals for treatment of,
rs429358,"[['APOC1', '(PA51)'], ['APOE', '(PA55)'], ['TOMM40', '(PA38274)']]",belongs to,
rs9344,"[['cetuximab', '(PA10040)']]",decreased overall survival and progression-free survival when treated with cetuximab in people with Colorectal Neoplasms as compared to,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
rs7297610,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs7297610,"[['YEATS4', '(PA134992686)']]",belongs to,
rs6413432,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased progression-free survival when treated with cisplatin and cyclophosphamide in women with Ovarian Neoplasms as compared to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs17244841,"[['pravastatin', '(PA451089)']]",decreased reduction in total cholesterol when treated with pravastatin as compared to,
rs17244841,"[['HMGCR', '(PA189)']]",belongs to,
rs17238540,"[['pravastatin', '(PA451089)']]",decreased reduction in total cholesterol when treated with pravastatin as compared to,
rs17238540,"[['HMGCR', '(PA189)']]",belongs to,
rs5729,"[['bumetanide', '(PA448682)'], ['furosemide', '(PA449719)'], ['torasemide', '(PA451733)']]",decreased 24-h excretion of,
rs5729,"[['SCNN1G', '(PA307)']]",belongs to,
rs1800693,"[['TNFRSF1A', '(PA36609)']]",belongs to,
rs1885301,"[['ABCC2', '(PA116)']]",belongs to,
rs1885301,"[['ABCC2', '(PA116)']]",belongs to,
rs2804402,"[['ABCC2', '(PA116)']]",belongs to,
rs2804402,"[['ABCC2', '(PA116)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs11749035,"[['bupropion', '(PA448687)'], ['nicotine', '(PA450626)']]",increased likelihood of,
rs11749035,"[['DRD1', '(PA147)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs1801131,"[['capecitabine', '(PA448771)']]",decreased Drug Toxicity when treated with capecitabine in people with Colorectal Neoplasms as compared to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs2227983,"[['egfr', 'inhibitors', '(PA153561371)']]",increased likelihood of,
rs2227983,"[['EGFR', '(PA7360)']]",belongs to,
rs17655,"[['platinum', '(PA150595617)']]",increased survival when treated with platinum in women with Ovarian Neoplasms as compared to,
rs17655,"[['ERCC5', '(PA27851)']]",belongs to,
rs1042713,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs6280,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs602633,"[['CELSR2', '(PA26394)'], ['PSRC1', '(PA142671120)']]",belongs to,
rs7121,"[['GNAS', '(PA175)']]",belongs to,
rs8192709,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs8192709,"[['CYP2B6', '(PA123)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs2569190,"[['fluticasone', 'propionate', '(PA449686)']]",increased PC20 when treated with fluticasone propionate in children with Asthma as compared to,
rs2569190,"[['CD14', '(PA26188)'], ['TMCO6', '(PA162405810)']]",belongs to,
rs2305364,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs2305364,"[['SLC28A1', '(PA387)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs12721655,"[['bupropion', '(PA448687)'], ['efavirenz', '(PA449441)']]",decreased metabolism of,
rs12721655,"[['CYP2B6', '(PA123)']]",belongs to,
rs7563206,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs7563206,"[['ATIC', '(PA25094)']]",belongs to,
rs3821353,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs3821353,"[['ATIC', '(PA25094)']]",belongs to,
rs12517451,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs12517451,"[['DHFR', '(PA143)']]",belongs to,
rs1643657,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs1643657,"[['DHFR', '(PA143)']]",belongs to,
rs10072026,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs10072026,"[['DHFR', '(PA143)'], ['MSH3', '(PA31134)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased functional MRI reactivity to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A","[['nicotine', '(PA450626)']]",decreased metabolism of,
"CYP2A6*1A, CYP2A6*4A","[['CYP2A6', '(PA121)']]",belongs to,
rs3215400,"[['cytarabine', '(PA449177)']]",increased cytotoxicity when exposed to,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs16853834,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs16853834,"[['ATIC', '(PA25094)']]",belongs to,
rs11702425,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs11702425,"[['SLC19A1', '(PA327)']]",belongs to,
rs11231825,"[['cytarabine', '(PA449177)'], ['fludarabine', '(PA449655)'], ['gemtuzumab', 'ozogamicin', '(PA164749431)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs11231825,"[['SLC22A12', '(PA38478)']]",belongs to,
HLA-A*03:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs17216177,"[['ABCC2', '(PA116)']]",belongs to,
rs17216177,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs1885301,"[['ABCC2', '(PA116)']]",belongs to,
rs17216177,"[['ABCC2', '(PA116)']]",belongs to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs7297610,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs7297610,"[['YEATS4', '(PA134992686)']]",belongs to,
rs10771973,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs10771973,"[['FGD4', '(PA134907925)']]",belongs to,
rs7001034,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs7001034,"[['FZD3', '(PA28458)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]","increased plasma 4beta-OHC/Chol ratio when treated with efavirenz, lamivudine, stavudine and zidovudine in people with HIV as compared to",['*1.']
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,['*1.']
rs9514091,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs9514091,"[['SLC10A2', '(PA318)']]",belongs to,
rs6759892,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs6759892,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs2108623,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs2108623,"[['CYP4F2', '(PA27121)']]",belongs to,
rs4148808,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs4148808,"[['ABCB4', '(PA268)']]",belongs to,
rs2237717,"[['MET', '(PA30763)']]",belongs to,
rs3130,"[['PROM1', '(PA33807)']]",belongs to,
rs6151031,"[['carboplatin', '(PA448803)'], ['cyclophosphamide', '(PA449165)'], ['thiotepa', '(PA451668)']]",increased severity of,
rs6151031,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs211247,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs211247,"[['KL', '(PA30130)']]",belongs to,
rs1799971,"[['morphine', '(PA450550)']]",increased reduction in pain when treated with morphine in people with Neoplasms as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs776746,"[['erlotinib', '(PA134687924)']]",increased severity of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs6280,"[['risperidone', '(PA451257)']]",decreased likelihood of,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs708272,"[['pravastatin', '(PA451089)']]",increased risk of,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs8192924,"[['capecitabine', '(PA448771)']]",increased severity of,
rs8192924,"[['CES2', '(PA377)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs662799,"[['atorvastatin', '(PA448500)'], ['lovastatin', '(PA450272)'], ['simvastatin', '(PA451363)']]","decreased reduction in LDLc when treated with atorvastatin, lovastatin or simvastatin in people with Hyperlipidemias as compared to",
rs662799,"[['APOA5', '(PA24888)']]",belongs to,
DPYD*7,"[['DPYD', '(PA145)']]",belongs to,
rs25487,"[['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['gemcitabine', '(PA449748)']]","decreased overall survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to",
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1057910,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['celecoxib', '(PA448871)'], ['diclofenac', '(PA449293)'], ['ibuprofen', '(PA449957)'], ['naproxen', '(PA450595)'], ['piroxicam', '(PA450985)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['tenofovir', '(PA10204)']]",increased risk of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs11568695,"[['ABCC4', '(PA397)']]",belongs to,
rs1751034,"[['ABCC4', '(PA397)']]",belongs to,
rs1557070,"[['ABCC4', '(PA397)']]",belongs to,
rs2274406,"[['ABCC4', '(PA397)']]",belongs to,
rs899494,"[['ABCC4', '(PA397)']]",belongs to,
ABCC2 H2,"[['tenofovir', '(PA10204)']]",increased risk of,
ABCC2 H2,"[['ABCC2', '(PA116)']]",belongs to,
rs9977268,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs9977268,"[['SLC19A1', '(PA327)']]",belongs to,
rs7279445,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs7279445,"[['SLC19A1', '(PA327)']]",belongs to,
rs7499,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs7499,"[['COL18A1', '(PA26711)'], ['SLC19A1', '(PA327)']]",belongs to,
rs2838956,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2838956,"[['SLC19A1', '(PA327)']]",belongs to,
rs1886629,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs1886629,"[['KCNT2', '(PA38726)']]",belongs to,
rs17024608,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs17024608,"[['RBMS3', '(PA34276)']]",belongs to,
rs7740004,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs7740004,"[['TBC1D32', '(PA134871908)']]",belongs to,
rs11064477,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs11064477,"[['PHB2', '(PA142671181)']]",belongs to,
rs17751934,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs17751934,"[['MEX3C', '(PA162395821)']]",belongs to,
rs11934877,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs11934877,"[['IGFBP7', '(PA29709)']]",belongs to,
rs1805128,"[['amiodarone', '(PA448383)'], ['Antibiotics', '(PA164712406)'], ['antipsychotics', '(PA452233)'], ['diuretics', '(PA151249535)'], ['quinidine', '(PA451209)'], ['sotalol', '(PA451457)']]",increased risk of,
rs1805128,"[['KCNE1', '(PA211)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*5,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*6,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*9,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
rs1529927,"[['bumetanide', '(PA448682)'], ['furosemide', '(PA449719)'], ['torasemide', '(PA451733)']]",increased 24-h excretion of,
rs1529927,"[['SLC12A3', '(PA321)']]",belongs to,
rs121912777,"[['oseltamivir', '(PA450721)']]",significantly larger mean AUC of,
rs121912777,"[['CES1', '(PA107)']]",belongs to,
rs2011425,"[['UGT1A4', '(PA37179)']]",belongs to,
rs2011425,"[['olanzapine', '(PA450688)']]",increased glucuronidated metabolites of,
rs2011425,"[['UGT1A4', '(PA37179)']]",belongs to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['midazolam', '(PA450496)']]",decreased CYP3A4 hydroxylation of,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs4341,"[['furosemide', '(PA449719)'], ['spironolactone', '(PA451483)']]",increased likelihood of,
rs4341,"[['ACE', '(PA139)']]",belongs to,
rs1799998,"[['furosemide', '(PA449719)'], ['spironolactone', '(PA451483)']]",increased likelihood of,
rs1799998,"[['CYP11B2', '(PA134)']]",belongs to,
rs4961,"[['furosemide', '(PA449719)'], ['spironolactone', '(PA451483)']]",increased likelihood of,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
rs61886492,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs61886492,"[['FOLH1', '(PA28205)']]",belongs to,
CYP2C19*7,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['folic', 'acid', '(PA449692)'], ['vitamin', 'b-complex,', 'plain', '(PA10505)']]",decreased severity of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['folic', 'acid', '(PA449692)'], ['vitamin', 'b-complex,', 'plain', '(PA10505)']]","greater reduction in homocysteine when treated with folic acid and vitamin b-complex, plain in women with Migraine with Aura as compared to",
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801394,"[['folic', 'acid', '(PA449692)'], ['vitamin', 'b-complex,', 'plain', '(PA10505)']]",decreased severity of,
rs1801394,"[['MTRR', '(PA31277)']]",belongs to,
"DPYD*3, DPYD*8","[['DPYD', '(PA145)']]",belongs to,
rs1656402,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]","decreased survival when treated with carboplatin and paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1656402,"[['EIF4E2', '(PA27720)'], ['TIGD1', '(PA38382)']]",belongs to,
rs9981861,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]","decreased survival when treated with carboplatin and paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs9981861,"[['DSCAM', '(PA27491)']]",belongs to,
rs1205,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs1205,"[['CRP', '(PA120)']]",belongs to,
rs4648276,"[['Coxibs', '(PA164712669)']]",increased likelihood of,
rs4648276,"[['PTGS2', '(PA293)']]",belongs to,
DPYD*10,"[['DPYD', '(PA145)']]",belongs to,
rs2235047,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs2235047,"[['ABCB1', '(PA267)']]",belongs to,
rs4877847,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs4877847,"[['SLC28A3', '(PA426)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1801131,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs6072262,"[['irinotecan', '(PA450085)']]",decreased severity of,
rs6072262,"[['TOP1', '(PA353)']]",belongs to,
rs712829,"[['erlotinib', '(PA134687924)']]",increased severity of,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs1050565,"[['bleomycin', '(PA448645)']]",decreased survival when treated with bleomycin in men with Testicular Neoplasms as compared to,
rs1050565,"[['BLMH', '(PA25370)']]",belongs to,
rs2032582,"[['digoxin', '(PA449319)']]",increased serum concentrations digoxin as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs532545,"[['cytarabine', '(PA449177)']]",increased cytotoxicity when exposed to,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs1678387,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs1678387,"[['ABCC4', '(PA397)']]",belongs to,
rs242941,"[['corticosteroids', '(PA10832)']]",increased percent change in FEV when treated with corticosteroids in people with Asthma as compared to,
rs242941,"[['CRHR1', '(PA26874)']]",belongs to,
rs242939,"[['beclomethasone', '(PA448547)'], ['budesonide', '(PA448681)'], ['fluticasone', 'propionate', '(PA449686)']]","decreased mean annual change in FEV when treated with beclomethasone, budesonide or fluticasone propionate in people with Asthma as compared to",
rs242939,"[['CRHR1', '(PA26874)']]",belongs to,
rs1876828,"[['budesonide', '(PA448681)'], ['fluticasone', 'propionate', '(PA449686)']]",delayed cortisol response to,
rs1876828,"[['CRHR1', '(PA26874)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1045642,"[['cisplatin', '(PA449014)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['cisplatin', '(PA449014)'], ['fluorouracil', '(PA128406956)']]",decreased survival rate when treated with cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3815583,"[['isoniazid', '(PA450112)']]",decreased likelihood of,
rs3815583,"[['CES1', '(PA107)']]",belongs to,
"TPMT*1, TPMT*12","[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased severity of,
"TPMT*1, TPMT*12","[['TPMT', '(PA356)']]",belongs to,
rs45445694,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs1051266,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1979277,"[['SHMT1', '(PA35753)']]",belongs to,
rs602950,"[['cytarabine', '(PA449177)']]",increased cytotoxicity when exposed to,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs7349683,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs7349683,"[['EPHA5', '(PA27821)']]",belongs to,
rs2072671,"[['cytarabine', '(PA449177)']]",increased cytotoxicity when exposed to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",increased AUC simvastatin acid when treated with simvastatin in healthy individuals as compared to,['*1/*1.']
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",belongs to,['*1/*1.']
rs12353214,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs12353214,"[['PTGS1', '(PA24346)']]",belongs to,
rs7952081,"[['GSTP1', '(PA29028)']]",belongs to,
rs4261716,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs4261716,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs2228100,"[['carboplatin', '(PA448803)'], ['cyclophosphamide', '(PA449165)'], ['thiotepa', '(PA451668)']]",increased likelihood of,
rs2228100,"[['ALDH3A1', '(PA24697)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",decreased overall survival when treated with tegafur in people with Stomach Neoplasms as compared to,"['*1/*5', '+', '*5/*5.']"
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,"['*1/*5', '+', '*5/*5.']"
rs10841661,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs10841661,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs1209950,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]","decreased survival when treated with carboplatin and paclitaxel in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1209950,"[['ETS2', '(PA27903)']]",belongs to,
rs8087522,"[['clozapine', '(PA449061)']]",increased Weight gain when treated with clozapine in people with Schizophrenia as compared to,
rs8087522,"[['MC4R', '(PA30676)']]",belongs to,
rs10306135,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs10306135,"[['PTGS1', '(PA24346)']]",belongs to,
rs7945189,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased likelihood of,
rs7945189,"[['MMP1', '(PA30867)'], ['MMP10', '(PA30868)']]",belongs to,
rs943580,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased likelihood of,
rs943580,"[['AGT', '(PA42)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs2020933,"[['SLC6A4', '(PA312)']]",belongs to,
rs1876828,"[['CRHR1', '(PA26874)']]",belongs to,
rs242941,"[['budesonide', '(PA448681)'], ['fluticasone', 'propionate', '(PA449686)']]",delayed cortisol response to,
rs242941,"[['CRHR1', '(PA26874)']]",belongs to,
rs1876828,"[['CRHR1', '(PA26874)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs10981694,"[['cisplatin', '(PA449014)']]",increased severity of,
rs10981694,"[['SLC31A1', '(PA118)']]",belongs to,
rs1994862,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",decreased risk of,
rs1994862,"[['GRIA1', '(PA28966)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['fluorouracil', '(PA128406956)']]",Drug Toxicity when treated with fluorouracil in people with Neoplasms as compared to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs45589337,"[['DPYD', '(PA145)']]",belongs to,
rs11739136,"[['KCNIP1', '(PA30041)'], ['KCNMB1', '(PA221)']]",belongs to,
rs11739136,"[['KCNIP1', '(PA30041)'], ['KCNMB1', '(PA221)']]",belongs to,
"CYP2C9*1, CYP2C9*8","[['warfarin', '(PA451906)']]",decreased unbound oral clearance of,
"CYP2C9*1, CYP2C9*8","[['CYP2C9', '(PA126)']]",belongs to,
rs41291556,"[['mephenytoin', '(PA450373)'], ['tolbutamide', '(PA451718)']]",decreased metabolism of,
rs41291556,"[['CYP2C19', '(PA124)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs11231809,"[['SLC22A11', '(PA38295)']]",belongs to,
rs1751034,"[['ABCC4', '(PA397)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs7080681,"[['ABCC2', '(PA116)']]",belongs to,
rs17222723,"[['tenofovir', '(PA10204)']]",decreased risk of,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
rs2073618,"[['pamidronate', '(PA450767)'], ['zoledronate', '(PA10235)']]",increased likelihood of,
rs2073618,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs12458117,"[['pamidronate', '(PA450767)'], ['zoledronate', '(PA10235)']]",increased likelihood of,
rs12458117,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs11212617,"[['metformin', '(PA450395)']]","treatment success, achieving an HbA1c below 7% when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs11212617,"[['C11orf65', '(PA144596484)']]",belongs to,
rs1799983,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in diastolic blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs5186,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in women with Essential hypertension as compared to,
rs5186,"[['AGTR1', '(PA43)']]",belongs to,
rs1057910,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['celecoxib', '(PA448871)'], ['diclofenac', '(PA449293)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs1799793,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased likelihood of,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs1150226,"[['HTR3A', '(PA29555)']]",belongs to,
rs11730582,"[['pamidronate', '(PA450767)'], ['zoledronate', '(PA10235)']]",increased likelihood of,
rs11730582,"[['SPP1', '(PA36085)']]",belongs to,
rs1800012,"[['pamidronate', '(PA450767)'], ['zoledronate', '(PA10235)']]",increased likelihood of,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs201522,"[['antidepressants', '(PA452229)']]",likelihood of,
rs201522,"[['CUX1', '(PA162382924)']]",belongs to,
rs1661167,"[['irinotecan', '(PA450085)']]",increased severity of,
rs11128347,"[['irinotecan', '(PA450085)']]",increased severity of,
rs11128347,"[['PDZRN3', '(PA134931098)']]",belongs to,
rs11979430,"[['irinotecan', '(PA450085)']]",increased severity of,
rs11979430,"[['SEMA3C', '(PA35647)']]",belongs to,
rs1801253,"[['carvedilol', '(PA448817)']]",decreased response (heart-rate lowering) when treated with carvedilol in people with Heart Failure as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs12046844,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs11141915,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs11141915,"[['DAPK1', '(PA27142)']]",belongs to,
rs10757274,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased likelihood of,
rs10757274,"[['CDKN2B-AS1', '(PA164717802)']]",belongs to,
rs20417,"[['Coxibs', '(PA164712669)']]",increased likelihood of,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs1045642,"[['ondansetron', '(PA450705)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs16857540,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs16857540,"[['NLGN1', '(PA31647)']]",belongs to,
rs2569190,"[['fluticasone', 'propionate', '(PA449686)']]",decreased FEV1/FVC ratio when treated with fluticasone propionate in children with Asthma as compared to,
rs2569190,"[['CD14', '(PA26188)'], ['TMCO6', '(PA162405810)']]",belongs to,
rs7725278,"[['DRD1', '(PA147)']]",belongs to,
rs17782313,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased Weight gain when treated with clozapine or olanzapine in people with Schizophrenia as compared to,
rs17782313,"[['MC4R', '(PA30676)']]",belongs to,
rs10049380,"[['UMPS', '(PA363)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs9274407,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased likelihood of,
rs9274407,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs2465403,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs2465403,"[['COLEC10', '(PA26736)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
CYP2A6*28A,"[['nicotine', '(PA450626)']]",decreased metabolism of,
CYP2A6*28A,"[['CYP2A6', '(PA121)']]",belongs to,
rs11719165,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs55886062,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C9*1, CYP2C9*8","[['warfarin', '(PA451906)']]",decreased in vitro intrinsic clearance of,
"CYP2C9*1, CYP2C9*8","[['CYP2C9', '(PA126)']]",belongs to,
ABCB1*2(PMID:11503014),"[['erlotinib', '(PA134687924)']]",increased likelihood of,
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",belongs to,
CYP2A6*24A,"[['nicotine', '(PA450626)']]",decreased metabolism of,
CYP2A6*24A,"[['CYP2A6', '(PA121)']]",belongs to,
SLCO1B1*15,"[['atorvastatin', '(PA448500)']]",increased AUC0-infinity of,
SLCO1B1*15,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs5723,"[['hydrochlorothiazide', '(PA449899)']]",decreased reduction in office diastolic blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs5723,"[['SCNN1G', '(PA307)']]",belongs to,
rs2072671,"[['cytarabine', '(PA449177)']]",increased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs4292394,"[['methadone', '(PA450401)']]",increased severity of,
rs4292394,"[['UGT2B7', '(PA361)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs7779029,"[['irinotecan', '(PA450085)']]",increased severity of,
rs7779029,"[['SEMA3C', '(PA35647)']]",belongs to,
rs5051,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in women with Essential hypertension as compared to,
rs5051,"[['AGT', '(PA42)']]",belongs to,
rs2235040,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2235040,"[['ABCB1', '(PA267)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs7483,"[['GSTM3', '(PA29024)']]",belongs to,
rs2306283,"[['atorvastatin', '(PA448500)']]",increased reduction in LDL when treated with atorvastatin in people with Hypercholesterolemia as compared to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1801131,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs10784749,"[['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs5751876,"[['ADORA2A', '(PA24584)']]",belongs to,
rs4148350,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs4148350,"[['ABCC1', '(PA244)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs11872992,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased Weight gain when treated with clozapine or olanzapine in people with Schizophrenia as compared to,
rs11872992,"[['MC4R', '(PA30676)']]",belongs to,
rs10876844,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs10876844,"[['OR10AE3P', '(PA134987112)'], ['PSMB3P', '(PA134925224)']]",belongs to,
rs17116806,"[['DPYD', '(PA145)']]",belongs to,
rs11615,"[['cisplatin', '(PA449014)']]",increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs4149056,"[['pravastatin', '(PA451089)']]",increased mean peak concentration in plasma and area under the plasma concentration when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs7295250,"[['CACNA1C', '(PA83)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs365836,"[['antidepressants', '(PA452229)']]",likelihood of,
rs365836,"[['CUX1', '(PA162382924)']]",belongs to,
rs2070673,"[['cytarabine', '(PA449177)'], ['fludarabine', '(PA449655)'], ['gemtuzumab', 'ozogamicin', '(PA164749431)'], ['idarubicin', '(PA449961)']]",decreased likelihood of,
rs2070673,"[['CYP2E1', '(PA129)']]",belongs to,
rs1789891,"[['ADH1B', '(PA24571)']]",belongs to,
rs11045585,"[['docetaxel', '(PA449383)']]",increased AUC of,
rs11045585,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs6511720,"[['LDLR', '(PA227)']]",belongs to,
rs28364072,"[['corticosteroids', '(PA10832)']]",increased likelihood of,
rs28364072,"[['FCER2', '(PA28058)']]",belongs to,
rs885004,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs885004,"[['SLC28A3', '(PA426)']]",belongs to,
rs776746,"[['erlotinib', '(PA134687924)']]",increased likelihood of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased plasma concentration of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs3834935,"[['docetaxel', '(PA449383)']]",increased AUC of,
rs3834935,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs1042522,"[['cisplatin', '(PA449014)'], ['paclitaxel', '(PA450761)']]",decreased one year progression free survival when treated with cisplatin and paclitaxel in people with Stomach Neoplasms as compared to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs3211371,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs8192709,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased time to,
rs8192709,"[['CYP2B6', '(PA123)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2243250,"[['aspirin', '(PA448497)']]",decreased aspirin-induced asthma when treated with aspirin in people with Asthma as compared to,
rs2243250,"[['IL4', '(PA197)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs304478,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased SVR (sustained virological response) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to,
rs304478,"[['IFIT1', '(PA29648)']]",belongs to,
"SLCO1B1*1A, SLCO1B1*1B","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3846662,"[['atorvastatin', '(PA448500)']]",increased low-density lipoprotein cholesterol level in basal state and possibly in response to,
rs3846662,"[['HMGCR', '(PA189)']]",belongs to,
rs2278294,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149032,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]","decreased rifampicin exposure when treated with ethambutol, isoniazid, pyrazinamide and rifampin in people with Tuberculosis as compared to",
rs4149032,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['dextromethorphan', '(PA449273)']]",decreased clearance of,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2228478,"[['desipramine', '(PA449233)']]",increased likelihood of,
rs2228478,"[['MC1R', '(PA30673)']]",belongs to,
rs2125739,"[['tenofovir', '(PA10204)']]",increased kidney tubular dysfunction when treated with tenofovir in people with HIV as compared to,
rs2125739,"[['ABCC10', '(PA24392)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",severity of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2070676,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs2070676,"[['CYP2E1', '(PA129)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs3742106,"[['ABCC4', '(PA397)']]",belongs to,
rs899494,"[['ABCC4', '(PA397)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs11568655,"[['ABCC4', '(PA397)']]",belongs to,
rs1557070,"[['ABCC4', '(PA397)']]",belongs to,
rs2274405,"[['ABCC4', '(PA397)']]",belongs to,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs11568658,"[['ABCC4', '(PA397)']]",belongs to,
rs4674470,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['hydrocortisone', '(PA449905)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",decreased likelihood of,
rs4674470,"[['MIR4268', '(PA165696875)']]",belongs to,
rs324420,"[['aripiprazole', '(PA10026)'], ['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs4244285,"[['cyclophosphamide', '(PA449165)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs10792367,"[['hydrochlorothiazide', '(PA449899)']]",decreased blood pressure (BP) reduction when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs3842787,"[['rofecoxib', '(PA451268)']]",reduction in COX-1 inhibition and depression of,
rs3842787,"[['PTGS1', '(PA24346)']]",belongs to,
rs1057910,"[['celecoxib', '(PA448871)']]",decreased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased plasma nortiptyline when treated with amitriptyline in people with Mental Disorders as compared to,['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",increased plasma nortiptyline when treated with amitriptyline in people with Mental Disorders as compared to,['*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
rs735482,"[['thalidomide', '(PA451644)']]",increased overall survival when treated with thalidomide in people with Multiple Myeloma as compared to,
rs735482,"[['ERCC1', '(PA155)']]",belongs to,
rs1801253,"[['atenolol', '(PA448499)']]",increased reduction in blood pressure when treated with atenolol in healthy individuals as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs2815752,"[['metformin', '(PA450395)']]",increased likelihood of,
rs4149056,"[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs25487,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1799782,"[['XRCC1', '(PA369)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs1760217,"[['antineoplastic', 'agents', '(PA452621)']]",decreased survival when treated with antineoplastic agents in people with Pancreatic Neoplasms as compared to,
rs1760217,"[['DPYD', '(PA145)']]",belongs to,
rs2231164,"[['antineoplastic', 'agents', '(PA452621)']]",increased survival when treated with antineoplastic agents in people with Pancreatic Neoplasms as compared to,
rs2231164,"[['ABCG2', '(PA390)']]",belongs to,
rs2230054,"[['bevacizumab', '(PA130232992)'], ['cyclophosphamide', '(PA449165)']]",decreased progression free survival when treated with bevacizumab and cyclophosphamide in women with Ovarian Neoplasms as compared to,
rs2230054,"[['CXCR2', '(PA29843)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1152003,"[['zoledronate', '(PA10235)']]",increased risk of,
rs1152003,"[['PPARG', '(PA281)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs16889462,"[['repaglinide', '(PA451234)']]","increased efficacy when treated with repaglinide in people with Diabetes Mellitus, Type 2 as compared to",
rs16889462,"[['SLC30A8', '(PA134915546)']]",belongs to,
rs1127354,"[['methotrexate', '(PA450428)']]","gastrointestinal toxicities when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1799793,"[['cisplatin', '(PA449014)']]",increased overall survival and progression-free survival when treated with cisplatin in people with Esophageal Neoplasms as compared to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",decreased magnitude of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs6956344,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs6956344,"[['CYP3A4', '(PA130)']]",belongs to,
rs72552713,"[['ABCG2', '(PA390)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['dextromethorphan', '(PA449273)']]",decreased clearance of,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs1127354,"[['interferon', 'alfa-2b,', 'recombinant', '(PA164783990)'], ['ribavirin', '(PA451241)']]",decreased frequency of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs2189784,"[['warfarin', '(PA451906)']]",decreased time to,
rs2189784,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1800477,"[['interferons', '(PA451999)'], ['ribavirin', '(PA451241)']]","increased frequency (about double) in non-responder patients compared with responder patients (HCV genotype 4) when treated with interferons and ribavirin in people with Hepatitis C, Chronic as compared to",
rs1800477,"[['BCL2', '(PA25302)']]",belongs to,
rs495828,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","Cough when treated with Ace Inhibitors, Plain as compared to",
rs495828,"[['ABO', '(PA24415)']]",belongs to,
rs4244285,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]","higher composite har outcome (cardiac death, non fatal myocardial infarction and stent thrombosis) up to",
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1219648,"[['FGFR2', '(PA28128)']]",belongs to,
rs2391191,"[['aripiprazole', '(PA10026)']]",decreased brief psychiatric rating scale scores when treated with aripiprazole in people with Schizophrenia as compared to,
rs2391191,"[['DAOA', '(PA134924986)']]",belongs to,
rs1799732,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs2278294,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs71647871,"[['clopidogrel', '(PA449053)']]",increased levels of,
rs71647871,"[['CES1', '(PA107)']]",belongs to,
rs6265,"[['metformin', '(PA450395)']]",increased likelihood of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
"SLCO1B1*15, SLCO1B1*1A","[['pravastatin', '(PA451089)']]",increased relative bioavailability of,
"SLCO1B1*15, SLCO1B1*1A","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
rs1360780,"[['FKBP5', '(PA28162)']]",belongs to,
rs3800373,"[['FKBP5', '(PA28162)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1049353,"[['CNR1', '(PA26681)']]",belongs to,
ABCC10 H1,"[['tenofovir', '(PA10204)']]",increased risk of,
ABCC10 H1,"[['ABCC10', '(PA24392)']]",belongs to,
rs7588295,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs7588295,"[['CSRNP3', '(PA164718184)']]",belongs to,
rs4431170,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs4431170,"[['MARCH1', '(PA134986392)']]",belongs to,
rs11189381,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs11189381,"[['SFRP5', '(PA35695)']]",belongs to,
rs12903202,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs12903202,"[['ALDH1A2', '(PA24693)']]",belongs to,
rs5768434,"[['Bisphosphonates', '(PA164712563)']]",increased likelihood of,
rs5768434,"[['FAM19A5', '(PA134887312)']]",belongs to,
rs2515641,"[['cytarabine', '(PA449177)'], ['fludarabine', '(PA449655)'], ['gemtuzumab', 'ozogamicin', '(PA164749431)'], ['idarubicin', '(PA449961)']]",decreased likelihood of,
rs2515641,"[['CYP2E1', '(PA129)']]",belongs to,
rs4149056,"[['cytarabine', '(PA449177)'], ['fludarabine', '(PA449655)'], ['gemtuzumab', 'ozogamicin', '(PA164749431)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2302948,"[['cytarabine', '(PA449177)'], ['fludarabine', '(PA449655)'], ['gemtuzumab', 'ozogamicin', '(PA164749431)'], ['idarubicin', '(PA449961)']]",decreased likelihood of,
rs2302948,"[['SULT2B1', '(PA36249)']]",belongs to,
rs1801282,"[['metformin', '(PA450395)']]",increased likelihood of,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
"CYP2A6*1A, CYP2A6*7, CYP2A6*9A","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*7, CYP2A6*9A","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs140700,"[['SLC6A4', '(PA312)']]",belongs to,
rs12995526,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs12995526,"[['ATIC', '(PA25094)']]",belongs to,
rs12681874,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs12681874,"[['GGH', '(PA432)']]",belongs to,
rs2274808,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2274808,"[['COL18A1', '(PA26711)']]",belongs to,
rs1876828,"[['CRHR1', '(PA26874)']]",belongs to,
rs1876828,"[['corticosteroids', '(PA10832)']]",increased percent change in FEV when treated with corticosteroids in people with Asthma as compared to,
rs1876828,"[['CRHR1', '(PA26874)']]",belongs to,
rs1801253,"[['bucindolol', '(PA165945764)']]",increased response when treated with bucindolol in people with Heart Failure as compared to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs1799793,"[['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['gemcitabine', '(PA449748)']]","increased overall survival when treated with capecitabine, cisplatin, docetaxel, epirubicin and gemcitabine in people with Pancreatic Neoplasms as compared to",
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs1801282,"[['metformin', '(PA450395)']]",increased likelihood of,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs1042858,"[['RRM1', '(PA298)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A, CYP2A6*7","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*4A, CYP2A6*7","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
rs1057910,"[['celecoxib', '(PA448871)']]",increased AUC of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs4149056,"[['rosuvastatin', '(PA134308647)']]",increased AUC (p=0.002) and Cmax (p=0.003) when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)'], ['DUX1', '(PA27535)']]",belongs to,
rs25489,"[['XRCC1', '(PA369)']]",belongs to,
rs1799782,"[['XRCC1', '(PA369)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2275622,"[['CYP2C8', '(PA125)']]",belongs to,
rs4630,"[['thalidomide', '(PA451644)']]",increased likelihood of,
rs4630,"[['GSTT1', '(PA183)']]",belongs to,
rs1051685,"[['thalidomide', '(PA451644)']]",increased overall survival when treated with thalidomide in people with Multiple Myeloma as compared to,
rs1051685,"[['XRCC5', '(PA37425)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs4267385,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","same protective properties against angiotensin-converting enzyme inhibitors-induced cough when treated with Ace Inhibitors, Plain in people with homozygous GG genotype for rs4343 as compared to",
rs2257401,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs2257401,"[['CYP3A7', '(PA122)']]",belongs to,
rs757110,"[['ABCC8', '(PA24395)']]",belongs to,
rs7903146,"[['sulfonamides,', 'urea', 'derivatives', '(PA10390)']]","increased response (reductions in haemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) levels) when treated with sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to",
rs7903146,"[['TCF7L2', '(PA36394)']]",belongs to,
rs1127354,"[['interferon', 'alfa-2b,', 'recombinant', '(PA164783990)'], ['ribavirin', '(PA451241)']]",cumulative reduction of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1042927,"[['gemcitabine', '(PA449748)'], ['Platinum', 'compounds', '(PA164713176)']]",decreased overall survival probability when treated with gemcitabine and Platinum compounds in people with Mesothelioma as compared to,
rs1042927,"[['RRM1', '(PA298)']]",belongs to,
rs11030918,"[['gemcitabine', '(PA449748)'], ['Platinum', 'compounds', '(PA164713176)']]",decreased likelihood of,
rs11030918,"[['RRM1', '(PA298)']]",belongs to,
rs4646437,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs1851426,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs1851426,"[['CYP3A4', '(PA130)']]",belongs to,
rs2687116,"[['tacrolimus', '(PA451578)']]",tacrolimus concentration to,
rs2687116,"[['CYP3A4', '(PA130)']]",belongs to,
rs11983225,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs11983225,"[['ABCB1', '(PA267)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*4A","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
rs5443,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs5443,"[['CDCA3', '(PA26276)'], ['GNB3', '(PA176)'], ['USP5', '(PA37253)']]",belongs to,
rs2306283,"[['repaglinide', '(PA451234)']]",decreased repaglinide plasma concentration (AUC) and Cmax when exposed to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1799752,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in blood pressure when treated with hydrochlorothiazide in women with Essential hypertension as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs28399504,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs2277869,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in whole day ambulatory blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs2277869,"[['RAD52', '(PA34180)'], ['WNK1', '(PA33782)']]",belongs to,
rs2107614,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in whole day ambulatory blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs2107614,"[['WNK1', '(PA33782)']]",belongs to,
rs1159744,"[['hydrochlorothiazide', '(PA449899)']]",increased reduction in whole day ambulatory blood pressure when treated with hydrochlorothiazide in people with Essential hypertension as compared to,
rs1159744,"[['WNK1', '(PA33782)']]",belongs to,
rs2286007,"[['WNK1', '(PA33782)']]",belongs to,
HLA-A*03:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs3215400,"[['cytarabine', '(PA449177)']]",increased risk of,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs4149056,"[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) and Cmax when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A, CYP2A6*9A","[['CYP2A6', '(PA121)']]",decreased daily cigarette consumption as compared to,['*1A/*1A.']
"CYP2A6*1A, CYP2A6*4A, CYP2A6*9A","[['CYP2A6', '(PA121)']]",belongs to,['*1A/*1A.']
rs11568626,"[['adefovir', 'dipivoxil', '(PA10005)'], ['cidofovir', '(PA448997)'], ['tenofovir', '(PA10204)']]",decreased the K(m) for the nucleoside phosphonate analogs of,
rs11568626,"[['SLC22A6', '(PA388)']]",belongs to,
rs1799853,"[['celecoxib', '(PA448871)']]",higher plasma concentrations of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs2306283,"[['pitavastatin', '(PA142650384)']]",increased pitavastatin plasma concentrations (AUC) and Cmax when exposed to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2032582,"[['ondansetron', '(PA450705)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs17287570,"[['irinotecan', '(PA450085)']]",decreased likelihood of,
rs17287570,"[['ABCC1', '(PA244)']]",belongs to,
rs7977213,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs7977213,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs11692021,"[['irinotecan', '(PA450085)']]",decreased likelihood of,
rs11692021,"[['UGT1A10', '(PA37174)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
rs35320474,"[['caffeine', '(PA448710)']]",increased anxiety when exposed to,
rs35320474,"[['ADORA2A', '(PA24584)']]",belongs to,
rs2020870,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs2020870,"[['FMO2', '(PA164741534)']]",belongs to,
rs2290271,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs2290271,"[['SLC28A1', '(PA387)']]",belongs to,
rs17645700,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs17583889,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs17583889,"[['HNMT', '(PA190)']]",belongs to,
rs1736557,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",decreased likelihood of,
rs1736557,"[['FMO3', '(PA166)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['morphine', '(PA450550)']]",increased reduction in pain when treated with morphine in people with Neoplasms as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2229109,"[['cyclosporine', '(PA449167)']]",increased intracellular and blood concentration of,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs6907567,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs6907567,"[['SLC22A16', '(PA134911502)']]",belongs to,
"NAT2*5B, NAT2*7B","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5B, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2070673,"[['CYP2E1', '(PA129)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased likelihood of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs10737062,"[['CAMK1D', '(PA134992438)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)'], ['phenprocoumon', '(PA450921)'], ['warfarin', '(PA451906)']]",8.3% higher mean daily coumarin dose to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs6313,"[['citalopram', '(PA449015)']]",decreased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs1128503,"[['sirolimus', '(PA451365)']]",increased triglycerides when treated with sirolimus in people with Kidney Transplantation as compared to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs2291767,"[['cisplatin', '(PA449014)']]",decreased risk of,
rs2291767,"[['OTOS', '(PA134906408)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased Overall survival (OS) time when treated with erlotinib in people with non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased response rate when treated with erlotinib in people with lung adenocarcinoma as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs12364283,"[['amphetamine', '(PA448408)']]",decreased stop reaction time when treated with amphetamine in healthy individuals as compared to,
rs12364283,"[['DRD2', '(PA27478)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)'], ['indinavir', '(PA449977)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased severity of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs6413432,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs6413432,"[['CYP2E1', '(PA129)'], ['DUX1', '(PA27535)']]",belongs to,
rs231775,"[['cyclosporine', '(PA449167)']]",increased likelihood of,
rs231775,"[['CTLA4', '(PA27006)']]",belongs to,
rs1801262,"[['repaglinide', '(PA451234)']]","decreased difference in fasting plasma glucose (before and after drug treatment) when treated with repaglinide in people with Diabetes Mellitus, Type 2 as compared to",
rs1801262,"[['NEUROD1', '(PA31564)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs2231142,"[['gefitinib', '(PA131301952)']]",increased likelihood of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased response rate when treated with erlotinib or gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs1801253,"[['verapamil', '(PA451868)']]",increased risk of,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs113993960,"[['ivacaftor', '(PA165950341)']]",lack of,
rs113993960,"[['CFTR', '(PA109)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7142143,"[['asparaginase', '(PA448492)'], ['dexamethasone', '(PA449247)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs7142143,"[['PYGL', '(PA34068)']]",belongs to,
HLA-DQB1*03:03:03,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-DQB1*03:03:03,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs11568315,"[['gefitinib', '(PA131301952)']]",increased better clinical response when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
rs1695,"[['doxorubicin', '(PA449412)']]",decreased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs121434569,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased acquired resistance when treated with erlotinib or gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs351855,"[['cyclophosphamide', '(PA449165)'], ['fluorouracil', '(PA128406956)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
rs351855,"[['FGFR4', '(PA28130)']]",belongs to,
rs6265,"[['fluoxetine', '(PA449673)']]",decreased likelihood of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased plasma level when treated with nevirapine in people with HIV-positive as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in lung adenocarcinoma patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2297480,"[['zoledronate', '(PA10235)']]",increased likelihood of,
rs2297480,"[['FDPS', '(PA28075)']]",belongs to,
rs4969170,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs4969170,"[['SOCS3', '(PA134885765)']]",belongs to,
rs1049353,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",decreased likelihood of,
rs1049353,"[['CNR1', '(PA26681)']]",belongs to,
rs1057868,"[['midazolam', '(PA450496)']]",decreased midazolam metabolic ratios by 45% when exposed to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased overall survival (OS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs10945919,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs557881,"[['aspirin', '(PA448497)']]",increased likelihood of,
rs557881,"[['SLC6A12', '(PA35908)']]",belongs to,
rs4838547,"[['nicotine', '(PA450626)']]",decreased risk of,
rs4838547,"[['CHAT', '(PA26448)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased mean AUC (area under curve) prothrombin time when exposed to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1042597,"[['UGT1A8', '(PA37183)']]",belongs to,
rs17863762,"[['UGT1A8', '(PA37183)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs10919035,"[['amiodarone', '(PA448383)']]",amiodarone-induced ventricular arrhythmia and QT prolongation when treated with amiodarone as compared to,
rs10919035,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1205,"[['rosuvastatin', '(PA134308647)']]",decreased plasma level of,
rs1205,"[['CRP', '(PA120)']]",belongs to,
rs1169288,"[['rosuvastatin', '(PA134308647)']]",decreased plasma level of,
rs1169288,"[['HNF1A', '(PA36380)']]",belongs to,
CYP2E1*5B,"[['CYP2E1', '(PA129)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",rapid virological response (rvr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in chemorefractory advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",decreased clopidogrel response in Chinese patients undergoing percutaneous coronary intervention (PCI) when treated with clopidogrel as compared to,['*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased clopidogrel response in Chinese patients undergoing percutaneous coronary intervention (PCI) when treated with clopidogrel as compared to,['*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"DPYD*2A, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs7877,"[['olanzapine', '(PA450688)']]",increased dose-adjusted serum olanzapine concentrations when treated with olanzapine as compared to,
rs7877,"[['FMO1', '(PA165)']]",belongs to,
rs6279,"[['olanzapine', '(PA450688)']]",increased prolactin when treated with olanzapine in women as compared to,
rs6279,"[['DRD2', '(PA27478)']]",belongs to,
rs7566605,"[['INSIG2', '(PA134890284)']]",belongs to,
rs17587100,"[['INSIG2', '(PA134890284)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4149117,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs12720462,"[['olanzapine', '(PA450688)']]",increased dose-adjusted serum olanzapine concentrations when treated with olanzapine as compared to,
rs12720462,"[['FMO1', '(PA165)']]",belongs to,
rs10490624,"[['INSIG2', '(PA134890284)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",increased small-dense LDL levels when treated with clopidogrel as compared to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs121434569,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",decreased progression-free survival (PFS) time when treated with erlotinib or gefitinib in people with EGFR mutation positive non-small-cell lung cancer as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs3813567,"[['nicotine', '(PA450626)']]",decreased risk of,
rs3813567,"[['CHRNB4', '(PA26496)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased risk of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs3743078,"[['nicotine', '(PA450626)']]",decreased risk of,
rs3743078,"[['CHRNA3', '(PA113)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs6275,"[['olanzapine', '(PA450688)']]",increased prolactin when treated with olanzapine in women as compared to,
rs6275,"[['DRD2', '(PA27478)']]",belongs to,
rs12979860,"[['boceprevir', '(PA165948902)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with boceprevir, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['fluoxetine', '(PA449673)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased overall survival (OS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",faster viral elimination (early virologic response) at week 2 or week 4 of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs2072661,"[['nicotine', '(PA450626)']]",increased abstinence due to,
rs2072661,"[['CHRNB2', '(PA115)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased severity of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs669,"[['Enzymes', '(PA164712734)']]",increased risk of,
rs669,"[['A2M', '(PA24357)']]",belongs to,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs833061,"[['sunitinib', '(PA162372840)']]",increased systolic blood pressure and increased risk of,
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
"CYP2E1*1A, CYP2E1*5A","[['CYP2E1', '(PA129)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased overall survival (OS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased severity of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs713729,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs713729,"[['PICK1', '(PA33760)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased median survial time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2252281,"[['metformin', '(PA450395)']]",increased response to,
rs2252281,"[['SLC47A1', '(PA162403808)']]",belongs to,
rs2252281,"[['metformin', '(PA450395)']]",increased response to,
rs2252281,"[['SLC47A1', '(PA162403808)']]",belongs to,
rs12943590,"[['metformin', '(PA450395)']]",increased renal and secretory clearance of,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs12943590,"[['metformin', '(PA450395)']]",decreased response to,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)']]",decreased oral clearance of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs10509681,"[['rosiglitazone', '(PA451283)']]",decreased mean trough steady-state plasma concentrations of,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs10192566,"[['LPIN1', '(PA30436)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs2279345,"[['efavirenz', '(PA449441)']]",decreased plasma concentration of,
rs2279345,"[['CYP2B6', '(PA123)']]",belongs to,
CYP2E1*6,"[['CYP2E1', '(PA129)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs2660,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs2660,"[['OAS1', '(PA31875)']]",belongs to,
rs2278293,"[['mycophenolic', 'acid', '(PA164748728)'], ['tacrolimus', '(PA451578)']]",decreased likelihood of,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs9380524,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]",poor response after 8 weeks of,
rs9380524,"[['FKBP5', '(PA28162)']]",belongs to,
rs352428,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]",poor response at 8 week of,
rs352428,"[['citalopram', '(PA449015)']]",poor response at 6 week of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2A6*10, CYP2A6*1A","[['nicotine', '(PA450626)']]",decreased plasma and urinary ratio of,
"CYP2A6*10, CYP2A6*1A","[['CYP2A6', '(PA121)']]",belongs to,
"CYP2A6*1A, CYP2A6*9A","[['nicotine', '(PA450626)']]",decreased plasma and urinary ratio of,
"CYP2A6*1A, CYP2A6*9A","[['CYP2A6', '(PA121)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['fluoxetine', '(PA449673)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs3093726,"[['LST1', '(PA37856)'], ['LTA', '(PA30474)'], ['LTB', '(PA30475)'], ['TNF', '(PA435)']]",belongs to,
rs17189632,"[['nicotine', '(PA450626)']]",risk of,
rs17189632,"[['GRIN3A', '(PA28983)']]",belongs to,
rs12041331,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased collagen induced platelet aggregation after Aspirin or dual antiplatelet therapy (DAPT) administration when treated with aspirin and clopidogrel as compared to,
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
rs3836790,"[['cocaine', '(PA449072)']]",increased risk of,
rs3836790,"[['SLC6A3', '(PA311)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased stable warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate (RR) when treated with gefitinib in lung adenocarcinoma patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1045642,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased severity of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs4148323,"[['indinavir', '(PA449977)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs761142,"[['sulfamethoxazole', '(PA451544)']]",decreased risk of,
rs761142,"[['GCLC', '(PA28612)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased severity of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434568,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with erlotinib or gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['atazanavir', '(PA10251)']]",increased oral clearance (CL) of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased severity of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs8192678,"[['PPARGC1A', '(PA33558)']]",belongs to,
rs2970847,"[['PPARGC1A', '(PA33558)']]",belongs to,
rs10509681,"[['rosiglitazone', '(PA451283)']]",decreased risk of,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs35599367,"[['atorvastatin', '(PA448500)'], ['lovastatin', '(PA450272)'], ['simvastatin', '(PA451363)']]","decreased statin doses for optimal lipid control when treated with atorvastatin, lovastatin or simvastatin as compared to",
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs1799752,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","increased major cardiovascular events (MACE) rate when treated with Ace Inhibitors, Plain in people with Coronary Artery Disease as compared to",
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs5186,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]","increased major cardiovascular events (MACE) rate when treated with Ace Inhibitors, Plain in people with Coronary Artery Disease as compared to",
rs5186,"[['AGTR1', '(PA43)']]",belongs to,
rs35599367,"[['cyclosporine', '(PA449167)']]",increased risk of,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs35599367,"[['cyclosporine', '(PA449167)']]",decreased renal function (lower creatinine clearance) at 3 months of,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs1045642,"[['cyclosporine', '(PA449167)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1495741,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs1051266,"[['methotrexate', '(PA450428)']]",increased severity of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs121434568,"[['carboplatin', '(PA448803)'], ['erlotinib', '(PA134687924)'], ['paclitaxel', '(PA450761)']]","increased overall survival time when treated with carboplatin, erlotinib and paclitaxel in people with non-small-cell lung cancer as compared to",
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs4149056,"[['erythromycin', '(PA449493)']]",decreased erythromycin metabolism when treated with erythromycin in people with Neoplasms as compared to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2072660,"[['nicotine', '(PA450626)']]",increased severity of,
rs2072660,"[['CHRNB2', '(PA115)']]",belongs to,
rs10121600,"[['nicotine', '(PA450626)']]",increased risk of,
rs10121600,"[['GRIN3A', '(PA28983)']]",belongs to,
rs2299939,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]",decreased likelihood of,
rs2299939,"[['PTEN', '(PA33942)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",a 22% increase in therapeutic warfarin dose requirement after adjustment for clinical and genetic covariates in Hispanic-Americans when treated with warfarin as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1800566,"[['warfarin', '(PA451906)']]",a 34% increase in therapeutic warfarin dose requirement while holding clinical and genetic predictors constant in Hispanic-Americans when treated with warfarin as compared to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",increased severity of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs3784862,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs3784862,"[['ABCC1', '(PA244)']]",belongs to,
rs4148739,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs4148739,"[['ABCB1', '(PA267)']]",belongs to,
rs10280101,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs10280101,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased efficacy when treated with clopidogrel in patients that had undergone coronary angiography or had an uneventful PCI as compared to,['*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2308327,"[['temozolomide', '(PA451609)']]",increased risk of,
rs2308327,"[['MGMT', '(PA239)']]",belongs to,
rs1042713,"[['salmeterol', '(PA451300)']]",increased risk of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs12042763,"[['aspirin', '(PA448497)']]",decreased risk of,
rs12042763,"[['PTGS2', '(PA293)']]",belongs to,
rs10515115,"[['CARTPT', '(PA162381084)']]",belongs to,
rs628031,"[['metformin', '(PA450395)']]","gastrointestinal toxicity when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs628031,"[['SLC22A1', '(PA329)']]",belongs to,
HLA-B*40:01:01,"[['carbamazepine', '(PA448785)']]",decreased likelihood of,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1045642,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",decreased efficacy when treated with clopidogrel in patients that had undergone coronary angiography or had an uneventful PCI as compared to,['*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs2279343,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs1124493,"[['olanzapine', '(PA450688)']]",increased prolactin when treated with olanzapine in women as compared to,
rs1124493,"[['DRD2', '(PA27478)']]",belongs to,
rs4727494,"[['aspirin', '(PA448497)']]",decreased risk of,
rs4727494,"[['COL26A1', '(PA134887081)']]",belongs to,
rs10279545,"[['aspirin', '(PA448497)']]",decreased risk of,
rs10279545,"[['COL26A1', '(PA134887081)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased response (SVR and RVR) in HCV-HIV coinfected patients when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin as compared to",
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs1799930,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs13432159,"[['sertraline', '(PA451333)']]","increased general side-effects when treated with sertraline in people with Depressive Disorder, Major as compared to",
rs2072671,"[['cytarabine', '(PA449177)']]",increased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs1127354,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased event free survival when treated with mercaptopurine and methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7903146,"[['cyclosporine', '(PA449167)'], ['sirolimus', '(PA451365)'], ['tacrolimus', '(PA451578)']]",increased likelihood of,
rs7903146,"[['TCF7L2', '(PA36394)']]",belongs to,
rs3793790,"[['nicotine', '(PA450626)']]",decreased risk of,
rs3793790,"[['CHAT', '(PA26448)']]",belongs to,
rs10509681,"[['rosiglitazone', '(PA451283)']]","decreased mean absolute difference in HbA1c when treated with rosiglitazone in people with Diabetes Mellitus, Type 2 as compared to",
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs915120,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]",decreased likelihood of,
rs915120,"[['GRK5', '(PA180)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs9934438,"[['fluindione', '(PA165980614)']]",decreased the time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs712830,"[['cetuximab', '(PA10040)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)'], ['tegafur', '(PA452620)']]",increased severity of,
rs712830,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs8192719,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs8192719,"[['CYP2B6', '(PA123)']]",belongs to,
NAT2*4,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased likelihood of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased exposure of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2308321,"[['temozolomide', '(PA451609)']]",increased risk of,
rs2308321,"[['MGMT', '(PA239)']]",belongs to,
rs1801262,"[['repaglinide', '(PA451234)']]","decreased difference in postprandial plasma glucose (before and after drug treatment) when treated with repaglinide in people with Diabetes Mellitus, Type 2 as compared to",
rs1801262,"[['NEUROD1', '(PA31564)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased response rate when treated with erlotinib in people with lung adenocarcinoma as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate (RR) when treated with gefitinib in lung adenocarcinoma patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2494732,"[['AKT1', '(PA24684)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased exposure of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs11575893,"[['CARTPT', '(PA162381084)']]",belongs to,
"SLCO1B1*1, SLCO1B1*15","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*5","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*5","[['CYP2C19', '(PA124)']]",belongs to,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased progression-free survival (PFS) time when treated with erlotinib in bronchioloalveolar carcinoma and adenocarcinoma patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs25531,"[['citalopram', '(PA449015)']]",increased likelihood of,
rs25531,"[['SLC6A4', '(PA312)']]",belongs to,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs1051730,"[['Opium', 'alkaloids', 'and', 'derivatives', '(PA164712950)']]",increased severity of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs16871471,"[['CARTPT', '(PA162381084)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs846664,"[['ethanol', '(PA448073)']]",increased risk of,
rs846664,"[['TAS2R16', '(PA37931)']]",belongs to,
rs1042858,"[['gemcitabine', '(PA449748)']]",increased likelihood of,
rs1042858,"[['RRM1', '(PA298)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['atorvastatin', '(PA448500)']]",increased serum creatine kinase levels (increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
NAT2*6B,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6B,"[['NAT2', '(PA18)']]",belongs to,
rs1044396,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1044396,"[['CHRNA4', '(PA26490)']]",belongs to,
rs328,"[['pioglitazone', '(PA450970)']]",decreased response rate after 10 weeks of,
rs328,"[['LPL', '(PA232)']]",belongs to,
rs20455,"[['pravastatin', '(PA451089)']]",decreased risk of,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs699947,"[['sunitinib', '(PA162372840)']]",increased systolic blood pressure and increased risk of,
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['sunitinib', '(PA162372840)']]",increased systolic blood pressure and increased risk of,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
"CYP2E1*1, CYP2E1*5B","[['acetaminophen', '(PA448015)']]",increased elimination rate of,
"CYP2E1*1, CYP2E1*5B","[['CYP2E1', '(PA129)']]",belongs to,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
rs6949799,"[['aspirin', '(PA448497)']]",increased risk of,
rs6949799,"[['COL26A1', '(PA134887081)']]",belongs to,
rs13233066,"[['aspirin', '(PA448497)']]",decreased risk of,
rs13233066,"[['COL26A1', '(PA134887081)']]",belongs to,
rs17470799,"[['aspirin', '(PA448497)']]",decreased risk of,
rs17470799,"[['COL26A1', '(PA134887081)']]",belongs to,
rs11600347,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
rs11600347,"[['KCNJ1', '(PA213)']]",belongs to,
rs658903,"[['hydrochlorothiazide', '(PA449899)']]",decreased likelihood of,
rs658903,"[['KCNJ1', '(PA213)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['fluindione', '(PA165980614)']]",decreased average daily dose during the first period of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1131873,"[['EPHX1', '(PA27829)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1176744,"[['ethanol', '(PA448073)']]",increased likelihood of,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
rs967591,"[['melphalan', '(PA450354)']]",increased overall survival and time-to-treat failure when treated with melphalan in people with Multiple Myeloma as compared to,
rs967591,"[['CD3EAP', '(PA142672156)']]",belongs to,
rs2734842,"[['olanzapine', '(PA450688)']]",increased prolactin when treated with olanzapine in women as compared to,
rs2734842,"[['DRD2', '(PA27478)']]",belongs to,
NAT2*6A,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased plasma level when treated with nevirapine in people with HIV-positive as compared to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in people with non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'erlotinib', 'or', 'gefitinib', 'in', 'advanced', 'non-small-cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs4271002,"[['aspirin', '(PA448497)']]",increased risk of,
rs4271002,"[['NAT2', '(PA18)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",decreased variance in Tobacco Use Disorder associated with peer smoking when exposed to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs3765534,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs3765534,"[['ABCC4', '(PA397)']]",belongs to,
rs10515115,"[['CARTPT', '(PA162381084)']]",belongs to,
rs3857384,"[['CARTPT', '(PA162381084)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A","[['nicotine', '(PA450626)']]",decreased plasma and urinary ratio of,
"CYP2A6*1A, CYP2A6*4A","[['CYP2A6', '(PA121)']]",belongs to,
rs6535454,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs6535454,"[['COQ2', '(PA142672084)']]",belongs to,
rs17381194,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs17381194,"[['ATP2B1', '(PA25107)']]",belongs to,
rs8177516,"[['SLC22A2', '(PA331)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['warfarin', '(PA451906)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs2742417,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2742417,"[['SACM1L', '(PA34925)']]",belongs to,
rs2251954,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2251954,"[['SACM1L', '(PA34925)']]",belongs to,
rs2742421,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2742421,"[['SACM1L', '(PA34925)']]",belongs to,
rs2742423,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2742423,"[['SACM1L', '(PA34925)']]",belongs to,
rs17137967,"[['hydrochlorothiazide', '(PA449899)']]",increased fasting glucose when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs9934438,"[['fluindione', '(PA165980614)']]",shorter time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rates when treated with gefitinib in people with non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in people with EGFR mutation positive non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
rs17047764,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs17047764,"[['INSIG2', '(PA134890284)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",lower warfarin dose requirement when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",lower warfarin dose requirement when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs12041331,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased cardiovascular events in patients undergoing PCI when treated with aspirin and clopidogrel as compared to,
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
rs5219,"[['sulfonamides,', 'urea', 'derivatives', '(PA10390)']]","increased efficacy as measured by decrease in HbA1c after 6-month treatment when treated with sulfonamides, urea derivatives in people with Diabetes Mellitus, Type 2 as compared to",
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs713729,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs713729,"[['PICK1', '(PA33760)']]",belongs to,
rs8175347,"[['sorafenib', '(PA7000)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased median survival time (MST) when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2125739,"[['ABCC10', '(PA24392)']]",belongs to,
rs2293347,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs2293347,"[['EGFR', '(PA7360)']]",belongs to,
rs2808630,"[['rosuvastatin', '(PA134308647)']]",decreased plasma level of,
rs4646244,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs4646244,"[['NAT2', '(PA18)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs28399504,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs28399504,"[['CYP2C19', '(PA124)']]",belongs to,
rs4646267,"[['NAT2', '(PA18)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased progression-free survival (PFS) time when exposed to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs3813867,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased severity of,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs2235067,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs2235067,"[['ABCB1', '(PA267)']]",belongs to,
rs7270101,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","decreased anemia when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
rs1695,"[['temozolomide', '(PA451609)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs2717162,"[['nicotine', '(PA450626)']]",increased severity of,
rs2717162,"[['GALR1', '(PA28545)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs118192172,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",severe statin myopathy and unknown myopathy when exposed to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs4693075,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs4693075,"[['COQ2', '(PA142672084)']]",belongs to,
rs121434569,"[['gefitinib', '(PA131301952)']]",increased resistance when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs1969624,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs1969624,"[['SACM1L', '(PA34925)']]",belongs to,
rs2742435,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2742435,"[['SACM1L', '(PA34925)']]",belongs to,
rs2245705,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2245705,"[['SACM1L', '(PA34925)']]",belongs to,
rs2742390,"[['bupropion', '(PA448687)']]","decreased sexual side-effects when treated with bupropion in people with Depressive Disorder, Major as compared to",
rs2742390,"[['SACM1L', '(PA34925)']]",belongs to,
rs430397,"[['Platinum', 'compounds', '(PA164713176)']]",increased likelihood of,
rs430397,"[['HSPA5', '(PA29504)']]",belongs to,
rs41291556,"[['mephenytoin', '(PA450373)'], ['tolbutamide', '(PA451718)']]",dramatic (approximately 90% and 70%) reduction in the metabolism of,
rs41291556,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19*6,"[['CYP2C19', '(PA124)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]","increased maximal platelet aggregation when treated with aspirin, cilostazol and clopidogrel in high risk patients (acute myocaridal infarction, diabetes e.g.) as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs121434568,"[['erlotinib', '(PA134687924)']]",increased progression-free survival (PFS) time when treated with erlotinib in people with non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1800566,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs712829,"[['gefitinib', '(PA131301952)']]",increased response rate (RR) when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs11568315,"[['gefitinib', '(PA131301952)']]",increased median survival time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
rs2070401,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs2070401,"[['BACH1', '(PA25234)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","decreased anemia when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs2717162,"[['nicotine', '(PA450626)']]",increased severity of,
rs2717162,"[['GALR1', '(PA28545)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1130214,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]",decreased risk of,
rs1130214,"[['AKT1', '(PA24684)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with erlotinib or gefitinib in EGFR mutation positive non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs13266634,"[['SLC30A8', '(PA134915546)']]",belongs to,
rs2734841,"[['olanzapine', '(PA450688)']]",increased prolactin when treated with olanzapine in women as compared to,
rs2734841,"[['DRD2', '(PA27478)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs5219,"[['gliclazide', '(PA10892)']]","increased efficacy as measured by decrease in HbA1c when treated with gliclazide in people with Diabetes Mellitus, Type 2 as compared to",
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
NAT2*7B,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*7B,"[['NAT2', '(PA18)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased physical and life well-being quality of,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",increased overall survival (OS) time when treated with erlotinib or gefitinib in EGFR mutation positive non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs121434569,"[['gefitinib', '(PA131301952)']]",decreased response rate (RR) when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs2266780,"[['olanzapine', '(PA450688)']]",decreased dose-adjusted serum olanzapine N-oxide concentrations when treated with olanzapine as compared to,
rs2266780,"[['FMO3', '(PA166)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs684513,"[['nicotine', '(PA450626)']]",decreased risk of,
rs684513,"[['CHRNA5', '(PA26491)']]",belongs to,
rs578776,"[['nicotine', '(PA450626)']]",decreased risk of,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
rs4572514,"[['melphalan', '(PA450354)']]",increased overall survival and time-to-treat failure when treated with melphalan in people with Multiple Myeloma as compared to,
rs4572514,"[['CD3EAP', '(PA142672156)']]",belongs to,
rs1042713,"[['salbutamol', '(PA448068)'], ['salmeterol', '(PA451300)']]",increased risk of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
"NAT2*5A, NAT2*6A","[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5A, NAT2*6A","[['NAT2', '(PA18)']]",belongs to,
rs7160796,"[['corticosteroids', '(PA10832)']]",increased change in forced expiratory volume in 1 s (FEV1) when treated with corticosteroids in people with Asthma as compared to,
rs7160796,"[['DCAF4', '(PA165478762)']]",belongs to,
rs9934438,"[['fluindione', '(PA165980614)']]",shorter time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2B6*6,"[['CYP2B6', '(PA123)']]",belongs to,
rs3213729,"[['DCAF4', '(PA165478762)']]",belongs to,
rs675388,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
rs675388,"[['KCNJ1', '(PA213)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs71647871,"[['clopidogrel', '(PA449053)']]",decreased on-treatment ADP-induced platelet aggregation when treated with clopidogrel in healthy individuals as compared to,
rs71647871,"[['CES1', '(PA107)']]",belongs to,
rs1799964,"[['stavudine', '(PA451494)']]",increased likelihood of,
rs1799964,"[['TNF', '(PA435)']]",belongs to,
rs637137,"[['nicotine', '(PA450626)']]",decreased risk of,
rs637137,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1051730,"[['nicotine', '(PA450626)']]",increased risk of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs12041331,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased cardiovascular events in patients undergoing PCI when treated with aspirin and clopidogrel as compared to,
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
rs2283265,"[['cocaine', '(PA449072)']]",increased risk of,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs4149117,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs1801058,"[['atenolol', '(PA448499)'], ['verapamil', '(PA451868)']]",increased risk of,
rs1801058,"[['GRK4', '(PA28941)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1204014,"[['TAS2R16', '(PA37931)']]",belongs to,
rs978739,"[['TAS2R16', '(PA37931)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs4363657,"[['simvastatin', '(PA451363)']]",increased likelihood of,
rs4363657,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs717620,"[['leucovorin', '(PA450198)'], ['methotrexate', '(PA450428)']]",increased distribution volume when treated with leucovorin and methotrexate in people with Lymphoma as compared to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs71647871,"[['clopidogrel', '(PA449053)']]",decreased on-treatment ADP-induced platelet aggregation when treated with clopidogrel in people with Coronary Disease as compared to,
rs71647871,"[['CES1', '(PA107)']]",belongs to,
rs10919035,"[['amiodarone', '(PA448383)']]",amiodarone-induced ventricular arrhythmia and QT prolongation when treated with amiodarone as compared to,
rs10919035,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
rs231775,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (RVR) in HCV-HIV coinfected patients when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin as compared to",
rs231775,"[['CTLA4', '(PA27006)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",lack of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in people with non-small-cell lung cancer as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs9516519,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs9516519,"[['ABCC4', '(PA397)']]",belongs to,
rs2228075,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased likelihood of,
rs2228075,"[['IMPDH1', '(PA29862)']]",belongs to,
rs59172778,"[['KCNJ1', '(PA213)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
CYP2E1*1A,"[['CYP2E1', '(PA129)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs430397,"[['Platinum', 'compounds', '(PA164713176)']]","decreased progression-free survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs430397,"[['HSPA5', '(PA29504)']]",belongs to,
rs3740065,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs671,"[['heroin', '(PA452619)']]",increased Heroin Dependence due to,
rs671,"[['ALDH2', '(PA24696)']]",belongs to,
rs10033464,"[['antiarrhythmics,', 'class', 'i', 'and', 'iii', '(PA452249)']]",increased likelihood of,
rs36056065,"[['metformin', '(PA450395)']]","gastrointestinal side effects when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs36056065,"[['SLC22A1', '(PA329)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased response (SVR) in HCV genotype 1 patients when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs121434569,"[['erlotinib', '(PA134687924)']]",decreased progression-free survival (PFS) time when exposed to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
rs11568315,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2498804,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]",decreased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased warfarin dose requirement when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs12041331,"[['aspirin', '(PA448497)']]",increased risk of,
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
rs6295,"[['methamphetamine', '(PA450403)']]",Psychotic Disorders when exposed to,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
NAT2*5A,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*5A,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7A,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*7A,"[['NAT2', '(PA18)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs9332096,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
rs9332096,"[['CYP2C9', '(PA126)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",rapid viral response (RVR) to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs13393173,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs13393173,"[['CERS6', '(PA134925480)']]",belongs to,
rs12795437,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
rs12795437,"[['KCNJ1', '(PA213)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4654327,"[['naltrexone', '(PA450588)']]",increased naltrexone-induced blunting of,
rs4654327,"[['OPRD1', '(PA31942)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2070672,"[['CYP2E1', '(PA129)']]",belongs to,
rs121434568,"[['erlotinib', '(PA134687924)']]",increased response rate when treated with erlotinib in bronchioloalveolar carcinoma and adenocarcinoma patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
CYP2E1*1A,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased likelihood of,
CYP2E1*1A,"[['CYP2E1', '(PA129)']]",belongs to,
rs1044397,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1044397,"[['CHRNA4', '(PA26490)']]",belongs to,
rs1044396,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1044396,"[['CHRNA4', '(PA26490)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1570360,"[['cyclophosphamide', '(PA449165)'], ['docetaxel', '(PA449383)']]",decreased progression-free survival when treated with cyclophosphamide and docetaxel in people with Prostatic Neoplasms as compared to,
rs1570360,"[['VEGFA', '(PA37302)']]",belongs to,
rs10752271,"[['losartan', '(PA450268)']]",decreased systolic blood pressure when treated with losartan in people with Essential hypertension as compared to,
rs10752271,"[['CAMK1D', '(PA134992438)']]",belongs to,
rs10752271,"[['CAMK1D', '(PA134992438)']]",belongs to,
rs10737062,"[['losartan', '(PA450268)']]",decreased systolic blood pressure when treated with losartan in people with Essential hypertension as compared to,
rs10737062,"[['CAMK1D', '(PA134992438)']]",belongs to,
rs25531,"[['venlafaxine', '(PA451866)']]",increased reduction in HAM-A when treated with venlafaxine in people with Anxiety Disorders as compared to,
rs25531,"[['SLC6A4', '(PA312)']]",belongs to,
rs10033464,"[['antiarrhythmics,', 'class', 'i', 'and', 'iii', '(PA452249)']]","increased recurrence when treated with antiarrhythmics, class i and iii in people with Atrial Fibrillation as compared to",
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"NAT2*5A, NAT2*7A","[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5A, NAT2*7A","[['NAT2', '(PA18)']]",belongs to,
rs2070744,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs9934438,"[['fluindione', '(PA165980614)']]",decreased the time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs114202595,"[['repaglinide', '(PA451234)']]","decreased difference in postprandial plasma glucose (before and after drug treatment) when treated with repaglinide in people with Diabetes Mellitus, Type 2 as compared to",
rs114202595,"[['PAX4', '(PA32958)']]",belongs to,
rs12979860,"[['interferons', '(PA451999)']]","increased sustained virological response (svr) when treated with interferons in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs4646244,"[['NAT2', '(PA18)']]",belongs to,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs3740065,"[['methotrexate', '(PA450428)']]",increased risk of,
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs622342,"[['amantadine', '(PA448360)'], ['Anticholinergics', '(PA164712420)'], ['Dopamine', 'agonists', '(PA164712697)'], ['levodopa', '(PA450213)'], ['selegiline', '(PA451316)']]",increased risk of,
rs622342,"[['SLC22A1', '(PA329)']]",belongs to,
rs2070474,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs2070474,"[['UPB1', '(PA418)']]",belongs to,
rs231775,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs231775,"[['CTLA4', '(PA27006)']]",belongs to,
rs3803304,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]",risk of,
rs3803304,"[['AKT1', '(PA24684)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['warfarin', '(PA451906)']]",higher mean peak INR during week 1 of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs4149601,"[['NEDD4L', '(PA31534)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs11568315,"[['gefitinib', '(PA131301952)']]",increased survival time when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'non-small', 'cell', 'lung', 'cancer', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitors', 'when', 'treated', 'with', 'gefitinib', 'in', 'non-small', 'cell', 'lung', 'cancer', 'as', 'compared', 'to', 'allele', 'C.']"
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4969170,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs16969968,"[['Opium', 'alkaloids', 'and', 'derivatives', '(PA164712950)']]",increased severity of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs660652,"[['Opium', 'alkaloids', 'and', 'derivatives', '(PA164712950)']]",increased Tobacco Use Disorder when treated with Opium alkaloids and derivatives in people with Pain as compared to,
rs660652,"[['CHRNA5', '(PA26491)']]",belongs to,
rs2072661,"[['nicotine', '(PA450626)']]",increased severity of,
rs2072661,"[['CHRNB2', '(PA115)']]",belongs to,
rs2293347,"[['gefitinib', '(PA131301952)']]",increased response rate (RR) when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs2293347,"[['EGFR', '(PA7360)']]",belongs to,
rs121434569,"[['EGFR', '(PA7360)']]",increased acquired resistance to,"['inhibitor', 'when', 'treated', 'with', 'gefitinib', 'in', 'non-small', 'cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,"['inhibitor', 'when', 'treated', 'with', 'gefitinib', 'in', 'non-small', 'cell', 'lung', 'cancer', 'patients', 'as', 'compared', 'to', 'allele', 'C.']"
rs2031920,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
CYP2E1*5B,"[['CYP2E1', '(PA129)']]",belongs to,
NAT2*5B,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
rs2854116,"[['ritonavir', '(PA451260)']]",increased risk of,
rs2854116,"[['APOC3', '(PA53)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4693570,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs7543182,"[['aspirin', '(PA448497)']]",increased risk of,
rs7543182,"[['PTGER3', '(PA288)']]",belongs to,
rs12279250,"[['hydrochlorothiazide', '(PA449899)']]",increased plasma triglycerides when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs12279250,"[['NELL1', '(PA31552)']]",belongs to,
rs3763153,"[['CARTPT', '(PA162381084)']]",belongs to,
rs3763153,"[['CARTPT', '(PA162381084)']]",belongs to,
rs3857384,"[['CARTPT', '(PA162381084)']]",belongs to,
rs16871471,"[['CARTPT', '(PA162381084)']]",belongs to,
rs11195419,"[['nortriptyline', '(PA450657)']]","increased suicidal ideation when treated with nortriptyline in people with Depressive Disorder, Major as compared to",
rs11195419,"[['ADRA2A', '(PA35)']]",belongs to,
rs948854,"[['GAL', '(PA28529)']]",belongs to,
rs578776,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs7142086,"[['DCAF4', '(PA165478762)']]",belongs to,
rs10248420,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs10248420,"[['ABCB1', '(PA267)']]",belongs to,
rs4148740,"[['amitriptyline', '(PA448385)'], ['citalopram', '(PA449015)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased likelihood of,
rs4148740,"[['ABCB1', '(PA267)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs11575893,"[['CARTPT', '(PA162381084)']]",belongs to,
rs1045642,"[['sirolimus', '(PA451365)']]",increased low-density lipoprotein cholesterol when treated with sirolimus in people with Kidney Transplantation as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2061174,"[['CHRM2', '(PA111)']]",belongs to,
rs8175347,"[['raloxifene', '(PA451221)']]",increased bone mineral density when treated with raloxifene in women with Osteoporosis as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs17868320,"[['sorafenib', '(PA7000)']]",increased risk of,
rs17868320,"[['UGT1A9', '(PA419)']]",belongs to,
NAT2*6A,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs11568315,"[['gefitinib', '(PA131301952)']]",increased response rate (RR) when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
rs705379,"[['PON1', '(PA33529)']]",belongs to,
rs1801274,"[['cetuximab', '(PA10040)']]",increased overall survival when treated with cetuximab in people with Colorectal Neoplasms as compared to,
rs1801274,"[['FCGR2A', '(PA28063)']]",belongs to,
NAT2*4,"[['sulfasalazine', '(PA451547)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs2699887,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)']]",increased likelihood of,
rs2699887,"[['PIK3CA', '(PA33308)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased mean peak INR during week 1 of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",higher mean peak INR during week 1 of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1076560,"[['cocaine', '(PA449072)']]",increased risk of,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs2960306,"[['atenolol', '(PA448499)'], ['verapamil', '(PA451868)']]",increased risk of,
rs2960306,"[['GRK4', '(PA28941)']]",belongs to,
rs1024323,"[['atenolol', '(PA448499)'], ['verapamil', '(PA451868)']]",increased risk of,
rs1024323,"[['GRK4', '(PA28941)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased response rate when treated with gefitinib in advanced non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",increased rapid virological response (rvr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C as compared to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2E1*1, CYP2E1*5B","[['acetaminophen', '(PA448015)']]",increased elimination rate of,
"CYP2E1*1, CYP2E1*5B","[['CYP2E1', '(PA129)']]",belongs to,
rs10800397,"[['amiodarone', '(PA448383)']]",amiodarone-induced ventricular arrhythmia and QT prolongation when treated with amiodarone as compared to,
rs10800397,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased risk of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs396991,"[['cetuximab', '(PA10040)']]",increased antibody-dependent cellular cytotoxicity when exposed to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs499368,"[['aspirin', '(PA448497)']]",increased likelihood of,
rs499368,"[['SLC6A12', '(PA35908)']]",belongs to,
rs6347,"[['cocaine', '(PA449072)']]",increased risk of,
rs6347,"[['SLC6A3', '(PA311)']]",belongs to,
rs672348,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs672348,"[['DMPK', '(PA27380)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased progression-free survival (PFS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs3892097,"[['amitriptyline', '(PA448385)'], ['clomipramine', '(PA449048)'], ['doxepin', '(PA449409)'], ['imipramine', '(PA449969)'], ['maprotiline', '(PA450322)'], ['nortriptyline', '(PA450657)'], ['opipramol', '(PA144614922)']]",increased risk of,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs2070474,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",decreased severity of,
rs2070474,"[['UPB1', '(PA418)']]",belongs to,
rs959,"[['aspirin', '(PA448497)']]",increased risk of,
rs959,"[['PTGER3', '(PA288)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4148323,"[['indinavir', '(PA449977)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs761142,"[['sulfamethoxazole', '(PA451544)']]",decreased risk of,
rs761142,"[['GCLC', '(PA28612)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased severity of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs878567,"[['methamphetamine', '(PA450403)']]",Psychotic Disorders when exposed to,
rs878567,"[['HTR1A', '(PA192)']]",belongs to,
rs2298771,"[['SCN1A', '(PA301)']]",belongs to,
rs962369,"[['escitalopram', '(PA10074)'], ['nortriptyline', '(PA450657)']]",increased likelihood of,
rs962369,"[['BDNF', '(PA31891)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1824024,"[['CHRM2', '(PA111)']]",belongs to,
rs324650,"[['nicotine', '(PA450626)']]",increased risk of,
rs324650,"[['CHRM2', '(PA111)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1801020,"[['Enzymes', '(PA164712734)']]",increased risk of,
rs1801020,"[['F12', '(PA161)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1800629,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs430397,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs430397,"[['HSPA5', '(PA29504)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs2031920,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs59172778,"[['hydrochlorothiazide', '(PA449899)']]",increased serum potassium when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs59172778,"[['KCNJ1', '(PA213)']]",belongs to,
rs2846680,"[['hydrochlorothiazide', '(PA449899)']]",increased fasting glucose when treated with hydrochlorothiazide in people with Hypertension as compared to,
rs2846680,"[['KCNJ1', '(PA213)']]",belongs to,
rs1801160,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs4149601,"[['NEDD4L', '(PA31534)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2440390,"[['olanzapine', '(PA450688)']]",increased Weight gain when treated with olanzapine in people with Mental Disorders as compared to,
rs2440390,"[['DRD2', '(PA27478)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs860170,"[['TAS2R16', '(PA37931)']]",belongs to,
rs1042858,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs1042858,"[['RRM1', '(PA298)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",sustained virological response (SVR) and changes in viral load after 4 weeks of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs10800397,"[['amiodarone', '(PA448383)'], ['diuretics', '(PA151249535)'], ['sotalol', '(PA451457)']]","drug-induced ventricular arrhythmia and QT prolongation when treated with amiodarone, diuretics or sotalol as compared to",
rs10800397,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs3814055,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
rs3814055,"[['NR1I2', '(PA378)']]",belongs to,
rs11788456,"[['nicotine', '(PA450626)']]",risk of,
rs11788456,"[['GRIN3A', '(PA28983)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs4986893,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs11887534,"[['ABCG8', '(PA24412)']]",belongs to,
rs3813929,"[['risperidone', '(PA451257)']]",decreased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs806378,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased likelihood of,
rs806378,"[['CNR1', '(PA26681)']]",belongs to,
rs20455,"[['pravastatin', '(PA451089)']]",decreased risk of,
rs20455,"[['KIF6', '(PA134920075)']]",belongs to,
rs11101191,"[['nicotine', '(PA450626)']]",increased risk of,
rs11101191,"[['CHAT', '(PA26448)']]",belongs to,
rs867687,"[['nicotine', '(PA450626)']]",increased risk of,
"NAT2*6A, NAT2*7B","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]","increased high on-treatment platelet reactivity when treated with aspirin, cilostazol and clopidogrel in high risk patients (acute myocaridal infarction, diabetes e.g.) as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs8099917,"[['interferons', '(PA451999)']]",increased response (SVR) to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs121434568,"[['carboplatin', '(PA448803)'], ['erlotinib', '(PA134687924)'], ['paclitaxel', '(PA450761)']]","increased progression-free survival (PFS) time when treated with carboplatin, erlotinib and paclitaxel in people with non-small-cell lung cancer as compared to",
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs121434568,"[['gefitinib', '(PA131301952)']]",increased overall survival (OS) time when treated with gefitinib in non-small-cell lung cancer patients as compared to,
rs121434568,"[['EGFR', '(PA7360)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs6318,"[['olanzapine', '(PA450688)']]",increased Weight gain when treated with olanzapine in women with Mental Disorders as compared to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs2497538,"[['olanzapine', '(PA450688)']]",increased Weight gain when treated with olanzapine in women with Mental Disorders as compared to,
rs2497538,"[['HTR2C', '(PA194)']]",belongs to,
rs1414334,"[['olanzapine', '(PA450688)']]",increased Weight gain when treated with olanzapine in women with Mental Disorders as compared to,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs3812718,"[['carbamazepine', '(PA448785)']]",increased risk of,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
rs1045642,"[['sirolimus', '(PA451365)']]",increased total cholesterol when treated with sirolimus in people with Kidney Transplantation as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1495741,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)'], ['isoniazid', '(PA450112)']]",decreased mean cumulative doses of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",more frequent high platelet reactivity in Japanese patients in a steady state receiving dual antiplatelet therapy after coronary stent implantation when treated with clopidogrel as compared to,['*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",more frequent high platelet reactivity in Japanese patients in a steady state receiving dual antiplatelet therapy after coronary stent implantation when treated with clopidogrel as compared to,['*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased Neutropenia when treated with irinotecan in people with Colonic Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs1663330,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
UGT1A1*6,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs6809699,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
NAT2*14B,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*14B,"[['NAT2', '(PA18)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs7973796,"[['olanzapine', '(PA450688)']]",increased likelihood of,
rs7973796,"[['PMCH', '(PA33435)']]",belongs to,
rs1045280,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs1045280,"[['ARRB2', '(PA60)']]",belongs to,
rs110402,"[['CRHR1', '(PA26874)']]",belongs to,
HLA-DQA1*01:02:01:01,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased likelihood of,
HLA-DQA1*01:02:01:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
rs1414334,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs1880676,"[['CHAT', '(PA26448)']]",belongs to,
"NAT1*11B, NAT1*4","[['NAT1', '(PA17)']]",belongs to,
NAT2*5C,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*5C,"[['NAT2', '(PA18)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs3813928,"[['HTR2C', '(PA194)']]",belongs to,
rs34834489,"[['metformin', '(PA450395)']]",increased renal clearance and secretion clearance of,
rs34834489,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs34834489,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs1042597,"[['UGT1A8', '(PA37183)']]",belongs to,
rs12468274,"[['UGT1A4', '(PA37179)']]",belongs to,
rs2011404,"[['UGT1A4', '(PA37179)']]",belongs to,
rs1801030,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs2060761,"[['nicotine', '(PA450626)']]",increased risk of,
rs2060761,"[['DDC', '(PA140)']]",belongs to,
rs352046,"[['CXCL5', '(PA35573)']]",belongs to,
rs7186128,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3832043,"[['irinotecan', '(PA450085)']]",increased risk of,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs17701271,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs10509681,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs1800532,"[['TPH1', '(PA355)']]",belongs to,
NAT2*6A,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs3754446,"[['busulfan', '(PA448691)'], ['cytarabine', '(PA449177)'], ['etoposide', '(PA449552)']]","decreased Disease-Free Survival when treated with busulfan, cytarabine and etoposide in people with Leukemia, Myeloid, Acute as compared to",
rs3754446,"[['GSTM1', '(PA182)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
NAT2*6,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]",increased DPD activity when exposed to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased platelet inhibition after a clopidogrel 600-mg loading dose when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased venlafaxine levels when treated with venlafaxine in people with Obsessive-Compulsive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
CYP2D6 haplotype,"[['citalopram', '(PA449015)'], ['clomipramine', '(PA449048)'], ['duloxetine', '(PA10066)'], ['escitalopram', '(PA10074)'], ['fluoxetine', '(PA449673)'], ['fluvoxamine', '(PA449690)'], ['mirtazapine', '(PA450522)'], ['paroxetine', '(PA450801)'], ['sertraline', '(PA451333)'], ['venlafaxine', '(PA451866)']]",decreased number of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs4655567,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs8020368,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased risk of,
rs8020368,"[['SYNE3', '(PA134931380)']]",belongs to,
rs71647871,"[['clopidogrel', '(PA449053)']]",impaired catalytic activity towards hydrolysis of,
rs71647871,"[['CES1', '(PA107)']]",belongs to,
"NAT1*10, NAT1*11A","[['NAT1', '(PA17)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs3740066,"[['irinotecan', '(PA450085)']]",increased risk of,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs4149056,"[['irinotecan', '(PA450085)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
NAT2*5,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs1799930,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs1799931,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
rs1208,"[['NAT2', '(PA18)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased severity of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased progression-free survival when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs4793665,"[['ABCC3', '(PA376)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs1800532,"[['TPH1', '(PA355)']]",belongs to,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased pharmacodynamic response when exposed to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs28399504,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs28399504,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1057910,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs4148405,"[['busulfan', '(PA448691)'], ['cytarabine', '(PA449177)'], ['etoposide', '(PA449552)']]","decreased Disease-Free Survival when treated with busulfan, cytarabine and etoposide in people with Leukemia, Myeloid, Acute as compared to",
rs4148405,"[['ABCC3', '(PA376)']]",belongs to,
rs4680,"[['nicotine', '(PA450626)']]",decreased risk of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs12762549,"[['ABCC2', '(PA116)']]",belongs to,
rs11045585,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs6755571,"[['ABT-751', '(PA166104276)']]",decreased plasma predose concentration (Ctrough) when treated with ABT-751 in people with Neoplasms as compared to,
rs6755571,"[['UGT1A4', '(PA37179)']]",belongs to,
rs1042605,"[['UGT1A8', '(PA37183)']]",belongs to,
rs13401281,"[['UGT1A4', '(PA37179)']]",belongs to,
rs3760091,"[['SULT1A1', '(PA343)']]",belongs to,
rs12718541,"[['nicotine', '(PA450626)']]",increased risk of,
rs12718541,"[['DDC', '(PA140)']]",belongs to,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
rs1057910,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1801368,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]","decreased biochemical response, optimal cytoreduction, and sensitivity to",
rs1801368,"[['MAD1L1', '(PA372)']]",belongs to,
rs4680,"[['nicotine', '(PA450626)']]",increased blood pressure when treated with nicotine in people with Tobacco Use Disorder as compared to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs2018683,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased risk of,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2231137,"[['irinotecan', '(PA450085)']]",increased risk of,
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",risk of,
"UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs1042597,"[['cyclosporine', '(PA449167)'], ['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs1042597,"[['UGT1A8', '(PA37183)']]",belongs to,
rs6714486,"[['UGT1A9', '(PA419)']]",belongs to,
GSTT1 null,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
"NAT1*10, NAT1*4","[['NAT1', '(PA17)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs1800470,"[['TGFB1', '(PA350)']]",belongs to,
rs4790694,"[['ARRB2', '(PA60)']]",belongs to,
rs77005399,"[['CYB5A', '(PA27068)']]",belongs to,
rs7284807,"[['CYB5R3', '(PA27331)']]",belongs to,
rs1800795,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs1800795,"[['IL6', '(PA198)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs684513,"[['cocaine', '(PA449072)']]",increased likelihood of,
rs684513,"[['CHRNA5', '(PA26491)']]",belongs to,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
NAT2*5A,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*5A,"[['NAT2', '(PA18)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","increased Neutropenia when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1041983,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1041983,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7B,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*7B,"[['NAT2', '(PA18)']]",belongs to,
rs28399504,"[['clopidogrel', '(PA449053)']]",decreased platelet inhibition after a clopidogrel 600-mg loading dose when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs28399504,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C8*3,"[['paclitaxel', '(PA450761)']]",decreased clerance of,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs1495741,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)'], ['isoniazid', '(PA450112)']]",decreased mean cumulative doses of,
"CYP2B6*1, CYP2B6*6","[['bupropion', '(PA448687)']]",decreased hydroxybupropion concentrations and hydroxybupropion/bupropion ratio when exposed to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs17574269,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs17574269,"[['DCBLD1', '(PA134903108)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2C8*3,"[['amodiaquine', '(PA448404)']]",decreased metabolism of,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)'], ['raltitrexed', '(PA131625240)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased severity of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",ADP-induced maximum platelet aggregation (MPA) in clopidogrel-treated patients undergoing pe rcutaneous coronary intervention when treated with clopidogrel as compared to,['*1.']
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,['*1.']
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs6431558,"[['ABT-751', '(PA166104276)']]",increased glucuronidation metabolic ratios when treated with ABT-751 in people with Neoplasms as compared to,
rs6431558,"[['UGT1A8', '(PA37183)']]",belongs to,
rs7997012,"[['HTR2A', '(PA193)']]",belongs to,
"TPMT*1, TPMT*3A","[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs1056663,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs1056663,"[['HUS1', '(PA29564)']]",belongs to,
rs2037483,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs2037483,"[['HUS1', '(PA29564)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",increase in serum concentrations of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)'], ['raltitrexed', '(PA131625240)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs45445694,"[['irinotecan', '(PA450085)'], ['raltitrexed', '(PA131625240)']]",decreased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased Death when treated with irinotecan in people with Colorectal Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)'], ['oxcarbazepine', '(PA450732)'], ['phenobarbital', '(PA450911)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs1799971,"[['methadone', '(PA450401)'], ['morphine', '(PA450550)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs4680,"[['methadone', '(PA450401)'], ['morphine', '(PA450550)']]",decreased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs6002674,"[['salbutamol', '(PA448068)']]",decreased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs16969968,"[['ethanol', '(PA448073)']]",increased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs947267,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs947267,"[['DAOA', '(PA134924986)']]",belongs to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs9340799,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs9340799,"[['ESR1', '(PA156)']]",belongs to,
CYP2C19*3,"[['CYP2C19', '(PA124)']]",ADP-induced maximum platelet aggregation (MPA) in clopidogrel-treated patients undergoing pe rcutaneous coronary intervention when treated with clopidogrel as compared to,['*1.']
CYP2C19*3,"[['CYP2C19', '(PA124)']]",belongs to,['*1.']
rs2244613,"[['Dabigatran', '(PA165110351)']]",decreased risk of,
rs2244613,"[['CES1', '(PA107)']]",belongs to,
CYP2D6 haplotype,"[['venlafaxine', '(PA451866)']]",increased risk of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"TPMT*1, TPMT*3C","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"TPMT*3A, TPMT*3C","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",increased paroxetine serum concentrations (Cmin) when treated with paroxetine in healthy individuals as compared to,"['*1/*1', '+', '*1/*41.']"
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*41.']"
rs4680,"[['nicotine', '(PA450626)']]",increased severity of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs8020368,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs8020368,"[['SYNE3', '(PA134931380)']]",belongs to,
rs1423515,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs75160992,"[['CYB5A', '(PA27068)']]",belongs to,
rs2244613,"[['Dabigatran', '(PA165110351)']]",decreased adjusted trough concentrations when treated with Dabigatran in people with Atrial Fibrillation as compared to,
rs2244613,"[['CES1', '(PA107)']]",belongs to,
CYP2D6 haplotype,"[['fluoxetine', '(PA449673)']]",a trend of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased venlafaxine levels when treated with venlafaxine in people with Obsessive-Compulsive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs2018683,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs6809699,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs17183814,"[['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)'], ['valproic', 'acid', '(PA451846)']]","non-response when treated with carbamazepine, phenytoin or valproic acid in people with Epilepsy as compared to",
rs17183814,"[['SCN2A', '(PA35004)']]",belongs to,
rs1051730,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1801160,"[['fluorouracil', '(PA128406956)']]",decreased DPD activity when exposed to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs77499608,"[['CYB5R3', '(PA27331)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*6","[['venlafaxine', '(PA451866)']]",increased risk of,
"CYP2D6*1, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['venlafaxine', '(PA451866)']]",increased risk of,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
NAT2*5B,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
NAT2*14B,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*14B,"[['NAT2', '(PA18)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs4793665,"[['ABCC3', '(PA376)']]",belongs to,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs324420,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs578776,"[['nicotine', '(PA450626)']]",increased plasma level of,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['Calcineurin', 'inhibitors', '(PA164712580)'], ['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['cerivastatin', '(PA448897)']]",increased cerivastatin intrinsic clearance when exposed to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
APOE E4,"[['bupropion', '(PA448687)'], ['nicotine', '(PA450626)']]",increased likelihood of,
APOE E4,"[['APOE', '(PA55)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs76458556,"[['CYB5R3', '(PA27331)']]",belongs to,
CYP2C8*4,"[['paclitaxel', '(PA450761)']]",decreased enzyme activity and decreased paclitaxel 6 a -hydroxylase activity in vitro when exposed to,
CYP2C8*4,"[['CYP2C8', '(PA125)']]",belongs to,
"NAT1*11B, NAT1*3","[['NAT1', '(PA17)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)'], ['raltitrexed', '(PA131625240)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs10929302,"[['irinotecan', '(PA450085)']]",increased risk of,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs11572076,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs11572076,"[['CYP2C8', '(PA125)']]",belongs to,
rs2166219,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs12248560,"[['clopidogrel', '(PA449053)']]",decreased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
"NAT2*6, NAT2*7","[['isoniazid', '(PA450112)']]",increased risk of,
"NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
rs3916965,"[['methamphetamine', '(PA450403)']]",decreased likelihood of,
rs3916965,"[['DAOA', '(PA134924986)']]",belongs to,
rs3957357,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisone', '(PA451100)'], ['rituximab', '(PA451261)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
rs2234693,"[['ESR1', '(PA156)']]",belongs to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs66501115,"[['paclitaxel', '(PA450761)']]",decreased metabolism/clearance of,
rs66501115,"[['CYP2C8', '(PA125)']]",belongs to,
NAT1*10,"[['NAT1', '(PA17)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)']]",increased Neutropenia when treated with fluorouracil and irinotecan in people with Colorectal Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
NAT2*7,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs6431625,"[['UGT1A3', '(PA37178)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs9332096,"[['CYP2C9', '(PA126)']]",belongs to,
rs1080989,"[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1551285,"[['UGT1A8', '(PA37183)']]",belongs to,
rs871514,"[['UGT1A4', '(PA37179)']]",belongs to,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
rs16950650,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]","decreased overall survival when treated with cisplatin and irinotecan in people with Carcinoma, Small Cell as compared to",
rs16950650,"[['ABCC4', '(PA397)']]",belongs to,
rs8175347,"[['capecitabine', '(PA448771)'], ['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-B*15:02:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs4646267,"[['NAT2', '(PA18)']]",belongs to,
rs2369049,"[['exemestane', '(PA449563)']]",decreased likelihood of,
rs2369049,"[['TCL1A', '(PA36400)']]",belongs to,
rs1138518,"[['PTH1R', '(PA33953)']]",belongs to,
rs2229531,"[['ACP5', '(PA24448)']]",belongs to,
rs750155,"[['SULT1A1', '(PA343)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs11572103,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs11572103,"[['CYP2C8', '(PA125)']]",belongs to,
CYP2C8*3,"[['Calcineurin', 'inhibitors', '(PA164712580)'], ['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased Asthenia when treated with irinotecan in people with Colorectal Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4410790,"[['olanzapine', '(PA450688)']]",29% lower mean 4'-desmethyl OLA/olanzapine (OLA) ratio when treated with olanzapine in people with Psychotic Disorders as compared to,
rs4410790,"[['AHR', '(PA24641)']]",belongs to,
HLA-DRB1*16:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-DRB1*16:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1800872,"[['cyclosporine', '(PA449167)'], ['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs1800872,"[['IL10', '(PA29778)']]",belongs to,
rs1800871,"[['IL10', '(PA29778)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['citalopram', '(PA449015)'], ['fluoxetine', '(PA449673)'], ['paroxetine', '(PA450801)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['venlafaxine', '(PA451866)']]",increased risk of,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs3892097,"[['venlafaxine', '(PA451866)']]","increased venlafaxine concentration per unit dose when treated with venlafaxine in people with Depressive Disorder, Major as compared to",
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]","increased venlafaxine levels when treated with venlafaxine in people with Depressive Disorder, Major as compared to",['*1/*1.']
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs4655567,"[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased Neutropenia when treated with irinotecan in people with Colorectal Neoplasms as compared to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased residual platelet reactivity when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['prasugrel', '(PA154410481)']]",decreased rate of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs1051730,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs12233719,"[['UGT2B7', '(PA361)']]",belongs to,
rs4149117,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased dose-adjusted area under the curve (AUC6-12) of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2306862,"[['LRP5', '(PA30455)']]",belongs to,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
GSTM1 null,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
NAT2*14A,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*14A,"[['NAT2', '(PA18)']]",belongs to,
rs6214,"[['IGF1', '(PA29697)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",decreased bleeding events when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet aggregation when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
NAT2*6,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs10848635,"[['citalopram', '(PA449015)']]",increased risk of,
rs10848635,"[['CACNA1C', '(PA83)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",decreased oral clearance (CL/F) of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs1800247,"[['BGLAP', '(PA25345)']]",belongs to,
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs578776,"[['ethanol', '(PA448073)']]",decreased likelihood of,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs10868138,"[['SLC28A3', '(PA426)']]",belongs to,
rs1060896,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs1060896,"[['SLC28A2', '(PA386)']]",belongs to,
rs8187758,"[['SLC28A1', '(PA387)']]",belongs to,
rs2242046,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs2242046,"[['SLC28A1', '(PA387)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs72551330,"[['mycophenolate', 'mofetil', '(PA450566)']]",diminished estimated glomerular filtration rate (eGFR) during the first year after engraftment when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to,
rs72551330,"[['UGT1A9', '(PA419)']]",belongs to,
rs4244285,"[['prasugrel', '(PA154410481)']]",higher platelet reactivity index (PRI) vasodilator-stimulated phosphoprotein (VASP) at 1 month of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2279020,"[['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)'], ['valproic', 'acid', '(PA451846)']]","drug-resistant phenotype when treated with carbamazepine, phenytoin or valproic acid in people with Epilepsy as compared to",
rs2279020,"[['GABRA1', '(PA28489)']]",belongs to,
rs778293,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs778293,"[['DAOA', '(PA134924986)']]",belongs to,
rs1799971,"[['tramadol', '(PA451735)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs16965962,"[['citalopram', '(PA449015)']]","increased general side-effect burden when treated with citalopram in people with Depressive Disorder, Major as compared to",
rs487989,"[['POLA2', '(PA411)']]",belongs to,
rs17215836,"[['SLC28A1', '(PA387)']]",belongs to,
rs2242048,"[['SLC28A1', '(PA387)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs4986914,"[['CYP3A4', '(PA130)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs2069762,"[['IL2', '(PA195)']]",belongs to,
rs9322336,"[['exemestane', '(PA449563)']]",increased likelihood of,
rs9322336,"[['ESR1', '(PA156)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs615470,"[['CHRNA5', '(PA26491)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs568408,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs568408,"[['IL12A', '(PA29784)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs7900194,"[['warfarin', '(PA451906)']]",decreased S-warfarin clearance when treated with warfarin as compared to,
rs7900194,"[['CYP2C9', '(PA126)']]",belongs to,
rs71647872,"[['clopidogrel', '(PA449053)']]",impaired catalytic activity towards hydrolysis of,
rs71647872,"[['CES1', '(PA107)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs10929302,"[['irinotecan', '(PA450085)']]",increased Neutropenia when treated with irinotecan in people with Colonic Neoplasms as compared to,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs4149015,"[['irinotecan', '(PA450085)']]","increased Neutropenia when treated with irinotecan in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4149015,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs6714486,"[['UGT1A9', '(PA419)']]",belongs to,
rs2032582,"[['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)'], ['valproic', 'acid', '(PA451846)']]","drug-resistant phenotype when treated with carbamazepine, phenytoin or valproic acid in people with Epilepsy as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs211037,"[['GABRG2', '(PA28501)']]",belongs to,
rs2066853,"[['AHR', '(PA24641)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs4149015,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2072671,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs9859552,"[['cangrelor', '(PA165945763)']]",20% and 17% less inhibition of,
rs9859552,"[['P2RY12', '(PA134971947)']]",belongs to,
rs12248560,"[['prasugrel', '(PA154410481)']]",decreased platelet reactivity index (PRI) vasodilator-stimulated phosphoprotein (VASP) at 1 month of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['prasugrel', '(PA154410481)']]",increased rate of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['prasugrel', '(PA154410481)']]",increased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['prasugrel', '(PA154410481)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C9*3,"[['ibuprofen', '(PA449957)']]",increased duration of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
"NAT2*5B, NAT2*7B","[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5B, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs3750117,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased risk of,
rs3750117,"[['NT5C3A', '(PA31802)']]",belongs to,
"NAT2*4, NAT2*6","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)'], ['streptomycin', '(PA451512)']]",increased likelihood of,
"NAT2*4, NAT2*6","[['NAT2', '(PA18)']]",belongs to,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs5443,"[['opioids', '(PA452618)']]",increased likelihood of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs4673,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisone', '(PA451100)'], ['rituximab', '(PA451261)'], ['vincristine', '(PA451879)']]",decreased likelihood of,
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
NAT2*5A,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*5A,"[['NAT2', '(PA18)']]",belongs to,
"NAT2*6A, NAT2*7B","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs4694362,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs4694362,"[['DCK', '(PA137)']]",belongs to,
rs3745274,"[['mitotane', '(PA164746157)']]",being a predictor of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"NAT2*4, NAT2*5","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
"NAT2*4, NAT2*5","[['NAT2', '(PA18)']]",belongs to,
rs3755319,"[['UGT1A1', '(PA420)']]",belongs to,
rs3814637,"[['CYP2C19', '(PA124)']]",belongs to,
rs4918758,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2B6*18,"[['bupropion', '(PA448687)']]",decreased hydroxybupropion concentrations when exposed to,
CYP2B6*18,"[['CYP2B6', '(PA123)']]",belongs to,
rs2854744,"[['IGFBP3', '(PA29705)']]",belongs to,
CYP2C9*1,"[['phenytoin', '(PA450947)']]",decreased plasma concentration when exposed to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
"NAT2*4, NAT2*5","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)'], ['streptomycin', '(PA451512)']]",increased likelihood of,
"NAT2*4, NAT2*5","[['NAT2', '(PA18)']]",belongs to,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs9344,"[['fluorouracil', '(PA128406956)']]",decreased time-to-tumor recurrence when treated with fluorouracil in Colonic Neoplasms as compared to,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
NAT2*6,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
rs1800629,"[['cyclosporine', '(PA449167)'], ['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1799930,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs135745,"[['CSNK1E', '(PA26953)']]",belongs to,
rs3795247,"[['antineoplastic', 'agents', '(PA452621)']]",decreased progression-free survival when treated with antineoplastic agents in women with Ovarian Neoplasms as compared to,
rs3795247,"[['ZNF100', '(PA37469)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",decreased international normalized ratio variability (inr-var) when treated with warfarin as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1495741,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs35599367,"[['fluticasone', 'propionate', '(PA449686)']]",improved asthma control (as measured by decrease in average asthma control score) when treated with fluticasone propionate in children with Asthma as compared to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs4918758,"[['CYP2C9', '(PA126)']]",belongs to,
NAT2*5,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs7136446,"[['IGF1', '(PA29697)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs72551330,"[['UGT1A9', '(PA419)']]",belongs to,
rs2273697,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased area under the concentration versus time curve (AUC6-12) level of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs2070672,"[['CYP2E1', '(PA129)']]",belongs to,
rs2228075,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1799732,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs7566605,"[['INSIG2', '(PA134890284)']]",belongs to,
CYP2C19*17,"[['clopidogrel', '(PA449053)']]",enhanced response to,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
NAT2*6B,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*6B,"[['NAT2', '(PA18)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
CYP2C8*3,"[['paclitaxel', '(PA450761)']]",decreased metabolism/clearance of,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs1801123,"[['IRS1', '(PA203)']]",belongs to,
rs2854744,"[['IGFBP3', '(PA29705)']]",belongs to,
rs2946834,"[['IGF1', '(PA29697)']]",belongs to,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6714486,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs6714486,"[['UGT1A9', '(PA419)']]",belongs to,
"NAT2*6A, NAT2*7B","[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
NAT2*4,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs3832043,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased dose-adjusted area under the concentration versus time curve (AUC6-12) level of,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs10494366,"[['amlodipine', '(PA448388)'], ['Dihydropyridine', 'derivatives', '(PA164712688)'], ['nifedipine', '(PA450631)']]",increased risk of,
rs10494366,"[['NOS1AP', '(PA142671259)']]",belongs to,
rs2008584,"[['UGT1A3', '(PA37178)']]",belongs to,
rs2003569,"[['UGT1A1', '(PA420)']]",belongs to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1080983,"[['CYP2D6', '(PA128)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs1522113,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs1522113,"[['CLOCK', '(PA26609)']]",belongs to,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs1421292,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
NAT2*6A,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs17135437,"[['citalopram', '(PA449015)']]","increased hearing and vision-related side-effects when treated with citalopram in people with Depressive Disorder, Major as compared to",
rs17135437,"[['COL26A1', '(PA134887081)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['venlafaxine', '(PA451866)']]",increased risk of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs2016347,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs2016347,"[['IGF1R', '(PA29698)']]",belongs to,
CYP2C9*1,"[['phenytoin', '(PA450947)']]",decreased plasma concentration when exposed to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",increased adverse drug reactions when treated with phenytoin in Epilepsy as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs2391191,"[['methamphetamine', '(PA450403)']]",decreased likelihood of,
rs2391191,"[['DAOA', '(PA134924986)']]",belongs to,
rs1051730,"[['ethanol', '(PA448073)']]",increased likelihood of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
"NAT2*6A, NAT2*7B","[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
"NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs9344,"[['fluorouracil', '(PA128406956)']]",decreased time-to-tumor recurrence when treated with fluorouracil in Colonic Neoplasms as compared to,
rs9344,"[['CCND1', '(PA75)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
"NAT2*6, NAT2*7","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
"NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
NAT2*6,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
NAT2*13,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased risk of,
NAT2*13,"[['NAT2', '(PA18)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs1801123,"[['IRS1', '(PA203)']]",belongs to,
"NAT2*4, NAT2*7","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)'], ['streptomycin', '(PA451512)']]",increased likelihood of,
"NAT2*4, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
NAT2*6A,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs1883112,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisone', '(PA451100)'], ['rituximab', '(PA451261)'], ['vincristine', '(PA451879)']]",decreased risk of,
rs1883112,"[['NCF4', '(PA31465)']]",belongs to,
"NAT2*5, NAT2*7","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
"NAT2*5, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
NAT2*6A,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
NAT2*6A,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs11111201,"[['PMCH', '(PA33435)']]",belongs to,
rs2036657,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs2036657,"[['ARRB2', '(PA60)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased on-treatment platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs17868320,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs17868320,"[['UGT1A9', '(PA419)']]",belongs to,
NAT2*5,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
NAT2*14,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*14,"[['NAT2', '(PA18)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs2804402,"[['ABCC2', '(PA116)']]",belongs to,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs6295,"[['paroxetine', '(PA450801)']]",increased response at 4 weeks after the initiation of,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs7900194,"[['warfarin', '(PA451906)']]",decreased median weekly warfarin dose requirements when treated with warfarin as compared to,
rs7900194,"[['CYP2C9', '(PA126)']]",belongs to,
rs11030918,"[['RRM1', '(PA298)'], ['STIM1', '(PA36195)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs6988229,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs6988229,"[['COL22A1', '(PA134914705)']]",belongs to,
CYP2C9*1,"[['phenytoin', '(PA450947)']]",decreased plasma concentration when exposed to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased toxicity when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*15:02:01,"[['antiepileptics', '(PA143485705)'], ['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2279020,"[['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)'], ['valproic', 'acid', '(PA451846)']]","drug-resistant phenotype when treated with carbamazepine, phenytoin or valproic acid in people with Epilepsy as compared to",
rs2279020,"[['GABRA1', '(PA28489)']]",belongs to,
NAT2*7,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs9552679,"[['salbutamol', '(PA448068)']]",decreased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased toxicity when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased steady state concentration when treated with phenytoin in Epilepsy as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs2070673,"[['CYP2E1', '(PA129)']]",belongs to,
rs1800894,"[['IL10', '(PA29778)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs1044396,"[['nicotine', '(PA450626)']]",increased cotinine levels when exposed to,
rs1044396,"[['CHRNA4', '(PA26490)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs115632870,"[['fluorouracil', '(PA128406956)']]",decreased DPD activity when exposed to,
rs115632870,"[['DPYD', '(PA145)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*13:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*15:01:01:01, HLA-B*15:02:01, HLA-B*54:01:01","[['phenytoin', '(PA450947)']]",increased risk of,
"HLA-B*15:01:01:01, HLA-B*15:02:01, HLA-B*54:01:01","[['HLA-B', '(PA35056)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs17868320,"[['UGT1A9', '(PA419)']]",belongs to,
rs17863762,"[['UGT1A8', '(PA37183)']]",belongs to,
NAT2*6,"[['isoniazid', '(PA450112)']]",increased risk of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs2869950,"[['nicotine', '(PA450626)']]",increased BMI when exposed to,
rs2869950,"[['CHRNB4', '(PA26496)']]",belongs to,
rs578427,"[['metformin', '(PA450395)']]",increased renal clearance and secretion clearance of,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs3755319,"[['UGT1A1', '(PA420)']]",belongs to,
rs62298861,"[['UGT2B7', '(PA361)']]",belongs to,
rs9282861,"[['SULT1A1', '(PA343)'], ['SULT1A2', '(PA341)']]",belongs to,
rs1805054,"[['HTR6', '(PA29560)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs12806698,"[['RRM1', '(PA298)'], ['STIM1', '(PA36195)']]",belongs to,
rs11854484,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs11854484,"[['SLC28A2', '(PA386)']]",belongs to,
rs2290272,"[['SLC28A1', '(PA387)']]",belongs to,
rs2242047,"[['SLC28A1', '(PA387)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
P2RY12 H2,"[['clopidogrel', '(PA449053)']]",increased risk of,
P2RY12 H2,"[['P2RY12', '(PA134971947)']]",belongs to,
rs518350,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs1042597,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs1042597,"[['UGT1A8', '(PA37183)']]",belongs to,
rs2234693,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs2234693,"[['ESR1', '(PA156)']]",belongs to,
rs2069763,"[['IL2', '(PA195)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs3775289,"[['DCK', '(PA137)']]",belongs to,
rs17868320,"[['UGT1A9', '(PA419)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3924999,"[['NRG1', '(PA31776)']]",belongs to,
NAT2*5,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs9394992,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs9394992,"[['SLC29A1', '(PA154)']]",belongs to,
rs72551330,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs72551330,"[['UGT1A9', '(PA419)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"HLA-B*37:01:01, HLA-B*46:01:01","[['phenytoin', '(PA450947)']]",increased risk of,
"HLA-B*37:01:01, HLA-B*46:01:01","[['HLA-B', '(PA35056)']]",belongs to,
rs1006737,"[['citalopram', '(PA449015)']]",increased risk of,
rs1006737,"[['CACNA1C', '(PA83)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs115232898,"[['fluorouracil', '(PA128406956)']]",decreased DPD activity when exposed to,
rs115232898,"[['DPYD', '(PA145)']]",belongs to,
rs9332094,"[['CYP2C9', '(PA126)']]",belongs to,
rs4742,"[['DCTD', '(PA138)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
rs4244285,"[['etravirine', '(PA166014703)']]",decreased etravirine clearance when treated with etravirine in people with HIV as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs11252394,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs2298771,"[['SCN1A', '(PA301)']]",belongs to,
rs1864729,"[['estradiol', '(PA449503)']]",increased plasma level of,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs1799930,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs2032582,"[['cyclosporine', '(PA449167)'], ['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1800471,"[['TGFB1', '(PA350)']]",belongs to,
rs1799929,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs6438552,"[['GSK3B', '(PA29009)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs61764370,"[['cetuximab', '(PA10040)'], ['panitumumab', '(PA162373091)']]",nonresponse to,
rs61764370,"[['KRAS', '(PA30196)']]",belongs to,
rs9937,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
NAT2*5B,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
NAT2*7A,"[['NAT2', '(PA18)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs334558,"[['lithium', '(PA450243)']]",decreased response when treated with lithium in people with Bipolar Disorder as compared to,
rs334558,"[['GSK3B', '(PA29009)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs17587100,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs17587100,"[['INSIG2', '(PA134890284)']]",belongs to,
rs61764370,"[['ETFRF1', '(PA162394773)'], ['KRAS', '(PA30196)']]",belongs to,
rs1663332,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs10511905,"[['salbutamol', '(PA448068)']]",decreased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
"HLA-B*15:02:01, HLA-B*46:01:01","[['phenytoin', '(PA450947)']]",increased risk of,
"HLA-B*15:02:01, HLA-B*46:01:01","[['HLA-B', '(PA35056)']]",belongs to,
rs6714486,"[['UGT1A9', '(PA419)']]",belongs to,
NAT2*6,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
NAT2*14,"[['NAT2', '(PA18)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",decreased antiplatelet response and reduced clopidogrel active metabolite formation when exposed to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs55886062,"[['fluorouracil', '(PA128406956)']]",decreased DPD activity when exposed to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased clopi-H4 concentrations after 300 or 900 mg clopidogrel loading dose when treated with clopidogrel in men with Myocardial Infarction as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased platelet inhibition when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
NAT2*12,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased risk of,
NAT2*12,"[['NAT2', '(PA18)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs11706052,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs1799931,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs11706052,"[['cyclosporine', '(PA449167)'], ['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
rs11849538,"[['exemestane', '(PA449563)']]",decreased likelihood of,
rs11849538,"[['TCL1A', '(PA36400)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
NAT2*4,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",decreased likelihood of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs3745274,"[['mitotane', '(PA164746157)']]",increased mitotane plasma concentrations when treated with mitotane in people with Adrenocortical Carcinoma as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs17868320,"[['mycophenolate', 'mofetil', '(PA450566)']]",changes in mycophenolic acid exposure-related parameters on day 7 after transplantation (treatment with 2g per day) when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to,
rs17868320,"[['UGT1A9', '(PA419)']]",belongs to,
rs6714486,"[['mycophenolate', 'mofetil', '(PA450566)']]",changes in mycophenolic acid exposure-related parameters on day 7 after transplantation (treatment with 2g per day) when treated with mycophenolate mofetil in people with Kidney Transplantation as compared to,
rs6714486,"[['UGT1A9', '(PA419)']]",belongs to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
rs17863762,"[['UGT1A8', '(PA37183)']]",belongs to,
rs7311358,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased dose-adjusted area under the curve (AUC6-12) of,
rs7311358,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs1045642,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs1048977,"[['CDA', '(PA98)']]",belongs to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs6809699,"[['clopidogrel', '(PA449053)']]",stronger aggreagtion when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2472297,"[['olanzapine', '(PA450688)']]",25% higher mean 4'-desmethyl OLA/olanzapine (OLA) ratio when treated with olanzapine in people with Psychotic Disorders as compared to,
rs2472297,"[['CYP1A1', '(PA27092)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
NAT2*5B,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",decreased antiplatelet response and reduced clopidogrel active metabolite formation when exposed to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs3798220,"[['aspirin', '(PA448497)']]",decreased risk of,
rs3798220,"[['LPA', '(PA30432)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
"NAT1*10, NAT1*11B","[['NAT1', '(PA17)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1419555,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased therapeutic serum concentration when treated with phenytoin in Epilepsy as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"HLA-B*46:01:01, HLA-B*51:02:01","[['phenytoin', '(PA450947)']]",increased risk of,
"HLA-B*46:01:01, HLA-B*51:02:01","[['HLA-B', '(PA35056)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs3832043,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased dose-adjusted area under the concentration versus time curve (AUC6-12) level of,
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",increased metabolic ratio (defined as ratio of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1800497,"[['disulfiram', '(PA449376)']]",increased likelihood of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
HLA-C*08:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-C*08:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1042597,"[['UGT1A8', '(PA37183)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs3798220,"[['LPA', '(PA30432)']]",belongs to,
NAT2*4,"[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)'], ['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7B,"[['isoniazid', '(PA450112)']]",increased likelihood of,
NAT2*7B,"[['NAT2', '(PA18)']]",belongs to,
rs1137617,"[['calcium', 'channel', 'blockers', '(PA10407)'], ['nitrendipine', '(PA146096020)']]",increased reduction in blood pressure when treated with calcium channel blockers or nitrendipine in people with Essential hypertension as compared to,
rs1137617,"[['KCNH2', '(PA212)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs72728438,"[['fluorouracil', '(PA128406956)']]",decreased DPD activity when exposed to,
rs72728438,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",decreased oral clearance (CL/F) of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs3798220,"[['LPA', '(PA30432)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",increased metabolic ratio (defined as ratio of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs4790694,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs4790694,"[['ARRB2', '(PA60)']]",belongs to,
rs4790694,"[['nicotine', '(PA450626)']]",increased risk of,
rs4790694,"[['ARRB2', '(PA60)']]",belongs to,
HLA-DQB1*02:01:01,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased likelihood of,
HLA-DQB1*02:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs2486001,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs2486001,"[['SLC6A9', '(PA35916)']]",belongs to,
rs1880676,"[['CHAT', '(PA26448)']]",belongs to,
rs686,"[['nicotine', '(PA450626)']]",increased risk of,
rs686,"[['DRD1', '(PA147)']]",belongs to,
rs4532,"[['nicotine', '(PA450626)']]",increased risk of,
rs4532,"[['DRD1', '(PA147)']]",belongs to,
rs2305799,"[['ACP5', '(PA24448)']]",belongs to,
rs6254,"[['PTH', '(PA33951)']]",belongs to,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
NAT2*13,"[['NAT2', '(PA18)']]",belongs to,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
GSTM1 null,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",increased area under curve (AUC) of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs6092,"[['dexamethasone', '(PA449247)']]",increased risk of,
rs6092,"[['SERPINE1', '(PA261)']]",belongs to,
NAT2*4,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs1041983,"[['NAT2', '(PA18)']]",belongs to,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs45607939,"[['NAT2', '(PA18)']]",belongs to,
rs9922316,"[['dexmedetomidine', '(PA449256)']]",increased dexmedetomidine ED50 values for drug-induced dorsal hand vein (DHV) constriction when exposed to,
rs9922316,"[['PRKCB', '(PA33761)']]",belongs to,
rs1045642,"[['olanzapine', '(PA450688)']]",increased social and clinical needs when treated with olanzapine in people with Psychotic Disorders as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2C19*2,"[['clopidogrel', '(PA449053)']]",decreased antiplatelet response and reduced clopidogrel active metabolite formation when exposed to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['efavirenz', '(PA449441)'], ['omeprazole', '(PA450704)']]",increased area under curve (AUC) of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2248829,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs2248829,"[['SLC6A9', '(PA35916)']]",belongs to,
rs518147,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs684513,"[['CHRNA5', '(PA26491)']]",belongs to,
CYP2C8*2,"[['amodiaquine', '(PA448404)']]",decreased metabolism of,
CYP2C8*2,"[['CYP2C8', '(PA125)']]",belongs to,
rs34834489,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased plasma exposure to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs10929302,"[['irinotecan', '(PA450085)']]",increased risk of,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased severity of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","higher mean baseline HCV RNA level and steeper 1st phase HCV RNA decline in genotype 2 and 3 HCV infected patients when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to",
rs12979860,"[['IFNL3', '(PA134952671)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs2283265,"[['disulfiram', '(PA449376)']]",increased likelihood of,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
"NAT1*11A, NAT1*4","[['NAT1', '(PA17)']]",belongs to,
rs17495520,"[['salbutamol', '(PA448068)']]",increased bronchodilator response (FEV1) when treated with salbutamol in Asthma as compared to,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs7663179,"[['CYB5A', '(PA27068)']]",belongs to,
rs8190370,"[['CYB5R3', '(PA27331)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs615470,"[['ethanol', '(PA448073)']]",decreased likelihood of,
rs615470,"[['CHRNA5', '(PA26491)']]",belongs to,
NAT2*7A,"[['sulfamethoxazole', '(PA451544)'], ['trimethoprim', '(PA451788)']]",increased risk of,
NAT2*7A,"[['NAT2', '(PA18)']]",belongs to,
CYP2C8*3,"[['repaglinide', '(PA451234)']]",decreased repaglinide AUC when exposed to,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
CYP2C8*4,"[['cerivastatin', '(PA448897)']]",increased cerivastatin intrinsic clearance when exposed to,
CYP2C8*4,"[['CYP2C8', '(PA125)']]",belongs to,
rs12943590,"[['metformin', '(PA450395)']]",increased renal clearance and secretion clearance of,
rs12943590,"[['SLC47A2', '(PA162403847)']]",belongs to,
rs8060157,"[['raloxifene', '(PA451221)'], ['tamoxifen', '(PA451581)']]",decreased risk of,
rs8060157,"[['ZNF423', '(PA134903681)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",decreased platelet inhibition by aspirin when exposed to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs3842787,"[['PTGS1', '(PA24346)']]",belongs to,
rs10654848,"[['GGCX', '(PA28660)']]",belongs to,
rs1045642,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol when treated with simvastatin as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799752,"[['perindopril', '(PA450877)']]",increased likelihood of,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1800888,"[['ADRB2', '(PA39)']]",belongs to,
rs1105879,"[['UGT1A6', '(PA37181)']]",belongs to,
CYP2C9*3,"[['doxepin', '(PA449409)']]",decreased median oral clearance of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",increased sensitivity to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs5896,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs5896,"[['F2', '(PA157)']]",belongs to,
rs705379,"[['atorvastatin', '(PA448500)']]",decreased oxidative stress when treated with atorvastatin in people with Hypercholesterolemia as compared to,
rs705379,"[['PON1', '(PA33529)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased plasma Cmin values when treated with efavirenz in HIV as compared to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4646316,"[['cisplatin', '(PA449014)']]",increased risk of,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs1051730,"[['Drugs', 'used', 'in', 'nicotine', 'dependence', '(PA164712720)']]",increased chance of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs6785930,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity index (PRI) at 4 h after the dosing when treated with clopidogrel in healthy individuals as compared to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs2032582,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol when treated with simvastatin as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
ABCB1*2(PMID:12893986),"[['ABCB1', '(PA267)']]",increased reduction in total cholesterol when treated with simvastatin in men as compared to,['*1.']
ABCB1*2(PMID:12893986),"[['ABCB1', '(PA267)']]",belongs to,['*1.']
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs11587213,"[['FCER1G', '(PA28057)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",increased hospital stay when treated with tacrolimus in people with Kidney Transplantation as compared to,"['*1/*1', '+', '*1/*2.']"
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
CYP2C9*3,"[['acenocoumarol', '(PA452632)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs12248560,"[['clopidogrel', '(PA449053)']]",greater platelet inhibition 2 h after a 600-mg dose when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",increased plasma thioguanine nucleotides metabolites when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*3C.']
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,['*1/*3C.']
"SLCO1B1*15, SLCO1B1*1A","[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) and Cmax when exposed to,
"SLCO1B1*15, SLCO1B1*1A","[['SLCO1B1', '(PA134865839)']]",belongs to,
"SLCO1B1*15, SLCO1B1*1A","[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) and Cmax when exposed to,
"SLCO1B1*15, SLCO1B1*1A","[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1799930,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased inhibition of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799853,"[['clopidogrel', '(PA449053)']]",decreased inhibition of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['clopidogrel', '(PA449053)']]",decreased inhibition of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased warfarin dose in Korean patients with mechanical heart valve replacement since day 7 of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*13","[['warfarin', '(PA451906)']]",decreased warfarin dose in Korean patients with mechanical heart valve replacement since day 7 of,
"CYP2C9*1, CYP2C9*13","[['CYP2C9', '(PA126)']]",belongs to,
rs1801280,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
CYP2C9*1,"[['phenytoin', '(PA450947)']]",increased the mean maximal elimination rates (V(max)) when exposed to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet aggregation values when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased platelet responsiveness to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",decreased antiplatelet effect when treated with clopidogrel in healthy individuals as compared to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs16851030,"[['aspirin', '(PA448497)']]",increased risk of,
rs16851030,"[['ADORA1', '(PA24583)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]","increased trough blood concentration normalized for the daily dose (C) per kilogram body weight (D) (C/D, ng/ml/mg/kg/day) ratio during the first month after transplantation when treated with tacrolimus as compared to",
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",high post-clopidogrel platelet reactivity when treated with clopidogrel in undergoing scheduled percutaneous coronary intervention as compared to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*2,"[['phenprocoumon', '(PA450921)']]",increased risk of,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
rs510317,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs510317,"[['F7', '(PA160)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1800460,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs5050,"[['aspirin', '(PA448497)']]",increased risk of,
rs5050,"[['AGT', '(PA42)']]",belongs to,
rs3775291,"[['aspirin', '(PA448497)']]",increased risk of,
rs3775291,"[['TLR3', '(PA36551)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1805094,"[['LEPR', '(PA229)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1042714,"[['metoprolol', '(PA450480)']]",increased triglycerides due to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
"CYP2C19*1, CYP2C19*6","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*6","[['CYP2C19', '(PA124)']]",belongs to,
NAT2*5A,"[['NAT2', '(PA18)']]",belongs to,
NAT2*5C,"[['NAT2', '(PA18)']]",belongs to,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs61767072,"[['ADRA2C', '(PA37)']]",belongs to,
rs1131882,"[['aspirin', '(PA448497)']]",increased risk of,
rs1131882,"[['TBXA2R', '(PA348)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs701265,"[['P2RY1', '(PA32868)']]",belongs to,
rs1042714,"[['metoprolol', '(PA450480)']]",decreased total cholesterol due to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs429358,"[['APOE', '(PA55)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs4133101,"[['celecoxib', '(PA448871)']]",increased risk of,
rs4133101,"[['PTGER4', '(PA289)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",non response when exposed to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs12201199,"[['cisplatin', '(PA449014)']]",increased risk of,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased ADP-induced maximum platelet aggregation when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs4291,"[['aspirin', '(PA448497)']]",increased risk of,
rs4291,"[['ACE', '(PA139)']]",belongs to,
CYP2C9*3,"[['phenprocoumon', '(PA450921)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs4994,"[['ADRB3', '(PA24598)']]",belongs to,
CYP2D6*4,"[['metoprolol', '(PA450480)']]",increased risk of,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs17671591,"[['HMGCR', '(PA189)']]",belongs to,
rs10474433,"[['HMGCR', '(PA189)']]",belongs to,
"CYP2C19*1, CYP2C19*5","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*5","[['CYP2C19', '(PA124)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased maintenance dose of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2046934,"[['clopidogrel', '(PA449053)']]",increased platelet activation response to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
"CYP2D6*3, CYP2D6*4","[['doxepin', '(PA449409)']]",Poisoning when exposed to,
"CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1041983,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1041983,"[['NAT2', '(PA18)']]",belongs to,
CYP2C9*1,"[['phenytoin', '(PA450947)']]",increased the intrinsic metabolic activity (V(max)/K(m)) when exposed to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",increased the maximal elimination rate (Vmax) when treated with phenytoin in Epilepsy as compared to,['*1/*3.']
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,['*1/*3.']
rs2228079,"[['aspirin', '(PA448497)']]",decreased risk of,
rs2228079,"[['ADORA1', '(PA24583)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*4, CYP2D6*6","[['clomipramine', '(PA449048)'], ['quetiapine', '(PA451201)']]",increased risk of,
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",higher P2Y12 reaction units (PRU) and lower percent inhibition when treated with clopidogrel in people with Cerebrovascular Disorders as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased Cmax of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
VKORC1*2,"[['warfarin', '(PA451906)']]",shorter time to,
VKORC1*2,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1126742,"[['CYP4A11', '(PA27118)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs5985,"[['aspirin', '(PA448497)']]",increased inhibition of,
rs5985,"[['F13A1', '(PA162)']]",belongs to,
SLCO1B1*15,"[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) when exposed to,
SLCO1B1*15,"[['SLCO1B1', '(PA134865839)']]",belongs to,
SLCO1B1*15,"[['pravastatin', '(PA451089)']]",increased pravastatin plasma concentrations (AUC) when exposed to,
SLCO1B1*15,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs776746,"[['fluconazole', '(PA449653)'], ['tacrolimus', '(PA451578)']]",decreased dose of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased the mean maximal elimination rate (Vmax) when treated with phenytoin in Epilepsy as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased response when treated with fluvastatin or simvastatin as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs4244285,"[['clopidogrel', '(PA449053)']]",high post-clopidogrel platelet reactivity when treated with clopidogrel in undergoing scheduled percutaneous coronary intervention as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1126510,"[['aspirin', '(PA448497)']]",decreased risk of,
rs1126510,"[['PTGIR', '(PA291)']]",belongs to,
rs12248560,"[['amitriptyline', '(PA448385)']]",decreased amitriptyline levels and metabolic ratio AT/NT when treated with amitriptyline as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
GSTM1 null,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",decreased severity of,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs12777823,"[['warfarin', '(PA451906)']]","reduced warfarin dose in African Americans, independent of",
rs776746,"[['fluconazole', '(PA449653)'], ['tacrolimus', '(PA451578)']]",decreased time to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1042713,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)'], ['Angiotensin', 'II', 'Antagonists', '(PA164712372)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['digoxin', '(PA449319)'], ['diuretics', '(PA151249535)'], ['spironolactone', '(PA451483)']]",increased risk of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs1799752,"[['hydrochlorothiazide', '(PA449899)']]",increased hydrochlorothiazide induced potassium excretion when treated with hydrochlorothiazide in men with Hypertension as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1051640,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1051640,"[['ABCC3', '(PA376)']]",belongs to,
rs9332377,"[['cisplatin', '(PA449014)']]",increased risk of,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
"CYP2C19*1, CYP2C19*5","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*5","[['CYP2C19', '(PA124)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*8","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs6759892,"[['UGT1A9', '(PA419)']]",belongs to,
rs2740574,"[['tacrolimus', '(PA451578)']]",decreased dose-adjusted tacrolimus blood concentrations when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799752,"[['enalapril', '(PA449456)']]",increased bone mineral density response when treated with enalapril in women with Hypertension as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19*2,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",increased venlafaxine Cmax and AUC when treated with venlafaxine in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs4244285,"[['clomipramine', '(PA449048)']]",increased mean clomipramine concentrations corrected for dose and weight and higher metabolic ratio of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs12777823,"[['warfarin', '(PA451906)']]","reduced warfarin dose in African Americans, independent of",
rs1937840,"[['doxorubicin', '(PA449412)']]",decreased absolute leucocyte and neutrophil counts on day 15 when treated with doxorubicin in women with Breast Neoplasms as compared to,
rs1937840,"[['AKR1C3', '(PA24679)']]",belongs to,
rs4680,"[['morphine', '(PA450550)']]",increased numerical rating scale (NRS) score for pain during painful procedure when treated with morphine in a painful procedure as compared to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",decreased phenytoin metabolic clearance (PMC) and phenytoin metabolic ratio (PMR) when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1801133,"[['pravastatin', '(PA451089)']]",decreased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
CYP2C19*3,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19*3,"[['CYP2C19', '(PA124)']]",belongs to,
rs11587213,"[['aspirin', '(PA448497)']]",increased risk of,
rs11587213,"[['FCER1G', '(PA28057)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs2070959,"[['irinotecan', '(PA450085)']]",increased risk of,
rs2070959,"[['UGT1A6', '(PA37181)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",increased post-treatment ADP-stimulated platelet aggregation when treated with clopidogrel in healthy individuals as compared to,['*1.']
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,['*1.']
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1937840,"[['docetaxel', '(PA449383)'], ['doxorubicin', '(PA449412)']]",increased overall survival (OS) time when treated with docetaxel and doxorubicin in women with Breast Neoplasms as compared to,
rs1937840,"[['AKR1C3', '(PA24679)']]",belongs to,
rs1126643,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs12529,"[['Antiandrogens', '(PA164712397)']]",increased risk of,
rs12529,"[['AKR1C3', '(PA24679)']]",belongs to,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
APOE E4,"[['APOE', '(PA55)']]",belongs to,
rs2075797,"[['aspirin', '(PA448497)']]",decreased risk of,
rs2075797,"[['PTGER2', '(PA287)']]",belongs to,
rs2241883,"[['fenofibrate', '(PA449594)']]",increased risk of,
rs2241883,"[['FABP1', '(PA27956)']]",belongs to,
P2RY12 F,"[['P2RY12', '(PA134971947)']]",decreased residual on-clopidogrel platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,['A.']
P2RY12 F,"[['P2RY12', '(PA134971947)']]",belongs to,['A.']
rs5128,"[['APOC3', '(PA53)']]",belongs to,
rs2231142,"[['fluvastatin', '(PA449688)']]",increased exposure to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1042714,"[['atenolol', '(PA448499)'], ['metoprolol', '(PA450480)']]",increased risk of,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs5918,"[['clopidogrel', '(PA449053)']]",less decrease in the platelet reactivity after 600 mg of,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs1045642,"[['oxaliplatin', '(PA131285527)']]",increased recurrence-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs6065,"[['aspirin', '(PA448497)']]",increased risk of,
rs6065,"[['GP1BA', '(PA178)']]",belongs to,
rs428785,"[['pravastatin', '(PA451089)']]",decreased likelihood of,
rs428785,"[['ADAMTS1', '(PA24536)']]",belongs to,
CYP2C19*3,"[['CYP2C19', '(PA124)']]",belongs to,
rs8330,"[['acetaminophen', '(PA448015)']]",decreased risk of,
rs8330,"[['UGT1A', '(PA37173)']]",belongs to,
rs60282872,"[['SREBF1', '(PA335)']]",belongs to,
rs1137101,"[['simvastatin', '(PA451363)']]",increased percentage change in HDL-C levels when treated with simvastatin in people with Coronary Disease as compared to,
rs1137101,"[['LEPR', '(PA229)']]",belongs to,
rs8050894,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs8050894,"[['VKORC1', '(PA133787052)']]",belongs to,
rs4680,"[['morphine', '(PA450550)']]",increased overall mean numerical rating scale (NRS) score for pain when treated with morphine in a painful procedure as compared to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
"APOE E2, APOE E4","[['APOE', '(PA55)']]",belongs to,
rs1353411,"[['aspirin', '(PA448497)']]",increased risk of,
rs1353411,"[['PTGER2', '(PA287)']]",belongs to,
rs2230806,"[['pravastatin', '(PA451089)']]",increased HDL-cholesterol when treated with pravastatin in people with Coronary Disease as compared to,
rs2230806,"[['ABCA1', '(PA24373)']]",belongs to,
rs569108,"[['MS4A2', '(PA31109)']]",belongs to,
rs10929303,"[['acetaminophen', '(PA448015)']]",decreased risk of,
rs10929303,"[['UGT1A', '(PA37173)']]",belongs to,
rs1042640,"[['acetaminophen', '(PA448015)']]",decreased risk of,
rs1042640,"[['UGT1A', '(PA37173)']]",belongs to,
CYP2D6*4,"[['doxepin', '(PA449409)']]",decreased median oral clearance of,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*3, CYP2D6*5","[['doxepin', '(PA449409)']]",decreased median oral clearance of,
"CYP2D6*3, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs1048943,"[['CYP1A1', '(PA27092)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",higher P2Y12 reaction units (PRU) and lower percent inhibition when treated with clopidogrel in people with Cerebrovascular Disorders as compared to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased residual platelet reactivity when treated with clopidogrel in people with Coronary Disease as compared to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs8050894,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirements on day 14 when treated with warfarin as compared to,
rs8050894,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs3812718,"[['fluorouracil', '(PA128406956)']]",decreased time to,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4292,"[['aspirin', '(PA448497)']]",increased risk of,
rs4292,"[['ACE', '(PA139)']]",belongs to,
"CYP2D6*4, CYP2D6*5","[['doxepin', '(PA449409)']]",decreased median oral clearance of,
"CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose (40% lower) when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2D6*4,"[['atorvastatin', '(PA448500)']]",increased likelihood of,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs1801252,"[['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['metoprolol', '(PA450480)']]",increased improvement in left ventricular(LV) remodeling when treated with Beta Blocking Agents and metoprolol in people with Heart Failure as compared to,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
rs17655652,"[['pravastatin', '(PA451089)']]",increased reduction in LDL-C when treated with pravastatin in men as compared to,
rs17655652,"[['NPC1L1', '(PA31699)']]",belongs to,
rs11591147,"[['PCSK9', '(PA38617)']]",belongs to,
"CYP2C9*2, CYP2C9*3","[['sulfamethoxazole', '(PA451544)']]",increased risk of,
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
NAT2*7B,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*5","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*5","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased warfarin dose in Korean patients with mechanical heart valve replacement since day 7 of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*13","[['warfarin', '(PA451906)']]",delayed time to,
"CYP2C9*1, CYP2C9*13","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose and increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2070744,"[['atorvastatin', '(PA448500)']]",increased anti-inflammatory effects of,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs16944,"[['pravastatin', '(PA451089)']]",increased adenosine-stimulated myocardial flow when treated with pravastatin in men as compared to,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs510335,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs510335,"[['F7', '(PA160)']]",belongs to,
rs28371685,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs28371685,"[['CYP2C9', '(PA126)']]",belongs to,
rs5985,"[['F13A1', '(PA162)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs8050894,"[['warfarin', '(PA451906)']]",decreased warfarin dose and increased risk of,
rs8050894,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2241883,"[['FABP1', '(PA27956)']]",belongs to,
rs1799752,"[['atorvastatin', '(PA448500)'], ['quinapril', '(PA451205)']]",increased reduction in CRP levels when treated with atorvastatin and quinapril in men with Coronary Artery Disease as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",increased prothrombin time (PT) at induction when treated with warfarin as compared to,['*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*2,"[['warfarin', '(PA451906)']]",decreased warfarin dose and increased risk of,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
rs700519,"[['CYP19A1', '(PA27091)']]",belongs to,
rs10455872,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",poorer reduction in low-density lipoprotein cholesterol (LDLc) when treated with hmg coa reductase inhibitors as compared to,
rs10455872,"[['LPA', '(PA30432)']]",belongs to,
"CYP2C9*1, CYP2C9*6","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*6","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased warfarin dose in Japanese patients when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs1142345,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs7551789,"[['aspirin', '(PA448497)']]",increased risk of,
rs7551789,"[['PTGER3', '(PA288)']]",belongs to,
rs7412,"[['APOE', '(PA55)']]",belongs to,
rs2010851,"[['fluorouracil', '(PA128406956)']]",decreased time to,
rs2010851,"[['WNT5B', '(PA38104)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose after adjustment for VKORC1*1173 when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs776746,"[['CYP3A', '(PA27114)'], ['CYP3A5', '(PA131)']]",belongs to,
rs58425034,"[['CYP2B6', '(PA123)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel in PCI-scheduled patients as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2289669,"[['SLC47A1', '(PA162403808)'], ['SNORA59B', '(PA144596299)']]",belongs to,
rs4986790,"[['TLR4', '(PA36552)']]",belongs to,
rs6787801,"[['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity in CYP2C19*1/*1 carriers when treated with clopidogrel in patients undergoing percutaneous coronary intervention as compared to,
rs6787801,"[['P2RY12', '(PA134971947)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['phenytoin', '(PA450947)']]",decreased phenytoin metabolic clearance (PMC) and phenytoin metabolic ratio (PMR) when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs1128503,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol when treated with simvastatin as compared to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs72552763,"[['SLC22A1', '(PA329)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs2901783,"[['warfarin', '(PA451906)']]",outcome time to,
rs2901783,"[['CYP2C18', '(PA127)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
VKORC1 H7,"[['VKORC1', '(PA133787052)']]",increased warfarin dose when treated with warfarin as compared to,['H1.']
VKORC1 H7,"[['VKORC1', '(PA133787052)']]",belongs to,['H1.']
rs2359612,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs2359612,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased unbound oral clearance for S-warfarin when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs2032582,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol when treated with simvastatin as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs7572857,"[['aspirin', '(PA448497)']]",increased risk of,
rs7572857,"[['CEP68', '(PA134991391)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs9376230,"[['hydroxyurea', '(PA449942)']]",increased likelihood of,
rs9376230,"[['MAP3K5', '(PA30601)']]",belongs to,
rs5788,"[['PTGS1', '(PA24346)']]",belongs to,
rs1799752,"[['atorvastatin', '(PA448500)'], ['quinapril', '(PA451205)']]",decreased reduction in D-dimer levels when treated with atorvastatin and quinapril in men with Coronary Artery Disease as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs9332096,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirement in mechanical heart valve replacement patients when treated with warfarin as compared to,
rs9332096,"[['CYP2C9', '(PA126)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",increased plasma methylmercaptopurine nucleotides levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*3C.']
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,['*1/*3C.']
rs2484516,"[['ADRA2A', '(PA35)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1051740,"[['phenprocoumon', '(PA450921)']]",increased likelihood of,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
rs11078659,"[['celecoxib', '(PA448871)']]",increased risk of,
rs11078659,"[['ALOX12', '(PA45)']]",belongs to,
rs60282872,"[['SREBF1', '(PA335)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs4673,"[['simvastatin', '(PA451363)']]",increased reduction in DNA damage when treated with simvastatin in people with Hypercholesterolemia as compared to,
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased VASP index when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs9483947,"[['hydroxyurea', '(PA449942)']]",increased likelihood of,
rs9483947,"[['MAP3K5', '(PA30601)']]",belongs to,
APOE E4,"[['APOE', '(PA55)']]",belongs to,
rs4918758,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirement in mechanical heart valve replacement patients when treated with warfarin as compared to,
rs4918758,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",decreased clopidogrel active metabolite level when treated with clopidogrel in healthy individuals as compared to,['*1.']
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
"CYP2C9*1, CYP2C9*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
HMGCR H7,"[['HMGCR', '(PA189)']]",belongs to,
rs2302821,"[['celecoxib', '(PA448871)']]",increased risk of,
rs2302821,"[['PTGES', '(PA33948)']]",belongs to,
rs17655652,"[['pravastatin', '(PA451089)']]",decreased reduction in LDL-C when treated with pravastatin in women as compared to,
rs17655652,"[['NPC1L1', '(PA31699)']]",belongs to,
rs8014194,"[['CLMN', '(PA134945356)']]",belongs to,
rs1799752,"[['atorvastatin', '(PA448500)'], ['quinapril', '(PA451205)']]",decreased reduction in IL-6 levels when treated with atorvastatin and quinapril in men with Coronary Artery Disease as compared to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs16944,"[['pravastatin', '(PA451089)']]",increased IL1B serum levels when treated with pravastatin in men as compared to,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs16944,"[['pravastatin', '(PA451089)']]",increased coronary flow reserve when treated with pravastatin in men as compared to,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs699664,"[['GGCX', '(PA28660)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs2066844,"[['tacrolimus', '(PA451578)']]",increased hospital stay when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs2066844,"[['NOD2', '(PA26074)']]",belongs to,
rs730012,"[['aspirin', '(PA448497)']]",increased risk of,
rs730012,"[['LTC4S', '(PA235)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",increased risk of,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs11676382,"[['warfarin', '(PA451906)']]",decreased dose of,
rs11676382,"[['GGCX', '(PA28660)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity when treated with clopidogrel in patients undergoing percutaneous coronary intervention as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",a more rapid attainment of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3856806,"[['aspirin', '(PA448497)']]",increased decline in FEV 1 after aspirin provocation when exposed to,
rs3856806,"[['PPARG', '(PA281)']]",belongs to,
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased residual platelet reactivity when treated with clopidogrel in people with Coronary Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs699664,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs699664,"[['GGCX', '(PA28660)']]",belongs to,
"CYP2C9*1, CYP2C9*14","[['warfarin', '(PA451906)']]",decreased warfarin dose in Korean patients with mechanical heart valve replacement since day 7 of,
"CYP2C9*1, CYP2C9*14","[['CYP2C9', '(PA126)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs705379,"[['PON1', '(PA33529)']]",belongs to,
rs2740574,"[['atorvastatin', '(PA448500)'], ['simvastatin', '(PA451363)']]",decreased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs7518660,"[['celecoxib', '(PA448871)']]",increased risk of,
rs7518660,"[['IL23R', '(PA134935109)']]",belongs to,
rs1613662,"[['aspirin', '(PA448497)']]",increased risk of,
rs1613662,"[['GP6', '(PA28824)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",shorter bleeding time when exposed to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs4986790,"[['pravastatin', '(PA451089)']]",decreased risk of,
rs4986790,"[['TLR4', '(PA36552)']]",belongs to,
rs2032582,"[['simvastatin', '(PA451363)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
APOE E2,"[['APOE', '(PA55)']]",belongs to,
"CYP2C19*1, CYP2C19*4","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",decreased clopidogrel inhibition of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs5918,"[['clopidogrel', '(PA449053)']]",decreased antiplatelet effect to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirements on day 14 when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirements on day 14 when treated with warfarin as compared to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2B6*5,"[['CYP2B6', '(PA123)']]",high on-treatment platelet reactivity in CYP2C19*1/*1 carriers when treated with clopidogrel in patients undergoing percutaneous coronary intervention as compared to,['*1.']
CYP2B6*5,"[['CYP2B6', '(PA123)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs1937840,"[['docetaxel', '(PA449383)'], ['doxorubicin', '(PA449412)']]",increased progression-free survival (PFS) time when treated with docetaxel and doxorubicin in women with Breast Neoplasms as compared to,
rs1937840,"[['AKR1C3', '(PA24679)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs8050894,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs8050894,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",increased mean INR values in patients with heart valve replacement when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs7572857,"[['aspirin', '(PA448497)']]",increased decline of,
rs7572857,"[['CEP68', '(PA134991391)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clomipramine', '(PA449048)']]",increased mean clomipramine concentrations corrected for dose and weight and higher metabolic ratio of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs11692021,"[['irinotecan', '(PA450085)']]",increased risk of,
rs11692021,"[['UGT1A9', '(PA419)']]",belongs to,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs717620,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs11615,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",decreased Cmax of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs25487,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",later onset of,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased exposure to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799853,"[['clopidogrel', '(PA449053)']]",decreased exposure to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['clopidogrel', '(PA449053)']]",decreased exposure to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1126643,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased collagen-induced platelet aggregation when treated with aspirin and clopidogrel in patients undergoing coronary stenting as compared to,
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
rs16846673,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6136,"[['SELP', '(PA35643)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity index (PRI) at 4 h after the dosing when treated with clopidogrel in healthy individuals as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['citalopram', '(PA449015)']]",increased metabolic ratio CIT/DCIT values and mean citalopram dose when treated with citalopram as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799929,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs12721646,"[['CYP2B6', '(PA123)']]",belongs to,
APOE E2,"[['APOE', '(PA55)']]",belongs to,
rs34059508,"[['SLC22A1', '(PA329)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
CYP2D6*10,"[['venlafaxine', '(PA451866)']]",increased Cmax and AUC of,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs6977967,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['hydrocortisone', '(PA449905)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs12248560,"[['clopidogrel', '(PA449053)']]",decreased platelet aggregation values when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirements on day 14 when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
rs4149056,"[['pravastatin', '(PA451089)']]",increased AUC0-12 when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs8050894,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs8050894,"[['VKORC1', '(PA133787052)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
CYP2D6*10,"[['venlafaxine', '(PA451866)']]",increased Cmax and AUC of,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8667,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['hydrocortisone', '(PA449905)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs8667,"[['ATF5', '(PA25090)']]",belongs to,
rs230493,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",decreased likelihood of,
rs230493,"[['NFKB1', '(PA248)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased ADP-induced maximum platelet aggregation when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs9934438,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4961,"[['hydrochlorothiazide', '(PA449899)']]",increased hydrochlorothiazide induced calcium retention when treated with hydrochlorothiazide in men with Hypertension as compared to,
rs4961,"[['ADD1', '(PA31)']]",belongs to,
CYP3A5*3A,"[['CYP3A5', '(PA131)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs461473,"[['SLC22A1', '(PA329)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
APOE E2,"[['APOE', '(PA55)']]",belongs to,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased dose-adjusted tacrolimus blood concentration when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1059288,"[['aspirin', '(PA448497)']]",increased FEV1 decrease after aspirin challenge when exposed to,
rs1059288,"[['TAPBP', '(PA36331)']]",belongs to,
rs28399504,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs28399504,"[['CYP2C19', '(PA124)']]",belongs to,
rs2286461,"[['warfarin', '(PA451906)']]",warfarin dose when treated with warfarin as compared to,
rs2286461,"[['FGFBP2', '(PA162388435)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799971,"[['opioids', '(PA452618)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",aspirin-depressed thrombin generation and prolonged bleeding time after aspirin when treated with aspirin in people with Coronary Artery Disease as compared to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",increased blood loss when exposed to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs708272,"[['atorvastatin', '(PA448500)'], ['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",increased risk of,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs3812718,"[['fluorouracil', '(PA128406956)']]",decreased time to,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1.']
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,['*1.']
rs12248560,"[['citalopram', '(PA449015)']]",decreased metabolic ratio CIT/DCIT values when treated with citalopram as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['doxepin', '(PA449409)']]",decreased median oral clearance of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs17782313,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs17782313,"[['MC4R', '(PA30676)']]",belongs to,
rs1065852,"[['iloperidone', '(PA161199368)']]",increased QTc interval when treated with iloperidone in people with Schizophrenia as compared to,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2B6*18,"[['CYP2B6', '(PA123)']]",increased plasma efavirenz levels when treated with efavirenz in people with HIV as compared to,['*1/*1.']
CYP2B6*18,"[['CYP2B6', '(PA123)']]",belongs to,['*1/*1.']
rs2242480,"[['clopidogrel', '(PA449053)']]",reduced GP IIb/IIIa activation and lower platelet activation when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*11","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*11","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs367543000,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased venlafaxine Cmax and AUC when treated with venlafaxine in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs702553,"[['diuretics', '(PA151249535)']]",decreased baseline mean arterial blood pressure when treated with diuretics in people with Nephrosclerosis as compared to,
rs702553,"[['PDE4D', '(PA33130)']]",belongs to,
CYP2C9*2,"[['warfarin', '(PA451906)']]",shorter time to,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
rs510335,"[['F7', '(PA160)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs4803419,"[['efavirenz', '(PA449441)']]",increased plasma Cmin values when treated with efavirenz in HIV as compared to,
rs4803419,"[['CYP2B6', '(PA123)']]",belongs to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs1065776,"[['aspirin', '(PA448497)']]",increased net decrease in AA-induced platelet aggregation after aspirin treatment when treated with aspirin in healthy individuals as compared to,
rs1065776,"[['P2RY1', '(PA32868)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",suboptimal reperfusion (post-PCI TIMI flow <3) when treated with clopidogrel in people with Myocardial Infarction as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time in therapeutic range of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['venlafaxine', '(PA451866)']]",increased Cmax and AUC of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs4244285,"[['amitriptyline', '(PA448385)']]",increased amitriptyline plasma levels and metabolic ratio AT/NT values but not amtriptyline+nortriptyline plasma concentration when treated with amitriptyline as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased platelet function when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",decreased in vivo metabolism of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased platelet responsiveness to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs17878544,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",delayed time to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*14","[['warfarin', '(PA451906)']]",delayed time to,
"CYP2C9*1, CYP2C9*14","[['CYP2C9', '(PA126)']]",belongs to,
rs1050891,"[['aspirin', '(PA448497)']]",decreased risk of,
rs1050891,"[['HNMT', '(PA190)']]",belongs to,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",increased risk of,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",a lower risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*3,"[['warfarin', '(PA451906)']]",decreased warfarin dose and increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs1128503,"[['simvastatin', '(PA451363)']]",decreased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['simvastatin', '(PA451363)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma Cmin values when treated with efavirenz in HIV as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1236913,"[['PTGS1', '(PA24346)']]",belongs to,
rs1062535,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs1062535,"[['ITGA2', '(PA204)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenprocoumon', '(PA450921)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2252281,"[['SLC47A1', '(PA162403808)']]",belongs to,
rs3749598,"[['purine', 'analogues', '(PA452634)']]",risk of,
rs3749598,"[['FSTL5', '(PA134978045)']]",belongs to,
CYP2C9*2,"[['acenocoumarol', '(PA452632)']]",increased risk of,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2046934,"[['clopidogrel', '(PA449053)']]",decreased platelet function when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs11558538,"[['HNMT', '(PA190)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs12979860,"[['IFNL3', '(PA134952671)']]",belongs to,
rs588765,"[['Drugs', 'used', 'in', 'nicotine', 'dependence', '(PA164712720)']]",increased chance of,
rs588765,"[['CHRNA5', '(PA26491)']]",belongs to,
"CYP2B6*1, CYP2B6*18","[['CYP2B6', '(PA123)']]",increased plasma efavirenz levels when treated with efavirenz in people with HIV as compared to,['*1/*1.']
"CYP2B6*1, CYP2B6*18","[['CYP2B6', '(PA123)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*3, CYP2C9*4","[['CYP2C9', '(PA126)']]",decreased warfarin dose when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3, CYP2C9*4","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1801253,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)'], ['Angiotensin', 'II', 'Antagonists', '(PA164712372)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['digoxin', '(PA449319)'], ['diuretics', '(PA151249535)'], ['spironolactone', '(PA451483)']]",decreased risk of,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose in Japanese patients when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1799983,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)'], ['Angiotensin', 'II', 'Antagonists', '(PA164712372)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['digoxin', '(PA449319)'], ['diuretics', '(PA151249535)'], ['spironolactone', '(PA451483)']]",increased risk of,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs8192715,"[['CYP2B7P1', '(PA27106)']]",belongs to,
rs1800469,"[['aspirin', '(PA448497)']]",increased risk of,
rs1800469,"[['TGFB1', '(PA350)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",belongs to,
rs10306114,"[['aspirin', '(PA448497)']]",increased risk of,
rs10306114,"[['PTGS1', '(PA24346)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1128503,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs4148416,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased risk of,
rs4148416,"[['ABCC3', '(PA376)']]",belongs to,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs7179742,"[['aspirin', '(PA448497)']]",increased risk of,
rs7179742,"[['FSIP1', '(PA142671750)']]",belongs to,
rs4986791,"[['TLR4', '(PA36552)']]",belongs to,
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",increased mean INR value when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs2125739,"[['ABCC10', '(PA24392)']]",belongs to,
rs4523,"[['aspirin', '(PA448497)']]",increased risk of,
rs4523,"[['TBXA2R', '(PA348)']]",belongs to,
rs2231142,"[['simvastatin', '(PA451363)']]",increased exposure to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs588765,"[['CHRNA5', '(PA26491)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs5789,"[['PTGS1', '(PA24346)']]",belongs to,
CYP2C9*3,"[['warfarin', '(PA451906)']]",shorter time to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased risk of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs2229107,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['atorvastatin', '(PA448500)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C9*3,"[['phenprocoumon', '(PA450921)']]",increased likelihood of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs4148737,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased risk of,
rs4148737,"[['ABCB1', '(PA267)']]",belongs to,
rs10276036,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['vincristine', '(PA451879)']]",increased risk of,
rs10276036,"[['ABCB1', '(PA267)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs1799971,"[['heroin', '(PA452619)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2246709,"[['CYP3A4', '(PA130)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs705379,"[['PON1', '(PA33529)']]",belongs to,
rs3856806,"[['aspirin', '(PA448497)']]",increased risk of,
rs3856806,"[['PPARG', '(PA281)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs1065776,"[['P2RY1', '(PA32868)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased clopidogrel inhibition of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2470890,"[['CYP1A2', '(PA27093)']]",belongs to,
rs17880887,"[['warfarin', '(PA451906)']]",lower levels of,
rs17880887,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1126643,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]","increased platelet aggregation after stimuli with adenosine diphosphate, collagen, and epinephrine when treated with aspirin and clopidogrel in people with Coronary Disease as compared to",
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased time in therapeutic range of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs10030044,"[['raloxifene', '(PA451221)'], ['tamoxifen', '(PA451581)']]",increased risk of,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
CYP2B6*6,"[['CYP2B6', '(PA123)']]",increased plasma efavirenz levels when treated with efavirenz in people with HIV as compared to,['*1/*1.']
CYP2B6*6,"[['CYP2B6', '(PA123)']]",belongs to,['*1/*1.']
rs2071888,"[['aspirin', '(PA448497)']]",increased FEV1 decrease after aspirin challenge when exposed to,
rs2071888,"[['TAPBP', '(PA36331)']]",belongs to,
rs17708472,"[['warfarin', '(PA451906)']]",higher dose of,
rs17708472,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['oxaliplatin', '(PA131285527)']]",increased overall survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)']]",less effective platelet inhibition by aspirin when treated with aspirin in patients after cardiopulmonary bypass as compared to,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased time to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",increased reduction in total cholesterol when treated with simvastatin in men as compared to,['*1.']
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",belongs to,['*1.']
rs701265,"[['P2RY1', '(PA32868)']]",belongs to,
rs4244285,"[['clomipramine', '(PA449048)']]",increased metabolic ratio CLOM/DCLOM values when treated with clomipramine as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2228043,"[['purine', 'analogues', '(PA452634)']]",risk of,
rs2228043,"[['IL6ST', '(PA29837)']]",belongs to,
rs1057910,"[['clopidogrel', '(PA449053)']]",decreased platelet inhibition 7h after a clopidogrel 600-mg loading dose when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1128503,"[['oxaliplatin', '(PA131285527)']]",increased overall survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1799752,"[['spironolactone', '(PA451483)']]","improvement in left ventricular ejection fraction, end-systolic and end-diastolic volume when treated with spironolactone in people with chronic heart failure as compared to",
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C9*2,"[['phenprocoumon', '(PA450921)']]",increased likelihood of,
CYP2C9*2,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2","[['doxepin', '(PA449409)']]",decreased AUC of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased antiplatelet effect when treated with clopidogrel in healthy individuals as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs708272,"[['CETP', '(PA108)']]",belongs to,
rs2884737,"[['warfarin', '(PA451906)']]",decreased warfarin dose requirements on day 14 when treated with warfarin as compared to,
rs2884737,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs1143627,"[['aspirin', '(PA448497)']]",Peptic Ulcer when treated with aspirin in people with Cardiovascular Diseases as compared to,
rs1143627,"[['IL1B', '(PA29808)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs622342,"[['metformin', '(PA450395)']]",decreased CL renal reference and lower and CL sec reference when exposed to,
rs622342,"[['SLC22A1', '(PA329)']]",belongs to,
rs2427827,"[['FCER1A', '(PA28056)']]",belongs to,
rs2768759,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['amitriptyline', '(PA448385)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['escitalopram', '(PA10074)']]",increased frequency of,
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs5443,"[['nortriptyline', '(PA450657)']]","improvements in neurovegetative symptoms when treated with nortriptyline in people with Depressive Disorder, Major as compared to",
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs5443,"[['nortriptyline', '(PA450657)']]","Weight gain when treated with nortriptyline in people with Depressive Disorder, Major as compared to",
rs5443,"[['GNB3', '(PA176)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['amitriptyline', '(PA448385)'], ['clomipramine', '(PA449048)'], ['doxepin', '(PA449409)'], ['imipramine', '(PA449969)'], ['maprotiline', '(PA450322)'], ['nortriptyline', '(PA450657)'], ['opipramol', '(PA144614922)']]",increased risk of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased intragastric pH when treated with lansoprazole in healthy individuals as compared to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
rs2952768,"[['fentanyl', '(PA449599)'], ['opioids', '(PA452618)']]",increased analgesic requirements in patients after cosmetic orthognathic surgery when treated with fentanyl and opioids as compared to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",Respiratory Insufficiency when treated with tramadol as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs2279020,"[['GABRA1', '(PA28489)']]",belongs to,
rs2229944,"[['GABRB2', '(PA28496)']]",belongs to,
"CYP2D6*4, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*6,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased intragastric pH when treated with lansoprazole in healthy individuals as compared to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
rs2108622,"[['warfarin', '(PA451906)']]",increased serum R -warfarin concentration when treated with warfarin as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased On-clopidogrel platelet aggregation (PA) and higher platelet reactivity index (PRI) in patients undergoing elective percutaneous coronary intervention (PCI) when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['citalopram', '(PA449015)']]",decreased citalopram oral clearances of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
G6PD A- 202A_376G,"[['rasburicase', '(PA10176)']]",Hemolysis when exposed to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['rosuvastatin', '(PA134308647)']]",decreased plasma concentrations of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",increased plasma concentrations of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",decreased percentage change in LDL-cholesterol levels when treated with rosuvastatin in people with Hypercholesterolemia as compared to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['levofloxacin', '(PA450214)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1045642,"[['levofloxacin', '(PA450214)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['levofloxacin', '(PA450214)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['levofloxacin', '(PA450214)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",increased side effects when treated with oxycodone in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased tramadol metabolism and response when treated with tramadol in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",decreased tramadol clearance in chinese volunteers when treated with tramadol in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs4291,"[['amlodipine', '(PA448388)'], ['chlorthalidone', '(PA448970)'], ['lisinopril', '(PA450242)']]","decreased fasting glucose when treated with amlodipine, chlorthalidone or lisinopril in people with Hypertension as compared to",
rs4291,"[['ACE', '(PA139)']]",belongs to,
rs10455872,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",poorer reduction in low-density lipoprotein cholesterol (LDLc) when treated with hmg coa reductase inhibitors as compared to,
rs10455872,"[['LPA', '(PA30432)']]",belongs to,
rs10455872,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs10455872,"[['LPA', '(PA30432)']]",belongs to,
rs10455872,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs10455872,"[['LPA', '(PA30432)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tramadol', '(PA451735)']]",decreased metabolism of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1800497,"[['risperidone', '(PA451257)']]",increased Neurotoxicity Syndromes when treated with risperidone in healthy individuals as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs139887,"[['SOX10', '(PA36027)']]",belongs to,
rs544093,"[['carboplatin', '(PA448803)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs544093,"[['OPRM1', '(PA31945)']]",belongs to,
rs544093,"[['OPRM1', '(PA31945)']]",belongs to,
rs879207,"[['carboplatin', '(PA448803)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]","increased fluoxetine plasma concentration when treated with fluoxetine in people with Depressive Disorder, Major as compared to","['extensive', 'metabolizers.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]","decreased paroxetine serum concentration when treated with paroxetine in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['flecainide', '(PA449646)']]",decreased oral clearance (CL/F) of,
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*36","[['flecainide', '(PA449646)']]",decreased oral clearance (CL/F) of,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*36","[['CYP2D6', '(PA128)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['oxycodone', '(PA450741)']]",decreased response (pain relief) to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",increased age-related decline in flecainide clearance patients treated with oral flecainide for supraventricular tachyarrhythmias when treated with flecainide as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",Respiratory Insufficiency when treated with codeine as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*3","[['nortriptyline', '(PA450657)']]",increased apparent terminal elimination half-life when exposed to,
"CYP2D6*1, CYP2D6*3","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['nortriptyline', '(PA450657)']]",increased apparent terminal elimination half-life when exposed to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['mirtazapine', '(PA450522)']]",increased serum concentrations of,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1799853,"[['acenocoumarol', '(PA452632)']]",increased risk of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs6787801,"[['cangrelor', '(PA165945763)']]",5% lower ADP-induced peak platelet aggregation in-vitro when exposed to,
rs6787801,"[['P2RY12', '(PA134971947)']]",belongs to,
rs7699188,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","increased tumor response rate when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs7699188,"[['ABCG2', '(PA390)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased meal-stimulated plasma gastrin concentrations when treated with omeprazole in people with Ulcer as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs2452600,"[['PDLIM5', '(PA134917248)']]",belongs to,
rs193922803,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs2884129,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",increased paroxetine Vm (maximal rate) when treated with paroxetine in people with Depressive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
CYP2D6*4,"[['amitriptyline', '(PA448385)']]",toxicity when exposed to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased amitriptyline/nortriptyline ratio corrected for dose and weight when treated with amitriptyline in people with Mental Disorders as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
CYP2D6*1xN,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['citalopram', '(PA449015)']]",increased AUC of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]","increased median concentration/dose ratio and median parent drug/metabolite ratio when treated with citalopram or escitalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs5896,"[['warfarin', '(PA451906)']]",decreased warfarin dose when treated with warfarin as compared to,
rs5896,"[['F2', '(PA157)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2231142,"[['efavirenz', '(PA449441)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased paroxetine Vm (maximal rate) when treated with paroxetine in people with Depressive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP3A4*1, CYP3A4*22","[['ticagrelor', '(PA165374673)']]",increased platelet aggregation inhibition when exposed to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['nortriptyline', '(PA450657)']]",decreased maximum plasma concentration of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6","[['mirtazapine', '(PA450522)']]",increased S-mirtazapine plasma levels in non-smokers at day 14 of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs11212617,"[['metformin', '(PA450395)']]","increased treatment success when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs11212617,"[['C11orf65', '(PA144596484)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased pain tolerance in cold pressor test when treated with oxycodone in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['nortriptyline', '(PA450657)']]",increased maximum plasma concentration of,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]","decreased mean logarithm escitalopram concentration and higher mean metabolic ratio when treated with escitalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*35","[['doxepin', '(PA449409)']]",decreased AUC of,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN, CYP2D6*35","[['CYP2D6', '(PA128)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs2853826,"[['efavirenz', '(PA449441)'], ['lopinavir', '(PA450264)'], ['Nucleoside', 'and', 'nucleotide', 'reverse', 'transcriptase', 'inhibitors', '(PA164712943)'], ['ritonavir', '(PA451260)']]","increased baseline adiponectin and with greater adiponectin decline when treated with efavirenz, lopinavir, Nucleoside and nucleotide reverse transcriptase inhibitors or ritonavir in people with HIV as compared to",
rs2952768,"[['opioids', '(PA452618)']]",less vulnerability to,
rs3745274,"[['efavirenz', '(PA449441)']]",risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2D6*4, CYP2D6*6","[['hydrocodone', '(PA449900)']]",response to,
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]","increased paroxetine plasma concentration when treated with paroxetine in people with Depressive Disorder, Major as compared to","['extensive', 'metabolizers.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
"CYP2D6*3, CYP2D6*4","[['paroxetine', '(PA450801)']]",increased paroxetine plasma concentrations increased during the course of,
"CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs2274407,"[['efavirenz', '(PA449441)']]",risk of,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs12407843,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs12407843,"[['PEAR1', '(PA162399233)']]",belongs to,
rs3737224,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs3737224,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tramadol', '(PA451735)']]",decreased metabolism and decreased response to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased S(+)-N-desmethylmirtazapine when treated with mirtazapine in people with Mental Disorders as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['cisplatin', '(PA449014)']]",increased risk of,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs7699188,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs7699188,"[['ABCG2', '(PA390)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs5443,"[['nortriptyline', '(PA450657)']]",decreased likelihood of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
"CYP2D6*11, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*5,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased intragastric pH when treated with omeprazole in people with Ulcer as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs12948783,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]",decreased efficact as measured by lower pain relief to,
rs12948783,"[['RHBDF2', '(PA134980674)']]",belongs to,
rs12211463,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
rs6313,"[['efavirenz', '(PA449441)']]",decreased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs2230345,"[['atenolol', '(PA448499)'], ['hydrochlorothiazide', '(PA449899)'], ['trandolapril', '(PA451737)'], ['verapamil', '(PA451868)']]",decreased risk of,
rs2230345,"[['GRK5', '(PA180)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs13422094,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",decreased response to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*6","[['tramadol', '(PA451735)']]",decreased tramadol metabolism when exposed to,
"CYP2D6*1, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*6","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased age-related decline in flecainide clearance patients treated with oral flecainide for supraventricular tachyarrhythmias when treated with flecainide as compared to,['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*36","[['CYP2D6', '(PA128)']]",increased age-related decline in flecainide clearance patients treated with oral flecainide for supraventricular tachyarrhythmias when treated with flecainide as compared to,['*1.']
"CYP2D6*1, CYP2D6*36","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
rs2473967,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased amitriptyline/nortriptyline ratio corrected for dose and weight when treated with amitriptyline in people with Mental Disorders as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*3","[['tramadol', '(PA451735)']]",decreased tramadol metabolism when exposed to,
"CYP2D6*1, CYP2D6*3","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['escitalopram', '(PA10074)']]",increased frequency of,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased citalopram AUC and terminal elimination half-life when treated with citalopram in healthy individuals as compared to,"['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['escitalopram', '(PA10074)']]",increased serum concentration of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]","increased mean escitalopram concentration when treated with escitalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]","increased mean logarithm escitalopram concentration when treated with escitalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['propafenone', '(PA451131)']]","decreased metabolism, elevated plasma concentration and better efficacy of",
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]","increased plasma concentrations when treated with antidepressants in people with Depressive Disorder, Major as compared to","['*1/*1', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
rs6314,"[['HTR2A', '(PA193)']]",belongs to,
"CYP2D6*3, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*4, CYP2D6*6","[['oxycodone', '(PA450741)'], ['tramadol', '(PA451735)']]",intolerance to,
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['codeine', '(PA449088)'], ['hydrocodone', '(PA449900)'], ['oxycodone', '(PA450741)']]",increased risk of,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tramadol', '(PA451735)']]",decreased tramadol metabolism when exposed to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*4, CYP2D6*5","[['donepezil', '(PA449394)']]",increased likelihood of,
"CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['mirtazapine', '(PA450522)']]",increased serum concentrations of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs6313,"[['paroxetine', '(PA450801)']]",increased risk of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
"CYP2C19*1, CYP2C19*4","[['CYP2C19', '(PA124)']]","increased intolerance when treated with citalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['escitalopram', '(PA10074)']]",decreased serum concentration of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['citalopram', '(PA449015)']]",decreased citalopram oral clearances of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]","increased paroxetine plasma concentration when treated with paroxetine in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['paroxetine', '(PA450801)']]",increased paroxetine plasma concentrations increased during the course of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs822442,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs822442,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['amitriptyline', '(PA448385)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*4, CYP2D6*6","[['codeine', '(PA449088)']]",intolerance to,
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['escitalopram', '(PA10074)']]",increased serum concentration of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
G6PD A- 202A_376G,"[['methylene', 'blue', '(PA450457)']]",a lack of,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN, CYP2D6*5","[['desipramine', '(PA449233)']]",a trend towards increased clearance of,
"CYP2D6*1, CYP2D6*2xN, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs4646425,"[['escitalopram', '(PA10074)']]","increased nausea/vomiting when treated with escitalopram in people with Depressive Disorder, Major as compared to",
rs4646425,"[['CYP1A2', '(PA27093)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased paroxetine Vm (maximal rate) when treated with paroxetine in people with Depressive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['tramadol', '(PA451735)']]",decreased metabolism and decreased response to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]","increased paroxetine plasma concentration when treated with paroxetine in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
rs9282564,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]","nonsignificantly higher paroxetine concentration when treated with paroxetine in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased sedation when treated with trimipramine in healthy individuals as compared to,"['*1/*2xN', '+', '*1/*1.']"
"CYP2D6*1, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*2xN', '+', '*1/*1.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C8*1A, CYP2C8*2","[['pioglitazone', '(PA450970)']]",decreased M-III:pioglitazone AUC0-48 ratio and M-III:M-IV AUC0-48 ratio in healthy African-American volunteers when exposed to,
"CYP2C8*1A, CYP2C8*2","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6","[['oxycodone', '(PA450741)']]",decreased serum concentrations of,
"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs2952768,"[['opioids', '(PA452618)']]",increased analgesic requirements in patients underwent major open abdominal surgery under combined general and epidural anesthesia when treated with opioids as compared to,
"CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
rs822441,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs822441,"[['PEAR1', '(PA162399233)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['nortriptyline', '(PA450657)']]",increased mean nortriptyline concentrations and nortriptyline concentrations per unit dose of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['paroxetine', '(PA450801)']]",decreased paroxetine plasma concentrations increased during the course of,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased age-related decline in flecainide clearance patients treated with oral flecainide for supraventricular tachyarrhythmias when treated with flecainide as compared to,['*1.']
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
rs77235035,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs77235035,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['antidepressants', '(PA452229)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*21, CYP2D6*36","[['flecainide', '(PA449646)']]",decreased oral clearance (CL/F) of,
"CYP2D6*1, CYP2D6*2, CYP2D6*21, CYP2D6*36","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased desipramine/2-hydroxy-desipramine ratio when treated with desipramine in people with Mental Disorders as compared to,"['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['desipramine', '(PA449233)']]",decreased metabolic ratios of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['imipramine', '(PA449969)']]",decreased dose-corrected plasma concentrations of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['nortriptyline', '(PA450657)']]",increased mean nortriptyline concentrations and nortriptyline concentrations per unit dose of,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]","increased S-CIT serum concentrations when treated with escitalopram in people with Depressive Disorder, Major as compared to","['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['oxycodone', '(PA450741)']]",mean plasma concentration of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*6, CYP2D6*9","[['desipramine', '(PA449233)']]",increased elimination half-life and drug exposure when exposed to,
"CYP2D6*1, CYP2D6*2, CYP2D6*6, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['desipramine', '(PA449233)']]",decreased metabolic ratios of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",increased pain tolerance in cold pressor test when treated with oxycodone in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*5","[['tramadol', '(PA451735)']]",decreased metabolism and decreased response to,
"CYP2D6*1, CYP2D6*3, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*5","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*3, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",decreased tramadol clearance in chinese volunteers when treated with tramadol in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*3","[['nortriptyline', '(PA450657)']]",increased mean nortriptyline concentrations and nortriptyline concentrations per unit dose of,
"CYP2D6*1, CYP2D6*3","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]","increased nortriptyline concentrations corrected for dose and weight when treated with nortriptyline in people with Depressive Disorder, Major as compared to","['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased paroxetine levels when treated with paroxetine in people with Obsessive-Compulsive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['desipramine', '(PA449233)']]",increased steady-state plasma concentrations of,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*41","[['desipramine', '(PA449233)']]",decreased desipramine elimination half-life and total exposure when exposed to,
"CYP2D6*1, CYP2D6*2, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
rs2069521,"[['escitalopram', '(PA10074)']]","increased Fatigue when treated with escitalopram in people with Depressive Disorder, Major as compared to",
"CYP2D6*1, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]","increased nortriptyline concentrations corrected for dose and weight when treated with nortriptyline in people with Depressive Disorder, Major as compared to","['*1/*1', '+', '*1/*2.']"
"CYP2D6*1, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
rs6265,"[['risperidone', '(PA451257)']]",decreased severity of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs3813929,"[['risperidone', '(PA451257)']]",decreased severity of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4","[['oxycodone', '(PA450741)']]",decreased serum concentrations of,
"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1062613,"[['HTR3A', '(PA29555)']]",belongs to,
rs1806201,"[['quetiapine', '(PA451201)']]",increased neurological adverse reactions when treated with quetiapine in healthy individuals as compared to,
rs1806201,"[['GRIN2B', '(PA28980)']]",belongs to,
rs1800497,"[['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased risk of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]","increased clomipramine and desmethyl clomipramine plasma concentration when treated with clomipramine in people with Depressive Disorder, Major as compared to",['*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
rs1801028,"[['DRD2', '(PA27478)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['paroxetine', '(PA450801)']]",increased paroxetine plasma concentration at an administered dose of,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['risperidone', '(PA451257)']]",increased severity of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs4646427,"[['escitalopram', '(PA10074)']]","increased Fatigue when treated with escitalopram in people with Depressive Disorder, Major as compared to",
rs4646427,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4646427,"[['escitalopram', '(PA10074)']]","increased nausea/vomiting when treated with escitalopram in people with Depressive Disorder, Major as compared to",
rs4646427,"[['CYP1A2', '(PA27093)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN","[['codeine', '(PA449088)']]",increased risk of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
rs1800042,"[['HTR1A', '(PA192)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs7757130,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",decreased response to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased mean amitriptyline concentrations corrected for dose and weight when treated with amitriptyline in people with Mental Disorders as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['amitriptyline', '(PA448385)']]",increased ratio of,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN","[['doxepin', '(PA449409)']]",decreased AUC of,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['paroxetine', '(PA450801)']]",increased risk of,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN","[['amitriptyline', '(PA448385)'], ['fluoxetine', '(PA449673)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs1695,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]","increased clomipramine and desmethyl clomipramine plasma concentration when treated with clomipramine in people with Depressive Disorder, Major as compared to",['*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
rs4646425,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2069521,"[['escitalopram', '(PA10074)']]","increased nausea/vomiting when treated with escitalopram in people with Depressive Disorder, Major as compared to",
"CYP2D6*1, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]","increased S-norfluoxetine/S-fluoxetine ratios when treated with fluoxetine in people with Depressive Disorder, Major as compared to","['*1/*5', '+', '*1/*6.']"
"CYP2D6*1, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*5', '+', '*1/*6.']"
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]","dose-normalized R-fluoxetine concentrations and and the active moiety in CYP2D6*1/*1 patients when treated with fluoxetine in people with Depressive Disorder, Major as compared to","['*2', '+', '*3.']"
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,"['*2', '+', '*3.']"
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['fluoxetine', '(PA449673)']]",increased dose-corrected plasma concentrations of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs5443,"[['escitalopram', '(PA10074)'], ['nortriptyline', '(PA450657)']]","improved response (marginally significant) when treated with escitalopram or nortriptyline in people with Depressive Disorder, Major as compared to",
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
"CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs8192726,"[['efavirenz', '(PA449441)']]",risk of,
rs8192726,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clomipramine', '(PA449048)']]",increased mean clomipramine concentrations corrected for dose and weight and higher metabolic ratio of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['mirtazapine', '(PA450522)']]",increased dose/weight adjusted AUC for mirtazapine when exposed to,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['mirtazapine', '(PA450522)']]",decreased clearance of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*3","[['CYP2D6', '(PA128)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased paroxetine levels when treated with paroxetine in people with Obsessive-Compulsive Disorder as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1805054,"[['risperidone', '(PA451257)']]",decreased severity of,
rs6313,"[['risperidone', '(PA451257)']]",decreased severity of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]","increased S-norfluoxetine/S-fluoxetine ratios when treated with fluoxetine in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['fluoxetine', '(PA449673)']]",increased dose-corrected plasma concentrations of,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['nortriptyline', '(PA450657)']]",decreased concentrations of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['nortriptyline', '(PA450657)']]",very low nortriptyline after 7 days of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased mean amitriptyline concentrations corrected for dose and weight when treated with amitriptyline in people with Mental Disorders as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]","decreased plasma concentrations when treated with antidepressants in people with Depressive Disorder, Major as compared to","['*1/*2', '+', '*2/*2.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*2', '+', '*2/*2.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['flecainide', '(PA449646)']]",increased systemic exposure (AUC) and lower oral clearance of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*36, CYP2D6*5","[['flecainide', '(PA449646)']]",decreased oral clearance (CL/F) of,
"CYP2D6*1, CYP2D6*2, CYP2D6*36, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs6295,"[['paroxetine', '(PA450801)']]",increased risk of,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",significantly higher (S)-fluoxetine and lower and (S)-norfluoxetine concentrations when treated with fluoxetine in people with Mental Disorders as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased nevirapine AUC0-6 h when treated with nevirapine in people with HIV as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clomipramine', '(PA449048)']]",increased mean clomipramine concentrations corrected for dose and weight and higher metabolic ratio of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['citalopram', '(PA449015)']]",decreased remission (reported as trend of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*21","[['CYP2D6', '(PA128)']]",increased age-related decline in flecainide clearance patients treated with oral flecainide for supraventricular tachyarrhythmias when treated with flecainide as compared to,['*1.']
"CYP2D6*1, CYP2D6*21","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*35","[['doxepin', '(PA449409)']]",decreased AUC of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*35","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]","increased S-norfluoxetine/S-fluoxetine ratios when treated with fluoxetine in people with Depressive Disorder, Major as compared to","['*1/*4', '+', '*1/*3.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*4', '+', '*1/*3.']"
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['fluoxetine', '(PA449673)']]",decreased dose-corrected plasma concentrations of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['cisplatin', '(PA449014)']]",increased risk of,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs1806201,"[['quetiapine', '(PA451201)']]",increased likelihood of,
rs1806201,"[['GRIN2B', '(PA28980)']]",belongs to,
rs2032582,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","overall survival when treated with fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs10413396,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
"CYP2D6*1, CYP2D6*2, CYP2D6*4","[['clomipramine', '(PA449048)']]",increased risk of,
"CYP2D6*1, CYP2D6*2, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]","increased clomipramine and desmethyl clomipramine plasma concentration when treated with clomipramine in people with Depressive Disorder, Major as compared to",['*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]","increased intolerance when treated with citalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['citalopram', '(PA449015)']]",decreased oral clearance of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1695,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs2075252,"[['LRP2', '(PA30452)']]",belongs to,
GSTM1 non-null,"[['GSTM1', '(PA182)']]",belongs to,
rs1800497,"[['olanzapine', '(PA450688)']]",increased Drug Toxicity when treated with olanzapine in healthy individuals as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs6313,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs1045642,"[['risperidone', '(PA451257)']]",tendency toward greater improvement in PANSS-T when treated with risperidone in people with Schizophrenia as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['mirtazapine', '(PA450522)']]",increased clearance of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['mirtazapine', '(PA450522)']]",decreased total clearance of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['paroxetine', '(PA450801)']]",increased plasma paroxetine concentrations at administered dose of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP1A2*1A, CYP1A2*1F","[['flecainide', '(PA449646)']]",decreased systemic exposure and increased clearance of,
"CYP1A2*1A, CYP1A2*1F","[['CYP1A2', '(PA27093)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs2228171,"[['cisplatin', '(PA449014)']]",increased risk of,
rs2228171,"[['LRP2', '(PA30452)']]",belongs to,
rs1806201,"[['risperidone', '(PA451257)']]",increased general adverse reactions when treated with risperidone in healthy individuals as compared to,
rs1806201,"[['GRIN2B', '(PA28980)']]",belongs to,
rs3219151,"[['GABRA6', '(PA28494)']]",belongs to,
rs211037,"[['GABRG2', '(PA28501)']]",belongs to,
rs7104613,"[['fentanyl', '(PA449599)'], ['morphine', '(PA450550)'], ['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]","opioids response when treated with fentanyl, morphine, opioids or oxycodone in people with Neoplasms as compared to",
rs41273215,"[['prasugrel', '(PA154410481)']]",decreased inhibition of,
rs41273215,"[['PEAR1', '(PA162399233)']]",belongs to,
rs11264579,"[['PEAR1', '(PA162399233)']]",belongs to,
CYP2D6*2xN,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['mirtazapine', '(PA450522)']]",increased total clearance of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs7963521,"[['vincristine', '(PA451879)']]",increased likelihood of,
rs3212986,"[['cisplatin', '(PA449014)'], ['fluorouracil', '(PA128406956)']]",increased overall survival when treated with cisplatin and fluorouracil in people with Esophageal Neoplasms as compared to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs12566888,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['nortriptyline', '(PA450657)']]",increased apparent terminal elimination half-life when exposed to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*2xN, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*36","[['CYP2D6', '(PA128)']]",decreased codeine metabolism and morphine and glucuronides formation when treated with codeine in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*36","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",Life-threatening opioid intoxication when treated with codeine as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs5443,"[['GNB3', '(PA176)']]",belongs to,
"CYP2D6*3, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1065634,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival due to,
rs1065634,"[['NRAS', '(PA31768)']]",belongs to,
rs17661089,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",decreased overall survival due to,
CYB5R3 deficiency,"[['CYB5R3', '(PA27331)']]",belongs to,
rs6265,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs901865,"[['HRH1', '(PA29456)']]",belongs to,
rs11665084,"[['HRH4', '(PA134982275)']]",belongs to,
HLA-DRB1*04:10:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)'], ['vitamin', 'c', '(PA451898)']]",lack of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs6265,"[['heroin', '(PA452619)']]",increased risk of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased median paroxetine steady-state plasma concentration when treated with paroxetine in healthy individuals as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs1176744,"[['paroxetine', '(PA450801)']]",increased risk of,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
rs396991,"[['antithymocyte', 'globulin', '(PA164743704)']]",increased sensitive to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs11710163,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['gemcitabine', '(PA449748)'], ['paclitaxel', '(PA450761)']]",increased overall survival due to,
rs11710163,"[['RAF1', '(PA34183)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['codeine', '(PA449088)']]",increased plasma level of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs113993960,"[['CFTR', '(PA109)']]",belongs to,
rs806368,"[['cocaine', '(PA449072)']]",decreased risk of,
rs806368,"[['CNR1', '(PA26681)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
CYP2C19 extensive metabolizers,"[['clopidogrel', '(PA449053)']]",decreased risk of,
CYP2C19 extensive metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs719235,"[['methotrexate', '(PA450428)']]",increased risk of,
rs719235,"[['GGH', '(PA432)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-A*24:20,"[['HLA-A', '(PA35055)']]",belongs to,
"CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",decreased wakefulness activity level when treated with risperidone in healthy individuals as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased on-treatment platelet aggregation when treated with clopidogrel in people with Coronary Artery Disease as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2A6*1A, CYP2A6*9","[['nicotine', '(PA450626)']]",increased nicotine toxicity and cardiovascular effects in non-smokers when exposed to,
"CYP2A6*1A, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]","increased AUC, higher half-life and lower flurbiprofen clearance when treated with flurbiprofen in healthy individuals as compared to",['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs1799929,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased risk of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2067482,"[['antipsychotics', '(PA452233)']]",increased exposure when treated with antipsychotics in people with Schizophrenia as compared to,
rs2067482,"[['CHRM4', '(PA26485)']]",belongs to,
HLA-A*24:02:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*40:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs6454674,"[['cocaine', '(PA449072)']]",increased risk of,
rs6454674,"[['CNR1', '(PA26681)']]",belongs to,
rs4986910,"[['CYP3A4', '(PA130)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs2067474,"[['HRH2', '(PA29457)']]",belongs to,
rs11662595,"[['HRH4', '(PA134982275)']]",belongs to,
rs28399433,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",higher average daily dose in patients with hyper- kinetic movement disorders when treated with tetrabenazine as compared to,"['poor', 'metabolizer.']"
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,"['poor', 'metabolizer.']"
"CYP2C19*1, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C8*1A, CYP2C8*4","[['diclofenac', '(PA449293)']]",increased diclofenac/5-hydroxydiclofenac urinary concentration ratio when exposed to,
"CYP2C8*1A, CYP2C8*4","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
NAT2*5,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased likelihood of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['tenoxicam', '(PA131890625)']]",increased exposure (area under the plasma concentration-time curve (AUC)) and decreased oral clearance when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['ibuprofen', '(PA449957)']]","decreased racemic, S-ibuprofen and R-ibuprofen metabolism, with increase of",
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs3786047,"[['methadone', '(PA450401)']]",increased risk of,
rs3786047,"[['ARRB2', '(PA60)']]",belongs to,
rs34230287,"[['ARRB2', '(PA60)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs2032582,"[['codeine', '(PA449088)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)']]",lack of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['tenoxicam', '(PA131890625)']]",increased exposure (area under the plasma concentration-time curve (AUC)) and decreased oral clearance when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['ibuprofen', '(PA449957)']]",increased R-ibuprofen metabolism when exposed to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
"HLA-DRB1*01:01:01, HLA-DRB1*15:01:01:01","[['lumiracoxib', '(PA164769031)']]",increased risk of,
"HLA-DRB1*01:01:01, HLA-DRB1*15:01:01:01","[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",increased (S)-methadone plasma levels when treated with methadone as compared to,"['*1/*1', '+', '*1/*6.']"
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,"['*1/*1', '+', '*1/*6.']"
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1799971,"[['fentanyl', '(PA449599)']]",higher fentanyl dose requirement to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['fentanyl', '(PA449599)']]",higher responsiveness to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1062613,"[['HTR3A', '(PA29555)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN","[['codeine', '(PA449088)']]",increased opioid related adverse events ( immediate pain relief from codeine but stopped taking it due to,
"CYP2D6*1, CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs11191561,"[['didanosine', '(PA449301)']]",increased risk of,
rs11191561,"[['NT5C2', '(PA31801)']]",belongs to,
rs602950,"[['capecitabine', '(PA448771)']]",increased risk of,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs4253728,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
HLA-A*33:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",increased AUC and longer longer flurbiprofen elimination half-life when treated with flurbiprofen in healthy individuals as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
NAT2*5,"[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['piroxicam', '(PA450985)']]",increased inhibitory effect on cyclooxygenase 1 activity when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
CYP2D6*1xN,"[['codeine', '(PA449088)']]",severity of,
CYP2D6*1xN,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]","increased imipramine and desipramine plasma concentrations when treated with imipramine in people with Depressive Disorder, Major as compared to","['extensive', 'metabolizers.']"
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
"CYP2D6*4, CYP2D6*5","[['atomoxetine', '(PA134688071)'], ['methylphenidate', '(PA450464)']]",increased atomoxetine and methylphenidateplasma concentration after overdose when exposed to,
"CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs16947,"[['timolol', '(PA451690)']]",increased risk of,
rs61750900,"[['nicotine', '(PA450626)']]",decreased nicotine glucuronidation when exposed to,
rs61750900,"[['UGT2B10', '(PA37186)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs1045642,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6*1,"[['acetaminophen', '(PA448015)'], ['codeine', '(PA449088)'], ['levomepromazine', '(PA134687942)']]",inhibition of,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",greater increase in pulse and diastolic blood pressure and decreased weigh gain when treated with atomoxetine in children with Attention Deficit Disorder with Hyperactivity as compared to,"['extensive', 'metabolizer.']"
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer.']"
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs9806699,"[['GATM', '(PA28590)']]",belongs to,
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs7643645,"[['risperidone', '(PA451257)']]",decreased active moiety levels when treated with risperidone in people with Psychotic Disorders as compared to,
rs7643645,"[['NR1I2', '(PA378)']]",belongs to,
CYP2D6 poor metabolizer,"[['citalopram', '(PA449015)']]",increased ratio of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*15:11:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:11:01,"[['HLA-B', '(PA35056)']]",belongs to,
NAT2*4,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs3814058,"[['NR1I2', '(PA378)']]",belongs to,
rs2071197,"[['HNF4A', '(PA29349)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2071197,"[['carbamazepine', '(PA448785)']]",increased concentration-to-dose ratios when treated with carbamazepine in people with Epilepsy as compared to,
rs2071197,"[['HNF4A', '(PA29349)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",significantly delayed time to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs35599367,"[['tacrolimus', '(PA451578)']]",increased creatinine clearance when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP4F2*1, CYP4F2*3","[['warfarin', '(PA451906)']]",decreased risk of,
"CYP4F2*1, CYP4F2*3","[['CYP4F2', '(PA27121)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2011425,"[['UGT1A4', '(PA37179)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['escitalopram', '(PA10074)']]",lower relative dose-adjusted serum concentrations of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
HLA-A*02:07:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs2289669,"[['metformin', '(PA450395)'], ['trimethoprim', '(PA451788)']]",lack of,
rs2289669,"[['SLC47A1', '(PA162403808)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]","increased plasma ratio citalopram (CIT)/N-desmethylCIT (DCIT) when treated with citalopram in people with Depressive Disorder, Major as compared to","['extensive', 'metabolizer.']"
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,"['extensive', 'metabolizer.']"
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased analgesia from codeine for postpartum pain management when treated with codeine in women as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)']]",lack of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)']]",lack of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs5883,"[['CETP', '(PA108)']]",belongs to,
rs11603334,"[['atenolol', '(PA448499)']]",increased glucose elevation when treated with atenolol in people with Hypertension as compared to,
rs11603334,"[['ARAP1', '(PA164715867)']]",belongs to,
CYP2D6 poor metabolizer,"[['tolterodine', '(PA164746757)']]",increased serum tolterodine concentrations when exposed to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
rs8175347,"[['nilotinib', '(PA165958345)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['timolol', '(PA451690)']]",increased exposure to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['codeine', '(PA449088)']]",risk of,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['sertraline', '(PA451333)']]",increased mean serum concentrations of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1042713,"[['corticosteroids', '(PA10832)']]",increased risk of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
CYP2D6 poor metabolizer,"[['citalopram', '(PA449015)']]",decreased demethylation clearance of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs2134688,"[['ARNT', '(PA24994)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased on-treatment platelet aggregation when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4823613,"[['PPARA', '(PA280)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['diclofenac', '(PA449293)']]",increased diclofenac/5-hydroxydiclofenac urinary concentration ratio when exposed to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs1799929,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs11598702,"[['didanosine', '(PA449301)']]",increased risk of,
rs11598702,"[['NT5C2', '(PA31801)']]",belongs to,
rs1128503,"[['codeine', '(PA449088)']]",increased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)']]",Hyperbilirubinemia when exposed to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",decreased Cmax and AUC of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C8*1A, CYP2C8*4","[['ibuprofen', '(PA449957)']]",decreased likelihood of,
"CYP2C8*1A, CYP2C8*4","[['CYP2C8', '(PA125)']]",belongs to,
HLA-DQB1*06:02:01,"[['lumiracoxib', '(PA164769031)']]",increased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs4823613,"[['PPARA', '(PA280)']]",belongs to,
rs4149601,"[['NEDD4L', '(PA31534)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 poor metabolizer,"[['clomipramine', '(PA449048)']]",increased plasma concentrations of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['desipramine', '(PA449233)']]",increased desipramine to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",decreased plasma oxymorphone/oxycodone ratio when treated with oxycodone in healthy individuals as compared to,"['extensive', 'metabolizer', 'phenotype.']"
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer', 'phenotype.']"
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['fluoxetine', '(PA449673)']]",increased plasma concentrations of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['cyclosporine', '(PA449167)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['cyclosporine', '(PA449167)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 poor metabolizer,"[['timolol', '(PA451690)']]",increased plasma timolol concentration and excerice heart rate reduction when exposed to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1801252,"[['timolol', '(PA451690)']]",increased systolic (SAP) and diastolic (DAP) arterial pressure responses to,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
rs17026688,"[['lithium', '(PA450243)']]",increased response to,
rs17026688,"[['GADL1', '(PA134944477)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs28365062,"[['UGT2B7', '(PA361)']]",belongs to,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs4132670,"[['hydrochlorothiazide', '(PA449899)']]",increased risk of,
rs4132670,"[['TCF7L2', '(PA36394)']]",belongs to,
CYP2D6 ultrarapid metabolizer genotype,"[['CYP2D6', '(PA128)']]",increased pain threshold and pain tolerance when treated with tramadol in healthy individuals as compared to,"['extensive', 'metabolizer', 'genotype.']"
CYP2D6 ultrarapid metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer', 'genotype.']"
CYP2D6 poor metabolizers,"[['paroxetine', '(PA450801)']]","increased median AUC, plasma half-life and steady-state plasma concentrations of",
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs7643645,"[['risperidone', '(PA451257)']]",decreased 9-hydroxy-risperidone levels when treated with risperidone in people with Psychotic Disorders as compared to,
rs7643645,"[['NR1I2', '(PA378)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['piroxicam', '(PA450985)']]",increased Piroxicam's area under the plasma concentration-time curve and decreased oral clearance when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['piroxicam', '(PA450985)']]",increased Piroxicam's area under the plasma concentration-time curve and decreased oral clearance when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4823613,"[['PPARA', '(PA280)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma concentration of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
CYP2C19*1,"[['CYP2C19', '(PA124)']]",belongs to,
rs2276314,"[['dofetilide', '(PA449389)'], ['ibutilide', '(PA449958)'], ['quinidine', '(PA451209)'], ['sotalol', '(PA451457)']]",increased risk of,
rs2276314,"[['C18orf21', '(PA134888949)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",decreased event-free survival when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",decreased plasma oxymorphone/oxycodone ratio when treated with oxycodone in healthy individuals as compared to,"['extensive', 'metabolizer', 'phenotype.']"
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer', 'phenotype.']"
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased wakefulness activity level when treated with risperidone in healthy individuals as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased wakefulness activity level when treated with risperidone in healthy individuals as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2C9*1, CYP2C9*2","[['ibuprofen', '(PA449957)']]",decreased iNOS expression when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased Weight gain when treated with olanzapine in men with Schizophrenia as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)']]",lack of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs112561475,"[['nicotine', '(PA450626)']]",increased glucuronidation of,
rs112561475,"[['UGT2B10', '(PA37186)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs2562456,"[['ketorolac', '(PA450150)']]",slower analgesic onset in European Americans undergoing oral surgery when treated with ketorolac as compared to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['tenoxicam', '(PA131890625)']]",increased AUC and half-life time (t1/2) when exposed to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C8*1A, CYP2C8*2","[['ibuprofen', '(PA449957)']]",increased R-ibuprofen metabolism when exposed to,
"CYP2C8*1A, CYP2C8*2","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['ibuprofen', '(PA449957)']]",decreased iNOS expression and fewer adverse events when exposed to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs1861591,"[['methadone', '(PA450401)']]",increased risk of,
rs1861591,"[['CRY1', '(PA26904)']]",belongs to,
rs1714984,"[['methadone', '(PA450401)']]",increased risk of,
rs1714984,"[['MYOCD', '(PA134946896)']]",belongs to,
rs1045280,"[['methadone', '(PA450401)']]",increased risk of,
rs1045280,"[['ARRB2', '(PA60)']]",belongs to,
rs2036657,"[['methadone', '(PA450401)']]",increased risk of,
rs2036657,"[['ARRB2', '(PA60)']]",belongs to,
CYP2C9 poor metabolizer,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",decreased reduction in pain AUC when treated with oxycodone in healthy individuals as compared to,"['extensive', 'metabolizer', 'phenotype.']"
CYP2D6 poor metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer', 'phenotype.']"
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
HLA-B*58:01,"[['antiepileptics', '(PA143485705)']]",decreased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*2, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",significantly delayed time to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs4769060,"[['gemcitabine', '(PA449748)']]",decreased Cmax and a lower mean AUC when treated with gemcitabine as compared to,
rs4769060,"[['ALOX5AP', '(PA47)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
CYP2D6 poor metabolizers,"[['imipramine', '(PA449969)']]",increased mean area under the plasma concentration-time curve (AUC) of,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs8175347,"[['nilotinib', '(PA165958345)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1135840,"[['CYP2D6', '(PA128)']]",belongs to,
rs1705772,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs1705772,"[['ALG10', '(PA134732019)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased wakefulness activity level when treated with risperidone in healthy individuals as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['methadone', '(PA450401)']]",increased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]","increased trough ( R , S )-methadone plasma concentrations when treated with methadone as compared to","['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
rs1799971,"[['fentanyl', '(PA449599)']]",less pain control in Japanese patients undergoing painful orofacial cosmetic surgery when treated with fentanyl as compared to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs6311,"[['fluvoxamine', '(PA449690)']]",increased risk of,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs1176744,"[['HTR3B', '(PA29556)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['fluvoxamine', '(PA449690)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs8175347,"[['nilotinib', '(PA165958345)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['tolterodine', '(PA164746757)']]",increased tolterodine exposure and increased active metabolite (5-HM) concentrations when exposed to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tolterodine', '(PA164746757)']]",increased tolterodine exposure and unquantifiable active metabolite (5-HM) concentrations when exposed to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1155463,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
CYP2C9*3,"[['warfarin', '(PA451906)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",increased S-propranolol plasma concentration when treated with propranolol in healthy individuals as compared to,['*1.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs113993960,"[['CFTR', '(PA109)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",increased fluvoxamine plasma concentrations when treated with fluvoxamine in people with Mental Disorders as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs2433320,"[['fluoxetine', '(PA449673)']]","decreased HAMD scores when treated with fluoxetine in people with Depressive Disorder, Major as compared to",
rs12118636,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival due to,
rs17309872,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['gemcitabine', '(PA449748)'], ['paclitaxel', '(PA450761)']]",decreased overall survival due to,
rs17309872,"[['ACSS2', '(PA24429)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['acetaminophen', '(PA448015)'], ['codeine', '(PA449088)']]",risk of,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",increased antidepressant serum levels when treated with mianserin in people with Mental Disorders as compared to,"['extensive', 'metabolizers.']"
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
rs767531,"[['dofetilide', '(PA449389)'], ['ibutilide', '(PA449958)'], ['quinidine', '(PA451209)'], ['sotalol', '(PA451457)']]",decreased risk of,
rs4149056,"[['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
"HLA-DQA1*01:01:01, HLA-DQA1*01:02:01:01","[['lumiracoxib', '(PA164769031)']]",increased risk of,
"HLA-DQA1*01:01:01, HLA-DQA1*01:02:01:01","[['HLA-DQA1', '(PA35066)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",increased areas under the serum concentration-time curve when treated with fluvoxamine in healthy individuals as compared to,"['extensive', 'metabolizer.']"
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer.']"
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",increased on-clopidogrel platelet reactivity (HPR) when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4253728,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol and LDL-cholesterol when treated with simvastatin as compared to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['tamoxifen', '(PA451581)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2A6*17, CYP2A6*1A, CYP2A6*2, CYP2A6*20, CYP2A6*9","[['cotinine', '(PA166114414)']]",shorter continin half-life when exposed to,
"CYP2A6*17, CYP2A6*1A, CYP2A6*2, CYP2A6*20, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs340874,"[['atenolol', '(PA448499)']]",increased glucose elevation when treated with atenolol in people with Hypertension as compared to,
rs340874,"[['PROX1', '(PA33812)']]",belongs to,
rs72551330,"[['UGT1A9', '(PA419)']]",belongs to,
rs7194667,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs7194667,"[['ABCC11', '(PA24393)']]",belongs to,
rs1042713,"[['corticosteroids', '(PA10832)'], ['salmeterol', '(PA451300)']]",increased risk of,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs16886403,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",decreased overall survival due to,
rs16886403,"[['MAP3K1', '(PA30592)']]",belongs to,
rs4363657,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs642990,"[['gemcitabine', '(PA449748)']]",decreased risk of,
CYP2D6 poor metabolizer,"[['pimozide', '(PA450965)']]",a trend of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs2849380,"[['carboplatin', '(PA448803)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs2849380,"[['BCL2', '(PA25302)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",increased area under the time-plasma concentration curve (AUC(0-24)) when treated with escitalopram as compared to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"NAT2*5, NAT2*7","[['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['piroxicam', '(PA450985)']]",increased inhibitory effect on cyclooxygenase 1 activity when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
rs2232228,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs2232228,"[['HAS3', '(PA29196)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs1719247,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)'], ['simvastatin', '(PA451363)']]",decreased likelihood of,
rs4506565,"[['hydrochlorothiazide', '(PA449899)']]",increased risk of,
rs4506565,"[['TCF7L2', '(PA36394)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]","increased peak plasma metoprolol concentration (CMax/dose), increased area under the concentration-time curve (AUC/dose), increased elimination half-life, and decreased apparent oral clearance (CL/F) when treated with metoprolol as compared to","['ultra-metabolizer', 'phenotype.']"
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,"['ultra-metabolizer', 'phenotype.']"
rs3832043,"[['UGT1A9', '(PA419)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs3025039,"[['VEGFA', '(PA37302)']]",belongs to,
rs3732218,"[['anastrozole', '(PA448432)']]",increased glucuronidation of,
rs3732218,"[['UGT1A4', '(PA37179)']]",belongs to,
rs6755571,"[['UGT1A4', '(PA37179)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased intragastric ph when treated with omeprazole in people with Helicobacter Infections as compared to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*2/*2', '+', '*2/*3', '+', '*3/*3.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs3764261,"[['CETP', '(PA108)']]",belongs to,
rs9930761,"[['CETP', '(PA108)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['bosentan', '(PA10034)']]",decreased Bosentan metabolism in vitro when exposed to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-DRB1*08:03:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['fluvoxamine', '(PA449690)']]","increased AUC, Cmax and half-life time of",
"CYP2D6*1, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased on-clopidogrel platelet reactivity (HPR) when treated with clopidogrel in people with Acute coronary syndrome as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs662,"[['clopidogrel', '(PA449053)']]",increased ADP-induced platelet aggregation when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs4149056,"[['simvastatin', '(PA451363)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs806368,"[['CNR1', '(PA26681)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs139887,"[['carboplatin', '(PA448803)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs139887,"[['SOX10', '(PA36027)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased on-clopidogrel platelet aggregation (PA) and higher platelet reactivity index (PRI) in patients undergoing elective percutaneous coronary intervention (PCI) when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased acenocoumarol dose when treated with acenocoumarol in people with Atrial Fibrillation as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
CYP2D6 poor metabolizers,"[['nortriptyline', '(PA450657)']]",increased risk of,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 ultrarapid metabolizer genotype,"[['codeine', '(PA449088)']]",increased likelihood of,
CYP2D6 ultrarapid metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]","increased antidepressant serum levels when treated with amitriptyline, clomipramine, doxepin, imipramine or trimipramine in people with Mental Disorders as compared to","['extensive', 'metabolizers.']"
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
"CYP2C9*1, CYP2C9*2","[['bosentan', '(PA10034)']]",decreased Bosentan metabolism in vitro when exposed to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
CYP2C19 ultrarapid metabolizer phenotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",decreased acenocoumarol dose when treated with acenocoumarol in people with Atrial Fibrillation as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2D6*1,"[['codeine', '(PA449088)']]",risk of,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
CYP2D6 ultrarapid metabolizer genotype,"[['tramadol', '(PA451735)']]",increased likelihood of,
CYP2D6 ultrarapid metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs2849380,"[['BCL2', '(PA25302)']]",belongs to,
rs4149601,"[['Beta', 'blocking', 'agents,', 'selective', '(PA164712547)'], ['diuretics', '(PA151249535)']]",decreased risk of,
rs4149601,"[['NEDD4L', '(PA31534)']]",belongs to,
rs1594160,"[['didanosine', '(PA449301)']]",increased risk of,
rs1594160,"[['XDH', '(PA37404)']]",belongs to,
rs1801131,"[['capecitabine', '(PA448771)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs602950,"[['capecitabine', '(PA448771)']]",increased risk of,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs3215400,"[['CDA', '(PA98)']]",belongs to,
rs2669429,"[['DPYS', '(PA146)']]",belongs to,
rs1045642,"[['codeine', '(PA449088)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2010963,"[['cyclophosphamide', '(PA449165)']]",decreased progression-free survival when treated with cyclophosphamide in people with Prostatic Neoplasms as compared to,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
CYP2D6 ultrarapid metabolizer phenotype,"[['codeine', '(PA449088)']]",increased risk of,
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs151264360,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
CYP2D6 poor metabolizer,"[['desipramine', '(PA449233)']]",increased risk of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs9930761,"[['CETP', '(PA108)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)'], ['fluvastatin', '(PA449688)'], ['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)'], ['pravastatin', '(PA451089)'], ['rosuvastatin', '(PA134308647)'], ['simvastatin', '(PA451363)']]","all statin-induced myopathy and severe myopathy when treated with atorvastatin, fluvastatin, hmg coa reductase inhibitors, pravastatin, rosuvastatin or simvastatin as compared to",
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['codeine', '(PA449088)']]",decreased plasma levels of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs1799963,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs1799963,"[['F2', '(PA157)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs451774,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",increased overall survival due to,
rs451774,"[['GPX5', '(PA28953)']]",belongs to,
rs2072671,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
"CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs7917983,"[['hydrochlorothiazide', '(PA449899)']]",increased risk of,
rs7917983,"[['TCF7L2', '(PA36394)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs3764261,"[['CETP', '(PA108)']]",belongs to,
rs5883,"[['CETP', '(PA108)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['bosentan', '(PA10034)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs9806699,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased likelihood of,
rs9806699,"[['GATM', '(PA28590)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1799963,"[['F2', '(PA157)']]",belongs to,
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs3732219,"[['anastrozole', '(PA448432)']]",increased glucuronidation of,
rs3732219,"[['UGT1A4', '(PA37179)']]",belongs to,
rs854560,"[['PON1', '(PA33529)']]",belongs to,
rs10509681,"[['CYP2C8', '(PA125)']]",belongs to,
rs4823613,"[['simvastatin', '(PA451363)']]",increased reduction in total cholesterol and LDL-cholesterol when treated with simvastatin as compared to,
rs4823613,"[['PPARA', '(PA280)']]",belongs to,
rs726501,"[['carboplatin', '(PA448803)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",decreased overall survival due to,
rs726501,"[['MAP3K1', '(PA30592)']]",belongs to,
rs1346268,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)'], ['simvastatin', '(PA451363)']]",decreased likelihood of,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs1429376,"[['didanosine', '(PA449301)']]",increased risk of,
rs1429376,"[['XDH', '(PA37404)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1057868,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
CYP2D6 intermediate metabolizer,"[['CYP2D6', '(PA128)']]",less robust treatment response when treated with tetrabenazine as compared to,"['extensive', 'metabolizer.']"
CYP2D6 intermediate metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer.']"
CYP2D6 poor metabolizers,"[['tolterodine', '(PA164746757)']]",increased AUC and C max of,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs2032582,"[['cyclosporine', '(PA449167)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2304016,"[['antiepileptics', '(PA143485705)']]",drug resistance when treated with antiepileptics in people with Epilepsy as compared to,
rs2304016,"[['SCN2A', '(PA35004)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['bosentan', '(PA10034)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased plasma level of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2032582,"[['codeine', '(PA449088)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs4693075,"[['COQ2', '(PA142672084)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
rs6454674,"[['cocaine', '(PA449072)']]",increased risk of,
rs6454674,"[['CNR1', '(PA26681)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2072671,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",increased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs115232898,"[['DPYD', '(PA145)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs6759892,"[['deferiprone', '(PA166118041)']]",increased risk of,
rs6759892,"[['UGT1A6', '(PA37181)']]",belongs to,
rs6759892,"[['deferiprone', '(PA166118041)']]",increased risk of,
rs6759892,"[['UGT1A6', '(PA37181)']]",belongs to,
rs2070959,"[['UGT1A6', '(PA37181)']]",belongs to,
rs35859249,"[['TBC1D1', '(PA36342)']]",belongs to,
rs9852,"[['TBC1D1', '(PA36342)']]",belongs to,
rs1045642,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased creatine kinase when treated with hmg coa reductase inhibitors as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['cyclophosphamide', '(PA449165)'], ['fludarabine', '(PA449655)']]",decreased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs4532,"[['methylphenidate', '(PA450464)']]",increased severity of,
rs4532,"[['DRD1', '(PA147)']]",belongs to,
rs4532,"[['dextroamphetamine', '(PA449269)'], ['methylphenidate', '(PA450464)']]",increased severity of,
rs4532,"[['DRD1', '(PA147)']]",belongs to,
rs4532,"[['dextroamphetamine', '(PA449269)'], ['methylphenidate', '(PA450464)']]",increased severity of,
rs4532,"[['DRD1', '(PA147)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
"CYP1A2*1A, CYP1A2*1F","[['clozapine', '(PA449061)']]",increased risk of,
"CYP1A2*1A, CYP1A2*1F","[['CYP1A2', '(PA27093)']]",belongs to,
rs2231142,"[['rosuvastatin', '(PA134308647)']]",increased plasma concentrations of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2306283,"[['atorvastatin', '(PA448500)']]",decreased plasma concentrations of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['rosuvastatin', '(PA134308647)']]",increased plasma concentrations of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)']]",increased plasma concentrations of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3812718,"[['carbamazepine', '(PA448785)']]",increased cortical silent period duration due to,
rs3812718,"[['SCN1A', '(PA301)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",increased reductions in glutathione levels when treated with primaquine as compared to,['non-deficient.']
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,['non-deficient.']
rs2077647,"[['ESR1', '(PA156)']]",belongs to,
rs6269,"[['opioids', '(PA452618)']]",increased likelihood of,
rs6269,"[['COMT', '(PA117)']]",belongs to,
rs4633,"[['opioids', '(PA452618)']]",increased likelihood of,
rs4633,"[['COMT', '(PA117)']]",belongs to,
rs4818,"[['opioids', '(PA452618)']]",increased likelihood of,
rs4818,"[['COMT', '(PA117)']]",belongs to,
rs4680,"[['opioids', '(PA452618)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs2234693,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased risk of,
rs2234693,"[['ESR1', '(PA156)']]",belongs to,
rs1128503,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased creatine kinase when treated with hmg coa reductase inhibitors as compared to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs9852,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased Weight gain when treated with clozapine or olanzapine in people with Schizophrenia as compared to,
rs9852,"[['TBC1D1', '(PA36342)']]",belongs to,
rs4294800,"[['darunavir', '(PA163522472)']]",increased volume of,
rs4294800,"[['SLCO3A1', '(PA35837)']]",belongs to,
rs442767,"[['pemetrexed', '(PA10810)']]",increased risk of,
rs442767,"[['DHFR', '(PA143)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2A6*1A, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
"CYP2A6*17, CYP2A6*1A","[['CYP2A6', '(PA121)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*11","[['CYP2B6', '(PA123)']]",belongs to,
rs3957357,"[['doxorubicin', '(PA449412)']]",increased progression-free survival when treated with doxorubicin in people with Sarcoma as compared to,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['aspirin', '(PA448497)']]","Anemia, Hemolytic when exposed to",
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs11628713,"[['citalopram', '(PA449015)']]",increased risk of,
rs11628713,"[['PAPLN', '(PA134914395)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs1801274,"[['infliximab', '(PA452639)']]","decreased improvement in [DELTA]DAS28 (Disease Activity Score) when treated with infliximab in people with Arthritis, Rheumatoid as compared to",
rs1801274,"[['FCGR2A', '(PA28063)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs495828,"[['enalapril', '(PA449456)']]",increased risk of,
rs8176746,"[['ABO', '(PA24415)']]",belongs to,
rs8176740,"[['ABO', '(PA24415)']]",belongs to,
rs7438135,"[['mycophenolate', 'mofetil', '(PA450566)']]",increased risk of,
rs7438135,"[['UGT2B7', '(PA361)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP4F2*1, CYP4F2*3","[['warfarin', '(PA451906)']]",decreased risk of,
"CYP4F2*1, CYP4F2*3","[['CYP4F2', '(PA27121)']]",belongs to,
rs9340799,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased risk of,
rs9340799,"[['ESR1', '(PA156)']]",belongs to,
rs3020314,"[['ESR1', '(PA156)']]",belongs to,
rs2228480,"[['ESR1', '(PA156)']]",belongs to,
rs3798577,"[['ESR1', '(PA156)']]",belongs to,
rs11224556,"[['PGR', '(PA266)']]",belongs to,
rs3740751,"[['PGR', '(PA266)']]",belongs to,
rs471767,"[['PGR', '(PA266)']]",belongs to,
rs561610,"[['PGR', '(PA266)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2D6*1, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs3957357,"[['GSTA1', '(PA29016)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs4680,"[['haloperidol', '(PA449841)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*2, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A","[['TPMT', '(PA356)']]",increased treatment duration when treated with azathioprine in people with Rheumatic Diseases as compared to,['*1/*3A.']
"TPMT*1, TPMT*2, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,['*1/*3A.']
TPMT haplotype,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased risk of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
TPMT haplotype,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased risk of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs572943,"[['PGR', '(PA266)']]",belongs to,
rs555653,"[['PGR', '(PA266)']]",belongs to,
rs537681,"[['PGR', '(PA266)']]",belongs to,
rs1152580,"[['ESR2', '(PA27886)']]",belongs to,
rs944459,"[['ESR2', '(PA27886)']]",belongs to,
rs1256120,"[['ESR2', '(PA27886)']]",belongs to,
rs3020445,"[['ESR2', '(PA27886)']]",belongs to,
rs1952586,"[['ESR2', '(PA27886)']]",belongs to,
rs4986938,"[['ESR2', '(PA27886)']]",belongs to,
rs1256064,"[['ESR2', '(PA27886)']]",belongs to,
rs701265,"[['P2RY1', '(PA32868)']]",belongs to,
rs4523,"[['aspirin', '(PA448497)']]",increased risk of,
rs4523,"[['TBXA2R', '(PA348)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['bleomycin', '(PA448645)'], ['dacarbazine', '(PA449197)'], ['doxorubicin', '(PA449412)'], ['vinblastine', '(PA451877)']]",decreased risk of,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs2010963,"[['bevacizumab', '(PA130232992)'], ['pegaptanib', '(PA164771236)'], ['ranibizumab', '(PA164746012)']]","increased anti-VEGF injections when treated with bevacizumab, pegaptanib or ranibizumab in people with Choroidal Neovascularization as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1043879,"[['RSRP1', '(PA142672513)']]",belongs to,
rs10903129,"[['MACO1', '(PA142670773)']]",belongs to,
rs6691117,"[['CR1', '(PA26855)']]",belongs to,
rs7527798,"[['CR1L', '(PA26856)']]",belongs to,
rs2287622,"[['ABCB11', '(PA374)']]",belongs to,
rs2287622,"[['ABCB11', '(PA374)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",increased risk of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",increased half-life at overdose when exposed to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs11868035,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased total cholesterol when treated with hmg coa reductase inhibitors in people with Schizophrenia as compared to,
rs11868035,"[['SREBF1', '(PA335)']]",belongs to,
"NAT2*14, NAT2*5, NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
TPMT*3A,"[['azathioprine', '(PA448515)']]",increased severity of,
TPMT*3A,"[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs1256061,"[['ESR2', '(PA27886)']]",belongs to,
rs8017441,"[['ESR2', '(PA27886)']]",belongs to,
rs12435857,"[['ESR2', '(PA27886)']]",belongs to,
rs10148269,"[['ESR2', '(PA27886)']]",belongs to,
rs1256031,"[['ESR2', '(PA27886)']]",belongs to,
rs17179740,"[['ESR2', '(PA27886)']]",belongs to,
rs717620,"[['methotrexate', '(PA450428)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs495828,"[['enalapril', '(PA449456)']]",increased risk of,
rs11572076,"[['mycophenolate', 'mofetil', '(PA450566)']]",decreased risk of,
rs11572076,"[['CYP2C8', '(PA125)']]",belongs to,
"TPMT*1, TPMT*3A","[['azathioprine', '(PA448515)']]",increased likelihood of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased metabolic ratio CIT/DCIT values and mean citalopram dose when treated with citalopram as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",differences in the fluvoxamine plasma level at 50 mg/day when treated with fluvoxamine in people with as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['citalopram', '(PA449015)']]",increased likelihood of,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3D","[['TPMT', '(PA356)']]",belongs to,
TPMT*3A,"[['azathioprine', '(PA448515)']]",increased severity of,
TPMT*3A,"[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
G6PD A- 202A_376G,"[['tafenoquine', '(PA166115580)']]",increased loss of,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['citalopram', '(PA449015)']]",increased AUC of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['ondansetron', '(PA450705)']]",increased percentage of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
SLC6A4 HTTLPR short form (S allele),"[['risperidone', '(PA451257)']]",decreased likelihood of,
SLC6A4 HTTLPR short form (S allele),"[['SLC6A4', '(PA312)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased ADP-induced platelet aggregation (PA) when treated with clopidogrel as compared to,['*1/*2.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*2.']
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs1062613,"[['HTR3A', '(PA29555)']]",belongs to,
rs1176722,"[['HTR3A', '(PA29555)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",greater heart rate (HR) reduction when treated with metoprolol as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",decreased metabolic ratio CIT/DCIT values when treated with citalopram as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs934635,"[['exemestane', '(PA449563)']]",a significantly higher odds of,
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",increased dose when treated with antipsychotics in people with Schizophrenia as compared to,"['extensive', 'metabolizer.']"
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer.']"
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs4784333,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
rs4784333,"[['FTO', '(PA152208656)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9936750,"[['capecitabine', '(PA448771)']]",increased risk of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9","[['lansoprazole', '(PA450180)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs1176713,"[['HTR3A', '(PA29555)']]",belongs to,
rs10789970,"[['HTR3B', '(PA29556)']]",belongs to,
rs1176746,"[['HTR3B', '(PA29556)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",significantly higher tramadol consumption in chinese gastric cancer patients recovering from gastrectomy when treated with tramadol as compared to,"['*1/*1', '+', '*1/*10.']"
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*10.']"
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs6947309,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
rs6947309,"[['LUC7L2', '(PA134873425)']]",belongs to,
rs720106,"[['RRM1', '(PA298)']]",belongs to,
CYP2D6 haplotype,"[['citalopram', '(PA449015)']]",increased risk of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs7176005,"[['exemestane', '(PA449563)']]",a significantly higher odds of,
rs7176005,"[['CYP19A1', '(PA27091)']]",belongs to,
rs887829,"[['atazanavir', '(PA10251)']]",increased likelihood of,
rs887829,"[['UGT1A1', '(PA420)']]",belongs to,
CYP1A2 low activity,"[['caffeine', '(PA448710)']]",increased intake of,
CYP1A2 low activity,"[['CYP1A2', '(PA27093)']]",belongs to,
CYP2D6 haplotype,"[['antidepressants', '(PA452229)']]",decreased time between first drug administration and dose reduction or termination of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['paroxetine', '(PA450801)']]",positive correlation of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs887829,"[['atazanavir', '(PA10251)']]",increased likelihood of,
rs887829,"[['UGT1A1', '(PA420)']]",belongs to,
CYP1A2 high activity,"[['caffeine', '(PA448710)']]",increased risk of,
CYP1A2 high activity,"[['CYP1A2', '(PA27093)']]",belongs to,
"NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs11214763,"[['HTR3B', '(PA29556)']]",belongs to,
rs2276305,"[['HTR3B', '(PA29556)']]",belongs to,
rs2276307,"[['HTR3B', '(PA29556)']]",belongs to,
rs1065852,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]",plasma concentration of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1074145,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]",concentrations of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8, CYP2C19*9","[['CYP2C19', '(PA124)']]",belongs to,
rs934635,"[['exemestane', '(PA449563)']]",a significantly higher odds of,
rs16849146,"[['hydrochlorothiazide', '(PA449899)']]",increased likelihood of,
"CYP2D6*2, CYP2D6*2xN","[['antidepressants', '(PA452229)']]",increased risk of,
"CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C8*2, CYP2C8*3, CYP2C8*4","[['paclitaxel', '(PA450761)']]",increased risk of,
"CYP2C8*2, CYP2C8*3, CYP2C8*4","[['CYP2C8', '(PA125)']]",belongs to,
rs492338,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs492338,"[['ABCG1', '(PA24408)']]",belongs to,
rs492338,"[['ABCG1', '(PA24408)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['risperidone', '(PA451257)']]",decreased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs5985,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs5985,"[['F13A1', '(PA162)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased plasma metoprolol concentrations when treated with metoprolol as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased heart rate (HR) and diastolic blood pressure (DBP) reductions during early titration when treated with metoprolol as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
rs1042927,"[['RRM1', '(PA298)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B","[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B","[['TPMT', '(PA356)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['citalopram', '(PA449015)']]",increased likelihood of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs16964189,"[['exemestane', '(PA449563)']]",a significantly higher odds of,
rs3758987,"[['HTR3B', '(PA29556)']]",belongs to,
CYP2D6*1,"[['tamoxifen', '(PA451581)']]",increased risk of,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",increased reductions in glutathione levels when treated with chloramphenicol as compared to,['non-deficient.']
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,['non-deficient.']
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs5985,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased fibrin clot formation time when treated with aspirin and clopidogrel in people with Coronary Artery Disease as compared to,
rs5985,"[['F13A1', '(PA162)']]",belongs to,
rs5985,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs5985,"[['F13A1', '(PA162)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]","decreased mean logarithm escitalopram concentration when treated with escitalopram in people with Depressive Disorder, Major as compared to",['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs4460839,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",early decrease in the percentage of,
rs4460839,"[['DRD2', '(PA27478)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['fluvoxamine', '(PA449690)']]",Diarrhea when exposed to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs2734833,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",early decrease in the percentage of,
rs2734833,"[['DRD2', '(PA27478)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",increased tacrolimus plasma trough levels and severely diminished tacrolimus clearance when treated with tacrolimus as compared to,['*1A/*1A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*1A/*1A.']
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19*1,"[['CYP2C19', '(PA124)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['paroxetine', '(PA450801)']]",increased time to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",decreased reduction in psychotic symptoms when treated with risperidone in people with Schizophrenia as compared to,"['extensive', 'metabolizer.']"
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizer.']"
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['risperidone', '(PA451257)']]",increased risk of,
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
rs11030918,"[['RRM1', '(PA298)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",higher mean warfarin daily dose requirement when treated with warfarin in children as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2056527,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs2056527,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs588765,"[['nicotine', '(PA450626)']]",increased likelihood of,
rs588765,"[['CHRNA5', '(PA26491)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs472660,"[['CYP3A43', '(PA427)']]",belongs to,
"CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",converting into poor metabolizer after 14 days paroxetine treatments when exposed to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]","being overrepresented in non-responder group when treated with paroxetine in people with Depressive Disorder, Major as compared to","['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]","decreased response when measured by the Geriatric Depression Scale at day 7 and day 28 when treated with paroxetine in people with Depressive Disorder, Major as compared to","['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs1541333,"[['nicotine', '(PA450626)']]",decreased likelihood of,
rs1541333,"[['DBH', '(PA136)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",increased response (SVR rate) to,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",increased likelihood of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['clomipramine', '(PA449048)']]",increased clomipramine-induced prolactin release when exposed to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['antidepressants', '(PA452229)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased warfarin dose during 3-month daily observation period in patients with mechanical heart valve replacement when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased response (rapid and sustained virological response) for patients with hepatitis C virus genotype 1 when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
CYP2D6 haplotype,"[['antidepressants', '(PA452229)']]",increased risk of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs2306283,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased creatine kinase when treated with hmg coa reductase inhibitors as compared to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",increased response rate to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['galantamine', '(PA449726)']]",increased dose-adjusted plasma levels of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['galantamine', '(PA449726)']]",increased dose-adjusted plasma levels of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1799971,"[['hydrocodone', '(PA449900)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['hydrocodone', '(PA449900)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",higher rate of,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['aripiprazole', '(PA10026)']]",increased median serum concentration of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
rs72554665,"[['G6PD', '(PA28469)']]",belongs to,
"NAT2*4, NAT2*5A, NAT2*5B, NAT2*5C, NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
"CYP1A2*1A, CYP1A2*1F","[['caffeine', '(PA448710)']]",increased likelihood of,
"CYP1A2*1A, CYP1A2*1F","[['CYP1A2', '(PA27093)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['mirtazapine', '(PA450522)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['paroxetine', '(PA450801)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['paroxetine', '(PA450801)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",increased response rate to,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]","improved second treatment switch response when treated with antidepressants in people with Depressive Disorder, Major as compared to","['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele)', '+', 'HTTLPR', 'short', 'form', '(S', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele)', '+', 'HTTLPR', 'short', 'form', '(S', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['antidepressants', '(PA452229)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['escitalopram', '(PA10074)']]",attenuated response to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['escitalopram', '(PA10074)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased mean INR during 3-month daily observation period in patients with mechanical heart valve replacement when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
G6PD deficiency,"[['primaquine', '(PA451103)']]",increased likelihood of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased response (rapid and sustained virological response) for patients with hepatitis C virus genotype 1 when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs4149056,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased creatine kinase when exposed to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",increased likelihood of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*3C","[['CYP3A5', '(PA131)']]",decreased average cumulative neurotoxicity grade when treated with vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A, CYP3A5*3C","[['CYP3A5', '(PA131)']]",belongs to,['*3A/*3A.']
rs1799971,"[['hydrocodone', '(PA449900)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['hydrocodone', '(PA449900)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1229984,"[['ethanol', '(PA448073)']]",increased Vmax of,
rs1229984,"[['ADH1B', '(PA24571)']]",belongs to,
rs671,"[['ALDH2', '(PA24696)']]",belongs to,
rs1799752,"[['antidepressants', '(PA452229)'], ['antiepileptics', '(PA143485705)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['calcium', 'channel', 'blockers', '(PA10407)']]",decreased use of,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1799752,"[['antidepressants', '(PA452229)'], ['antiepileptics', '(PA143485705)'], ['Beta', 'Blocking', 'Agents', '(PA164712535)'], ['calcium', 'channel', 'blockers', '(PA10407)']]",decreased use of,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased ADP-induced platelet aggregation (PA) when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['citalopram', '(PA449015)']]",increased AUC of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased levels of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*3C","[['vincristine', '(PA451879)']]",decreased likelihood of,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*3C","[['CYP3A5', '(PA131)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['fluvoxamine', '(PA449690)'], ['paroxetine', '(PA450801)']]",decreased HAM-D score changes in fluvoxamine-treated patients compared to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['paroxetine', '(PA450801)']]",a correlation of,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",increased bleeding time when treated with paroxetine in people with Mood Disorders as compared to,"['L', 'allele-rs25531T/L', 'allele-rs25531T.']"
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,"['L', 'allele-rs25531T/L', 'allele-rs25531T.']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]","increased presentation in the non-reponder group when treated with paroxetine in people with Depressive Disorder, Major as compared to","['HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele).']"
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs3785161,"[['clopidogrel', '(PA449053)']]",increased on-treatment platelet activity when treated with clopidogrel in people with Coronary Disease as compared to,
rs3785161,"[['CES1P1', '(PA134906523)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased number of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs12132152,"[['DPYD', '(PA145)']]",belongs to,
rs12132152,"[['capecitabine', '(PA448771)']]",increased severity of,
rs12132152,"[['DPYD', '(PA145)']]",belongs to,
rs12132152,"[['capecitabine', '(PA448771)']]",increased severity of,
rs12132152,"[['DPYD', '(PA145)']]",belongs to,
rs76387818,"[['capecitabine', '(PA448771)']]",increased severity of,
rs76387818,"[['DPYD', '(PA145)']]",belongs to,
rs76387818,"[['capecitabine', '(PA448771)']]",increased severity of,
rs76387818,"[['DPYD', '(PA145)']]",belongs to,
"CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['paroxetine', '(PA450801)']]",tremor and rigidity when exposed to,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
G6PD A- 202A_376G,"[['dapsone', '(PA449211)']]",increased loss of,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['paroxetine', '(PA450801)']]",a trend of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['fluoxetine', '(PA449673)'], ['paroxetine', '(PA450801)']]",increased improvement based on change of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]","increased improvement based on HAM-D score percentage reduction when treated with fluvoxamine or paroxetine in people with Depressive Disorder, Major as compared to","['HTTLPR', 'short', 'form', '(S', 'allele)/HTTLPR', 'short', 'form', '(S', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'short', 'form', '(S', 'allele)/HTTLPR', 'short', 'form', '(S', 'allele).']"
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['risperidone', '(PA451257)']]",increased median serum concentration of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['risperidone', '(PA451257)']]",increased median serum concentration of,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['aripiprazole', '(PA10026)']]",increased concentration of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",increased paroxetine plasma concentration when treated with paroxetine in people with Diabetic Neuropathies as compared to,"['extensive', 'metabolizers.']"
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs76387818,"[['DPYD', '(PA145)']]",belongs to,
rs12022243,"[['capecitabine', '(PA448771)']]",increased severity of,
rs12022243,"[['DPYD', '(PA145)']]",belongs to,
rs12022243,"[['DPYD', '(PA145)']]",belongs to,
rs12022243,"[['capecitabine', '(PA448771)']]",increased severity of,
rs12022243,"[['DPYD', '(PA145)']]",belongs to,
rs7548189,"[['DPYD', '(PA145)']]",belongs to,
rs7548189,"[['DPYD', '(PA145)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
CYP2C19 haplotype,"[['sertraline', '(PA451333)']]",increased inhibition of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['buspirone', '(PA448689)'], ['paroxetine', '(PA450801)']]",Substance Withdrawal Syndrome when exposed to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",increased reductions in glutathione levels when treated with sulfanilamide as compared to,['non-deficient.']
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,['non-deficient.']
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]","increased mean logarithm escitalopram concentration when treated with escitalopram in people with Depressive Disorder, Major as compared to","['extensive', 'metabolizers.']"
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD A- 202A_376G,"[['sitamaquine', '(PA166115581)']]",increased loss of,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1065852,"[['escitalopram', '(PA10074)']]",decreased response and remission rate when treated with escitalopram in people with Depressive Disorder as compared to,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['aripiprazole', '(PA10026)']]",increased median serum concentration of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs316019,"[['cisplatin', '(PA449014)']]",severity of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1051730,"[['nicotine', '(PA450626)']]",decreased lung function when exposed to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs2741171,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2741171,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs2741171,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2741171,"[['ENOSF1', '(PA134897613)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
"G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['primaquine', '(PA451103)']]",increased loss of,
"G6PD B (wildtype), G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
"G6PD A- 202A_376G, G6PD B (wildtype)","[['primaquine', '(PA451103)']]",increased loss of,
"G6PD A- 202A_376G, G6PD B (wildtype)","[['G6PD', '(PA28469)']]",belongs to,
rs310786,"[['tamoxifen', '(PA451581)']]",increased lumbar bone loss when treated with tamoxifen in women with Breast Neoplasms as compared to,
rs310786,"[['E2F7', '(PA134894421)']]",belongs to,
rs1799735,"[['olanzapine', '(PA450688)']]",decreased area under the curve when exposed to,
rs1799735,"[['GSTM3', '(PA29024)']]",belongs to,
rs1695,"[['olanzapine', '(PA450688)']]",increased likelihood of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1800497,"[['olanzapine', '(PA450688)']]",decreased peak plasma concentration of,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs1800497,"[['olanzapine', '(PA450688)']]",decreased area under the curve from baseline to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6","[['olanzapine', '(PA450688)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3, CYP2C9*6","[['CYP2C9', '(PA126)']]",belongs to,
"CYP3A4*1, CYP3A4*1B","[['olanzapine', '(PA450688)']]",increased likelihood of,
"CYP3A4*1, CYP3A4*1B","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['olanzapine', '(PA450688)']]",increased area under the curve when exposed to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2741171,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs2612091,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2612091,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs7548189,"[['DPYD', '(PA145)']]",belongs to,
rs2612091,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs2612091,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2612091,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs11146020,"[['GRIN1', '(PA28978)']]",belongs to,
rs1126442,"[['methamphetamine', '(PA450403)']]",increased risk of,
rs1126442,"[['GRIN1', '(PA28978)']]",belongs to,
G6PD A- 202A_376G,"[['pamaquine', '(PA166115579)']]",increased loss of,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6 haplotype,"[['paroxetine', '(PA450801)']]",increased risk of,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['olanzapine', '(PA450688)']]",increased likelihood of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['olanzapine', '(PA450688)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['olanzapine', '(PA450688)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs6313,"[['HTR2A', '(PA193)']]",belongs to,
rs2269577,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs2269577,"[['XBP1', '(PA37400)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased ADP-induced platelet aggregation (PA) when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6*2,"[['CYP2D6', '(PA128)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['citalopram', '(PA449015)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
UGT1A6*2a,"[['UGT1A6', '(PA37181)']]",belongs to,
UGT1A6*2a,"[['irinotecan', '(PA450085)'], ['oxaliplatin', '(PA131285527)'], ['s', '1', '(combination)', '(PA166115442)']]",increased likelihood of,
UGT1A6*2a,"[['UGT1A6', '(PA37181)']]",belongs to,
CYP2C19 haplotype,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",shorter time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs662,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased relative inhibition of,
rs662,"[['PON1', '(PA33529)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased ADP-induced on treatment platelet aggregation (OTPR) when treated with aspirin and clopidogrel in people with Angina Pectoris as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased non-responsiveness when treated with aspirin and clopidogrel in people with Angina Pectoris as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased propertion of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs8187996,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs3764435,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased risk of,
rs3764435,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs3764435,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs168351,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased risk of,
rs168351,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs63319,"[['ALDH1A1', '(PA24692)']]",belongs to,
rs16967126,"[['ABCC1', '(PA244)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['clopidogrel', '(PA449053)']]",increased Platelet reactivity after 9month of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",decreased Mean oxymophone/oxycodone ratios when treated with oxycodone as compared to,"['*1/*1xN', '+', '*2/*2xN', '+', '*1xN/*2', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '+', '*2/*2xN', '+', '*1xN/*2', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['oxycodone', '(PA450741)']]",increased Oxycodone consumption up to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased time to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
CYP2C19 haplotype,"[['prasugrel', '(PA154410481)']]",decreased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['warfarin', '(PA451906)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs6280,"[['methylphenidate', '(PA450464)']]",increased intolerability of,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs121918592,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs903880,"[['ABCC1', '(PA244)']]",belongs to,
rs35596,"[['ABCC1', '(PA244)']]",belongs to,
rs4148350,"[['ABCC1', '(PA244)']]",belongs to,
rs4148354,"[['ABCC1', '(PA244)']]",belongs to,
rs2889517,"[['ABCC1', '(PA244)']]",belongs to,
rs11861115,"[['ABCC1', '(PA244)']]",belongs to,
rs35597368,"[['PDGFRA', '(PA33147)']]",belongs to,
rs35597368,"[['PDGFRA', '(PA33147)']]",belongs to,
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased Unbound oral clearance for S-warfarin when treated with warfarin in children as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",increased plasma MK-4 concentration when treated with warfarin in children as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",decreased warfarin sensitivity index (INR/Cpss) when treated with warfarin in children as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs118192172,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs2291075,"[['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['etoposide', '(PA449552)'], ['mitoxantrone', '(PA450526)']]","increased event-free survival and overall survival when treated with cytarabine, daunorubicin, etoposide and mitoxantrone in children with Leukemia, Myeloid, Acute as compared to",
rs2291075,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"DPYD*2B, DPYD*4","[['DPYD', '(PA145)']]",belongs to,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1048943,"[['CYP1A1', '(PA27092)']]",belongs to,
rs1933437,"[['FLT3', '(PA28181)']]",belongs to,
rs1799939,"[['RET', '(PA34335)']]",belongs to,
rs1799939,"[['RET', '(PA34335)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs75017182,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs1801019,"[['UMPS', '(PA363)']]",belongs to,
rs2236225,"[['MTHFD1', '(PA31236)']]",belongs to,
rs1979277,"[['SHMT1', '(PA35753)']]",belongs to,
rs112723255,"[['TYMP', '(PA162407502)']]",belongs to,
rs11479,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs11479,"[['TYMP', '(PA162407502)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs61162043,"[['warfarin', '(PA451906)']]",increased likelihood of,
rs9996584,"[['cetuximab', '(PA10040)'], ['panitumumab', '(PA162373091)']]",increased overall survival when treated with cetuximab or panitumumab in people with Colorectal Neoplasms as compared to,
rs9996584,"[['AREG', '(PA24933)']]",belongs to,
rs11942466,"[['cetuximab', '(PA10040)'], ['panitumumab', '(PA162373091)']]",decreased survival when treated with cetuximab or panitumumab in people with Colorectal Neoplasms as compared to,
rs11942466,"[['AREG', '(PA24933)']]",belongs to,
rs1803274,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs4149170,"[['SLC22A6', '(PA388)']]",belongs to,
rs11568563,"[['SLCO1A2', '(PA328)']]",belongs to,
rs10841795,"[['SLCO1A2', '(PA328)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['capecitabine', '(PA448771)'], ['paclitaxel', '(PA450761)']]",decreased overall survival when treated with capecitabine and paclitaxel in people with Stomach Neoplasms as compared to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs1803274,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",decreased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs10276036,"[['nevirapine', '(PA450616)']]",increased risk of,
rs10276036,"[['ABCB1', '(PA267)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",increased risk of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs17376848,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
rs712829,"[['cetuximab', '(PA10040)'], ['panitumumab', '(PA162373091)']]",increased survival when treated with cetuximab or panitumumab in people with Colorectal Neoplasms as compared to,
rs712829,"[['EGFR', '(PA7360)']]",belongs to,
rs12201199,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs7035753,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs7035753,"[['SLC28A3', '(PA426)']]",belongs to,
rs17087144,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs17087144,"[['SLC28A3', '(PA426)']]",belongs to,
CYP2D6 poor metabolizer,"[['imipramine', '(PA449969)']]",increased plasma concentration of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizer,"[['clomipramine', '(PA449048)']]",increased plasma concentrations of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs1800872,"[['IL10', '(PA29778)']]",belongs to,
rs1800872,"[['IL10', '(PA29778)']]",belongs to,
rs1800871,"[['tacrolimus', '(PA451578)']]",increased likelihood of,
rs1800871,"[['IL10', '(PA29778)']]",belongs to,
rs1800871,"[['IL10', '(PA29778)']]",belongs to,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
rs2868177,"[['POR', '(PA33532)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs7789655,"[['GRM3', '(PA28992)']]",belongs to,
rs2282966,"[['GRM3', '(PA28992)']]",belongs to,
rs274618,"[['heroin', '(PA452619)']]",increased risk of,
rs274618,"[['GRM3', '(PA28992)']]",belongs to,
rs274622,"[['heroin', '(PA452619)']]",increased risk of,
rs274622,"[['GRM3', '(PA28992)']]",belongs to,
rs1990040,"[['heroin', '(PA452619)']]",increased risk of,
rs1990040,"[['GRM3', '(PA28992)']]",belongs to,
rs13242038,"[['heroin', '(PA452619)']]",increased risk of,
rs13242038,"[['GRM3', '(PA28992)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",decreased leukocytes and neutrophils when treated with azathioprine in people with heart transplantation as compared to,['*1/*1.']
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['amitriptyline', '(PA448385)'], ['antidepressants', '(PA452229)'], ['clomipramine', '(PA449048)'], ['desipramine', '(PA449233)'], ['fluoxetine', '(PA449673)'], ['imipramine', '(PA449969)'], ['nortriptyline', '(PA450657)'], ['paroxetine', '(PA450801)'], ['venlafaxine', '(PA451866)']]",increased risk of,
"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs12806698,"[['RRM1', '(PA298)']]",belongs to,
rs9937,"[['carboplatin', '(PA448803)'], ['gemcitabine', '(PA449748)']]",risk of,
rs9937,"[['RRM1', '(PA298)']]",belongs to,
rs1042858,"[['RRM1', '(PA298)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"TPMT*1, TPMT*3C","[['azathioprine', '(PA448515)']]",increased likelihood of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs11226,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs11226,"[['RAD52', '(PA34180)']]",belongs to,
rs11226,"[['RAD52', '(PA34180)']]",belongs to,
rs3219484,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs3219484,"[['MUTYH', '(PA31328)']]",belongs to,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
rs1801280,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
"TPMT*1, TPMT*3E","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['purine', 'analogues', '(PA452634)'], ['thioguanine', '(PA451663)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
TPMT*3A,"[['TPMT', '(PA356)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs4646437,"[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs724226,"[['heroin', '(PA452619)']]",increased risk of,
rs724226,"[['GRM3', '(PA28992)']]",belongs to,
rs2189814,"[['heroin', '(PA452619)']]",increased risk of,
rs2189814,"[['GRM3', '(PA28992)']]",belongs to,
rs917071,"[['GRM3', '(PA28992)']]",belongs to,
rs2237558,"[['GRM3', '(PA28992)']]",belongs to,
rs2237562,"[['GRM3', '(PA28992)']]",belongs to,
rs6947784,"[['GRM3', '(PA28992)']]",belongs to,
rs2299225,"[['GRM3', '(PA28992)']]",belongs to,
rs1989796,"[['GRM3', '(PA28992)']]",belongs to,
"CYP2C9*1, CYP2C9*57","[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",hyper sensitivity to,
"CYP2C9*1, CYP2C9*57","[['CYP2C9', '(PA126)']]",belongs to,
rs698,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased likelihood of,
rs698,"[['ADH1C', '(PA24572)']]",belongs to,
rs1142345,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",decreased progression-free survival when treated with cisplatin and cyclophosphamide in women with Ovarian Neoplasms as compared to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1131341,"[['NQO1', '(PA31744)']]",belongs to,
rs1131341,"[['NQO1', '(PA31744)']]",belongs to,
rs17655,"[['ERCC5', '(PA27851)']]",belongs to,
rs17655,"[['ERCC5', '(PA27851)']]",belongs to,
rs1052536,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs1052536,"[['LIG3', '(PA30374)']]",belongs to,
rs1052536,"[['LIG3', '(PA30374)']]",belongs to,
rs2233945,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs3099844,"[['nevirapine', '(PA450616)']]",increased risk of,
rs3099844,"[['CYCSP5', '(PA142672032)']]",belongs to,
HLA-A*24:07,"[['HLA-A', '(PA35055)']]",belongs to,
rs13429709,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased Weight gain when treated with clozapine or olanzapine in people with Schizophrenia as compared to,
rs13429709,"[['GCG', '(PA28606)']]",belongs to,
rs1990761,"[['GCG', '(PA28606)']]",belongs to,
rs41368446,"[['GCG', '(PA28606)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs595961,"[['AGO1', '(PA27693)']]",belongs to,
rs197388,"[['DDX20', '(PA27209)']]",belongs to,
rs34115976,"[['MIR577', '(PA164722874)']]",belongs to,
rs2287584,"[['DROSHA', '(PA142671060)']]",belongs to,
rs639174,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",increased risk of,
rs639174,"[['DROSHA', '(PA142671060)']]",belongs to,
rs4867329,"[['DROSHA', '(PA142671060)']]",belongs to,
rs3805500,"[['DROSHA', '(PA142671060)']]",belongs to,
rs10035440,"[['C5orf22', '(PA144596503)']]",belongs to,
rs2910164,"[['MIR146A', '(PA164722497)']]",belongs to,
rs6465088,"[['GRM3', '(PA28992)']]",belongs to,
"TPMT*1, TPMT*3C","[['mercaptopurine', '(PA450379)']]",increased levels of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs1051740,"[['cisplatin', '(PA449014)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
TPMT*1,"[['TPMT', '(PA356)']]",increased 6-TG levels when treated with azathioprine or mercaptopurine in people with Inflammatory Bowel Diseases as compared to,['*1/*1.']
TPMT*1,"[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"CYP1A2*1A, CYP1A2*1C","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP1A2*1A, CYP1A2*1C","[['CYP1A2', '(PA27093)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
TPMT*1,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased likelihood of,
TPMT*1,"[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity by P2Y12 reaction units when treated with clopidogrel in patients undergoing percutaneous coronary intervention as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*35:05:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*35:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*07:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DRB1*12:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs10747673,"[['metformin', '(PA450395)']]","decreased post-HbA1c levels when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs10747673,"[['metformin', '(PA450395)']]",decreased metformin secretory clearance when exposed to,
rs2683511,"[['metformin', '(PA450395)']]","decreased post-HbA1c levels when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs2683511,"[['SP1', '(PA36042)']]",belongs to,
rs2683511,"[['metformin', '(PA450395)']]",decreased metformin secretory clearance when exposed to,
rs2683511,"[['SP1', '(PA36042)']]",belongs to,
rs784892,"[['metformin', '(PA450395)']]","decreased post-HbA1c levels when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs784892,"[['AMHR2', '(PA24770)']]",belongs to,
rs784892,"[['metformin', '(PA450395)']]",decreased metformin secretory clearance when exposed to,
rs784892,"[['AMHR2', '(PA24770)']]",belongs to,
rs784888,"[['metformin', '(PA450395)']]",decreased severity of,
rs784888,"[['SP1', '(PA36042)']]",belongs to,
rs149711321,"[['metformin', '(PA450395)']]","decreased post-HbA1c levels when treated with metformin in people with Diabetes Mellitus, Type 2 as compared to",
rs149711321,"[['PPARA', '(PA280)']]",belongs to,
rs6046,"[['warfarin', '(PA451906)']]",increased sen sitivity to,
rs6046,"[['F7', '(PA160)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs34324334,"[['XPO5', '(PA134979214)']]",belongs to,
rs10505168,"[['MIR2053', '(PA164722583)']]",belongs to,
rs2114358,"[['MIR1206', '(PA164722363)']]",belongs to,
rs2368393,"[['MIR604', '(PA164722900)']]",belongs to,
rs9611280,"[['TNRC6B', '(PA134992981)']]",belongs to,
rs6505162,"[['MIR423', '(PA164722710)']]",belongs to,
rs3744741,"[['GEMIN4', '(PA28646)']]",belongs to,
rs11866002,"[['CNOT1', '(PA26672)']]",belongs to,
rs7911488,"[['MIR1307', '(PA164722468)']]",belongs to,
TPMT*1,"[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs494852,"[['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",TPMT activity when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs494852,"[['XDH', '(PA37404)']]",belongs to,
rs4731448,"[['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",TPMT activity when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs4731448,"[['IMPDH1', '(PA29862)']]",belongs to,
rs17428030,"[['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",TPMT activity when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs17428030,"[['SLC28A3', '(PA426)']]",belongs to,
rs17268122,"[['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",TPMT activity when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs17268122,"[['ABCC4', '(PA397)']]",belongs to,
HLA-C*03:03:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:04:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*06:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*14:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1127354,"[['azathioprine', '(PA448515)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased PRU when treated with clopidogrel in people with Coronary Artery Disease as compared to,"['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",increased fluoxetine/(S)-norfluoxetine ratio when treated with fluoxetine in children with Depressive Disorder as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",increased fluoxetine/(S)-norfluoxetine ratio when treated with fluoxetine in children with Depressive Disorder as compared to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1xN', '(assigned', 'as', 'ultrarapid', 'metabolizer', 'phenotype)', '.']"
rs10061133,"[['MIR449B', '(PA164722719)']]",belongs to,
rs2682818,"[['MIR618', '(PA164722914)']]",belongs to,
rs2289030,"[['MIR492', '(PA164722738)']]",belongs to,
rs12894467,"[['MIR300', '(PA164722632)']]",belongs to,
rs6497759,"[['TNRC6A', '(PA36656)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
"CYP1A2*1A, CYP1A2*1C","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP1A2*1A, CYP1A2*1C","[['CYP1A2', '(PA27093)']]",belongs to,
"CYP2B6*1, CYP2B6*5","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*8","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*9","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*13","[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-B*13:01:01,"[['trichloroethylene', '(PA166115521)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*44:02:01:01, HLA-B*44:03:01","[['trichloroethylene', '(PA166115521)']]",increased risk of,
"HLA-B*44:02:01:01, HLA-B*44:03:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*07:02:01, HLA-B*08:01:01","[['carbamazepine', '(PA448785)']]",decreased risk of,
"HLA-B*07:02:01, HLA-B*08:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*08:01:01, HLA-B*44:02:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*08:01:01, HLA-B*57:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*08:01:01, HLA-B*40:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*08:01:01, HLA-B*51:01:01","[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*24:02:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:11:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:11:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs6046,"[['warfarin', '(PA451906)']]",increased risk of,
rs6046,"[['F7', '(PA160)']]",belongs to,
rs13429709,"[['GCG', '(PA28606)']]",belongs to,
rs2268639,"[['GLP1R', '(PA28725)']]",belongs to,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased P2Y12 reaction unit(PRU) values when treated with clopidogrel and rosuvastatin in patients undergoing percutaneous coronary intervention as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased P2Y12 reaction unit(PRU) values when treated with atorvastatin and clopidogrel in patients undergoing percutaneous coronary intervention as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*48:04,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*48:04,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['cyclosporine', '(PA449167)'], ['prednisone', '(PA451100)']]",severity of,
"TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['cyclosporine', '(PA449167)'], ['prednisone', '(PA451100)']]",increased likelihood of,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
TPMT*3C,"[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C, TPMT*6","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['azathioprine', '(PA448515)']]",increased likelihood of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"HLA-B*08:01:01, HLA-B*15:01:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*08:01:01, HLA-B*27:05:02","[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*57:01:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*57:01:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:18:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:18:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*59:01:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*07:04:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-C*07:04:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*01:02:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*59:01:01:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
TPMT haplotype,"[['azathioprine', '(PA448515)']]",increased likelihood of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
TPMT haplotype,"[['mercaptopurine', '(PA450379)']]",increased severity of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",decreased survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,['null.']
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,['null.']
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",decreased survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,['null.']
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,['null.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",decreased C/D ratio when treated with tacrolimus in people with liver transplantation as compared to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*3A/*3A.']
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",decreased C/D ratio when treated with tacrolimus in people with liver transplantation as compared to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased relative inhibition of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased non-responsiveness when treated with aspirin and clopidogrel in people with Angina Pectoris as compared to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
TPMT haplotype,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",decreased risk of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased risk of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['mercaptopurine', '(PA450379)'], ['purine', 'analogues', '(PA452634)']]",increased likelihood of,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
TPMT*3A,"[['TPMT', '(PA356)']]",belongs to,
rs1127354,"[['mercaptopurine', '(PA450379)']]",increased 6-MMPN levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
TPMT haplotype,"[['mercaptopurine', '(PA450379)']]",increased concentrations of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*59:01:01:01,"[['acetazolamide', '(PA448018)']]",risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
"TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs5215,"[['KCNJ11', '(PA217)']]",belongs to,
rs5215,"[['KCNJ11', '(PA217)']]",belongs to,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs757110,"[['ABCC8', '(PA24395)']]",belongs to,
rs757110,"[['ABCC8', '(PA24395)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['glibenclamide', '(PA449782)'], ['gliclazide', '(PA10892)'], ['glimepiride', '(PA449761)'], ['glipizide', '(PA449762)'], ['gliquidone', '(PA164744895)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",decreased 6-MMPN levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*1.']
"TPMT*1, TPMT*2, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet aggregation with ADP when treated with clopidogrel in people with Acute coronary syndrome as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs2108622,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased platelet aggregation with epinephrine when treated with aspirin and clopidogrel in people with Acute coronary syndrome as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",decreased hematological indices when treated with azathioprine in people with Kidney Transplantation as compared to,['*1/*1.']
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['cyclosporine', '(PA449167)']]",increased plasma levels of,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
TPMT*1,"[['azathioprine', '(PA448515)']]",increased likelihood of,
TPMT*1,"[['TPMT', '(PA356)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
HLA-B*15:02:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
TPMT*3A,"[['TPMT', '(PA356)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*74:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*74:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*15:11:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:11:01,"[['HLA-B', '(PA35056)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs25531,"[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['citalopram', '(PA449015)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['escitalopram', '(PA10074)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
TPMT haplotype,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*33:03:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:11:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:11:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs4803419,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs9556455,"[['thioguanine', '(PA451663)']]",6-thioguanine and 6-thioguanine nucleotide levels when treated with thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs9556455,"[['ABCC4', '(PA397)']]",belongs to,
rs4588940,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs4588940,"[['SLC28A3', '(PA426)']]",belongs to,
rs4305983,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs4305983,"[['SLC28A3', '(PA426)']]",belongs to,
rs7043257,"[['mercaptopurine', '(PA450379)']]",6-mercaptopurine and methyl-mercaptopurine nucleotide levels when treated with mercaptopurine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs7043257,"[['SLC28A3', '(PA426)']]",belongs to,
rs2032582,"[['tramadol', '(PA451735)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['tramadol', '(PA451735)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4244285,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1057910,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['clopidogrel', '(PA449053)']]",decreased mean peak plasma concentration of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*48:01:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*48:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*08:01:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*08:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DRB1*09:01:02,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-DRB1*09:01:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]","decreased survival when treated with methotrexate in children with Lymphoma, Non-Hodgkin as compared to",
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs1800559,"[['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs1800559,"[['CACNA1S', '(PA85)']]",belongs to,
"CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-A*02:01:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*02:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*30:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-A*30:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*33:03:01,"[['lamotrigine', '(PA450164)']]",decreased risk of,
HLA-A*33:03:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*58:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:02:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*13:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DRB1*14:05:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-DRB1*14:05:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*03:01:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-DRB1*03:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs3740065,"[['methotrexate', '(PA450428)']]","increased plasma level when treated with methotrexate in children with Leukemia, B-Cell, Acute as compared to",
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs9516519,"[['methotrexate', '(PA450428)']]",decreased plasma level when exposed to,
rs9516519,"[['ABCC4', '(PA397)']]",belongs to,
HLA-A*33:03:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*33:03:01,"[['HLA-A', '(PA35055)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
HLA-DRB1*14:01:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-DRB1*14:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A4*1, CYP3A4*1B","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['tacrolimus', '(PA451578)']]",increased trough concentrations of,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"TPMT*1, TPMT*1S","[['TPMT', '(PA356)']]",belongs to,
"CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*60,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*6,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*60,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*6,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A7*3,"[['UGT1A7', '(PA37182)']]",belongs to,
UGT1A7*3,"[['UGT1A7', '(PA37182)']]",belongs to,
UGT1A7*3,"[['irinotecan', '(PA450085)'], ['oxaliplatin', '(PA131285527)'], ['s', '1', '(combination)', '(PA166115442)']]",increased likelihood of,
UGT1A7*3,"[['UGT1A7', '(PA37182)']]",belongs to,
UGT1A6*2a,"[['UGT1A6', '(PA37181)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*03:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-C*03:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQB1*03:03:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-DQB1*03:03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs737865,"[['COMT', '(PA117)']]",belongs to,
rs4646312,"[['COMT', '(PA117)']]",belongs to,
rs6267,"[['COMT', '(PA117)']]",belongs to,
rs2239393,"[['COMT', '(PA117)']]",belongs to,
rs165599,"[['COMT', '(PA117)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased likelihood of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",increased creatinine clearance when treated with tacrolimus in children with Kidney Transplantation as compared to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*3A/*3A.']
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
TPMT haplotype,"[['mercaptopurine', '(PA450379)']]",increased severity of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['clopidogrel', '(PA449053)']]",decreased mean peak plasma concentration of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs12248560,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs5918,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased risk of,
rs5918,"[['ITGB3', '(PA205)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
HLA-A*33:03,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:01,"[['allopurinol', '(PA448320)']]",decreased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs1803274,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
"CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs10497203,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs10497203,"[['TANC1', '(PA142670838)']]",belongs to,
rs7582141,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs7582141,"[['TANC1', '(PA142670838)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased severity of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",decreased interval of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs12248560,"[['busulfan', '(PA448691)']]",increased metabolic ratio of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799853,"[['busulfan', '(PA448691)']]",increased metabolic ratio of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
"CYP2B6*1, CYP2B6*5, CYP2B6*9","[['CYP2B6', '(PA123)']]",increased event-free survival when treated with busulfan in children with hemopoietic stem cell transplant as compared to,"['*5/*5', '+', '*9/*9', '+', '*5/*9.']"
"CYP2B6*1, CYP2B6*5, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,"['*5/*5', '+', '*9/*9', '+', '*5/*9.']"
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['busulfan', '(PA448691)']]",increased metabolic ratio of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['rasburicase', '(PA10176)']]",adverse reaction due to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs1803274,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs6432512,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs6432512,"[['TANC1', '(PA142670838)']]",belongs to,
rs264663,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs264663,"[['TANC1', '(PA142670838)']]",belongs to,
rs264651,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs264651,"[['TANC1', '(PA142670838)']]",belongs to,
rs1803274,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs1799807,"[['succinylcholine', '(PA451522)']]",postanesthesia apnea when exposed to,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['citalopram', '(PA449015)']]",increased likelihood of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs8187707,"[['ABCC2', '(PA116)']]",belongs to,
rs3745274,"[['imatinib', '(PA10804)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['sulfadoxine', '(PA451540)']]",decreased survival of,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['sulfametopyrazine', '(PA164747038)']]",decreased survival of,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Mediterranean, Dallas, Panama' Sassari, Cagliari, Birmingham","[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs3815087,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs3815087,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs3824662,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['leucovorin', '(PA450198)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs3824662,"[['GATA3', '(PA28586)']]",belongs to,
rs699947,"[['docetaxel', '(PA449383)']]",increased progression-free survival when treated with docetaxel in women with Breast Neoplasms as compared to,
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs144854329,"[['docetaxel', '(PA449383)']]",decreased progression-free survival when treated with docetaxel in women with Breast Neoplasms as compared to,
rs144854329,"[['VEGFA', '(PA37302)']]",belongs to,
rs1005230,"[['VEGFA', '(PA37302)']]",belongs to,
rs35864111,"[['docetaxel', '(PA449383)']]",increased progression-free survival when treated with docetaxel in women with Breast Neoplasms as compared to,
rs35864111,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['docetaxel', '(PA449383)']]",increased overall survival when treated with docetaxel in women with Breast Neoplasms as compared to,
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs833062,"[['VEGFA', '(PA37302)']]",belongs to,
rs13207351,"[['docetaxel', '(PA449383)']]",decreased progression-free survival when treated with docetaxel in women with Breast Neoplasms as compared to,
rs13207351,"[['VEGFA', '(PA37302)']]",belongs to,
rs4704559,"[['levodopa', '(PA450213)']]",decreased risk of,
rs4704559,"[['HOMER1', '(PA134972608)']]",belongs to,
rs4704559,"[['levodopa', '(PA450213)']]",decreased risk of,
rs4704559,"[['HOMER1', '(PA134972608)']]",belongs to,
rs4704560,"[['HOMER1', '(PA134972608)']]",belongs to,
rs10942981,"[['HOMER1', '(PA134972608)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs6311,"[['escitalopram', '(PA10074)']]",increased risk of,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs11568817,"[['escitalopram', '(PA10074)']]",increased risk of,
rs11568817,"[['HTR1B', '(PA29549)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs3824662,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['leucovorin', '(PA450198)'], ['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]","increased minimal residual disease when treated with asparaginase, cyclophosphamide, cytarabine, daunorubicin, dexamethasone, doxorubicin, leucovorin, mercaptopurine, methotrexate, pegaspargase, prednisone, thioguanine and vincristine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to",
rs3824662,"[['GATA3', '(PA28586)']]",belongs to,
rs12054895,"[['citalopram', '(PA449015)'], ['escitalopram', '(PA10074)']]","increased improvement over the first 2 weeks when treated with citalopram or escitalopram in people with Depressive Disorder, Major as compared to",
rs264588,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs264588,"[['TANC1', '(PA142670838)']]",belongs to,
rs264631,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs264631,"[['TANC1', '(PA142670838)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1160351,"[['fluvoxamine', '(PA449690)'], ['milnacipran', '(PA164752812)'], ['paroxetine', '(PA450801)']]",increased risk of,
rs1160351,"[['MDGA2', '(PA162395090)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]","decreased adverse effect burden when treated with citalopram in people with Depressive Disorder, Major as compared to","['HTTLPR', 'short', 'form', '(S', 'allele)/L', 'allele-rs25531C.']"
"SLC6A4 HTTLPR short form (S allele), SLC6A4 L allele-rs25531C, SLC6A4 L allele-rs25531T","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'short', 'form', '(S', 'allele)/L', 'allele-rs25531C.']"
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs3815087,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3815087,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs2844665,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs2844665,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3130931,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3130931,"[['POU5F1', '(PA33545)']]",belongs to,
rs3130931,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs3130931,"[['POU5F1', '(PA33545)']]",belongs to,
rs3130501,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs3130501,"[['POU5F1', '(PA33545)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
rs924607,"[['vincristine', '(PA451879)']]",increased risk of,
rs924607,"[['CEP72', '(PA142672125)']]",belongs to,
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",increased serum anticholinergic activity when treated with Anticholinergic Agents as compared to,"['extensive', 'metabolizers.']"
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,"['extensive', 'metabolizers.']"
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
rs3130501,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3130501,"[['POU5F1', '(PA33545)']]",belongs to,
rs3094188,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs3094188,"[['PSORS1C3', '(PA33921)']]",belongs to,
rs3094188,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3094188,"[['PSORS1C3', '(PA33921)']]",belongs to,
rs9469003,"[['allopurinol', '(PA448320)'], ['carbamazepine', '(PA448785)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs9469003,"[['CYCSP5', '(PA142672032)']]",belongs to,
rs9469003,"[['allopurinol', '(PA448320)']]",increased risk of,
rs9469003,"[['CYCSP5', '(PA142672032)']]",belongs to,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*48:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3003596,"[['NR1I3', '(PA391)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['atazanavir', '(PA10251)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
UGT1A1*28,"[['atazanavir', '(PA10251)']]",increased risk of,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*6,"[['UGT1A1', '(PA420)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
"G6PD Canton, Taiwan-Hakka, Gifu-like, Agrigento-like","[['G6PD', '(PA28469)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
TPMT*2,"[['mercaptopurine', '(PA450379)']]",increased risk of,
TPMT*2,"[['TPMT', '(PA356)']]",belongs to,
rs1801086,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['antidepressants', '(PA452229)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['Antivirals', 'for', 'treatment', 'of', 'HIV', 'infections,', 'combinations', '(PA164712505)']]",increased likelihood of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
HLA-C*03:02,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased risk of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
G6PD haplotype,"[['G6PD', '(PA28469)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased bioavailability of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3C","[['mercaptopurine', '(PA450379)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs7645903,"[['PPARG', '(PA281)']]",belongs to,
rs1175542,"[['PPARG', '(PA281)']]",belongs to,
rs1177809,"[['PPARG', '(PA281)']]",belongs to,
rs1797912,"[['PPARG', '(PA281)']]",belongs to,
rs7650895,"[['PPARG', '(PA281)']]",belongs to,
rs6782475,"[['PPARG', '(PA281)']]",belongs to,
rs3856806,"[['PPARG', '(PA281)']]",belongs to,
rs1152003,"[['ANGPTL4', '(PA24797)']]",belongs to,
rs1656930,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs266729,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs1063539,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs6773957,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs3774261,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs3821799,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs2241766,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs9882205,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs12143842,"[['amlodipine', '(PA448388)']]",decreased risk of,
rs2036373,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs7627128,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs12495941,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs822396,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs16861210,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs182052,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs822393,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs822391,"[['ADIPOQ', '(PA134933118)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1045642,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs4680,"[['morphine', '(PA450550)']]",increased severity of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1799971,"[['morphine', '(PA450550)']]",increased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
NAT2 haplotype,"[['isoniazid', '(PA450112)']]",increased risk of,
NAT2 haplotype,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7,"[['NAT2', '(PA18)']]",belongs to,
NAT2*4,"[['isoniazid', '(PA450112)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
NAT2*5,"[['NAT2', '(PA18)']]",belongs to,
NAT2*6,"[['NAT2', '(PA18)']]",belongs to,
HLA-A*33:03,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-C*03:02,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
rs683369,"[['imatinib', '(PA10804)']]","decreased event-free survival when treated with imatinib in people with Leukemia, Myelogenous, Chronic, BCR-ABL Positive as compared to",
rs683369,"[['SLC22A1', '(PA329)']]",belongs to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
HLA-DPB1*03:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DQB1*05:01:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*03:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*09:01:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs9908694,"[['cyclophosphamide', '(PA449165)']]",increased event-free survival when treated with cyclophosphamide in children with Neuroblastoma as compared to,
rs9908694,"[['IKZF3', '(PA37750)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['simvastatin', '(PA451363)']]",increased bioavailability of,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
HLA-DRB1*03:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-DRB1*03:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1594,"[['allopurinol', '(PA448320)']]",severe cutaneous adverse reactions when treated with allopurinol as compared to,
rs1594,"[['CFLAR', '(PA26425)']]",belongs to,
rs1042114,"[['OPRD1', '(PA31942)']]",belongs to,
rs2236861,"[['opioids', '(PA452618)']]",decreased risk of,
rs2236861,"[['OPRD1', '(PA31942)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs6295,"[['HTR1A', '(PA192)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs510769,"[['OPRM1', '(PA31945)']]",belongs to,
rs3778151,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs2287622,"[['ABCB11', '(PA374)']]",belongs to,
rs11568367,"[['ABCB11', '(PA374)']]",belongs to,
rs4148777,"[['ABCB11', '(PA374)']]",belongs to,
rs9479757,"[['opioids', '(PA452618)']]",decreased risk of,
rs9479757,"[['OPRM1', '(PA31945)']]",belongs to,
HLA-DPB1*03:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DPB1*04:01:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DRB1*11:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*03:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
CYP2C19 haplotype,"[['citalopram', '(PA449015)']]",increased risk of,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs6277,"[['DRD2', '(PA27478)']]",belongs to,
rs2165870,"[['CHRM3', '(PA112)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['opioids', '(PA452618)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032588,"[['ABCB1', '(PA267)']]",belongs to,
rs1051660,"[['OPRK1', '(PA31943)']]",belongs to,
rs948854,"[['opioids', '(PA452618)']]",increased risk of,
rs948854,"[['GAL', '(PA28529)']]",belongs to,
rs151264360,"[['fluorouracil', '(PA128406956)']]",decreased event-free survival and overall survival when treated with fluorouracil in people with Rectal Neoplasms as compared to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs1801133,"[['fluorouracil', '(PA128406956)']]",increased event-free survival and overall survival when treated with fluorouracil in people with Rectal Neoplasms as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['risperidone', '(PA451257)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
rs4728709,"[['vincristine', '(PA451879)']]",decreased risk of,
rs4728709,"[['ABCB1', '(PA267)']]",belongs to,
rs1135989,"[['vincristine', '(PA451879)']]",increased risk of,
rs1135989,"[['ACTG1', '(PA24468)']]",belongs to,
rs3770102,"[['vincristine', '(PA451879)']]",decreased risk of,
rs3770102,"[['CAPG', '(PA26056)']]",belongs to,
rs363390,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs363390,"[['SLC18A2', '(PA325)']]",belongs to,
rs363224,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs363224,"[['SLC18A2', '(PA325)']]",belongs to,
rs14240,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs14240,"[['SLC18A2', '(PA325)']]",belongs to,
rs1615111,"[['AREG', '(PA24933)']]",belongs to,
rs40239,"[['MET', '(PA30763)']]",belongs to,
rs40239,"[['MET', '(PA30763)']]",belongs to,
rs40239,"[['MET', '(PA30763)']]",belongs to,
CYP2C19 haplotype,"[['lansoprazole', '(PA450180)']]",decreased intragastric ph when exposed to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['rabeprazole', '(PA451216)']]",decreased intragastric ph when exposed to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['lansoprazole', '(PA450180)']]",decreased intragastric ph when exposed to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['lansoprazole', '(PA450180)']]",decreased intragastric ph when exposed to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 extensive metabolizers,"[['omeprazole', '(PA450704)']]",decreased intragastric ph when exposed to,
CYP2C19 extensive metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
rs2960421,"[['ANGPTL4', '(PA24797)']]",belongs to,
rs2920500,"[['ANGPTL4', '(PA24797)']]",belongs to,
rs17036160,"[['PPARG', '(PA281)']]",belongs to,
rs7620165,"[['PPARG', '(PA281)']]",belongs to,
rs17793693,"[['PPARG', '(PA281)']]",belongs to,
rs10865710,"[['PPARG', '(PA281)']]",belongs to,
rs1801282,"[['PPARG', '(PA281)']]",belongs to,
rs4135247,"[['PPARG', '(PA281)']]",belongs to,
rs12629751,"[['PPARG', '(PA281)']]",belongs to,
rs4135256,"[['PPARG', '(PA281)']]",belongs to,
rs2120825,"[['PPARG', '(PA281)']]",belongs to,
rs4135258,"[['PPARG', '(PA281)']]",belongs to,
rs11568315,"[['EGFR', '(PA7360)']]",belongs to,
rs200148,"[['chlorthalidone', '(PA448970)']]",increased risk of,
rs4135268,"[['PPARG', '(PA281)']]",belongs to,
rs709149,"[['PPARG', '(PA281)']]",belongs to,
rs4135275,"[['PPARG', '(PA281)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*44:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased severity of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased severity of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased severity of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs4680,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",decreased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1799971,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",increased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1611115,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",decreased likelihood of,
rs1611115,"[['DBH', '(PA136)']]",belongs to,
rs6265,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",decreased likelihood of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs6275,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",decreased likelihood of,
rs6275,"[['DRD2', '(PA27478)']]",belongs to,
rs6305,"[['Analgesics', '(PA164712362)'], ['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['Ergot', 'alkaloids', '(PA164712741)'], ['opioids', '(PA452618)'], ['sumatriptan', '(PA451566)']]",increased likelihood of,
rs6305,"[['HTR2A', '(PA193)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs72554665,"[['G6PD', '(PA28469)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['atazanavir', '(PA10251)']]",increased likelihood of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased concentration/dose ratio of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-C*07:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-C*07:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DPB1*04:01:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DPB1*04:01:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DQB1*05:02:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DQB1*05:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased blood concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2239702,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Renal Cell as compared to",
rs2239702,"[['KDR', '(PA30086)']]",belongs to,
rs9806699,"[['GATM', '(PA28590)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-DRB3*02:02:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DRB3*02:02:01:01,"[['HLA-DRB3', '(PA35074)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentration of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",higher stable dose levels of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-DPB1*03:01:01,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DPB1*03:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DQB1*06:09,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DQB1*06:09,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*13:02:01,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DRB1*13:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
HLA-DPB1*03:01:01,"[['aspirin', '(PA448497)']]",decreased risk of,
HLA-DPB1*03:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DRB1*01:01:01,"[['clozapine', '(PA449061)']]",decreased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*09:01:02,"[['aspirin', '(PA448497)']]",decreased risk of,
HLA-DRB1*09:01:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DPB1*05:01:01,"[['aspirin', '(PA448497)']]",decreased risk of,
HLA-DPB1*05:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-DPB1*13:01,"[['aspirin', '(PA448497)']]",decreased risk of,
HLA-DPB1*13:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
HLA-DRB1*01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
HLA-DQB1*06:09,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DQB1*06:09,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
HLA-DQB1*06:04:01,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DQB1*06:04:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs7586110,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs7586110,"[['UGT1A7', '(PA37182)']]",belongs to,
rs17868323,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs17868323,"[['UGT1A7', '(PA37182)']]",belongs to,
rs17863778,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs17863778,"[['UGT1A7', '(PA37182)']]",belongs to,
rs3806596,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs3806596,"[['UGT1A3', '(PA37178)']]",belongs to,
HLA-A*02:01,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased trough concentration of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased trough concentration of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased trough concentration of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-DRB1*13:02:01,"[['aspirin', '(PA448497)']]",increased risk of,
HLA-DRB1*13:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-C*08:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased PBMC concentrations of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted concentration of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-DQB1*03:03:02:01,"[['aspirin', '(PA448497)']]",decreased risk of,
HLA-DQB1*03:03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased likelihood of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-A*03:01:01:01,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased risk of,
HLA-A*03:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*03:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-C*04:01:01:01,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQB1*05:01:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*05:01:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*02:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*02:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*02:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*02:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*03:02:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*05:01:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*05:01:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*03:02:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:02:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
UGT1A1*28,"[['atazanavir', '(PA10251)']]",increased likelihood of,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased dose-adjusted blood levels of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased concentration/dose ratio of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-DRB1*01:01:01,"[['efavirenz', '(PA449441)'], ['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:02,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQA1*02:01,"[['lapatinib', '(PA152241907)']]",increased risk of,
HLA-DQA1*02:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
HLA-DQA1*02:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased trough concentration of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs3786547,"[['nevirapine', '(PA450616)']]",increased risk of,
rs3786547,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-DRB1*11:01:01,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased risk of,
HLA-DRB1*11:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted AUC24 of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*35:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*48:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*52:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*54:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*55:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*33:03,"[['ticlopidine', '(PA451686)']]",increased risk of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*44:03:01,"[['ticlopidine', '(PA451686)']]",increased risk of,
HLA-B*44:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*14:03,"[['ticlopidine', '(PA451686)']]",increased risk of,
HLA-C*14:03,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQB1*06:04:01,"[['ticlopidine', '(PA451686)']]",increased risk of,
HLA-DQB1*06:04:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*13:02:01,"[['ticlopidine', '(PA451686)']]",increased risk of,
HLA-DRB1*13:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2054675,"[['nevirapine', '(PA450616)']]",increased risk of,
rs2054675,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-DQB1*02:02,"[['acetaminophen', '(PA448015)']]",increased likelihood of,
HLA-DQB1*02:02,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*04:05:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*11:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*13:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2C19*2,"[['phenobarbital', '(PA450911)']]",increased risk of,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:02,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*67:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs10485828,"[['anastrozole', '(PA448432)'], ['exemestane', '(PA449563)']]",increased risk of,
rs10485828,"[['TUBB1', '(PA38100)']]",belongs to,
rs4550690,"[['anastrozole', '(PA448432)'], ['exemestane', '(PA449563)']]",increased risk of,
rs4550690,"[['MAP4K4', '(PA30612)']]",belongs to,
rs6901146,"[['anastrozole', '(PA448432)'], ['exemestane', '(PA449563)']]",increased risk of,
HLA-B*40:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:03,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:06:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*44:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*52:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*54:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs9332377,"[['cisplatin', '(PA449014)']]",increased risk of,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs1063320,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased likelihood of,
rs1063320,"[['HLA-G', '(PA35083)']]",belongs to,
"HLA-B*15:18:01, HLA-B*40:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*15:18:01, HLA-B*40:01:01","[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:02,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*48:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*07:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:18:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:27:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*18:02,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*41:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQB1*02:02,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*05:02:01,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-DQB1*05:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:02:01,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-DRB1*15:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*04:05:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs5925720,"[['carboplatin', '(PA448803)'], ['gemcitabine', '(PA449748)']]",decreased severity of,
rs5925720,"[['DDX53', '(PA134863598)']]",belongs to,
rs1453542,"[['carboplatin', '(PA448803)'], ['gemcitabine', '(PA449748)']]",increased severity of,
rs1453542,"[['OR4D6', '(PA32273)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3813627,"[['TOMM40L', '(PA142670714)']]",belongs to,
rs3813628,"[['TOMM40L', '(PA142670714)']]",belongs to,
rs9351963,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs9351963,"[['KCNQ5', '(PA30077)']]",belongs to,
rs768172,"[['SLC25A13', '(PA35859)']]",belongs to,
rs10815019,"[['SLC1A1', '(PA35826)']]",belongs to,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*26:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*33:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*07:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DRB1*11:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*13:02:01,"[['allopurinol', '(PA448320)']]",increased likelihood of,
HLA-DRB1*13:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
rs12201199,"[['cisplatin', '(PA449014)']]",increased risk of,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs2071554,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs2071554,"[['HLA-DOB', '(PA35061)']]",belongs to,
rs2900420,"[['Platinum', 'compounds', '(PA164713176)']]",decreased risk of,
rs4648287,"[['atenolol', '(PA448499)']]",increased likelihood of,
rs4648287,"[['PTGS2', '(PA293)']]",belongs to,
rs699664,"[['GGCX', '(PA28660)']]",belongs to,
rs11022922,"[['KCNQ1', '(PA223)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*41:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*33:03,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs6275,"[['DRD2', '(PA27478)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11568563,"[['SLCO1A2', '(PA328)']]",belongs to,
rs45502302,"[['SLCO1A2', '(PA328)']]",belongs to,
rs841718,"[['STAT6', '(PA339)']]",belongs to,
rs1805007,"[['MC1R', '(PA30673)']]",belongs to,
rs1805008,"[['MC1R', '(PA30673)']]",belongs to,
rs5761122,"[['GRK3', '(PA41)']]",belongs to,
HLA-C*03:02,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-C*03:02,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-B*37:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1800896,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:06:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:07:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:10,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*26:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*26:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs307821,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs307821,"[['FLT4', '(PA28183)']]",belongs to,
rs4073054,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs4073054,"[['NR1I3', '(PA391)']]",belongs to,
rs112830684,"[['DNAH12', '(PA27397)']]",belongs to,
HLA-B*39:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*44:02:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs10157410,"[['atenolol', '(PA448499)']]",increased risk of,
rs10157410,"[['PLA2G4A', '(PA271)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*07:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:03:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:04:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs2647087,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
HLA-B*38:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-B*38:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQB1*03:01:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*04:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased blood concentration/dosage ratio of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1695,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['levamisole', '(PA450205)'], ['radiotherapy', '(PA166122986)']]","decreased overall survival when treated with fluorouracil, leucovorin, levamisole or radiotherapy in people with Rectal Neoplasms as compared to",
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1870377,"[['fluorouracil', '(PA128406956)'], ['radiotherapy', '(PA166122986)']]",risk of,
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs61399156,"[['DOCK4', '(PA134939318)']]",belongs to,
rs73728712,"[['DGKI', '(PA27316)']]",belongs to,
rs12248467,"[['PRKG1', '(PA33777)']]",belongs to,
rs66520040,"[['FLT3', '(PA28181)']]",belongs to,
rs4073,"[['fluorouracil', '(PA128406956)'], ['radiotherapy', '(PA166122986)']]",decreased risk of,
rs4073,"[['CXCL8', '(PA29841)']]",belongs to,
rs2144297,"[['atenolol', '(PA448499)']]",Hypercholesterolemia due to,
rs2144297,"[['GALNT2', '(PA28537)']]",belongs to,
rs2144300,"[['atenolol', '(PA448499)']]",Hypercholesterolemia due to,
rs2144300,"[['GALNT2', '(PA28537)']]",belongs to,
rs3213619,"[['atenolol', '(PA448499)']]",increased risk of,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
rs10267099,"[['atenolol', '(PA448499)']]",increased risk of,
rs10267099,"[['ABCB1', '(PA267)']]",belongs to,
rs12595985,"[['atenolol', '(PA448499)']]",increased risk of,
rs12595985,"[['FTO', '(PA152208656)']]",belongs to,
rs9940629,"[['atenolol', '(PA448499)']]",Hypercholesterolemia due to,
rs9940629,"[['FTO', '(PA152208656)']]",belongs to,
rs1051640,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1051640,"[['ABCC3', '(PA376)']]",belongs to,
HLA-A*68:01:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-A*68:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough levels of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs8092654,"[['DLGAP1', '(PA27361)']]",belongs to,
rs1126647,"[['pazopanib', '(PA165291492)'], ['sunitinib', '(PA162372840)']]","decreased overall survival when treated with pazopanib or sunitinib in people with Carcinoma, Renal Cell as compared to",
rs1126647,"[['CXCL8', '(PA29841)']]",belongs to,
rs4073,"[['pazopanib', '(PA165291492)'], ['sunitinib', '(PA162372840)']]","decreased overall survival when treated with pazopanib or sunitinib in people with Carcinoma, Renal Cell as compared to",
rs4073,"[['CXCL8', '(PA29841)']]",belongs to,
rs35112095,"[['SLC37A1', '(PA35892)']]",belongs to,
rs2231142,"[['imatinib', '(PA10804)']]",increased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs72552713,"[['ABCG2', '(PA390)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2981582,"[['FGFR2', '(PA28128)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2231142,"[['atorvastatin', '(PA448500)']]",increased likelihood of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs6822844,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs6822844,"[['IL2', '(PA195)']]",belongs to,
rs2293348,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased overall survival when treated with egfr inhibitors in people with Neoplasms as compared to,
rs2293348,"[['EGFR', '(PA7360)']]",belongs to,
HLA-B*58:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*07:18,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-C*07:18,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQB1*06:09,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-DQB1*06:09,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*13:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-DRB1*13:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"SLCO1B1*1, SLCO1B1*5","[['atorvastatin', '(PA448500)'], ['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",increased risk of,
"SLCO1B1*1, SLCO1B1*5","[['SLCO1B1', '(PA134865839)']]",belongs to,
HLA-B*38:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-B*38:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-A*02:01,"[['amoxicillin', '(PA448406)'], ['ampicillin', '(PA448419)'], ['bacampicillin', '(PA164745461)']]",increased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased concentration-to-adjusted dose ratio of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased concentration-to-adjusted dose ratio of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased concentration/dose ratio of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased concentration/dose ratio of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1142345,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs1800460,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs4646316,"[['cisplatin', '(PA449014)']]",increased risk of,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1803274,"[['cocaine', '(PA449072)']]",Cocaine-Related Disorders when exposed to,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs4680662,"[['BCHE', '(PA25294)']]",belongs to,
rs4263329,"[['BCHE', '(PA25294)']]",belongs to,
rs1803274,"[['mivacurium', '(PA450528)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
rs28933390,"[['mivacurium', '(PA450528)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs28933390,"[['BCHE', '(PA25294)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
UGT1A1*28,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased risk of,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
UGT1A1*28,"[['atazanavir', '(PA10251)']]",increased risk of,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*07:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQA1*02:01,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
HLA-DQA1*02:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased concentration/dose ratio of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased trough concentrations of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased blood pressure when exposed to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs28933389,"[['mivacurium', '(PA450528)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs28933389,"[['BCHE', '(PA25294)']]",belongs to,
rs1799807,"[['mivacurium', '(PA450528)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs1799807,"[['BCHE', '(PA25294)']]",belongs to,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*39:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*08:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*08:03:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*12:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*14:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*14:03,"[['HLA-C', '(PA35057)']]",belongs to,
CYP2C9*3,"[['phenytoin', '(PA450947)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C9*3,"[['phenytoin', '(PA450947)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C9*3,"[['phenytoin', '(PA450947)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C9*3,"[['phenytoin', '(PA450947)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)'], ['UGT1A10', '(PA37174)'], ['UGT1A3', '(PA37178)'], ['UGT1A4', '(PA37179)'], ['UGT1A5', '(PA37180)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
UGT1A1*28,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased likelihood of,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-DQB1*05:02:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DQB1*05:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased dose-adjusted trough concentrations of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased trough concentrations of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
HLA-DQB1*02:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DQB1*02:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB5*02:02,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-DRB5*02:02,"[['HLA-DRB5', '(PA35076)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"VKORC1*1, VKORC1*2","[['acenocoumarol', '(PA452632)']]",increased risk of,
"VKORC1*1, VKORC1*2","[['VKORC1', '(PA133787052)']]",belongs to,
rs10929303,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased risk of,
rs10929303,"[['UGT1A1', '(PA420)']]",belongs to,
rs1042640,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased risk of,
rs1042640,"[['UGT1A1', '(PA420)']]",belongs to,
rs8330,"[['atazanavir', '(PA10251)'], ['ritonavir', '(PA451260)']]",increased risk of,
rs8330,"[['UGT1A1', '(PA420)']]",belongs to,
rs1523130,"[['NR1I2', '(PA378)']]",belongs to,
rs1523127,"[['NR1I2', '(PA378)']]",belongs to,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs3732359,"[['NR1I2', '(PA378)']]",belongs to,
rs3732360,"[['NR1I2', '(PA378)']]",belongs to,
rs3814057,"[['NR1I2', '(PA378)']]",belongs to,
rs3814058,"[['NR1I2', '(PA378)']]",belongs to,
HLA-DQB1*06:02:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
HLA-DRB5*01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DRB5*01:01:01,"[['HLA-DRB5', '(PA35076)']]",belongs to,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",decreased dose-adjusted trough concentrations of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased formation of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased formation of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
rs3842,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs15524,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"UGT2B15*1, UGT2B15*2","[['UGT2B15', '(PA37188)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs63749869,"[['RYR1', '(PA34896)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1799983,"[['daunorubicin', '(PA449212)']]","increased overall survival when treated with daunorubicin in people with Leukemia, Myeloid, Acute as compared to",
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel as compared to,['*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
rs342293,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)']]",increased severity of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs895819,"[['MIR27A', '(PA164722621)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['capecitabine', '(PA448771)'], ['irinotecan', '(PA450085)'], ['oxaliplatin', '(PA131285527)']]",increased severity of,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
NAT2 deficiency,"[['NAT2', '(PA18)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4702484,"[['capecitabine', '(PA448771)']]",decreased progression-free survival when treated with capecitabine in people with Colorectal Neoplasms as compared to,
rs4702484,"[['ADCY2', '(PA24561)']]",belongs to,
CDA poor metabolizers,"[['azacitidine', '(PA451996)']]",increased risk of,
CDA poor metabolizers,"[['CDA', '(PA98)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*11, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
CYP2C19 intermediate metabolizer,"[['voriconazole', '(PA10233)']]",increased likelihood of,
CYP2C19 intermediate metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Acute coronary syndrome as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6 extensive metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*2, CYP2D6*2xN","[['tramadol', '(PA451735)']]",increased risk of,
"CYP2D6*2, CYP2D6*2xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*20, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6, CYP2D6*9","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with antineoplastic agents and tamoxifen in people with Breast Neoplasms as compared to,"['*3/*4', '+', '*4/*9', '+', '*9/*10', '+', '*9/*41', '+', '*41/*41', '+', '*1/*4', '+', '*1/*6', '+', '*2/*4', '+', '*2/*20', '+', '*35/*4', '+', '*1/*10', '+', '*1/*9', '+', '*1/*41', '+', '*35/*10', '+', '*2/*9', '+', '*2/*41', '+', '*35/*41', '+', '*35/*9', '+', '*1/*1', '+', '*2/*2', '+', '*1/*2', '+', '*1/*35', '+', '*1xN/*2.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*20, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,"['*3/*4', '+', '*4/*9', '+', '*9/*10', '+', '*9/*41', '+', '*41/*41', '+', '*1/*4', '+', '*1/*6', '+', '*2/*4', '+', '*2/*20', '+', '*35/*4', '+', '*1/*10', '+', '*1/*9', '+', '*1/*41', '+', '*35/*10', '+', '*2/*9', '+', '*2/*41', '+', '*35/*41', '+', '*35/*9', '+', '*1/*1', '+', '*2/*2', '+', '*1/*2', '+', '*1/*35', '+', '*1xN/*2.']"
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
rs1136201,"[['trastuzumab', '(PA451743)']]",increased risk of,
rs1136201,"[['ERBB2', '(PA27844)']]",belongs to,
rs9934438,"[['phenprocoumon', '(PA450921)']]",increased likelihood of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*46:01:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs12248560,"[['tamoxifen', '(PA451581)']]",increased event-free survival when treated with tamoxifen in people with Breast Neoplasms as compared to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1799971,"[['morphine', '(PA450550)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1801131,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]","decreased event-free survival and overall survival when treated with capecitabine, fluorouracil or oxaliplatin in people with Colorectal Neoplasms as compared to",
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs148399313,"[['RYR1', '(PA34896)']]",belongs to,
rs147136339,"[['RYR1', '(PA34896)']]",belongs to,
rs147213895,"[['RYR1', '(PA34896)']]",belongs to,
rs146429605,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Acute coronary syndrome as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs2227956,"[['HSPA1L', '(PA29500)']]",belongs to,
rs2069837,"[['IL6', '(PA198)']]",belongs to,
rs2066992,"[['IL6', '(PA198)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",decreased event-free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
"UGT2B15*1, UGT2B15*2","[['UGT2B15', '(PA37188)']]",increased event-free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"UGT2B15*1, UGT2B15*2","[['UGT2B15', '(PA37188)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs4149056,"[['tamoxifen', '(PA451581)']]",decreased overall survival when treated with tamoxifen in women with Breast Neoplasms as compared to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['antineoplastic', 'agents', '(PA452621)'], ['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*10', '+', '*1/*41.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*10', '+', '*1/*41.']"
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2B6*1, CYP2B6*4","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*22","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*5","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs7317112,"[['methotrexate', '(PA450428)']]",increased risk of,
rs7317112,"[['ABCC4', '(PA397)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs1045642,"[['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",increased serum anticholinergic activity when treated with Anticholinergic Agents as compared to,"['extensive', 'metabolizers.']"
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
rs1421085,"[['FTO', '(PA152208656)']]",belongs to,
"STAT3 CTA, STAT3 TTA","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)'], ['streptomycin', '(PA451512)']]",increased risk of,
"STAT3 CTA, STAT3 TTA","[['STAT3', '(PA337)']]",belongs to,
"STAT3 TCG, STAT3 TTA","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)'], ['streptomycin', '(PA451512)']]",increased risk of,
"STAT3 TCG, STAT3 TTA","[['STAT3', '(PA337)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*10.']"
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*10.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*14, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*14:02:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*14:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*08:02:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*08:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs4680,"[['antipsychotics', '(PA452233)']]",increased diastolic blood pressure and systolic blood pressure when treated with antipsychotics in children as compared to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs2661280,"[['bevacizumab', '(PA130232992)'], ['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","increased overall survival when treated with bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs2661280,"[['RGS5', '(PA34376)']]",belongs to,
rs2302273,"[['bevacizumab', '(PA130232992)'], ['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","increased progression-free survival when treated with bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs2302273,"[['PDGFRB', '(PA33148)']]",belongs to,
rs1127648,"[['bevacizumab', '(PA130232992)'], ['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]","decreased progression-free survival when treated with bevacizumab, fluorouracil, irinotecan and leucovorin in people with Colorectal Neoplasms as compared to",
rs1127648,"[['CSPG4', '(PA26963)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased overall survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*3', '+', '*1/*4', '+', '*1/*41', '+', '*41/*41.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*3', '+', '*1/*4', '+', '*1/*41', '+', '*41/*41.']"
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-DQB1*06:02:01,"[['Influenza', 'vaccines', '(PA164712830)']]",Narcolepsy when exposed to,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs118192124,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
"CYP3A4*1, CYP3A4*20, CYP3A4*8","[['paclitaxel', '(PA450761)']]",increased risk of,
"CYP3A4*1, CYP3A4*20, CYP3A4*8","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1, CYP3A4*20, CYP3A4*8","[['paclitaxel', '(PA450761)']]",increased risk of,
"CYP3A4*1, CYP3A4*20, CYP3A4*8","[['CYP3A4', '(PA130)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel as compared to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel as compared to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs11155012,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs11155012,"[['ECT2L', '(PA134893289)']]",belongs to,
rs3818822,"[['aspirin', '(PA448497)']]",increased risk of,
rs3818822,"[['CHIA', '(PA142672117)']]",belongs to,
rs1047626,"[['aspirin', '(PA448497)']]",decreased risk of,
rs1047626,"[['SLC30A9', '(PA25909)']]",belongs to,
rs3097671,"[['aspirin', '(PA448497)']]",increased risk of,
rs3097671,"[['HLA-DPB1', '(PA35064)']]",belongs to,
rs1042136,"[['aspirin', '(PA448497)']]",increased risk of,
rs1042136,"[['HLA-DPB1', '(PA35064)']]",belongs to,
rs1042151,"[['aspirin', '(PA448497)']]",increased risk of,
rs1042151,"[['HLA-DPB1', '(PA35064)']]",belongs to,
rs3129294,"[['aspirin', '(PA448497)']]",increased risk of,
rs3129294,"[['HLA-DPB2', '(PA35065)']]",belongs to,
rs3130100,"[['aspirin', '(PA448497)']]",increased risk of,
rs3130100,"[['ZBTB22', '(PA37661)']]",belongs to,
rs1074373,"[['aspirin', '(PA448497)']]",decreased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
HLA-C*04:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs4502225,"[['WWOX', '(PA37398)']]",belongs to,
rs6500843,"[['antineoplastic', 'agents', '(PA452621)']]",increased risk of,
rs6500843,"[['RBFOX1', '(PA166048951)']]",belongs to,
TPMT intermediate metabolizer phenotype,"[['TPMT', '(PA356)']]",belongs to,
TPMT intermediate metabolizer phenotype,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased likelihood of,
TPMT intermediate metabolizer phenotype,"[['TPMT', '(PA356)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7862221,"[['aspirin', '(PA448497)']]",increased risk of,
rs7862221,"[['TSC1', '(PA37034)']]",belongs to,
rs11819745,"[['aspirin', '(PA448497)']]",increased risk of,
rs11819745,"[['THRA', '(PA36507)']]",belongs to,
rs1801274,"[['trastuzumab', '(PA451743)']]",increased progression-free survival when treated with trastuzumab in women Breast Neoplasms as compared to,
rs1801274,"[['FCGR2A', '(PA28063)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased event-free survival and Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased event-free survival and Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased overall survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*10', '+', '*10/*10', '+', '*1/*5', '+', '*2/*10', '(assigned', 'as', 'intermediate', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*10', '+', '*10/*10', '+', '*1/*5', '+', '*2/*10', '(assigned', 'as', 'intermediate', 'metabolizers', 'phenotype)', '.']"
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['risperidone', '(PA451257)']]",increased electrocardiogram qt prolonged when treated with risperidone in people with Schizophrenia as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Disease as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased event-free survival and Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*4', '+', '*1/*1.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*4', '+', '*1/*1.']"
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs3768142,"[['methotrexate', '(PA450428)']]",increased risk of,
rs3768142,"[['MTR', '(PA31272)']]",belongs to,
rs1801133,"[['pemetrexed', '(PA10810)']]","decreased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to",
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*2', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*10', '+', '*10/*10', '+', '*1/*5', '+', '*2/*10', '(assigned', 'as', 'intermediate', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*10', '+', '*10/*10', '+', '*1/*5', '+', '*2/*10', '(assigned', 'as', 'intermediate', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased overall survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*2', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
rs4413407,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4413407,"[['CXXC4', '(PA134992016)']]",belongs to,
rs12819505,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs12819505,"[['WNT5B', '(PA38104)']]",belongs to,
rs10878232,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs10878232,"[['WIF1', '(PA38291)']]",belongs to,
rs11868547,"[['Platinum', 'compounds', '(PA164713176)']]","increased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs11868547,"[['AXIN2', '(PA25196)']]",belongs to,
rs4541111,"[['Platinum', 'compounds', '(PA164713176)']]","increased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs4541111,"[['AXIN2', '(PA25196)']]",belongs to,
"APOE E2, APOE E3, APOE E4","[['APOE', '(PA55)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tamoxifen', '(PA451581)']]",decreased risk of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*4, CYP2D6*5","[['antineoplastic', 'agents', '(PA452621)'], ['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs1650697,"[['pemetrexed', '(PA10810)']]",increased risk of,
rs1650697,"[['DHFR', '(PA143)']]",belongs to,
rs11545078,"[['pemetrexed', '(PA10810)']]",decreased risk of,
rs11545078,"[['GGH', '(PA432)']]",belongs to,
rs1051298,"[['pemetrexed', '(PA10810)']]","decreased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to",
rs1051298,"[['SLC19A1', '(PA327)']]",belongs to,
rs3788189,"[['pemetrexed', '(PA10810)']]","decreased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to",
rs3788189,"[['SLC19A1', '(PA327)']]",belongs to,
rs1042580,"[['warfarin', '(PA451906)']]",decreased risk of,
rs1042580,"[['THBD', '(PA36496)']]",belongs to,
rs3176123,"[['THBD', '(PA36496)']]",belongs to,
rs1205,"[['warfarin', '(PA451906)']]",increased risk of,
rs1205,"[['CRP', '(PA120)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs757639,"[['tenofovir', '(PA10204)']]",decreased creatinine clearance when treated with tenofovir in people with HIV as compared to,
rs757639,"[['OCRL', '(PA31896)']]",belongs to,
rs7917432,"[['tenofovir', '(PA10204)']]",decreased creatinine clearance when treated with tenofovir in people with HIV as compared to,
rs7917432,"[['ABCC2', '(PA116)']]",belongs to,
rs8187707,"[['tenofovir', '(PA10204)']]",decreased creatinine clearance when treated with tenofovir in people with HIV as compared to,
rs8187707,"[['ABCC2', '(PA116)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['sulfamethoxazole', '/', 'trimethoprim', '(PA10715)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*06:02:01:01,"[['sulfamethoxazole', '/', 'trimethoprim', '(PA10715)']]",increased risk of,
HLA-C*06:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*08:01,"[['sulfamethoxazole', '/', 'trimethoprim', '(PA10715)']]",increased risk of,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*21, TPMT*32, TPMT*33, TPMT*34, TPMT*3A, TPMT*3C, TPMT*9","[['TPMT', '(PA356)']]",decreased event-free survival when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,"['*1/*1', '+', '*1/*3A', '+', '*1/*2', '+', '*1/*21', '+', '*1/*9', '+', '*1/*32', '+', '*1/*33', '+', '*1/*34.']"
"TPMT*1, TPMT*2, TPMT*21, TPMT*32, TPMT*33, TPMT*34, TPMT*3A, TPMT*3C, TPMT*9","[['TPMT', '(PA356)']]",belongs to,"['*1/*1', '+', '*1/*3A', '+', '*1/*2', '+', '*1/*21', '+', '*1/*9', '+', '*1/*32', '+', '*1/*33', '+', '*1/*34.']"
"TPMT*1, TPMT*2, TPMT*21, TPMT*33, TPMT*34, TPMT*3A, TPMT*3C, TPMT*9","[['TPMT', '(PA356)']]",Neutropenia and Thrombocytopenia when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*1.']
"TPMT*1, TPMT*2, TPMT*21, TPMT*33, TPMT*34, TPMT*3A, TPMT*3C, TPMT*9","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",Neutropenia and Thrombocytopenia when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*1.']
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",Thrombocytopenia when treated with mercaptopurine or thioguanine in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,['*1/*1.']
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,['*1/*1.']
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
HLA-DQB1*06:02:01,"[['Influenza', 'vaccines', '(PA164712830)']]",Narcolepsy when exposed to,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*10x2, CYP2D6*1xN, CYP2D6*21, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*10,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*35, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with antineoplastic agents and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*2', '+', '*1/*5', '+', '*1/*10', '+', '*1/*36', '+', '*1/*41', '+', '*2/*2', '+', '*2/*4', '+', '*2/*10', '+', '*10/*35.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*35, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2', '+', '*1/*5', '+', '*1/*10', '+', '*1/*36', '+', '*1/*41', '+', '*2/*2', '+', '*2/*4', '+', '*2/*10', '+', '*10/*35.']"
rs113165732,"[['tenofovir', '(PA10204)']]",decreased creatinine clearance when treated with tenofovir in people with HIV as compared to,
rs113165732,"[['OCRL', '(PA31896)']]",belongs to,
CYP2A6 poor metabolizers,"[['nicotine', '(PA450626)']]",decreased risk of,
CYP2A6 poor metabolizers,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*1xN', '+', '*1/*35', '+', '*2/*2.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*1xN', '+', '*1/*35', '+', '*2/*2.']"
rs1128503,"[['tacrolimus', '(PA451578)']]",increased trough concentrations of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased Pain when treated with celecoxib in children as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1872328,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1872328,"[['ACYP2', '(PA24500)']]",belongs to,
rs2305948,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs7667298,"[['clopidogrel', '(PA449053)']]",decreased likelihood of,
rs7667298,"[['KDR', '(PA30086)']]",belongs to,
HLA-B*35:01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['tamoxifen', '(PA451581)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs1128503,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children with Cystic Fibrosis as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs118192161,"[['halothane', '(PA449845)']]",Malignant Hyperthermia when exposed to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs2965667,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['aspirin', '(PA448497)']]",decreased risk of,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs1934951,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs4880,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs2740574,"[['docetaxel', '(PA449383)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs1113129,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs1113129,"[['CYP2C8', '(PA125)']]",belongs to,
rs13181,"[['docetaxel', '(PA449383)']]",increased risk of,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs3212986,"[['docetaxel', '(PA449383)']]",increased risk of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in infants as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in infants as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children with as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs16973225,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)'], ['aspirin', '(PA448497)']]",decreased likelihood of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs3212986,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['docetaxel', '(PA449383)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
CYP2D6 haplotype,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",decreased Hot Flashes when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,['*1/*1.']
CYP2D6 poor metabolizers and intermediate metabolizers,"[['tamoxifen', '(PA451581)']]",increased risk of,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,
rs2654754,"[['heroin', '(PA452619)']]",increased risk of,
rs2654754,"[['DRD3', '(PA27479)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs11045879,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs10841753,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs9288993,"[['heroin', '(PA452619)']]",increased risk of,
rs9288993,"[['DRD3', '(PA27479)']]",belongs to,
rs1486009,"[['heroin', '(PA452619)']]",decreased risk of,
rs1486009,"[['DRD3', '(PA27479)']]",belongs to,
rs2734849,"[['heroin', '(PA452619)']]",decreased risk of,
rs2734849,"[['ANKK1', '(PA134872551)']]",belongs to,
rs2587548,"[['heroin', '(PA452619)']]",increased risk of,
rs2587548,"[['DRD2', '(PA27478)']]",belongs to,
rs1076563,"[['heroin', '(PA452619)']]",increased risk of,
rs1076563,"[['DRD2', '(PA27478)']]",belongs to,
rs1534891,"[['heroin', '(PA452619)']]",increased risk of,
rs1534891,"[['CSNK1E', '(PA26953)']]",belongs to,
rs6001093,"[['heroin', '(PA452619)']]",increased risk of,
rs6001093,"[['CSNK1E', '(PA26953)']]",belongs to,
rs135757,"[['heroin', '(PA452619)']]",increased risk of,
rs135757,"[['CSNK1E', '(PA26953)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
HLA-DRB1*01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials in children as compared to,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
HLA-DRB1*01:01:01,"[['nevirapine', '(PA450616)']]",increased risk of,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1801131,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",increased Weight gain when treated with clozapine or olanzapine in people with schizoaffective disorder and Schizophrenia as compared to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs316019,"[['cisplatin', '(PA449014)']]",decreased risk of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs76228616,"[['nevirapine', '(PA450616)']]",increased risk of,
rs76228616,"[['TRAF3IP2', '(PA25938)']]",belongs to,
rs1801133,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*10', '+', '*1/*1.']"
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*10', '+', '*1/*1.']"
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs806377,"[['CNR1', '(PA26681)']]",belongs to,
rs806368,"[['CNR1', '(PA26681)']]",belongs to,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs1049353,"[['risperidone', '(PA451257)']]",increased risk of,
rs1049353,"[['CNR1', '(PA26681)']]",belongs to,
rs6499640,"[['FTO', '(PA152208656)']]",belongs to,
rs1421085,"[['FTO', '(PA152208656)']]",belongs to,
rs1121980,"[['FTO', '(PA152208656)']]",belongs to,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased platelet reactivity when treated with clopidogrel in people with as compared to,"['*1/*2', '+', '*1/*3', '+', '*2/*2', '+', '*2/*3', '+', '*3/*3.']"
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*2', '+', '*1/*3', '+', '*2/*2', '+', '*2/*3', '+', '*3/*3.']"
rs3805787,"[['GJA1', '(PA28685)']]",belongs to,
rs151264360,"[['pemetrexed', '(PA10810)']]",decreased progression-free survival when treated with pemetrexed in people with Mesothelioma as compared to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs9282564,"[['morphine', '(PA450550)']]",increased risk of,
rs9282564,"[['ABCB1', '(PA267)']]",belongs to,
rs193922747,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5, CYP2D6*6, CYP2D6*7, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2032582,"[['tacrolimus', '(PA451578)']]",increased trough concentrations of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*35, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs1128503,"[['cytarabine', '(PA449177)']]","increased overall survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cytarabine', '(PA449177)']]","increased overall survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['cytarabine', '(PA449177)']]","increased overall survival when treated with cytarabine in people with Leukemia, Myeloid, Acute as compared to",
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs112563513,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['lapatinib', '(PA152241907)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs11854484,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['protease', 'inhibitors', '(PA451159)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs11854484,"[['SLC28A2', '(PA386)']]",belongs to,
CYP2D6 ultrarapid metabolizer phenotype,"[['tamoxifen', '(PA451581)']]",increased risk of,
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-A*01:01:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*01:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*23:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-A*23:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*40:02:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*40:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*35:01:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*57:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*08:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs10789038,"[['valproic', 'acid', '(PA451846)']]",increased Weight gain when treated with valproic acid in people with Epilepsy as compared to,
rs10789038,"[['PRKAA2', '(PA33745)']]",belongs to,
rs1137101,"[['valproic', 'acid', '(PA451846)']]",increased Weight gain when treated with valproic acid in people with Epilepsy as compared to,
rs1137101,"[['LEPR', '(PA229)']]",belongs to,
rs17143212,"[['haloperidol', '(PA449841)']]",increased Drug Toxicity when treated with haloperidol in people with Psychotic Disorders as compared to,
rs17143212,"[['ABCB5', '(PA24387)']]",belongs to,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs193922802,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs193922807,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922807,"[['RYR1', '(PA34896)']]",belongs to,
rs8175347,"[['atazanavir', '(PA10251)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs28933397,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2D6*1, CYP2D6*14, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192175,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs1800497,"[['valproic', 'acid', '(PA451846)']]",increased Weight gain when treated with valproic acid in people with Epilepsy as compared to,
rs1800497,"[['ANKK1', '(PA134872551)']]",belongs to,
rs11563250,"[['irinotecan', '(PA450085)']]",decreased risk of,
rs11563250,"[['UGT1A', '(PA37173)']]",belongs to,
rs193922876,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased likelihood of,
rs193922876,"[['RYR1', '(PA34896)']]",belongs to,
rs3087374,"[['valproic', 'acid', '(PA451846)']]",increased risk of,
rs3087374,"[['POLG', '(PA33500)']]",belongs to,
rs2307441,"[['valproic', 'acid', '(PA451846)']]",increased risk of,
rs2307441,"[['POLG', '(PA33500)']]",belongs to,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
rs8050136,"[['FTO', '(PA152208656)']]",belongs to,
rs9939609,"[['FTO', '(PA152208656)']]",belongs to,
rs9930506,"[['FTO', '(PA152208656)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*15:02:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs885036,"[['bevacizumab', '(PA130232992)'], ['capecitabine', '(PA448771)'], ['oxaliplatin', '(PA131285527)']]","decreased progression-free survival when treated with bevacizumab, capecitabine and oxaliplatin in people with Colorectal Neoplasms as compared to",
rs885036,"[['MGAT4A', '(PA30782)']]",belongs to,
rs885036,"[['bevacizumab', '(PA130232992)'], ['capecitabine', '(PA448771)'], ['cetuximab', '(PA10040)'], ['oxaliplatin', '(PA131285527)']]","increased progression-free survival when treated with bevacizumab, capecitabine, cetuximab and oxaliplatin in people with Colorectal Neoplasms as compared to",
rs885036,"[['MGAT4A', '(PA30782)']]",belongs to,
rs4377367,"[['ARHGEF4', '(PA24974)']]",belongs to,
rs2073016,"[['APOBEC2', '(PA24890)']]",belongs to,
rs2789047,"[['vancomycin', '(PA451850)']]",increased likelihood of,
rs2297480,"[['atorvastatin', '(PA448500)']]",increased bone density when treated with atorvastatin in people with Coronary Disease as compared to,
rs2297480,"[['FDPS', '(PA28075)']]",belongs to,
rs11264359,"[['atorvastatin', '(PA448500)']]",increased bone density when treated with atorvastatin in people with Coronary Disease as compared to,
rs11264359,"[['FDPS', '(PA28075)']]",belongs to,
rs17367421,"[['FDPS', '(PA28075)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",increased platelet aggregation inhibition when exposed to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs142474192,"[['RYR1', '(PA34896)']]",belongs to,
rs769120898,"[['RYR1', '(PA34896)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['protease', 'inhibitors', '(PA451159)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs28360521,"[['aspirin', '(PA448497)']]",increased risk of,
rs28360521,"[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
G6PD A- 202A_376G,"[['pegloticase', '(PA165963961)']]",Hemolysis and Methemoglobinemia when exposed to,
G6PD A- 202A_376G,"[['G6PD', '(PA28469)']]",belongs to,
rs267606618,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606618,"[['MT-RNR1', '(PA31274)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
HLA-A*30:02:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-A*30:02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*18:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-B*18:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQB1*06:02:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
UGT1A1*6,"[['UGT1A1', '(PA420)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased risk of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)']]",decreased likelihood of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['phenprocoumon', '(PA450921)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*35:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs118192124,"[['halothane', '(PA449845)']]",increased risk of,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-B*39:01:01:01,"[['sulfasalazine', '(PA451547)']]",increased risk of,
HLA-B*39:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['sulfasalazine', '(PA451547)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:05:01,"[['sulfasalazine', '(PA451547)']]",increased risk of,
HLA-B*15:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"UGT2B15*1, UGT2B15*2","[['UGT2B15', '(PA37188)']]",belongs to,
"SULT1A1*1, SULT1A1*2","[['SULT1A1', '(PA343)']]",increased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*2.']
"SULT1A1*1, SULT1A1*2","[['SULT1A1', '(PA343)']]",belongs to,['*2.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",increased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*1A.']
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
HLA-DQB1*04:02:01,"[['bucillamine', '(PA166123566)']]",increased risk of,
HLA-DQB1*04:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*08:02:01,"[['bucillamine', '(PA166123566)']]",increased risk of,
HLA-DRB1*08:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs396991,"[['trastuzumab', '(PA451743)']]",increased progression-free survival when treated with trastuzumab in women Breast Neoplasms as compared to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs5445,"[['GNB3', '(PA176)']]",belongs to,
rs5758,"[['TBXA2R', '(PA348)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenprocoumon', '(PA450921)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)'], ['indomethacin', '(PA449982)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]",increased severity of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Myocardial Infarction as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1045642,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel in people with Myocardial Infarction as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
HLA-B*59:01:01:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*01:02:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs899494,"[['ABCC4', '(PA397)']]",belongs to,
rs8330,"[['acetaminophen', '(PA448015)']]",decreased risk of,
rs8330,"[['UGT1A9', '(PA419)']]",belongs to,
CYP2D6*2,"[['tamoxifen', '(PA451581)']]",decreased likelihood of,
CYP2D6*2,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7","[['tamoxifen', '(PA451581)']]",increased likelihood of,
"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9934438,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",decreased risk of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1060463,"[['CYP4F11', '(PA27120)']]",belongs to,
rs4809957,"[['CYP24A1', '(PA27097)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,"['*1/*1', '+', '*1/*17', '+', '*17/*17.']"
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*17', '+', '*17/*17.']"
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['phenprocoumon', '(PA450921)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '(assigned', 'as', 'extensive', 'metabolizer', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1800559,"[['caffeine', '(PA448710)'], ['halothane', '(PA449845)']]",increased risk of,
rs1800559,"[['CACNA1S', '(PA85)']]",belongs to,
rs1544410,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs1544410,"[['VDR', '(PA37301)']]",belongs to,
rs6051702,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs6051702,"[['ITPA', '(PA29973)']]",belongs to,
rs9934438,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",increased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*4.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*4.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",decreased progression-free survival when treated with anthracyclines and related substances and tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*4.']"
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*4.']"
"CYP2D6*1, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*14, CYP2D6*21, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*11:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:01,"[['carbamazepine', '(PA448785)']]",decreased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*51:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['celecoxib', '(PA448871)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
G6PD deficiency,"[['nalidixic', 'acid', '(PA164746384)']]","Anemia, Hemolytic when exposed to",
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs25487,"[['Platinum', 'compounds', '(PA164713176)']]","increased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1799782,"[['XRCC1', '(PA369)']]",belongs to,
rs1052555,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival and progression-free survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1052555,"[['ERCC2', '(PA27848)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs238406,"[['ERCC2', '(PA27848)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*1xN, CYP2D6*21, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2D6*1, CYP2D6*10, CYP2D6*10x2, CYP2D6*14, CYP2D6*1xN, CYP2D6*21, CYP2D6*36, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,['*1/*1.']
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6*4,"[['tamoxifen', '(PA451581)']]",increased likelihood of,
CYP2D6*4,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['asparaginase', '(PA448492)']]",increased likelihood of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
ADRB1H1,"[['ADRB1', '(PA38)']]",belongs to,
ADRB1H1,"[['verapamil', '(PA451868)']]",increased risk of,
ADRB1H1,"[['ADRB1', '(PA38)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel in people with Acute coronary syndrome as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1800566,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*41, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*3, CYP2D6*4, CYP2D6*41, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
rs2032582,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*10.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1/*10.']
rs914232,"[['pemetrexed', '(PA10810)']]","decreased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung and Mesothelioma as compared to",
rs914232,"[['SLC19A1', '(PA327)']]",belongs to,
rs3213239,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival and progression-free survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs3213239,"[['APLF', '(PA164715842)']]",belongs to,
rs13181,"[['Platinum', 'compounds', '(PA164713176)']]",increased likelihood of,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
CYP2D6*1,"[['CYP2D6', '(PA128)']]",belongs to,
UGT2B7,"[['UGT2B7', '(PA361)']]",belongs to,
rs2295632,"[['opioids', '(PA452618)']]",increased risk of,
rs2295632,"[['FAAH', '(PA27955)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
HLA-DQB1*06:02:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:02:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:03:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*06:03:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:09,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DQB1*06:09,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:03:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-DRB1*15:03:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DQA1*02:01,"[['lapatinib', '(PA152241907)']]",increased risk of,
HLA-DQA1*02:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['lapatinib', '(PA152241907)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*10.']
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,['*1/*10.']
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['tamoxifen', '(PA451581)']]",increased likelihood of,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19 poor metabolizer and intermediate metabolizer genotypes,"[['CYP2C19', '(PA124)']]",belongs to,
CYP3A5 poor metabolizer genotype,"[['CYP3A5', '(PA131)']]",belongs to,
rs1799793,"[['Platinum', 'compounds', '(PA164713176)']]",increased likelihood of,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"NAT2*14, NAT2*5, NAT2*6, NAT2*7","[['dipyrone', '(PA166128206)']]",increased risk of,
"NAT2*14, NAT2*5, NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
"CYP2D6*11, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
CYP2C9 haplotype,"[['CYP2C9', '(PA126)']]",belongs to,
CYP2C19 poor metabolizers and intermediate metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs4880,"[['valproic', 'acid', '(PA451846)']]",decreased likelihood of,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs4702484,"[['ADCY2', '(PA24561)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs118192162,"[['caffeine', '(PA448710)'], ['isoflurane', '(PA450106)']]",Malignant Hyperthermia when exposed to,
rs118192162,"[['RYR1', '(PA34896)']]",belongs to,
rs11722476,"[['SMARCAD1', '(PA134954731)']]",belongs to,
rs1801394,"[['MTRR', '(PA31277)']]",belongs to,
rs1532268,"[['MTRR', '(PA31277)']]",belongs to,
rs162036,"[['MTRR', '(PA31277)']]",belongs to,
rs10380,"[['MTRR', '(PA31277)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs4240803,"[['melphalan', '(PA450354)']]",decreased risk of,
rs4240803,"[['SLC7A5', '(PA35923)']]",belongs to,
rs1138272,"[['cisplatin', '(PA449014)']]",decreased event-free survival and overall survival when treated with cisplatin in people with Osteosarcoma as compared to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs1799793,"[['cisplatin', '(PA449014)']]",increased event-free survival when treated with cisplatin in people with Osteosarcoma as compared to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
rs940052,"[['radiotherapy', '(PA166122986)']]",decreased risk of,
rs940052,"[['PRKCE', '(PA33765)']]",belongs to,
rs11125035,"[['radiotherapy', '(PA166122986)']]",decreased risk of,
rs11125035,"[['PRKCE', '(PA33765)']]",belongs to,
rs7259857,"[['radiotherapy', '(PA166122986)']]",decreased risk of,
rs11795343,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs11795343,"[['DDX58', '(PA134994272)']]",belongs to,
rs1239344,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs1239344,"[['OSMR', '(PA32837)']]",belongs to,
rs10711,"[['radiotherapy', '(PA166122986)']]",increased risk of,
rs10711,"[['CDK1', '(PA99)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs13306698,"[['PON1', '(PA33529)']]",belongs to,
rs1208,"[['NAT2', '(PA18)']]",belongs to,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
rs854552,"[['PON1', '(PA33529)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs854565,"[['PON1', '(PA33529)']]",belongs to,
rs854568,"[['PON1', '(PA33529)']]",belongs to,
rs854572,"[['PON1', '(PA33529)']]",belongs to,
rs854573,"[['PON1', '(PA33529)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
NAT2 slow acetylator,"[['isoniazid', '(PA450112)']]",increased risk of,
NAT2 slow acetylator,"[['NAT2', '(PA18)']]",belongs to,
"NAT2*5, NAT2*7","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
"NAT2*5, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
rs2075572,"[['methadone', '(PA450401)']]",decreased severity of,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs2070959,"[['UGT1A9', '(PA419)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['aspirin', '(PA448497)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"UGT1A1*1, UGT1A1*60","[['belinostat', '(PA165971474)']]",increased risk of,
"UGT1A1*1, UGT1A1*60","[['UGT1A1', '(PA420)']]",belongs to,
rs193922802,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs17021408,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
HLA-B*59:01:01:01,"[['clozapine', '(PA449061)']]",increased risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs1056836,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs4570625,"[['TPH2', '(PA128747823)']]",belongs to,
rs1800012,"[['valproic', 'acid', '(PA451846)']]",decreased bone density when treated with valproic acid in people with Epilepsy as compared to,
rs1800012,"[['COL1A1', '(PA35041)']]",belongs to,
rs10144771,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs10144771,"[['SERPINA6', '(PA35033)']]",belongs to,
rs10426628,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs10426628,"[['SULT2B1', '(PA36249)']]",belongs to,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased time in therapeutic range when treated with warfarin as compared to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9332197,"[['warfarin', '(PA451906)']]",time to,
rs9332197,"[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs80223967,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
rs117532069,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
rs117532069,"[['DOK5', '(PA25724)']]",belongs to,
rs141059755,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
rs141059755,"[['LINC00251', '(PA165585763)']]",belongs to,
rs1891059,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
rs79085477,"[['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['dexamethasone', '(PA449247)'], ['doxorubicin', '(PA449412)'], ['methotrexate', '(PA450428)'], ['pegaspargase', '(PA164760860)'], ['prednisone', '(PA451100)'], ['thioguanine', '(PA451663)'], ['vincristine', '(PA451879)']]",increased risk of,
rs79085477,"[['BMP7', '(PA25384)']]",belongs to,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['antipsychotics', '(PA452233)']]",increased risk of,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*114, CYP2D6*2","[['gefitinib', '(PA131301952)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*114, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*114, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs2066992,"[['duloxetine', '(PA10066)']]","decreased Depressive Disorder, Major in people not taking duloxetine in people with Depressive Disorder, Major as compared to",
rs2066992,"[['IL6', '(PA198)']]",belongs to,
rs118192170,"[['RYR1', '(PA34896)']]",belongs to,
"NAT2*6, NAT2*7","[['NAT2', '(PA18)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs1799929,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
NAT2 slow acetylator,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
NAT2 slow acetylator,"[['NAT2', '(PA18)']]",belongs to,
rs1800559,"[['CACNA1S', '(PA85)']]",belongs to,
rs28933397,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['succinylcholine', '(PA451522)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs71647871,"[['CES1', '(PA107)']]",belongs to,
HLA-B*38:02:01,"[['carbimazole', '(PA164742970)'], ['methimazole', '(PA450422)'], ['propylthiouracil', '(PA451156)']]",increased risk of,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DRB1*08:03:02,"[['carbimazole', '(PA164742970)'], ['methimazole', '(PA450422)'], ['propylthiouracil', '(PA451156)']]",increased risk of,
HLA-DRB1*08:03:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased time to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased time above therapeutic range when treated with phenprocoumon as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['quetiapine', '(PA451201)']]",increased severity of,
"CYP2C19*1, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:13:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:13:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['tacrolimus', '(PA451578)']]",decreased glomerular filtration rate when treated with tacrolimus in people with Kidney Transplantation as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['cisplatin', '(PA449014)'], ['radiotherapy', '(PA166122986)']]",decreased likelihood of,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs193922747,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192162,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",decreased time to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs118192178,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs193922767,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",Malignant Hyperthermia when exposed to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs1801160,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
CYP2C19 poor metabolizer,"[['CYP2C19', '(PA124)']]",belongs to,
rs2813543,"[['exemestane', '(PA449563)']]",decreased bone density when treated with exemestane in women with Breast Neoplasms as compared to,
rs2813543,"[['ESR1', '(PA156)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs111888148,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased time in therapeutic range when treated with acenocoumarol as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
NAT2 slow acetylator,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
NAT2 slow acetylator,"[['NAT2', '(PA18)']]",belongs to,
CYP2C9 poor metabolizer,"[['cyclophosphamide', '(PA449165)']]",increased likelihood of,
CYP2C9 poor metabolizer,"[['CYP2C9', '(PA126)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs3758149,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs3758149,"[['GGH', '(PA432)']]",belongs to,
rs1979277,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1979277,"[['SHMT1', '(PA35753)']]",belongs to,
rs45445694,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs209709,"[['EPHA8', '(PA27823)']]",belongs to,
rs301927,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs301927,"[['EPHA6', '(PA134866684)']]",belongs to,
rs182455,"[['platinum', '(PA150595617)'], ['vinorelbine', '(PA451881)']]",decreased progression-free survival when treated with platinum and vinorelbine in people with as compared to,
rs182455,"[['STMN1', '(PA35491)']]",belongs to,
rs10875989,"[['platinum', '(PA150595617)']]",increased severity of,
rs10875989,"[['AQP2', '(PA24920)']]",belongs to,
rs461872,"[['platinum', '(PA150595617)']]",decreased severity of,
rs461872,"[['AQP2', '(PA24920)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]","increased Infection, nephrotoxicity and Toxic liver disease when treated with fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to",
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]",increased event-free survival when treated with fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased Infection and Toxic liver disease when treated with fluorouracil in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs78060119,"[['DPYD', '(PA145)']]",belongs to,
rs78060119,"[['DPYD', '(PA145)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs193922878,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",Alopecia and Leukopenia when treated with azathioprine in children with Crohn Disease as compared to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs116855232,"[['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs1799971,"[['methadone', '(PA450401)']]",decreased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs11872992,"[['MC4R', '(PA30676)']]",belongs to,
rs8087522,"[['MC4R', '(PA30676)']]",belongs to,
rs489693,"[['MC4R', '(PA30676)']]",belongs to,
rs7799039,"[['risperidone', '(PA451257)']]",increased risk of,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs10244329,"[['LEP', '(PA228)']]",belongs to,
rs12706832,"[['LEP', '(PA228)']]",belongs to,
rs841844,"[['SLC2A1', '(PA35875)']]",belongs to,
rs4658,"[['platinum', '(PA150595617)']]",decreased severity of,
rs4658,"[['SLC2A1', '(PA35875)']]",belongs to,
rs3738514,"[['platinum', '(PA150595617)']]",decreased severity of,
rs3738514,"[['SLC2A1', '(PA35875)']]",belongs to,
rs1051685,"[['platinum', '(PA150595617)']]",decreased severity of,
rs1051685,"[['XRCC5', '(PA37425)']]",belongs to,
rs6941,"[['platinum', '(PA150595617)']]",increased severity of,
rs6941,"[['XRCC5', '(PA37425)']]",belongs to,
rs7305534,"[['platinum', '(PA150595617)']]",increased severity of,
rs7305534,"[['AQP2', '(PA24920)']]",belongs to,
rs3759125,"[['platinum', '(PA150595617)']]",increased severity of,
rs3759125,"[['AQP2', '(PA24920)']]",belongs to,
rs2294950,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs2294950,"[['CYP2J2', '(PA27112)']]",belongs to,
rs12059276,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs12059276,"[['GSTM3', '(PA29024)']]",belongs to,
rs4407290,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs4407290,"[['XDH', '(PA37404)']]",belongs to,
rs2236168,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs2236168,"[['XDH', '(PA37404)']]",belongs to,
CYP2D6 extensive metabolizers,"[['tamoxifen', '(PA451581)']]",increased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs193922878,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192175,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192175,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",decreased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs7946,"[['PEMT', '(PA33175)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs16870989,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs16870989,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs145489027,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs145489027,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs6021191,"[['asparaginase', '(PA448492)']]",increased risk of,
rs6021191,"[['NFATC2', '(PA31583)']]",belongs to,
rs17885382,"[['asparaginase', '(PA448492)']]",increased risk of,
rs17885382,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",decreased platelet reactivity when treated with cilostazol and clopidogrel in healthy individuals as compared to,['*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1.']
rs225440,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs225440,"[['ABCG1', '(PA24408)']]",belongs to,
rs1805034,"[['acetaminophen', '(PA448015)'], ['aspirin', '(PA448497)'], ['diclofenac', '(PA449293)'], ['propionic', 'acid', 'derivatives', '(PA451140)'], ['Pyrazolones', '(PA164713217)']]",increased risk of,
rs1805034,"[['TNFRSF11A', '(PA36601)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",decreased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs111888148,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs193922809,"[['RYR1', '(PA34896)']]",belongs to,
rs10497346,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs10497346,"[['ABCB11', '(PA374)']]",belongs to,
rs2600834,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs2600834,"[['SLCO4C1', '(PA134892408)']]",belongs to,
rs12658397,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs12658397,"[['SLCO6A1', '(PA134949852)']]",belongs to,
rs2233302,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs2233302,"[['GPX3', '(PA28951)']]",belongs to,
rs4149178,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs4149178,"[['SLC22A7', '(PA35848)']]",belongs to,
rs1214763,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs1214763,"[['ABCC10', '(PA24392)']]",belongs to,
rs2180314,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs2180314,"[['GSTA2', '(PA29017)']]",belongs to,
rs7754103,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs7754103,"[['SOD2', '(PA36017)']]",belongs to,
rs55886062,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs1045642,"[['ondansetron', '(PA450705)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ondansetron', '(PA450705)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4135385,"[['lenalidomide', '(PA162363968)']]",increased risk of,
rs4135385,"[['CTNNB1', '(PA27013)']]",belongs to,
rs4533622,"[['lenalidomide', '(PA162363968)']]",increased risk of,
rs4533622,"[['CTNNB1', '(PA27013)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs1059751,"[['tenofovir', '(PA10204)']]",increased likelihood of,
rs1059751,"[['ABCC4', '(PA397)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs17782313,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['paliperidone', '(PA163518919)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased risk of,
rs17782313,"[['MC4R', '(PA30676)']]",belongs to,
rs489693,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['paliperidone', '(PA163518919)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased risk of,
rs489693,"[['MC4R', '(PA30676)']]",belongs to,
rs193922747,"[['RYR1', '(PA34896)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased risk of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['tramadol', '(PA451735)']]",increased severity of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
rs4149056,"[['enalapril', '(PA449456)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs63749869,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['isoflurane', '(PA450106)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2231135,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2231135,"[['ABCG2', '(PA390)']]",belongs to,
rs1650723,"[['methotrexate', '(PA450428)']]",increased severity of,
rs1650723,"[['DHFR', '(PA143)']]",belongs to,
rs1053129,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1053129,"[['DHFR', '(PA143)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased overall survival when treated with methotrexate in people with Osteosarcoma as compared to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs4646316,"[['cisplatin', '(PA449014)']]",increased likelihood of,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['RYR1', '(PA34896)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs2108622,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased time to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs72558189,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased time to,
rs72558189,"[['CYP2C9', '(PA126)']]",belongs to,
rs42524,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs42524,"[['COL1A2', '(PA35042)']]",belongs to,
rs3887137,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs3887137,"[['ABCA1', '(PA24373)']]",belongs to,
rs11046217,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs11046217,"[['ABCC9', '(PA396)']]",belongs to,
rs8001466,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",increased likelihood of,
rs8001466,"[['SLC15A1', '(PA323)']]",belongs to,
rs4982753,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs4982753,"[['SLC22A17', '(PA134879149)']]",belongs to,
"DPYS Compound Heterozygote, DPYS Reference","[['capecitabine', '(PA448771)']]",increased risk of,
"DPYS Compound Heterozygote, DPYS Reference","[['DPYS', '(PA146)']]",belongs to,
rs7270101,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)']]",decreased risk of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",Alopecia when treated with azathioprine or mercaptopurine in people with Inflammatory Bowel Diseases as compared to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs1967309,"[['dalcetrapib', '(PA166131581)']]",decreased risk of,
rs1967309,"[['ADCY9', '(PA30)']]",belongs to,
rs1143634,"[['antipsychotics', '(PA452233)']]",decreased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to,
rs1143634,"[['IL1B', '(PA29808)']]",belongs to,
rs16944,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs4849127,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to,
rs4849127,"[['IL1B', '(PA29808)']]",belongs to,
rs6265,"[['antipsychotics', '(PA452233)']]",decreased Weight gain when treated with antipsychotics in people with schizoaffective disorder and Schizophrenia as compared to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs63749869,"[['RYR1', '(PA34896)']]",belongs to,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['succinylcholine', '(PA451522)']]",increased risk of,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['RYR1', '(PA34896)']]",belongs to,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['RYR1', '(PA34896)']]",belongs to,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
"RYR1 571I;3366R;3933Y, RYR1 571V;3366H;3933C","[['RYR1', '(PA34896)']]",belongs to,
rs9825762,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs9825762,"[['SCN10A', '(PA35000)']]",belongs to,
rs6900017,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs6900017,"[['VEGFA', '(PA37302)']]",belongs to,
rs9369421,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs9369421,"[['VEGFA', '(PA37302)']]",belongs to,
rs879825,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs879825,"[['VEGFA', '(PA37302)']]",belongs to,
rs3594,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs3594,"[['GSR', '(PA29014)']]",belongs to,
rs1801249,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs1801249,"[['ATP7B', '(PA73)']]",belongs to,
rs11549467,"[['HIF1A', '(PA29283)']]",belongs to,
"VKORC1*1, VKORC1*2","[['warfarin', '(PA451906)']]",increased risk of,
"VKORC1*1, VKORC1*2","[['VKORC1', '(PA133787052)']]",belongs to,
rs118192170,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs118192123,"[['isoflurane', '(PA450106)']]",increased risk of,
rs118192123,"[['RYR1', '(PA34896)']]",belongs to,
rs1061472,"[['carboplatin', '(PA448803)'], ['taxanes', '(PA150481189)']]",increased likelihood of,
rs1061472,"[['ATP7B', '(PA73)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
"UGT1A1*28, UGT1A1*37, UGT1A1*6","[['pazopanib', '(PA165291492)']]",increased risk of,
"UGT1A1*28, UGT1A1*37, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['pazopanib', '(PA165291492)']]",increased likelihood of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs121918592,"[['halothane', '(PA449845)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"APOE E2, APOE E3, APOE E4","[['warfarin', '(PA451906)']]",increased time to,
"APOE E2, APOE E3, APOE E4","[['APOE', '(PA55)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs118192116,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['enflurane', '(PA449461)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",decreased creatinine clearance when treated with tacrolimus in people with Kidney Transplantation as compared to,['*3A/*3A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,['*3A/*3A.']
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs6785049,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs6785049,"[['NR1I2', '(PA378)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs7239667,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs4941131,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs6567276,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs9646629,"[['TNFRSF11A', '(PA36601)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['sunitinib', '(PA162372840)']]",decreased risk of,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",belongs to,
rs1933437,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs1933437,"[['FLT3', '(PA28181)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs121918594,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
rs193922878,"[['RYR1', '(PA34896)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*44:03:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*44:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs118192161,"[['halothane', '(PA449845)']]",increased risk of,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2D6*11, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
rs3749438,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs3749438,"[['ABCC5', '(PA395)']]",belongs to,
rs10937158,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",decreased risk of,
rs10937158,"[['ABCC5', '(PA395)']]",belongs to,
rs2292997,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
rs12746200,"[['acetaminophen', '(PA448015)'], ['aspirin', '(PA448497)'], ['diclofenac', '(PA449293)'], ['propionic', 'acid', 'derivatives', '(PA451140)'], ['Pyrazolones', '(PA164713217)']]",increased risk of,
rs12746200,"[['PLA2G4A', '(PA271)']]",belongs to,
rs2228246,"[['acetaminophen', '(PA448015)'], ['aspirin', '(PA448497)'], ['diclofenac', '(PA449293)'], ['propionic', 'acid', 'derivatives', '(PA451140)'], ['Pyrazolones', '(PA164713217)']]",increased risk of,
rs2228246,"[['PLCG1', '(PA33392)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4802101,"[['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs4802101,"[['CYP2B6', '(PA123)']]",belongs to,
rs1128503,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",decreased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['isoflurane', '(PA450106)']]",increased risk of,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs4149117,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs193922747,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922747,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['phenprocoumon', '(PA450921)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1801265,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1059778,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with Schizophrenia as compared to,
rs1059778,"[['IBA57', '(PA142672519)']]",belongs to,
rs9346455,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with Schizophrenia as compared to,
rs7336345,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with Schizophrenia as compared to,
rs1012650,"[['antipsychotics', '(PA452233)']]",increased Weight gain when treated with antipsychotics in people with Schizophrenia as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4803419,"[['CYP2B6', '(PA123)']]",belongs to,
rs4244285,"[['cyclophosphamide', '(PA449165)']]",decreased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs13059232,"[['NR1I2', '(PA378)']]",belongs to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",decreased time in therapeutic range when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs7311358,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs7311358,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs193922878,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2E1*1A, CYP2E1*5B","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"CYP2E1*1A, CYP2E1*5B","[['CYP2E1', '(PA129)']]",belongs to,
GSTM1 null,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
GSTT1 null,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*51:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*14:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-C*14:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs25487,"[['fluorouracil', '(PA128406956)'], ['leucovorin', '(PA450198)'], ['oxaliplatin', '(PA131285527)']]",decreased risk of,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*11, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*11, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['antipsychotics', '(PA452233)']]",increased risk of,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*14, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['antipsychotics', '(PA452233)']]",increased risk of,
"CYP2D6*1, CYP2D6*14, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['antipsychotics', '(PA452233)']]",increased risk of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['antipsychotics', '(PA452233)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
rs118192122,"[['desflurane', '(PA164749136)'], ['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs772226819,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs772226819,"[['CACNA1S', '(PA85)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs352887,"[['KYNU', '(PA30258)']]",belongs to,
rs10140457,"[['letrozole', '(PA450196)']]",decreased bone density when treated with letrozole in women with Breast Neoplasms as compared to,
rs10140457,"[['ESR2', '(PA27886)']]",belongs to,
rs4290270,"[['TPH2', '(PA128747823)']]",belongs to,
rs4290270,"[['TPH2', '(PA128747823)']]",belongs to,
rs7305115,"[['TPH2', '(PA128747823)']]",belongs to,
rs1843809,"[['TPH2', '(PA128747823)']]",belongs to,
rs1843809,"[['TPH2', '(PA128747823)']]",belongs to,
rs4570625,"[['TPH2', '(PA128747823)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['voriconazole', '(PA10233)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*11, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*11, CYP2C9*2, CYP2C9*3, CYP2C9*5, CYP2C9*6","[['CYP2C9', '(PA126)']]",belongs to,
rs9322335,"[['exemestane', '(PA449563)'], ['letrozole', '(PA450196)']]",decreased bone density when treated with exemestane or letrozole in women with Breast Neoplasms as compared to,
rs9322335,"[['ESR1', '(PA156)']]",belongs to,
rs1799853,"[['warfarin', '(PA451906)']]",time to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs3814637,"[['warfarin', '(PA451906)']]",risk of,
rs3814637,"[['CYP2C19', '(PA124)']]",belongs to,
rs6018,"[['warfarin', '(PA451906)']]",risk of,
rs6018,"[['F5', '(PA159)']]",belongs to,
rs2901783,"[['warfarin', '(PA451906)']]",increased time to,
rs2901783,"[['CYP2C18', '(PA127)']]",belongs to,
rs8178607,"[['warfarin', '(PA451906)']]",decreased time to,
rs8178607,"[['PROS1', '(PA33809)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs1001179,"[['ethanol', '(PA448073)']]",increased risk of,
rs1001179,"[['CAT', '(PA26099)']]",belongs to,
rs1001179,"[['ethanol', '(PA448073)']]",increased severity of,
rs1001179,"[['CAT', '(PA26099)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['antipsychotics', '(PA452233)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['antipsychotics', '(PA452233)']]",increased risk of,
"CYP2D6*1, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*10","[['antipsychotics', '(PA452233)']]",risk of,
"CYP2D6*1, CYP2D6*10","[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['antipsychotics', '(PA452233)']]",increased risk of,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)']]",decreased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1051740,"[['phenprocoumon', '(PA450921)']]",increased time above therapeutic range when treated with phenprocoumon as compared to,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs17602729,"[['regadenoson', '(PA166129536)']]",increased systolic blood pressure when exposed to,
rs17602729,"[['AMPD1', '(PA24776)']]",belongs to,
rs17602729,"[['regadenoson', '(PA166129536)']]",increased risk of,
rs17602729,"[['AMPD1', '(PA24776)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['warfarin', '(PA451906)']]",increased risk of,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs1495509,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs1495509,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs3794087,"[['SLC1A2', '(PA35827)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs6493497,"[['exemestane', '(PA449563)']]",decreased bone density when treated with exemestane in women with Breast Neoplasms as compared to,
rs6493497,"[['CYP19A1', '(PA27091)']]",belongs to,
rs6493497,"[['exemestane', '(PA449563)'], ['letrozole', '(PA450196)']]",decreased bone density when treated with exemestane and letrozole in women with Breast Neoplasms as compared to,
rs6493497,"[['CYP19A1', '(PA27091)']]",belongs to,
rs118192172,"[['isoflurane', '(PA450106)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs1872328,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1872328,"[['ACYP2', '(PA24500)']]",belongs to,
rs489693,"[['amisulpride', '(PA162565877)'], ['aripiprazole', '(PA10026)'], ['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)'], ['ziprasidone', '(PA451974)']]",increased likelihood of,
rs489693,"[['MC4R', '(PA30676)']]",belongs to,
rs489693,"[['amisulpride', '(PA162565877)'], ['aripiprazole', '(PA10026)'], ['clozapine', '(PA449061)'], ['haloperidol', '(PA449841)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)'], ['ziprasidone', '(PA451974)']]",increased risk of,
rs489693,"[['MC4R', '(PA30676)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192162,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs118192162,"[['RYR1', '(PA34896)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
"UGT1A1*1, UGT1A1*27, UGT1A1*28, UGT1A1*6","[['nilotinib', '(PA165958345)']]",increased risk of,
"UGT1A1*1, UGT1A1*27, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2071045,"[['LEP', '(PA228)']]",belongs to,
rs806378,"[['risperidone', '(PA451257)']]",increased risk of,
rs806378,"[['CNR1', '(PA26681)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['isoflurane', '(PA450106)']]",increased risk of,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*4","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
rs2229109,"[['bleomycin', '(PA448645)'], ['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisone', '(PA451100)'], ['rituximab', '(PA451261)'], ['vincristine', '(PA451879)'], ['vindesine', '(PA10232)']]",increased risk of,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['enflurane', '(PA449461)'], ['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased time to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased time below therapeutic range when treated with phenprocoumon as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs9923231,"[['phenprocoumon', '(PA450921)']]",increased time above therapeutic range when treated with phenprocoumon as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs7661530,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs7661530,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs6838116,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs6838116,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs7675300,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs7675300,"[['KCNIP4', '(PA134893552)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4870061,"[['letrozole', '(PA450196)']]",decreased bone density when treated with letrozole in women with Breast Neoplasms as compared to,
rs4870061,"[['ESR1', '(PA156)']]",belongs to,
rs4870061,"[['exemestane', '(PA449563)'], ['letrozole', '(PA450196)']]",decreased bone density when treated with exemestane or letrozole in women with Breast Neoplasms as compared to,
rs4870061,"[['ESR1', '(PA156)']]",belongs to,
rs9322335,"[['letrozole', '(PA450196)']]",decreased bone density when treated with letrozole in women with Breast Neoplasms as compared to,
rs9322335,"[['ESR1', '(PA156)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs193922809,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",decreased risk of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['warfarin', '(PA451906)']]",decreased risk of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1468412,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1468412,"[['GRM3', '(PA28992)']]",belongs to,
rs717620,"[['atazanavir', '(PA10251)'], ['lopinavir', '(PA450264)'], ['ritonavir', '(PA451260)'], ['tenofovir', '(PA10204)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs118192167,"[['RYR1', '(PA34896)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs11122576,"[['chlorthalidone', '(PA448970)']]",increased risk of,
rs11122576,"[['AGT', '(PA42)']]",belongs to,
rs11122576,"[['lisinopril', '(PA450242)']]",increased risk of,
rs11122576,"[['AGT', '(PA42)']]",belongs to,
rs11122576,"[['chlorthalidone', '(PA448970)']]",decreased risk of,
rs11122576,"[['AGT', '(PA42)']]",belongs to,
rs11122576,"[['lisinopril', '(PA450242)']]",increased risk of,
rs11122576,"[['AGT', '(PA42)']]",belongs to,
rs1045642,"[['tacrolimus', '(PA451578)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs10106,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs10106,"[['FPGS', '(PA167)']]",belongs to,
rs770063251,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs770063251,"[['DPYS', '(PA146)']]",belongs to,
rs2669429,"[['fluorouracil', '(PA128406956)']]",decreased likelihood of,
rs2669429,"[['DPYS', '(PA146)']]",belongs to,
rs2959023,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs2959023,"[['DPYS', '(PA146)']]",belongs to,
rs2070474,"[['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs2070474,"[['UPB1', '(PA418)']]",belongs to,
rs9657362,"[['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs9657362,"[['ARHGEF10', '(PA24967)']]",belongs to,
"HLA-DQB1*05:01:01:01, HLA-DQB1*05:02:01, HLA-DQB1*05:03:01:01","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"HLA-DQB1*05:01:01:01, HLA-DQB1*05:02:01, HLA-DQB1*05:03:01:01","[['HLA-DQB1', '(PA35068)']]",belongs to,
rs2229774,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs2229774,"[['RARG', '(PA34227)']]",belongs to,
rs442767,"[['DHFR', '(PA143)']]",belongs to,
rs442767,"[['methotrexate', '(PA450428)']]",increased risk of,
rs442767,"[['DHFR', '(PA143)']]",belongs to,
rs408626,"[['methotrexate', '(PA450428)']]",increased risk of,
rs408626,"[['DHFR', '(PA143)']]",belongs to,
rs408626,"[['methotrexate', '(PA450428)']]",decreased event-free survival and overall survival when treated with methotrexate in people with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs408626,"[['DHFR', '(PA143)']]",belongs to,
rs4124874,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs10929302,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs776746,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs118192172,"[['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs193922770,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs193922770,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
CYP2D6 intermediate metabolizers,"[['CYP2D6', '(PA128)']]",decreased event-free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['extensive', 'metabolizers.']"
CYP2D6 intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,"['extensive', 'metabolizers.']"
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs895819,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs895819,"[['MIR27A', '(PA164722621)']]",belongs to,
rs11671784,"[['MIR27A', '(PA164722621)']]",belongs to,
rs2239702,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Renal Cell as compared to",
rs2239702,"[['KDR', '(PA30086)']]",belongs to,
rs1570360,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Renal Cell as compared to",
rs1570360,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['sorafenib', '(PA7000)']]",increased risk of,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs1045642,"[['sorafenib', '(PA7000)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs17223074,"[['GPR1', '(PA28846)']]",belongs to,
rs1913896,"[['PPP1R1C', '(PA33640)']]",belongs to,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs193922753,"[['RYR1', '(PA34896)']]",belongs to,
rs193922770,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs8175347,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs717620,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs8187710,"[['deferasirox', '(PA164760843)']]",increased risk of,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs1360780,"[['FKBP5', '(PA28162)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs1126647,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs1126647,"[['CXCL8', '(PA29841)']]",belongs to,
rs1800925,"[['sunitinib', '(PA162372840)']]",increased severity of,
rs1800925,"[['IL13', '(PA199)']]",belongs to,
rs1800925,"[['sunitinib', '(PA162372840)']]",increased risk of,
rs1800925,"[['IL13', '(PA199)']]",belongs to,
rs20541,"[['IL13', '(PA199)']]",belongs to,
rs11762213,"[['MET', '(PA30763)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918594,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['tamoxifen', '(PA451581)']]",increased risk of,
"CYP2D6*1, CYP2D6*1xN, CYP2D6*2, CYP2D6*2xN, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",decreased Recurrence free survival when treated with tamoxifen in women with Breast Neoplasms as compared to,"['*1/*1', '+', '*1/*2', '+', '*1/*35', '+', '*2/*2', '+', '*2/*35', '+', '*35/*35', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
"CYP2D6*1, CYP2D6*2, CYP2D6*3, CYP2D6*35, CYP2D6*4, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,"['*1/*1', '+', '*1/*2', '+', '*1/*35', '+', '*2/*2', '+', '*2/*35', '+', '*35/*35', '(assigned', 'as', 'extensive', 'metabolizers', 'phenotype)', '.']"
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['antiepileptics', '(PA143485705)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3815583,"[['CES1', '(PA107)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased time in therapeutic range when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4646903,"[['CYP1A1', '(PA27092)']]",belongs to,
rs4646903,"[['CYP1A1', '(PA27092)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs121918592,"[['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*14, CYP2D6*2, CYP2D6*5","[['gefitinib', '(PA131301952)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*14, CYP2D6*2, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['gefitinib', '(PA131301952)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*38:02:01,"[['carbimazole', '(PA164742970)'], ['methimazole', '(PA450422)']]",increased risk of,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs193922878,"[['RYR1', '(PA34896)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs121918593,"[['isoflurane', '(PA450106)']]",increased risk of,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
HLA-B*56:02,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*56:02,"[['HLA-B', '(PA35056)']]",belongs to,
rs7799039,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs1800497,"[['risperidone', '(PA451257)']]",decreased severity of,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
CYP2D6 extensive metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs3102724,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs1485286,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs1485288,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs11573856,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs3102728,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs3134068,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs2073618,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased likelihood of,
rs2073618,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs2073618,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased likelihood of,
rs2073618,"[['TNFRSF11B', '(PA36602)']]",belongs to,
rs7984870,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased likelihood of,
rs7984870,"[['TNFSF11', '(PA36619)']]",belongs to,
rs7984870,"[['anastrozole', '(PA448432)'], ['letrozole', '(PA450196)']]",increased likelihood of,
rs7984870,"[['TNFSF11', '(PA36619)']]",belongs to,
rs9594782,"[['TNFSF11', '(PA36619)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933397,"[['RYR1', '(PA34896)']]",belongs to,
rs118204423,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['succinylcholine', '(PA451522)']]",increased risk of,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192175,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs1800559,"[['CACNA1S', '(PA85)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['atomoxetine', '(PA134688071)']]",increased risk of,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*1xN, CYP2D6*3, CYP2D6*4, CYP2D6*4xN, CYP2D6*5, CYP2D6*6, CYP2D6*7","[['CYP2D6', '(PA128)']]",belongs to,
rs2277438,"[['TNFSF11', '(PA36619)']]",belongs to,
rs9566990,"[['TNFSF11', '(PA36619)']]",belongs to,
rs9533166,"[['TNFSF11', '(PA36619)']]",belongs to,
rs12457042,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs4941129,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs7237982,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs12969154,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs4369774,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs12956925,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs11877530,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs11664594,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs12455775,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs6567270,"[['TNFRSF11A', '(PA36601)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",decreased time in therapeutic range when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",increased time above therapeutic range when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",decreased time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs193922753,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['methoxyflurane', '(PA450434)']]",increased risk of,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['desflurane', '(PA164749136)']]",increased risk of,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs3730089,"[['egfr', 'inhibitors', '(PA153561371)']]",increased overall survival when treated with egfr inhibitors in people with Neoplasms as compared to,
rs3730089,"[['PIK3R1', '(PA33312)']]",belongs to,
rs73420732,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased likelihood of,
rs73420732,"[['EGFR', '(PA7360)']]",belongs to,
rs1061235,"[['HLA-A', '(PA35055)']]",belongs to,
rs2395029,"[['HCP5', '(PA134951826)']]",belongs to,
rs3909184,"[['FLOT1', '(PA28175)']]",belongs to,
rs3869066,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
rs3869066,"[['ZNRD1-AS1', '(PA165618433)']]",belongs to,
rs2241529,"[['alendronate', '(PA448082)']]","decreased bone density when treated with alendronate in women with Bone Diseases, Metabolic or Osteoporosis as compared to",
rs2241529,"[['DKK1', '(PA27345)']]",belongs to,
rs6265,"[['methamphetamine', '(PA450403)']]",decreased likelihood of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs4149056,"[['cyclophosphamide', '(PA449165)'], ['docetaxel', '(PA449383)'], ['doxorubicin', '(PA449412)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['goserelin', '(PA164747674)']]",increased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs16754,"[['WT1', '(PA37395)']]",belongs to,
rs2279238,"[['laropiprant', '(PA166129564)'], ['niacin', '(PA450617)']]",increased severity of,
rs2279238,"[['NR1H3', '(PA31751)']]",belongs to,
rs1695,"[['capecitabine', '(PA448771)'], ['epirubicin', '(PA449476)'], ['platinum', '(PA150595617)']]","increased overall survival when treated with capecitabine, epirubicin and platinum in people with Colorectal Neoplasms as compared to",
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs45445694,"[['capecitabine', '(PA448771)'], ['platinum', '(PA150595617)']]",decreased progression-free survival when treated with capecitabine and platinum in people with Colorectal Neoplasms or gastroesophageal cancer as compared to,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs4073,"[['pazopanib', '(PA165291492)']]","decreased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs4073,"[['CXCL8', '(PA29841)']]",belongs to,
rs1045642,"[['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2740574,"[['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs1136201,"[['ERBB2', '(PA27844)']]",belongs to,
rs1136201,"[['ERBB2', '(PA27844)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs10846744,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","decreased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs10846744,"[['SCARB1', '(PA97)']]",belongs to,
rs5888,"[['SCARB1', '(PA97)']]",belongs to,
rs3782287,"[['SCARB1', '(PA97)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs777425216,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs45589337,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a or peginterferon alfa-2b in people with Hepatitis D, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*40:02:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-B*40:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:01:01:01,"[['oxcarbazepine', '(PA450732)']]",decreased risk of,
HLA-B*15:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:11:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DRB1*04:03:01,"[['oxcarbazepine', '(PA450732)']]",increased risk of,
HLA-DRB1*04:03:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
CYP2C19 poor metabolizer and intermediate metabolizer genotypes,"[['valproic', 'acid', '(PA451846)']]",increased risk of,
CYP2C19 poor metabolizer and intermediate metabolizer genotypes,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 haplotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs3918289,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs56293913,"[['DPYD', '(PA145)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs324420,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs6864049,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs12444979,"[['antipsychotics', '(PA452233)']]",increased risk of,
"TPMT*1, TPMT*3A, TPMT*3C","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs7270101,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
rs79206939,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs79206939,"[['FTO', '(PA152208656)']]",belongs to,
rs16952570,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs16952570,"[['FTO', '(PA152208656)']]",belongs to,
rs2834826,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",decreased Weight gain when treated with rosiglitazone in people with Diabetes Mellitus as compared to,['*1A/*1A.']
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,['*1A/*1A.']
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
NAT2*4,"[['isoniazid', '(PA450112)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
"NAT2*4, NAT2*6A","[['isoniazid', '(PA450112)']]",increased risk of,
"NAT2*4, NAT2*6A","[['NAT2', '(PA18)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs45589337,"[['DPYD', '(PA145)']]",belongs to,
rs376073289,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",increased severity of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*4,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
DPYD*6,"[['DPYD', '(PA145)']]",belongs to,
rs7958375,"[['rifampin', '(PA451250)']]",increased risk of,
rs7958375,"[['CUX2', '(PA162382977)']]",belongs to,
rs10946739,"[['rifampin', '(PA451250)']]",increased risk of,
rs10946739,"[['RIPOR2', '(PA162387677)']]",belongs to,
rs10946737,"[['rifampin', '(PA451250)']]",increased risk of,
rs10946737,"[['RIPOR2', '(PA162387677)']]",belongs to,
rs320003,"[['rifampin', '(PA451250)']]",increased risk of,
rs320003,"[['AGBL4', '(PA142672636)']]",belongs to,
rs319952,"[['rifampin', '(PA451250)']]",increased risk of,
rs319952,"[['AGBL4', '(PA142672636)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4273729,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to",
rs7270101,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
rs6051702,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased severity of,
rs6051702,"[['C20orf194', '(PA134905007)'], ['ITPA', '(PA29973)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7574296,"[['sorafenib', '(PA7000)']]",increased risk of,
rs7574296,"[['UGT1A9', '(PA419)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"P2RY12 H1, P2RY12 H2","[['clopidogrel', '(PA449053)']]",decreased platelet aggregation when exposed to,
"P2RY12 H1, P2RY12 H2","[['P2RY12', '(PA134971947)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2279343,"[['cyclophosphamide', '(PA449165)'], ['dactinomycin', '(PA151917012)'], ['vincristine', '(PA451879)']]","increased event-free survival when treated with cyclophosphamide, dactinomycin and vincristine in children with Rhabdomyosarcoma as compared to",
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)']]",increased severity of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs7270101,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
TPMT poor metabolizers,"[['azathioprine', '(PA448515)']]",increased likelihood of,
TPMT poor metabolizers,"[['TPMT', '(PA356)']]",belongs to,
rs1127354,"[['DDRGK1', '(PA164718734)'], ['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs1127354,"[['DDRGK1', '(PA164718734)'], ['ITPA', '(PA29973)']]",belongs to,
rs316019,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs316019,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['azathioprine', '(PA448515)']]",increased likelihood of,
"TPMT*1, TPMT*3A, TPMT*3B, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs4407290,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs4407290,"[['XDH', '(PA37404)']]",belongs to,
rs6296,"[['citalopram', '(PA449015)']]",increased risk of,
rs6296,"[['HTR1B', '(PA29549)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs662,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs662,"[['PON1', '(PA33529)']]",belongs to,
rs2046934,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs2289669,"[['SLC47A1', '(PA162403808)']]",belongs to,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs10824095,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs10824095,"[['ADK', '(PA24579)']]",belongs to,
rs747199,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs747199,"[['SLC29A1', '(PA154)']]",belongs to,
rs45445694,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs2278294,"[['azathioprine', '(PA448515)']]",decreased likelihood of,
rs2278294,"[['IMPDH1', '(PA29862)']]",belongs to,
rs11706052,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs11706052,"[['IMPDH2', '(PA29863)']]",belongs to,
rs2074087,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs2074087,"[['ABCC1', '(PA244)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['sorafenib', '(PA7000)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['sorafenib', '(PA7000)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs2306283,"[['sorafenib', '(PA7000)']]",decreased likelihood of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['sorafenib', '(PA7000)']]",increased likelihood of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['sorafenib', '(PA7000)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*51:01:01,"[['clindamycin', '(PA449035)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:27:01,"[['clindamycin', '(PA449035)']]",increased risk of,
HLA-B*15:27:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7349683,"[['paclitaxel', '(PA450761)']]",increased risk of,
rs7349683,"[['EPHA5', '(PA27821)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs4147581,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs12208357,"[['SLC22A1', '(PA329)']]",belongs to,
rs34059508,"[['SLC22A1', '(PA329)']]",belongs to,
rs13431554,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]","increased platelet reactivity when treated with aspirin and clopidogrel in people with Coronary Artery Disease and Diabetes Mellitus, Type 2 as compared to",
rs13431554,"[['IRS1', '(PA203)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['cisplatin', '(PA449014)'], ['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs118192162,"[['RYR1', '(PA34896)']]",belongs to,
rs10510050,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs10510050,"[['EIF3A', '(PA27699)']]",belongs to,
rs7870226,"[['PDCD1LG2', '(PA134891547)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs12948783,"[['opioids', '(PA452618)'], ['oxycodone', '(PA450741)']]",decreased likelihood of,
rs12948783,"[['RHBDF2', '(PA134980674)']]",belongs to,
rs7016778,"[['oxycodone', '(PA450741)']]",decreased likelihood of,
rs7016778,"[['OPRK1', '(PA31943)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs10423928,"[['olanzapine', '(PA450688)']]",increased severity of,
rs10423928,"[['GIPR', '(PA28682)']]",belongs to,
rs3813929,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
NAT2*6A,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
NAT2*7B,"[['NAT2', '(PA18)']]",belongs to,
NAT2*5B,"[['NAT2', '(PA18)']]",belongs to,
NAT2*13,"[['NAT2', '(PA18)']]",belongs to,
NAT2*4,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased risk of,
NAT2*4,"[['NAT2', '(PA18)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
rs747199,"[['SLC29A1', '(PA154)']]",belongs to,
rs747199,"[['SLC29A1', '(PA154)']]",belongs to,
rs12208357,"[['SLC22A1', '(PA329)']]",belongs to,
rs628031,"[['SLC22A1', '(PA329)']]",belongs to,
rs628031,"[['SLC22A1', '(PA329)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs10868138,"[['SLC28A3', '(PA426)']]",belongs to,
rs3742106,"[['ABCC4', '(PA397)']]",belongs to,
rs3742106,"[['ABCC4', '(PA397)']]",belongs to,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs11568658,"[['valganciclovir', '(PA10227)']]",increased risk of,
rs11568658,"[['ABCC4', '(PA397)']]",belongs to,
rs2413775,"[['SLC28A2', '(PA386)']]",belongs to,
rs2413775,"[['SLC28A2', '(PA386)']]",belongs to,
HLA-DRB1*16:01:01,"[['flupirtine', '(PA166152829)']]",increased risk of,
HLA-DRB1*16:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['atazanavir', '(PA10251)']]",increased risk of,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 ultrarapid metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs985919,"[['NRXN1', '(PA31786)']]",belongs to,
rs17408276,"[['CHRNA5', '(PA26491)']]",belongs to,
rs10865246,"[['NRXN1', '(PA31786)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased Drug Toxicity when treated with methotrexate in children with as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs75017182,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
CYP2B6*6,"[['methadone', '(PA450401)']]",increased severity of,
CYP2B6*6,"[['CYP2B6', '(PA123)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['capecitabine', '(PA448771)']]",increased severity of,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)']]",decreased progression-free survival when treated with capecitabine in people with Colorectal Neoplasms as compared to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['capecitabine', '(PA448771)']]",increased risk of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['capecitabine', '(PA448771)']]",increased risk of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:12893986)","[['ABCB1', '(PA267)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",['*1.']
"ABCB1*1, ABCB1*2(PMID:12893986)","[['ABCB1', '(PA267)']]",belongs to,['*1.']
rs776746,"[['cabazitaxel', '(PA165958401)']]",decreased likelihood of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1128503,"[['cabazitaxel', '(PA165958401)']]",decreased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cabazitaxel', '(PA165958401)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['cabazitaxel', '(PA165958401)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['cabazitaxel', '(PA165958401)']]","decreased progression-free survival when treated with cabazitaxel in people with Carcinoma, Transitional Cell as compared to",
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs463312,"[['cabazitaxel', '(PA165958401)']]","decreased progression-free survival when treated with cabazitaxel in people with Carcinoma, Transitional Cell as compared to",
rs463312,"[['TUBB1', '(PA38100)']]",belongs to,
rs1061781,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased platelet reactivity when treated with aspirin and clopidogrel in people with Coronary Artery Disease as compared to,
rs1061781,"[['B4GALT2', '(PA25224)']]",belongs to,
rs11615,"[['oxaliplatin', '(PA131285527)']]",decreased overall survival and progression-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
rs1800888,"[['ADRB2', '(PA39)']]",belongs to,
rs1042718,"[['fentanyl', '(PA449599)'], ['propofol', '(PA451141)'], ['remifentanil', '(PA451232)'], ['sevoflurane', '(PA451341)']]",increased severity of,
rs1042718,"[['ADRB2', '(PA39)']]",belongs to,
rs1042719,"[['ADRB2', '(PA39)']]",belongs to,
rs2257212,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2257212,"[['SLC15A2', '(PA35812)']]",belongs to,
rs1560661,"[['platinum', '(PA150595617)']]",decreased severity of,
rs1560661,"[['CD74', '(PA26236)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs2748249,"[['platinum', '(PA150595617)']]",increased severity of,
rs2748249,"[['CD74', '(PA26236)']]",belongs to,
rs2858996,"[['pazopanib', '(PA165291492)']]",increased likelihood of,
rs2858996,"[['HFE', '(PA29263)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs868755,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs868755,"[['ABCB1', '(PA267)']]",belongs to,
rs10280623,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs10280623,"[['ABCB1', '(PA267)']]",belongs to,
"DPYD*5, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs25487,"[['oxaliplatin', '(PA131285527)']]",decreased progression-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1695,"[['oxaliplatin', '(PA131285527)']]",increased overall survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs13181,"[['oxaliplatin', '(PA131285527)']]",decreased overall survival and progression-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs13181,"[['ERCC2', '(PA27848)'], ['KLC3', '(PA142671588)']]",belongs to,
rs193922818,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192161,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs193922807,"[['RYR1', '(PA34896)']]",belongs to,
rs2066844,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased likelihood of,
rs2066844,"[['NOD2', '(PA26074)']]",belongs to,
DPYD deficiency,"[['fluorouracil', '(PA128406956)']]",risk of,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*4, DPYD*5, DPYD*9A","[['fluorouracil', '(PA128406956)']]",risk of,
"DPYD*4, DPYD*5, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs10760502,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs10760502,"[['FPGS', '(PA167)']]",belongs to,
rs10106,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs10106,"[['FPGS', '(PA167)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2372536,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs763110,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)']]",decreased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to,
rs763110,"[['FASLG', '(PA56)']]",belongs to,
rs4638843,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)']]",decreased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to,
rs4638843,"[['MSH2', '(PA31133)']]",belongs to,
rs939338,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)']]",decreased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to,
rs939338,"[['ABCC5', '(PA395)']]",belongs to,
rs2720376,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)']]",increased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to,
rs2720376,"[['CASP3', '(PA26087)']]",belongs to,
rs4646437,"[['cisplatin', '(PA449014)'], ['doxorubicin', '(PA449412)']]",increased progression-free survival when treated with cisplatin and doxorubicin in people with Osteosarcoma as compared to,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs163182,"[['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",decreased likelihood of,
rs163182,"[['KCNQ1', '(PA223)']]",belongs to,
rs776746,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1870377,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
DPYD*13,"[['DPYD', '(PA145)']]",belongs to,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs655130,"[['PPFIA1', '(PA33566)']]",belongs to,
rs1079199,"[['APBB1', '(PA24873)']]",belongs to,
rs868589,"[['ADAM12', '(PA24507)']]",belongs to,
rs2791188,"[['ADAMTS14', '(PA24540)']]",belongs to,
rs306468,"[['NLRP8', '(PA162398028)']]",belongs to,
rs271828,"[['PDE4C', '(PA264)']]",belongs to,
rs281018,"[['DLGAP1', '(PA27361)']]",belongs to,
rs3045983,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs3045983,"[['DHFR', '(PA143)']]",belongs to,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
rs3212935,"[['ERCC1', '(PA155)']]",belongs to,
rs3212935,"[['ERCC1', '(PA155)']]",belongs to,
rs2231137,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
rs3814055,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs3814055,"[['NR1I2', '(PA378)']]",belongs to,
rs2276707,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
"CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['tegafur', '(PA452620)']]",increased area under the plasma concentration-time curve of,
"CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,
rs199695765,"[['asparaginase', '(PA448492)']]",increased risk of,
rs199695765,"[['CPA2', '(PA26817)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs10948059,"[['mercaptopurine', '(PA450379)']]",decreased likelihood of,
rs10948059,"[['GNMT', '(PA28794)']]",belongs to,
rs3025040,"[['sorafenib', '(PA7000)']]",increased risk of,
rs3025040,"[['VEGFA', '(PA37302)']]",belongs to,
rs4379440,"[['warfarin', '(PA451906)']]",decreased time in therapeutic range when treated with warfarin as compared to,
rs4379440,"[['ASPH', '(PA25056)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1271562,"[['PPP2R5E', '(PA33677)']]",belongs to,
rs1436260,"[['ITGBL1', '(PA29963)']]",belongs to,
rs4767452,"[['RNFT2', '(PA162401944)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
rs4273729,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs7563206,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs7563206,"[['ATIC', '(PA25094)']]",belongs to,
rs12995526,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs12995526,"[['ATIC', '(PA25094)']]",belongs to,
rs7703002,"[['platinum', '(PA150595617)']]",increased likelihood of,
rs7703002,"[['RICTOR', '(PA165660455)']]",belongs to,
rs6878291,"[['platinum', '(PA150595617)']]","decreased progression-free survival when treated with platinum in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs6878291,"[['RICTOR', '(PA165660455)']]",belongs to,
rs316003,"[['SLC22A2', '(PA331)']]",belongs to,
rs4925193,"[['CDH4', '(PA26300)']]",belongs to,
HLA-A*02:06:01,"[['tetanus', 'antitoxin', '(PA451632)']]",increased likelihood of,
HLA-A*02:06:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",decreased time in therapeutic range when treated with warfarin as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs717620,"[['sorafenib', '(PA7000)']]",increased risk of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs1870377,"[['sorafenib', '(PA7000)']]",increased risk of,
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs1870377,"[['sorafenib', '(PA7000)']]",increased risk of,
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs4643786,"[['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['mitoxantrone', '(PA450526)']]","increased overall survival when treated with cytarabine, daunorubicin or mitoxantrone in people with Leukemia, Myeloid, Acute as compared to",
rs4643786,"[['DCK', '(PA137)']]",belongs to,
rs4291,"[['captopril', '(PA448780)']]",decreased severity of,
rs4291,"[['ACE', '(PA139)']]",belongs to,
rs4680,"[['Drugs', 'used', 'in', 'nicotine', 'dependence', '(PA164712720)']]",increased likelihood of,
rs4680,"[['COMT', '(PA117)']]",belongs to,
HLA-DQB1*05:03:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*14:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
rs121918594,"[['desflurane', '(PA164749136)']]",increased risk of,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
rs63749869,"[['RYR1', '(PA34896)']]",belongs to,
rs4149087,"[['misoprostol', '(PA450523)']]",increased likelihood of,
rs4149087,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs61764370,"[['cetuximab', '(PA10040)'], ['panitumumab', '(PA162373091)']]",increased progression-free survival when treated with cetuximab or panitumumab in people with Colorectal Neoplasms as compared to,
rs61764370,"[['KRAS', '(PA30196)']]",belongs to,
rs75527207,"[['ivacaftor', '(PA165950341)']]",decreased severity of,
rs75527207,"[['CFTR', '(PA109)']]",belongs to,
rs17300539,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs17300539,"[['ADIPOQ', '(PA134933118)']]",belongs to,
rs2046934,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs776746,"[['clopidogrel', '(PA449053)']]",decreased likelihood of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",decreased likelihood of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs45445694,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs147601618,"[['fluorouracil', '(PA128406956)']]",risk of,
rs147601618,"[['DPYD', '(PA145)']]",belongs to,
DPYD deficiency,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
CYP2C8*1A,"[['CYP2C8', '(PA125)']]",belongs to,
CYP2C9*1,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased risk of,
CYP2C9*1,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1882296,"[['NRXN1', '(PA31786)']]",belongs to,
rs10205923,"[['IRS1', '(PA203)']]",belongs to,
rs1078533,"[['IRS1', '(PA203)']]",belongs to,
rs2288586,"[['IRS1', '(PA203)']]",belongs to,
rs1801278,"[['IRS1', '(PA203)']]",belongs to,
rs13058338,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs13058338,"[['RAC2', '(PA34163)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
"DPYD*11, DPYD*12","[['fluorouracil', '(PA128406956)']]",risk of,
"DPYD*11, DPYD*12","[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs75017182,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs1801133,"[['fluorouracil', '(PA128406956)']]",decreased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2307424,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
rs61764370,"[['KRAS', '(PA30196)']]",belongs to,
HLA-DQA1*01:02:01:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
rs699664,"[['warfarin', '(PA451906)']]",increased international normalized ratio variability (inr-var) when treated with warfarin as compared to,
rs699664,"[['GGCX', '(PA28660)']]",belongs to,
rs11676382,"[['warfarin', '(PA451906)']]",decreased time in therapeutic range when treated with warfarin as compared to,
rs11676382,"[['GGCX', '(PA28660)']]",belongs to,
rs1800566,"[['warfarin', '(PA451906)']]",increased risk of,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs351855,"[['FGFR4', '(PA28130)']]",belongs to,
rs351855,"[['FGFR4', '(PA28130)']]",belongs to,
rs1045642,"[['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2740574,"[['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
DPYD*6,"[['DPYD', '(PA145)']]",belongs to,
"CYP2D6*1, CYP2D6*1xN","[['dolasetron', '(PA449390)']]",increased likelihood of,
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*3, CYP2D6*4, CYP2D6*5, CYP2D6*6","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*1, CYP2D6*2, CYP2D6*35","[['CYP2D6', '(PA128)']]",belongs to,
"CYP2D6*10, CYP2D6*41, CYP2D6*9","[['CYP2D6', '(PA128)']]",belongs to,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs747199,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs747199,"[['SLC29A1', '(PA154)']]",belongs to,
rs2278293,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2278293,"[['IMPDH1', '(PA29862)']]",belongs to,
rs10868138,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs10868138,"[['SLC28A3', '(PA426)']]",belongs to,
rs2274407,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs2229109,"[['valganciclovir', '(PA10227)']]",increased risk of,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs55754655,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs55754655,"[['AOX1', '(PA24842)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs2293348,"[['egfr', 'inhibitors', '(PA153561371)']]",decreased likelihood of,
rs2293348,"[['EGFR', '(PA7360)']]",belongs to,
rs118192172,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
DPYD*13,"[['DPYD', '(PA145)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs2413775,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2413775,"[['SLC28A2', '(PA386)']]",belongs to,
rs10106,"[['methotrexate', '(PA450428)']]","decreased disease activity score 28 joint in rheumatoid arthritis when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs10106,"[['FPGS', '(PA167)']]",belongs to,
rs35599367,"[['paclitaxel', '(PA450761)']]",increased severity of,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs151264360,"[['capecitabine', '(PA448771)']]",increased severity of,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs1870377,"[['sorafenib', '(PA7000)']]","increased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs2305948,"[['sorafenib', '(PA7000)']]","increased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs1870377,"[['sorafenib', '(PA7000)']]","increased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs1870377,"[['KDR', '(PA30086)']]",belongs to,
rs2071559,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2071559,"[['KDR', '(PA30086)']]",belongs to,
rs7349683,"[['paclitaxel', '(PA450761)']]",decreased risk of,
rs7349683,"[['EPHA5', '(PA27821)']]",belongs to,
rs7349683,"[['paclitaxel', '(PA450761)']]",increased likelihood of,
rs7349683,"[['EPHA5', '(PA27821)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801267,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
HLA-B*57:01:01,"[['abacavir', '(PA448004)']]",risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['tamoxifen', '(PA451581)']]",decreased severity of,
CYP2D6 poor metabolizers and intermediate metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs2549714,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",decreased overall survival when treated with carboplatin and paclitaxel in women with Ovarian Neoplasms as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs4644,"[['LGALS3', '(PA30340)']]",belongs to,
rs4652,"[['LGALS3', '(PA30340)']]",belongs to,
DPYD deficiency,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs2811178,"[['DPYD', '(PA145)']]",belongs to,
rs895819,"[['Pyrimidine', 'analogues', '(PA164713220)']]",increased risk of,
rs895819,"[['MIR27A', '(PA164722621)']]",belongs to,
rs11671784,"[['MIR27A', '(PA164722621)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1800629,"[['sorafenib', '(PA7000)']]",increased risk of,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",Drug Toxicity when treated with capecitabine in people with Neoplasms as compared to,['*1/*1.']
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,['*1/*1.']
CYP2D6*6,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-DQB1*02:01:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs6674079,"[['antineoplastic', 'agents', '(PA452621)']]",decreased overall survival when treated with antineoplastic agents in women with Ovarian Neoplasms as compared to,
rs7950311,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",decreased overall survival when treated with carboplatin and paclitaxel in women with Ovarian Neoplasms as compared to,
rs7950311,"[['TRIM5', '(PA38109)']]",belongs to,
rs11125,"[['Antibiotics', '(PA164712406)']]",increased risk of,
rs11125,"[['LGALS3', '(PA30340)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",risk of,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs2413739,"[['mercaptopurine', '(PA450379)']]",increased risk of,
rs2413739,"[['PACSIN2', '(PA32897)']]",belongs to,
"TPMT*1, TPMT*3A","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
rs10948059,"[['mercaptopurine', '(PA450379)']]",decreased risk of,
rs10948059,"[['GNMT', '(PA28794)']]",belongs to,
"TPMT*1, TPMT*3A","[['mercaptopurine', '(PA450379)']]",increased likelihood of,
"TPMT*1, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs11676382,"[['warfarin', '(PA451906)']]",increased international normalized ratio variability (inr-var) when treated with warfarin as compared to,
rs11676382,"[['GGCX', '(PA28660)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs45589337,"[['DPYD', '(PA145)']]",belongs to,
rs72549307,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs117648444,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to",
rs117648444,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs393994,"[['rifampin', '(PA451250)']]",increased risk of,
rs393994,"[['AGBL4', '(PA142672636)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2372536,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs3821353,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs3821353,"[['ATIC', '(PA25094)']]",belongs to,
rs121434569,"[['erlotinib', '(PA134687924)'], ['gefitinib', '(PA131301952)']]",Drug Resistance when treated with erlotinib or gefitinib in people with Lung Neoplasms as compared to,
rs121434569,"[['EGFR', '(PA7360)']]",belongs to,
NAT2*6A,"[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",increased risk of,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs780094,"[['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]","increased overall survival when treated with epirubicin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to",
rs780094,"[['GCKR', '(PA28611)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",increased risk of,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
G6PD deficiency,"[['methylene', 'blue', '(PA450457)'], ['rasburicase', '(PA10176)']]",risk of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
G6PD deficiency,"[['rasburicase', '(PA10176)']]",risk of,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs12826,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs12826,"[['ABCC2', '(PA116)']]",belongs to,
rs1967120,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs1967120,"[['ABCC1', '(PA244)']]",belongs to,
rs115232898,"[['DPYD', '(PA145)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
DPYD*9B,"[['DPYD', '(PA145)']]",belongs to,
rs11709385,"[['ITGA9', '(PA29945)']]",belongs to,
rs6265,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs9657362,"[['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs9657362,"[['ARHGEF10', '(PA24967)']]",belongs to,
rs7853758,"[['SLC28A3', '(PA426)']]",belongs to,
rs10306135,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs10306135,"[['PTGS1', '(PA24346)']]",belongs to,
rs5789,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased likelihood of,
rs5789,"[['PTGS1', '(PA24346)']]",belongs to,
rs3892408,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs3892408,"[['ALOX15', '(PA48)']]",belongs to,
rs2230395,"[['ITGB1', '(PA29953)']]",belongs to,
rs1187075,"[['ITGB1', '(PA29953)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs193922770,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs193922772,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs63749869,"[['RYR1', '(PA34896)']]",belongs to,
rs118192170,"[['RYR1', '(PA34896)']]",belongs to,
rs780093,"[['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]","increased overall survival when treated with epirubicin, fluorouracil and oxaliplatin in people with Stomach Neoplasms as compared to",
rs780093,"[['GCKR', '(PA28611)']]",belongs to,
rs4402960,"[['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",decreased likelihood of,
rs4402960,"[['IGF2BP2', '(PA128394577)']]",belongs to,
rs6769511,"[['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)'], ['oxaliplatin', '(PA131285527)']]",increased likelihood of,
rs6769511,"[['IGF2BP2', '(PA128394577)']]",belongs to,
rs1801131,"[['asparaginase', '(PA448492)'], ['daunorubicin', '(PA449212)'], ['methotrexate', '(PA450428)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['asparaginase', '(PA448492)'], ['daunorubicin', '(PA449212)'], ['methotrexate', '(PA450428)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased severity of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs376073289,"[['DPYD', '(PA145)']]",belongs to,
rs2032582,"[['docetaxel', '(PA449383)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs112563513,"[['RYR1', '(PA34896)']]",belongs to,
rs4673,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased likelihood of,
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
HLA-DQA1*01:01:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
HLA-DQB1*03:02:01,"[['aspirin', '(PA448497)']]",decreased severity of,
HLA-DQB1*03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs4877847,"[['SLC28A3', '(PA426)']]",belongs to,
rs9514091,"[['SLC10A2', '(PA318)']]",belongs to,
"DPYD*5, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs2228570,"[['interferons', '(PA451999)'], ['ribavirin', '(PA451241)']]",decreased risk of,
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs7319981,"[['SLC10A2', '(PA318)']]",belongs to,
rs2290271,"[['SLC28A1', '(PA387)']]",belongs to,
rs2305364,"[['SLC28A1', '(PA387)']]",belongs to,
rs4880,"[['asparaginase', '(PA448492)']]",increased risk of,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs301927,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
rs301927,"[['EPHA6', '(PA134866684)']]",belongs to,
rs9501929,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
rs9501929,"[['TUBB2A', '(PA142670670)']]",belongs to,
rs1045642,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3213619,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs3213619,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
"CYP2B6*1, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,
rs56038477,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*4, DPYD*5, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
rs111888148,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
"ABCB1*1, ABCB1*2(PMID:11503014)","[['ABCB1', '(PA267)']]",belongs to,
rs6894567,"[['IL12B', '(PA29785)']]",belongs to,
rs160919,"[['ANKRD55', '(PA145149863)']]",belongs to,
rs3172494,"[['IP6K2', '(PA164720999)']]",belongs to,
rs4148350,"[['ABCC1', '(PA244)']]",belongs to,
rs2019604,"[['SPG7', '(PA36067)']]",belongs to,
rs3737967,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs3737967,"[['MTHFR', '(PA245)']]",belongs to,
rs2274976,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2274976,"[['MTHFR', '(PA245)']]",belongs to,
rs17514110,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs17514110,"[['ATIC', '(PA25094)']]",belongs to,
rs1017860,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs1017860,"[['NFATC1', '(PA31582)']]",belongs to,
rs6123048,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs6123048,"[['NFATC2', '(PA31583)']]",belongs to,
rs2177735,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2177735,"[['ATIC', '(PA25094)']]",belongs to,
rs34965641,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs34965641,"[['DHFR', '(PA143)']]",belongs to,
rs3740065,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs3740065,"[['ABCC2', '(PA116)']]",belongs to,
rs4781712,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs4781712,"[['ABCC1', '(PA244)']]",belongs to,
rs8058040,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs8058040,"[['ABCC1', '(PA244)']]",belongs to,
rs17264736,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs17264736,"[['ABCC1', '(PA244)']]",belongs to,
rs8090560,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs8090560,"[['NFATC1', '(PA31582)']]",belongs to,
rs3787186,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs3787186,"[['NFATC2', '(PA31583)']]",belongs to,
rs4818789,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs4818789,"[['SLC19A1', '(PA327)']]",belongs to,
rs4819128,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs4819128,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['cyclosporine', '(PA449167)'], ['methotrexate', '(PA450428)']]",decreased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs113488022,"[['selumetinib', '(PA166129529)']]",increased progression-free survival when treated with selumetinib in people with Thyroid Neoplasms as compared to,
rs113488022,"[['BRAF', '(PA25408)']]",belongs to,
rs121913529,"[['KRAS', '(PA30196)']]",belongs to,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*13,"[['DPYD', '(PA145)']]",belongs to,
rs568132506,"[['DPYD', '(PA145)']]",belongs to,
rs6473187,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
rs6473187,"[['SPIDR', '(PA142671636)']]",belongs to,
rs8187710,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs8187710,"[['ABCC2', '(PA116)']]",belongs to,
rs17222723,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
rs3829306,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs3829306,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs8110536,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
rs8110536,"[['MISP', '(PA134861073)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,
"CYP2C8*1A, CYP2C8*4","[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['paclitaxel', '(PA450761)']]",increased likelihood of,
"CYP2C8*1A, CYP2C8*4","[['CYP2C8', '(PA125)']]",belongs to,
rs9679162,"[['doxorubicin', '(PA449412)']]","increased overall survival when treated with doxorubicin in people with Carcinoma, Hepatocellular as compared to",
rs9679162,"[['GALNT14', '(PA134920089)']]",belongs to,
rs13058338,"[['RAC2', '(PA34163)']]",belongs to,
rs1883112,"[['NCF4', '(PA31465)']]",belongs to,
rs1056892,"[['doxorubicin', '(PA449412)']]",increased likelihood of,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs7853758,"[['SLC28A3', '(PA426)']]",belongs to,
rs1045642,"[['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs10865801,"[['TOP2B', '(PA36672)']]",belongs to,
rs4149117,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs1523127,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs1523127,"[['NR1I2', '(PA378)']]",belongs to,
rs1523130,"[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",decreased likelihood of,
rs1523130,"[['NR1I2', '(PA378)']]",belongs to,
rs9725457,"[['docetaxel', '(PA449383)']]",increased severity of,
rs9725457,"[['NR1I3', '(PA391)']]",belongs to,
rs2502815,"[['docetaxel', '(PA449383)']]",increased severity of,
rs2502815,"[['NR1I3', '(PA391)']]",belongs to,
rs28738963,"[['docetaxel', '(PA449383)']]",increased severity of,
rs28738963,"[['NR1I3', '(PA391)']]",belongs to,
rs2501873,"[['docetaxel', '(PA449383)']]",decreased severity of,
rs2501873,"[['NR1I3', '(PA391)']]",belongs to,
rs10538494,"[['docetaxel', '(PA449383)']]",increased severity of,
rs10538494,"[['NR1I3', '(PA391)']]",belongs to,
rs75114882,"[['docetaxel', '(PA449383)']]",increased severity of,
rs75114882,"[['NR1I3', '(PA391)']]",belongs to,
rs3732359,"[['docetaxel', '(PA449383)']]",increased severity of,
rs3732359,"[['NR1I2', '(PA378)']]",belongs to,
rs3732360,"[['docetaxel', '(PA449383)']]",increased severity of,
rs3732360,"[['NR1I2', '(PA378)']]",belongs to,
rs3814058,"[['docetaxel', '(PA449383)']]",increased severity of,
rs3814058,"[['NR1I2', '(PA378)']]",belongs to,
rs11185647,"[['docetaxel', '(PA449383)']]",increased severity of,
rs11185647,"[['RXRA', '(PA34890)']]",belongs to,
rs11185648,"[['docetaxel', '(PA449383)']]",increased severity of,
rs62576288,"[['docetaxel', '(PA449383)']]",increased severity of,
rs62576288,"[['RXRA', '(PA34890)']]",belongs to,
rs2234753,"[['docetaxel', '(PA449383)']]",increased severity of,
rs2234753,"[['RXRA', '(PA34890)']]",belongs to,
rs1536475,"[['docetaxel', '(PA449383)']]",increased severity of,
rs1536475,"[['RXRA', '(PA34890)']]",belongs to,
rs6130615,"[['docetaxel', '(PA449383)']]",increased severity of,
rs6130615,"[['HNF4A', '(PA29349)']]",belongs to,
rs3746574,"[['docetaxel', '(PA449383)']]",increased severity of,
rs3746574,"[['HNF4A', '(PA29349)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
HLA-DQB1*05:02:01,"[['flupirtine', '(PA166152829)']]",increased risk of,
HLA-DQB1*05:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs2819742,"[['atorvastatin', '(PA448500)'], ['simvastatin', '(PA451363)']]",increased likelihood of,
rs2819742,"[['RYR2', '(PA300)']]",belongs to,
rs2276707,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs115349832,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs115349832,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs6668296,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs6668296,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs56276561,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs56276561,"[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*4,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
DPYD*6,"[['DPYD', '(PA145)']]",belongs to,
rs72549308,"[['DPYD', '(PA145)']]",belongs to,
rs193922770,"[['RYR1', '(PA34896)']]",belongs to,
rs17822471,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs17822471,"[['ABCC11', '(PA24393)']]",belongs to,
rs17822931,"[['ABCC11', '(PA24393)']]",belongs to,
rs8056100,"[['ABCC11', '(PA24393)']]",belongs to,
rs112445441,"[['KRAS', '(PA30196)']]",belongs to,
rs2070744,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs2070744,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2070744,"[['NOS3', '(PA254)']]",belongs to,
rs1799983,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs1799983,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs2273618,"[['docetaxel', '(PA449383)']]",increased severity of,
rs2273618,"[['HNF4A', '(PA29349)']]",belongs to,
rs55886062,"[['tegafur', '(PA452620)']]",risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs1736557,"[['FMO3', '(PA166)']]",belongs to,
rs17583889,"[['HNMT', '(PA190)']]",belongs to,
rs2108623,"[['CYP4F2', '(PA27121)']]",belongs to,
rs10426377,"[['SULT2B1', '(PA36249)']]",belongs to,
rs7853758,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs7853758,"[['SLC28A3', '(PA426)']]",belongs to,
rs885004,"[['daunorubicin', '(PA449212)'], ['doxorubicin', '(PA449412)']]",decreased likelihood of,
rs885004,"[['SLC28A3', '(PA426)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased overall survival when treated with tamoxifen in women with Breast Neoplasms as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs6461639,"[['RAPGEF5', '(PA134902361)']]",belongs to,
rs6461639,"[['RAPGEF5', '(PA134902361)']]",belongs to,
rs2010963,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs4604006,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs4604006,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs25648,"[['sorafenib', '(PA7000)']]","increased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs25648,"[['VEGFA', '(PA37302)']]",belongs to,
rs25648,"[['sorafenib', '(PA7000)']]","increased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs25648,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs699947,"[['sorafenib', '(PA7000)']]","increased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs664393,"[['sorafenib', '(PA7000)']]","decreased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs664393,"[['FLT1', '(PA28180)']]",belongs to,
rs2071559,"[['sorafenib', '(PA7000)']]","decreased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2071559,"[['KDR', '(PA30086)']]",belongs to,
rs2305948,"[['sorafenib', '(PA7000)']]","increased overall survival and progression-free survival when treated with sorafenib in people with Carcinoma, Hepatocellular as compared to",
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs2167270,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased likelihood of,
rs2167270,"[['LEP', '(PA228)']]",belongs to,
rs11568658,"[['misoprostol', '(PA450523)']]",increased likelihood of,
rs11568658,"[['ABCC4', '(PA397)']]",belongs to,
rs2523864,"[['triamcinolone', '(PA451749)']]",increased Ocular Hypertension when treated with triamcinolone in people with Retinal Diseases as compared to,
rs2523864,"[['HCG22', '(PA134876212)']]",belongs to,
rs3873352,"[['triamcinolone', '(PA451749)']]",increased Ocular Hypertension when treated with triamcinolone in people with Retinal Diseases as compared to,
rs3873352,"[['HCG22', '(PA134876212)']]",belongs to,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs3740066,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs56293913,"[['DPYD', '(PA145)']]",belongs to,
rs16930092,"[['pemetrexed', '(PA10810)']]","increased progression-free survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs16930092,"[['GGH', '(PA432)']]",belongs to,
rs12995526,"[['pemetrexed', '(PA10810)']]","increased overall survival when treated with pemetrexed in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs12995526,"[['ATIC', '(PA25094)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs3114018,"[['ABCG2', '(PA390)']]",belongs to,
rs843748,"[['ACYP2', '(PA24500)']]",belongs to,
rs1128503,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2981582,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2981582,"[['FGFR2', '(PA28128)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1045642,"[['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with clopidogrel as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs367619008,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
rs10886342,"[['EIF3A', '(PA27699)']]",belongs to,
rs11649514,"[['atenolol', '(PA448499)']]",increased likelihood of,
rs11649514,"[['PRKCB', '(PA33761)']]",belongs to,
rs875858,"[['docetaxel', '(PA449383)']]",increased risk of,
rs875858,"[['VAC14', '(PA142670633)']]",belongs to,
rs2811178,"[['DPYD', '(PA145)']]",belongs to,
rs72549307,"[['DPYD', '(PA145)']]",belongs to,
rs72549305,"[['DPYD', '(PA145)']]",belongs to,
rs72549304,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs72547601,"[['DPYD', '(PA145)']]",belongs to,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
DPYD*13,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
DPYD*13,"[['DPYD', '(PA145)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs4936453,"[['BTG4', '(PA25453)']]",belongs to,
rs2230641,"[['CCNH', '(PA26159)']]",belongs to,
rs12023000,"[['CAMK2N1', '(PA142672209)']]",belongs to,
rs797519,"[['DLEU7', '(PA142671974)']]",belongs to,
rs17140129,"[['FARS2', '(PA134954893)']]",belongs to,
rs2338,"[['FOXC1', '(PA28217)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs830884,"[['ITGA1', '(PA29935)']]",belongs to,
rs10486003,"[['TAC1', '(PA36297)']]",belongs to,
DPYD*4,"[['DPYD', '(PA145)']]",belongs to,
rs833061,"[['pazopanib', '(PA165291492)'], ['pemetrexed', '(PA10810)']]",increased severity of,
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801266,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs56160474,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*13, DPYD*2A","[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*6, DPYD*9A","[['DPYD', '(PA145)']]",belongs to,
rs2071559,"[['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with sorafenib in people with Carcinoma, Renal Cell as compared to",
rs2071559,"[['KDR', '(PA30086)']]",belongs to,
rs2071559,"[['sorafenib', '(PA7000)']]","decreased overall survival when treated with sorafenib in people with Carcinoma, Renal Cell as compared to",
rs2071559,"[['KDR', '(PA30086)']]",belongs to,
rs11549465,"[['axitinib', '(PA164924493)'], ['sorafenib', '(PA7000)']]","decreased progression-free survival when treated with axitinib or sorafenib in people with Carcinoma, Renal Cell as compared to",
rs11549465,"[['HIF1A', '(PA29283)']]",belongs to,
rs56293913,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs56293913,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*4,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['tegafur', '(PA452620)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3918290,"[['fluorouracil', '(PA128406956)']]",increased severity of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs1495741,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased likelihood of,
rs1409314,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1409314,"[['EIF3A', '(PA27699)']]",belongs to,
rs4752219,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs4752219,"[['EIF3A', '(PA27699)']]",belongs to,
rs4752220,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs4752220,"[['EIF3A', '(PA27699)']]",belongs to,
rs7091672,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs7091672,"[['EIF3A', '(PA27699)']]",belongs to,
rs11198804,"[['EIF3A', '(PA27699)']]",belongs to,
rs2275112,"[['EIF3A', '(PA27699)']]",belongs to,
rs10787899,"[['EIF3A', '(PA27699)']]",belongs to,
rs4752269,"[['EIF3A', '(PA27699)']]",belongs to,
"TPMT*1, TPMT*3C","[['azathioprine', '(PA448515)']]",increased risk of,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs7270101,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
CYP2C19 poor metabolizers and intermediate metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
DPYD*6,"[['DPYD', '(PA145)']]",belongs to,
rs118192161,"[['RYR1', '(PA34896)']]",belongs to,
rs193922753,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs193922770,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs118192163,"[['RYR1', '(PA34896)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",risk of,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs11615,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1799793,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs50872,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs50872,"[['ERCC2', '(PA27848)']]",belongs to,
rs7170924,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs7170924,"[['IL16', '(PA29793)']]",belongs to,
rs1690924,"[['MDM2', '(PA30718)']]",belongs to,
rs1128503,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['dabrafenib', '(PA166114911)']]",increased likelihood of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2413775,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs2413775,"[['SLC28A2', '(PA386)']]",belongs to,
rs1127354,"[['mercaptopurine', '(PA450379)'], ['methotrexate', '(PA450428)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs6413517,"[['docetaxel', '(PA449383)']]",increased severity of,
rs6413517,"[['RXRA', '(PA34890)']]",belongs to,
rs1330344,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1330344,"[['PTGS1', '(PA24346)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs28933396,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs121918594,"[['RYR1', '(PA34896)']]",belongs to,
rs121918595,"[['RYR1', '(PA34896)']]",belongs to,
rs4261716,"[['UGT1A6', '(PA37181)']]",belongs to,
rs6759892,"[['UGT1A6', '(PA37181)']]",belongs to,
rs17863783,"[['UGT1A6', '(PA37181)']]",belongs to,
rs729147,"[['ADH7', '(PA24577)']]",belongs to,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs1149222,"[['ABCB4', '(PA268)']]",belongs to,
rs4148808,"[['ABCB4', '(PA268)']]",belongs to,
rs2235047,"[['ABCB1', '(PA267)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)']]",risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)']]",risk of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",severity of,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*2A, DPYD*4","[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
"DPYD*2A, DPYD*4","[['DPYD', '(PA145)']]",belongs to,
rs2298383,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2298383,"[['ADORA2A', '(PA24584)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2372536,"[['ATIC', '(PA25094)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs5760410,"[['ADORA2A', '(PA24584)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['fluorouracil', '(PA128406956)']]",risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",severity of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs1128503,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs12621220,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs12621220,"[['IL1B', '(PA29808)']]",belongs to,
rs1143623,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs1143623,"[['IL1B', '(PA29808)']]",belongs to,
rs16944,"[['IL1B', '(PA29808)']]",belongs to,
rs193922802,"[['RYR1', '(PA34896)']]",belongs to,
rs307826,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs307826,"[['FLT4', '(PA28183)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD deficiency,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs9582036,"[['sunitinib', '(PA162372840)']]","decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs9582036,"[['FLT1', '(PA28180)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs2277984,"[['clozapine', '(PA449061)']]",increased risk of,
rs2277984,"[['C3', '(PA25897)']]",belongs to,
rs8024695,"[['PIGB', '(PA33290)']]",belongs to,
CYP2C19 extensive metabolizer genotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs9332377,"[['cisplatin', '(PA449014)']]",nephrotoxicity when treated with cisplatin as compared to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs1128503,"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
SLC6A4 HTTLPR long form (L allele),"[['Selective', 'serotonin', 'reuptake', 'inhibitors', '(PA164713257)']]",increased likelihood of,
SLC6A4 HTTLPR long form (L allele),"[['SLC6A4', '(PA312)']]",belongs to,
rs7709359,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs7709359,"[['FLT4', '(PA28183)']]",belongs to,
rs6877011,"[['sunitinib', '(PA162372840)']]",decreased likelihood of,
rs6877011,"[['FLT4', '(PA28183)']]",belongs to,
rs3025039,"[['sunitinib', '(PA162372840)']]",increased severity of,
rs3025039,"[['VEGFA', '(PA37302)']]",belongs to,
rs307821,"[['pazopanib', '(PA165291492)']]",decreased progression-free survival when treated with pazopanib in people with Gastrointestinal Neoplasms and Neuroendocrine Tumors as compared to,
rs307821,"[['FLT4', '(PA28183)'], ['SCGB3A1', '(PA34994)']]",belongs to,
rs717620,"[['diclofenac', '(PA449293)']]",increased likelihood of,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs1128503,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3761547,"[['FOXP3', '(PA201094)']]",belongs to,
rs3761548,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs3761548,"[['FOXP3', '(PA201094)']]",belongs to,
rs3761549,"[['FOXP3', '(PA201094)']]",belongs to,
rs2294021,"[['CCDC22', '(PA134947763)']]",belongs to,
rs2280883,"[['FOXP3', '(PA201094)']]",belongs to,
rs2232365,"[['FOXP3', '(PA201094)']]",belongs to,
rs8099917,"[['ledipasvir', '(PA166128166)'], ['sofosbuvir', '(PA166122593)']]","increased sustained virological response (svr) when treated with ledipasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP2D6*1, CYP2D6*10, CYP2D6*17, CYP2D6*2, CYP2D6*29, CYP2D6*35, CYP2D6*4, CYP2D6*41, CYP2D6*43, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs67376798,"[['bevacizumab', '(PA130232992)'], ['capecitabine', '(PA448771)'], ['cisplatin', '(PA449014)'], ['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)'], ['oxaliplatin', '(PA131285527)'], ['trastuzumab', '(PA451743)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2046934,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs75267292,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs75267292,"[['DPYD', '(PA145)']]",belongs to,
rs2235047,"[['doxorubicin', '(PA449412)'], ['paclitaxel', '(PA450761)'], ['trastuzumab', '(PA451743)']]",increased risk of,
rs2235047,"[['ABCB1', '(PA267)']]",belongs to,
rs1136201,"[['ERBB2', '(PA27844)']]",belongs to,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6","[['azathioprine', '(PA448515)']]",increased risk of,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*5, NUDT15*6","[['NUDT15', '(PA134963132)']]",belongs to,
rs1128503,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['cyclosporine', '(PA449167)']]",increased risk of,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs2612091,"[['ENOSF1', '(PA134897613)']]",belongs to,
rs2595500,"[['ZNF215', '(PA37586)']]",belongs to,
rs6280,"[['levodopa', '(PA450213)']]",increased risk of,
rs6280,"[['DRD3', '(PA27479)']]",belongs to,
rs1799732,"[['levodopa', '(PA450213)']]",increased risk of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs2276707,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs1058808,"[['ERBB2', '(PA27844)']]",belongs to,
rs4986893,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs2270860,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs2270860,"[['SLC22A7', '(PA35848)']]",belongs to,
rs4149178,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs4149178,"[['SLC22A7', '(PA35848)']]",belongs to,
rs2853741,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs2853741,"[['TYMS', '(PA359)']]",belongs to,
rs12208357,"[['morphine', '(PA450550)']]",increased likelihood of,
rs12208357,"[['SLC22A1', '(PA329)']]",belongs to,
rs4803217,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs4803217,"[['IFNL3', '(PA134952671)']]",belongs to,
rs4803217,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased likelihood of,
rs4803217,"[['IFNL3', '(PA134952671)']]",belongs to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs7993418,"[['FLT1', '(PA28180)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs11479,"[['TYMP', '(PA162407502)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['cyclosporine', '(PA449167)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs27072,"[['SLC6A3', '(PA311)']]",belongs to,
rs40184,"[['SLC6A3', '(PA311)']]",belongs to,
rs11133767,"[['SLC6A3', '(PA311)']]",belongs to,
rs6347,"[['SLC6A3', '(PA311)']]",belongs to,
rs1933695,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs1933695,"[['RGS2', '(PA34372)']]",belongs to,
rs12041331,"[['PEAR1', '(PA162399233)']]",belongs to,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs12637988,"[['P2RY12', '(PA134971947)']]",belongs to,
rs12497330,"[['P2RY12', '(PA134971947)']]",belongs to,
rs16863336,"[['P2RY12', '(PA134971947)']]",belongs to,
rs12487835,"[['P2RY12', '(PA134971947)']]",belongs to,
rs7634096,"[['P2RY12', '(PA134971947)']]",belongs to,
rs9859538,"[['P2RY12', '(PA134971947)']]",belongs to,
rs1491974,"[['P2RY12', '(PA134971947)']]",belongs to,
rs4603933,"[['P2RY12', '(PA134971947)']]",belongs to,
rs10935842,"[['P2RY12', '(PA134971947)']]",belongs to,
rs1907637,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6798347,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6798637,"[['P2RY12', '(PA134971947)']]",belongs to,
rs16863356,"[['MED12L', '(PA134884590)']]",belongs to,
rs1126643,"[['ITGA2', '(PA204)']]",belongs to,
rs1062535,"[['PEAR1', '(PA162399233)']]",belongs to,
rs1062535,"[['PEAR1', '(PA162399233)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1799983,"[['NOS3', '(PA254)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs4986893,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs8192950,"[['clopidogrel', '(PA449053)']]",decreased risk of,
rs8192950,"[['CES1', '(PA107)']]",belongs to,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
HLA-DRB3*01:01:02:01,"[['heparin', '(PA449855)']]",increased likelihood of,
HLA-DRB3*01:01:02:01,"[['HLA-DRB3', '(PA35074)']]",belongs to,
rs7574865,"[['STAT4', '(PA36185)']]",belongs to,
rs683369,"[['imatinib', '(PA10804)']]",decreased severity of,
rs683369,"[['SLC22A1', '(PA329)']]",belongs to,
rs1128503,"[['sevoflurane', '(PA451341)']]",decreased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
DPYD low activity,"[['DPYD', '(PA145)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased likelihood of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs6051702,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased likelihood of,
rs6051702,"[['C20orf194', '(PA134905007)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs586339,"[['KDM4A', '(PA164721403)']]",belongs to,
rs2669429,"[['atenolol', '(PA448499)']]",increased severity of,
rs2669429,"[['DPYS', '(PA146)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1806191,"[['GRIN2B', '(PA28980)']]",belongs to,
rs1019385,"[['GRIN2B', '(PA28980)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs215994,"[['CACNA1C', '(PA83)']]",belongs to,
rs2239128,"[['CACNA1C', '(PA83)']]",belongs to,
rs2072671,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs12119882,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs12119882,"[['DPYD', '(PA145)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3099844,"[['CYCSP5', '(PA142672032)']]",belongs to,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs200245496,"[['levothyroxine', '(PA450221)'], ['methimazole', '(PA450422)'], ['propylthiouracil', '(PA451156)']]",increased risk of,
rs200245496,"[['NOX3', '(PA31691)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7574865,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased likelihood of,
rs7574865,"[['STAT4', '(PA36185)']]",belongs to,
rs34550074,"[['Thiazides,', 'plain', '(PA164713347)']]",increased likelihood of,
rs34550074,"[['SLCO2A1', '(PA35840)']]",belongs to,
rs4646437,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs4646437,"[['CYP3A4', '(PA130)']]",belongs to,
rs1131882,"[['aspirin', '(PA448497)']]",increased risk of,
rs1131882,"[['TBXA2R', '(PA348)']]",belongs to,
rs1801252,"[['Beta', 'Blocking', 'Agents', '(PA164712535)']]",increased risk of,
rs1801252,"[['ADRB1', '(PA38)']]",belongs to,
rs1128503,"[['paclitaxel', '(PA450761)']]",increased severity of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
rs11506105,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) and sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs11506105,"[['EGFR', '(PA7360)']]",belongs to,
rs144470777,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs144470777,"[['NSUN3', '(PA134961151)']]",belongs to,
rs143414470,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs143414470,"[['ANK3', '(PA24800)']]",belongs to,
rs117308378,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs117308378,"[['ADGRG7', '(PA134982718)']]",belongs to,
rs141213385,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs141213385,"[['CCDC77', '(PA143485429)']]",belongs to,
rs138385713,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs138385713,"[['VPS13D', '(PA134970144)']]",belongs to,
rs191934521,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs191934521,"[['SIRPA', '(PA34006)']]",belongs to,
rs117412990,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs117412990,"[['TMEM131L', '(PA128394615)']]",belongs to,
rs139368788,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs139368788,"[['CCDC70', '(PA143485421)']]",belongs to,
rs1801394,"[['MTRR', '(PA31277)']]",belongs to,
rs10515074,"[['everolimus', '(PA164746311)']]",increased likelihood of,
rs10515074,"[['PIK3R1', '(PA33312)']]",belongs to,
rs1872328,"[['cisplatin', '(PA449014)']]",increased risk of,
rs1872328,"[['ACYP2', '(PA24500)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs2283265,"[['propofol', '(PA451141)']]",decreased heart rate when exposed to,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
rs3894049,"[['cyclosporine', '(PA449167)'], ['mycophenolic', 'acid', '(PA164748728)'], ['prednisone', '(PA451100)']]",decreased likelihood of,
rs3894049,"[['NFATC1', '(PA31582)']]",belongs to,
rs9376256,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased likelihood of,
rs9376256,"[['IL22RA2', '(PA134983729)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",decreased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",decreased likelihood of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['lapatinib', '(PA152241907)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs4149056,"[['rosuvastatin', '(PA134308647)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs429358,"[['APOE', '(PA55)']]",belongs to,
rs7412,"[['APOE', '(PA55)']]",belongs to,
rs7853758,"[['SLC28A3', '(PA426)']]",belongs to,
rs1056892,"[['doxorubicin', '(PA449412)'], ['paclitaxel', '(PA450761)'], ['trastuzumab', '(PA451743)']]",increased risk of,
rs1056892,"[['CBR3', '(PA26122)']]",belongs to,
rs17863783,"[['UGT1A6', '(PA37181)']]",belongs to,
rs185217050,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs185217050,"[['NCOA7', '(PA134905581)']]",belongs to,
rs117876855,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs117876855,"[['SPRY2', '(PA36099)']]",belongs to,
rs9906827,"[['everolimus', '(PA164746311)']]",increased likelihood of,
rs9906827,"[['RPTOR', '(PA165432629)']]",belongs to,
rs9906827,"[['everolimus', '(PA164746311)']]",decreased likelihood of,
rs9906827,"[['RPTOR', '(PA165432629)']]",belongs to,
rs10132552,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",increased risk of,
rs10132552,"[['MEG3', '(PA30737)']]",belongs to,
rs2242480,"[['haloperidol', '(PA449841)']]",increased severity of,
rs2242480,"[['CYP3A4', '(PA130)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs1045642,"[['efavirenz', '(PA449441)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1137070,"[['MAOA', '(PA236)']]",belongs to,
rs1799836,"[['MAOB', '(PA237)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs10929302,"[['irinotecan', '(PA450085)']]",increased severity of,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs2725264,"[['ABCG2', '(PA390)']]",belongs to,
rs12720066,"[['irinotecan', '(PA450085)']]",increased severity of,
rs12720066,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs8050881,"[['ABCC1', '(PA244)']]",belongs to,
rs152023,"[['ABCC1', '(PA244)']]",belongs to,
rs17501331,"[['irinotecan', '(PA450085)']]",decreased severity of,
rs17501331,"[['ABCC1', '(PA244)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased risk of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs10515074,"[['everolimus', '(PA164746311)']]",decreased likelihood of,
rs10515074,"[['PIK3R1', '(PA33312)']]",belongs to,
rs351855,"[['everolimus', '(PA164746311)']]",decreased likelihood of,
rs351855,"[['FGFR4', '(PA28130)']]",belongs to,
rs1045642,"[['everolimus', '(PA164746311)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['everolimus', '(PA164746311)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs187805828,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs187805828,"[['PHC1', '(PA27619)']]",belongs to,
rs518147,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs1414334,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['olanzapine', '(PA450688)']]",increased severity of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",Central Nervous System Diseases when treated with efavirenz in men with HIV as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs114577328,"[['fenofibrate', '(PA449594)'], ['sertraline', '(PA451333)'], ['terbinafine', '(PA451614)'], ['ticlopidine', '(PA451686)']]",increased risk of,
rs116561224,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs1801274,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]","decreased disease activity score 28 joint in rheumatoid arthritis when treated with Tumor necrosis factor alpha (TNF-alpha) inhibitors in people with Arthritis, Rheumatoid as compared to",
rs1801274,"[['FCGR2A', '(PA28063)']]",belongs to,
rs2243057,"[['dexamethasone', '(PA449247)']]",increased risk of,
rs2243057,"[['F2RL1', '(PA27947)']]",belongs to,
rs2243057,"[['dexamethasone', '(PA449247)']]",increased risk of,
rs2243057,"[['F2RL1', '(PA27947)']]",belongs to,
rs6453253,"[['dexamethasone', '(PA449247)']]",increased risk of,
rs2229774,"[['RARG', '(PA34227)']]",belongs to,
rs13058338,"[['RAC2', '(PA34163)']]",belongs to,
NAT2 slow acetylator,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
NAT2 slow acetylator,"[['NAT2', '(PA18)']]",belongs to,
rs2031920,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
HLA-A*33:01:01,"[['fenofibrate', '(PA449594)'], ['sertraline', '(PA451333)'], ['terbinafine', '(PA451614)'], ['ticlopidine', '(PA451686)']]",increased risk of,
HLA-A*33:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs215976,"[['CACNA1C', '(PA83)']]",belongs to,
rs146644707,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs146644707,"[['LMNTD1', '(PA162391895)']]",belongs to,
rs1045642,"[['risperidone', '(PA451257)']]",increased Weight gain when treated with risperidone in women with Schizophrenia as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs2032582,"[['risperidone', '(PA451257)']]",increased Weight gain when treated with risperidone in women with Schizophrenia as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['clozapine', '(PA449061)']]",decreased risk of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased complete early virological response when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs518147,"[['olanzapine', '(PA450688)']]",decreased risk of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs12975366,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased likelihood of,
rs12975366,"[['LILRB5', '(PA30383)']]",belongs to,
rs41285690,"[['DPYD', '(PA145)']]",belongs to,
rs17470762,"[['DPYD', '(PA145)']]",belongs to,
rs291593,"[['DPYD', '(PA145)']]",belongs to,
rs291592,"[['DPYD', '(PA145)']]",belongs to,
rs56160474,"[['DPYD', '(PA145)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1800795,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs1800795,"[['IL6', '(PA198)']]",belongs to,
rs12487736,"[['rosuvastatin', '(PA134308647)']]",decreased severity of,
rs12487736,"[['SCAP', '(PA162402461)']]",belongs to,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs727479,"[['anastrozole', '(PA448432)']]",increased Recurrence free survival when treated with anastrozole in women with Breast Neoplasms as compared to,
rs727479,"[['CYP19A1', '(PA27091)']]",belongs to,
rs3842,"[['efavirenz', '(PA449441)']]",increased bioavailability when exposed to,
rs3842,"[['ABCB1', '(PA267)']]",belongs to,
rs2179652,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs2179652,"[['RGS2', '(PA34372)']]",belongs to,
rs4606,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs4606,"[['RGS2', '(PA34372)']]",belongs to,
rs1152746,"[['antipsychotics', '(PA452233)']]",increased severity of,
rs1152746,"[['RGS2', '(PA34372)']]",belongs to,
rs1819741,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs1819741,"[['RGS2', '(PA34372)']]",belongs to,
rs3766522,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",decreased severity of,
rs3766522,"[['PRKAB2', '(PA33747)']]",belongs to,
rs10789038,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",decreased severity of,
rs10789038,"[['PRKAA2', '(PA33745)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs1803254,"[['gemtuzumab', 'ozogamicin', '(PA164749431)']]","increased treatment related mortality when treated with gemtuzumab ozogamicin in children with Leukemia, Myeloid, Acute as compared to",
rs1803254,"[['CD33', '(PA26210)']]",belongs to,
rs3093135,"[['aspirin', '(PA448497)'], ['ticagrelor', '(PA165374673)']]",decreased platelet aggregation when treated with aspirin and ticagrelor in people with Acute coronary syndrome and Myocardial Infarction as compared to,
rs3093135,"[['CYP4F2', '(PA27121)']]",belongs to,
rs3093135,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",decreased platelet aggregation when treated with aspirin and clopidogrel in people with Acute coronary syndrome and Myocardial Infarction as compared to,"['*1/*2', '+', '*2/*2.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*2', '+', '*2/*2.']"
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs4678145,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs4678145,"[['UMPS', '(PA363)']]",belongs to,
rs10883841,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",decreased likelihood of,
rs10883841,"[['NT5C2', '(PA31801)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs56293913,"[['DPYD', '(PA145)']]",belongs to,
rs56293913,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs75848562,"[['DPYD', '(PA145)']]",belongs to,
rs61786598,"[['DPYD', '(PA145)']]",belongs to,
rs61786599,"[['DPYD', '(PA145)']]",belongs to,
rs55684412,"[['DPYD', '(PA145)']]",belongs to,
rs56276561,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs2305948,"[['sunitinib', '(PA162372840)']]",increased severity of,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
ABCB1*2(PMID:11503014),"[['sunitinib', '(PA162372840)']]",increased likelihood of,
ABCB1*2(PMID:11503014),"[['ABCB1', '(PA267)']]",belongs to,
rs1801157,"[['CXCL12', '(PA35602)']]",belongs to,
rs3740085,"[['CXCL12', '(PA35602)']]",belongs to,
rs2228014,"[['bevacizumab', '(PA130232992)']]",decreased progression-free survival when treated with bevacizumab in people with Colorectal Neoplasms as compared to,
rs2228014,"[['CXCR4', '(PA27058)']]",belongs to,
rs1800460,"[['TPMT', '(PA356)']]",belongs to,
rs12201199,"[['TPMT', '(PA356)']]",belongs to,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs10981694,"[['SLC31A1', '(PA118)']]",belongs to,
rs1051640,"[['ABCC3', '(PA376)']]",belongs to,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
rs9332377,"[['COMT', '(PA117)']]",belongs to,
rs12468485,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased risk of,
rs12468485,"[['GPR35', '(PA28880)']]",belongs to,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs7799039,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs6318,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
CYP2B6 poor metabolizer and intermediate metabolizer genotypes,"[['efavirenz', '(PA449441)']]",increased risk of,
CYP2B6 poor metabolizer and intermediate metabolizer genotypes,"[['CYP2B6', '(PA123)']]",belongs to,
rs2072446,"[['NGFR', '(PA31615)']]",belongs to,
rs962369,"[['BDNF', '(PA31891)']]",belongs to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs1387923,"[['NTRK2', '(PA31818)']]",belongs to,
rs11140800,"[['NTRK2', '(PA31818)']]",belongs to,
rs10868235,"[['NTRK2', '(PA31818)']]",belongs to,
rs1867283,"[['NTRK2', '(PA31818)']]",belongs to,
rs1187286,"[['NTRK2', '(PA31818)']]",belongs to,
rs1439050,"[['antidepressants', '(PA452229)']]",increased risk of,
rs1439050,"[['NTRK2', '(PA31818)']]",belongs to,
rs1147198,"[['NTRK2', '(PA31818)']]",belongs to,
rs4675690,"[['CREB1', '(PA26864)']]",belongs to,
rs2551919,"[['CREB1', '(PA26864)']]",belongs to,
rs1334802,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs1334802,"[['GRIK3', '(PA28975)']]",belongs to,
rs363341,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs363341,"[['SLC18A2', '(PA325)']]",belongs to,
rs1124491,"[['antipsychotics', '(PA452233)']]",decreased risk of,
rs1124491,"[['DRD2', '(PA27478)']]",belongs to,
rs9567733,"[['antipsychotics', '(PA452233)']]",increased risk of,
rs9567733,"[['HTR2A', '(PA193)']]",belongs to,
rs61787828,"[['DPYD', '(PA145)']]",belongs to,
rs12459996,"[['glatiramer', 'acetate', '(PA449760)']]",increased risk of,
rs1056854,"[['glatiramer', 'acetate', '(PA449760)']]",increased risk of,
rs75041078,"[['glatiramer', 'acetate', '(PA449760)']]",increased risk of,
rs12210538,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs10276036,"[['ABCB1', '(PA267)']]",belongs to,
rs2228093,"[['ALDH1B1', '(PA24695)']]",belongs to,
rs2073478,"[['ALDH1B1', '(PA24695)']]",belongs to,
rs4878199,"[['ALDH1B1', '(PA24695)']]",belongs to,
rs142427338,"[['ALDH1B1', '(PA24695)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['carboplatin', '(PA448803)'], ['paclitaxel', '(PA450761)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2010963,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs11576941,"[['morphine', '(PA450550)']]",increased likelihood of,
rs11576941,"[['FAAH', '(PA27955)']]",belongs to,
rs324420,"[['morphine', '(PA450550)']]",increased likelihood of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs72552763,"[['morphine', '(PA450550)']]",increased likelihood of,
rs72552763,"[['SLC22A1', '(PA329)']]",belongs to,
"UGT1A1*1, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"HLA-B*07:02:01, HLA-B*13:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*07:02:01, HLA-B*13:01:01","[['phenytoin', '(PA450947)']]",increased likelihood of,
"HLA-B*07:02:01, HLA-B*13:01:01","[['HLA-B', '(PA35056)']]",belongs to,
"HLA-B*07:02:01, HLA-B*15:02:01","[['HLA-B', '(PA35056)']]",belongs to,
rs518147,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs1800544,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1800544,"[['ADRA2A', '(PA35)']]",belongs to,
rs6265,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs6265,"[['BDNF', '(PA31891)'], ['BDNF-AS', '(PA134953249)']]",belongs to,
rs6275,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs6275,"[['DRD2', '(PA27478)']]",belongs to,
rs7131056,"[['antipsychotics', '(PA452233)']]",decreased likelihood of,
rs7131056,"[['DRD2', '(PA27478)']]",belongs to,
rs1799732,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs5443,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs5443,"[['GNB3', '(PA176)']]",belongs to,
rs17047764,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs17047764,"[['INSIG2', '(PA134890284)']]",belongs to,
rs489693,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs489693,"[['MC4R', '(PA30676)']]",belongs to,
rs3788200,"[['SLC19A1', '(PA327)']]",belongs to,
"CYP3A4*1A, CYP3A4*1B","[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased likelihood of,
"CYP3A4*1A, CYP3A4*1B","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1A, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['capecitabine', '(PA448771)']]",increased risk of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
TPMT haplotype,"[['mercaptopurine', '(PA450379)']]",increased risk of,
TPMT haplotype,"[['TPMT', '(PA356)']]",belongs to,
ABCC4 deficiency,"[['mercaptopurine', '(PA450379)']]",increased risk of,
ABCC4 deficiency,"[['ABCC4', '(PA397)']]",belongs to,
rs6877011,"[['sunitinib', '(PA162372840)']]","increased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs6877011,"[['FLT4', '(PA28183)']]",belongs to,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6","[['mercaptopurine', '(PA450379)']]",increased risk of,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*6","[['NUDT15', '(PA134963132)']]",belongs to,
"CYP3A4*1A, CYP3A4*1B","[['CYP3A4', '(PA130)']]",belongs to,
rs3814055,"[['temsirolimus', '(PA164746890)']]",decreased likelihood of,
rs3814055,"[['NR1I2', '(PA378)']]",belongs to,
rs6785049,"[['temsirolimus', '(PA164746890)']]",decreased likelihood of,
rs6785049,"[['NR1I2', '(PA378)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
CYP2C19 poor metabolizer genotype,"[['3,4-methylenedioxymethamphetamine', '(PA131887008)']]",increased severity of,
CYP2C19 poor metabolizer genotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs45586133,"[['morphine', '(PA450550)']]",increased likelihood of,
rs45586133,"[['FAAH', '(PA27955)']]",belongs to,
rs2280055,"[['cyclosporine', '(PA449167)'], ['mycophenolic', 'acid', '(PA164748728)'], ['prednisone', '(PA451100)']]","decreased glomerular filtration rate when treated with cyclosporine, mycophenolic acid and prednisone in people with Kidney Transplantation as compared to",
rs2280055,"[['NFATC1', '(PA31582)']]",belongs to,
rs10774053,"[['ritodrine', '(PA451258)']]",decreased likelihood of,
rs10774053,"[['CACNA1C', '(PA83)']]",belongs to,
rs199564443,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
rs199564443,"[['FOXF2', '(PA28227)']]",belongs to,
rs1071816,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
rs1071816,"[['HLA-B', '(PA35056)']]",belongs to,
rs652888,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
rs652888,"[['EHMT2', '(PA25267)']]",belongs to,
rs111618861,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
HLA-B*27:05:02,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
HLA-B*27:05:02,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*08:01:01,"[['Antithyroid', 'Preparations', '(PA164712499)']]",increased likelihood of,
HLA-B*08:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs701265,"[['P2RY1', '(PA32868)']]",belongs to,
"TPMT*1, TPMT*2, TPMT*3A","[['mercaptopurine', '(PA450379)']]",increased risk of,
"TPMT*1, TPMT*2, TPMT*3A","[['TPMT', '(PA356)']]",belongs to,
DPYD low activity,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['leucovorin', '(PA450198)']]",increased risk of,
DPYD low activity,"[['DPYD', '(PA145)']]",belongs to,
rs57731889,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",low on-treatment platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs57731889,"[['PEAR1', '(PA162399233)']]",belongs to,
"CYP3A4*1A, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased likelihood of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs10132552,"[['MEG3', '(PA30737)']]",belongs to,
"HLA-B*07:02:01, HLA-B*15:21","[['carbamazepine', '(PA448785)']]",increased likelihood of,
"HLA-B*07:02:01, HLA-B*15:21","[['HLA-B', '(PA35056)']]",belongs to,
rs11264580,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs11264580,"[['PEAR1', '(PA162399233)']]",belongs to,
rs2644592,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs2644592,"[['PEAR1', '(PA162399233)']]",belongs to,
rs3737224,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs3737224,"[['PEAR1', '(PA162399233)']]",belongs to,
rs4986893,"[['CYP2C19', '(PA124)']]",belongs to,
rs8024695,"[['PIGB', '(PA33290)']]",belongs to,
rs4646316,"[['cisplatin', '(PA449014)']]",nephrotoxicity when treated with cisplatin as compared to,
rs4646316,"[['COMT', '(PA117)']]",belongs to,
CYP2D6 extensive metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 ultrarapid metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2D6 poor metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1371097,"[['P2RY1', '(PA32868)']]",belongs to,
rs2244614,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2244614,"[['CES1', '(PA107)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['phenytoin', '(PA450947)']]",increased likelihood of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1065852,"[['metoprolol', '(PA450480)']]",decreased heart rate when treated with metoprolol in people with as compared to,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs1801253,"[['ADRB1', '(PA38)']]",belongs to,
rs1045642,"[['trazodone', '(PA451744)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
CYP2D6 extensive metabolizer genotype,"[['trazodone', '(PA451744)']]",increased likelihood of,
CYP2D6 extensive metabolizer genotype,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*18:01:01,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
HLA-B*18:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['capecitabine', '(PA448771)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1128503,"[['gefitinib', '(PA131301952)']]",increased risk of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a, peginterferon alfa-2b or ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1045642,"[['clozapine', '(PA449061)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs2333227,"[['MPO', '(PA243)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['clozapine', '(PA449061)']]",decreased risk of,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['clozapine', '(PA449061)']]",increased risk of,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
HLA-DQB1*05:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs1695,"[['cisplatin', '(PA449014)']]",increased likelihood of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs4788863,"[['cisplatin', '(PA449014)']]",decreased likelihood of,
rs4788863,"[['SLC16A5', '(PA35817)']]",belongs to,
rs1799971,"[['methadone', '(PA450401)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
CYP1A2*1C,"[['clozapine', '(PA449061)']]",increased severity of,
CYP1A2*1C,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2470890,"[['antipsychotics', '(PA452233)'], ['haloperidol', '(PA449841)']]",increased likelihood of,
rs2470890,"[['CYP1A2', '(PA27093)']]",belongs to,
rs699947,"[['sunitinib', '(PA162372840)']]","decreased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs9582036,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs9582036,"[['FLT1', '(PA28180)']]",belongs to,
rs1800587,"[['IL1A', '(PA29807)']]",belongs to,
rs3750425,"[['Proton', 'pump', 'inhibitors', '(PA164713207)']]",increased risk of,
rs3750425,"[['TRPM6', '(PA38479)']]",belongs to,
"CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
CYP2D6 extensive metabolizer and ultra-metabolizer genotypes,"[['CYP2D6', '(PA128)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with clopidogrel as compared to,"['*1/*1', '+', '*1/*2.']"
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*2.']"
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs1045642,"[['clozapine', '(PA449061)']]",increased Weight gain when treated with clozapine in men with Schizophrenia as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs212090,"[['clozapine', '(PA449061)']]",increased Weight gain when treated with clozapine in men with as compared to,
rs212090,"[['ABCC1', '(PA244)']]",belongs to,
rs4149117,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2631367,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs2631367,"[['SLC22A5', '(PA333)']]",belongs to,
rs1805015,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs1805015,"[['IL4R', '(PA29832)']]",belongs to,
rs1801275,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs1801275,"[['IL4R', '(PA29832)']]",belongs to,
rs1057868,"[['sunitinib', '(PA162372840)']]",increased progression-free survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs7993418,"[['sunitinib', '(PA162372840)']]","decreased overall survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs7993418,"[['FLT1', '(PA28180)']]",belongs to,
rs9554320,"[['sunitinib', '(PA162372840)']]","decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs9554320,"[['FLT1', '(PA28180)']]",belongs to,
rs1801131,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs396991,"[['FCGR3A', '(PA28065)']]",belongs to,
rs659366,"[['UCP2', '(PA37165)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",increased platelet aggregation inhibition when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2B6*1, CYP2B6*6","[['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['pyrazinamide', '(PA451182)'], ['rifampin', '(PA451250)']]",decreased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs6699322,"[['morphine', '(PA450550)']]",increased likelihood of,
rs6699322,"[['FAAH', '(PA27955)']]",belongs to,
rs6785930,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs6809699,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs6809699,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2273697,"[['cisplatin', '(PA449014)'], ['pemetrexed', '(PA10810)']]",increased overall survival and progression-free survival when treated with cisplatin and pemetrexed in people with Mesothelioma as compared to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs11576941,"[['morphine', '(PA450550)']]",increased likelihood of,
rs11576941,"[['FAAH', '(PA27955)']]",belongs to,
rs2295632,"[['morphine', '(PA450550)']]",increased likelihood of,
rs2295632,"[['FAAH', '(PA27955)']]",belongs to,
rs2046934,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2236225,"[['cisplatin', '(PA449014)'], ['pemetrexed', '(PA10810)']]",decreased overall survival and progression-free survival when treated with cisplatin and pemetrexed in people with Mesothelioma as compared to,
rs2236225,"[['MTHFD1', '(PA31236)']]",belongs to,
rs25487,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival and progression-free survival when treated with cisplatin and gemcitabine in people with Mesothelioma as compared to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs6755571,"[['UGT1A4', '(PA37179)']]",belongs to,
rs2011425,"[['UGT1A4', '(PA37179)']]",belongs to,
rs3814995,"[['losartan', '(PA450268)']]",decreased diastolic blood pressure when treated with losartan in people with Hypertension as compared to,
rs3814995,"[['KIRREL2', '(PA38693)'], ['NPHS1', '(PA31709)']]",belongs to,
rs2514036,"[['atenolol', '(PA448499)'], ['bisoprolol', '(PA448641)']]",decreased diastolic blood pressure and systolic blood pressure when treated with atenolol or bisoprolol in men with Hypertension as compared to,
rs2514036,"[['ACY3', '(PA134936640)']]",belongs to,
rs2819742,"[['RYR2', '(PA300)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs9806699,"[['GATM', '(PA28590)']]",belongs to,
"HLA-DRB1*01:01:01, HLA-DRB1*04:06:01","[['atorvastatin', '(PA448500)'], ['fluvastatin', '(PA449688)'], ['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)'], ['pitavastatin', '(PA142650384)'], ['pravastatin', '(PA451089)'], ['rosuvastatin', '(PA134308647)'], ['simvastatin', '(PA451363)']]",increased risk of,
"HLA-DRB1*01:01:01, HLA-DRB1*04:06:01","[['HLA-DRB1', '(PA35072)']]",belongs to,
rs730154,"[['CYP19A1', '(PA27091)']]",belongs to,
rs749292,"[['CYP19A1', '(PA27091)']]",belongs to,
rs1008805,"[['anastrozole', '(PA448432)']]",decreased likelihood of,
rs1008805,"[['CYP19A1', '(PA27091)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs11209026,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs11209026,"[['IL23R', '(PA134935109)']]",belongs to,
rs3087243,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",decreased risk of,
rs3087243,"[['CTLA4', '(PA27006)']]",belongs to,
rs651630,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",decreased risk of,
rs651630,"[['SLC12A8', '(PA37991)']]",belongs to,
rs1135216,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",decreased risk of,
rs1135216,"[['TAP1', '(PA35021)']]",belongs to,
rs10782001,"[['Tumor', 'necrosis', 'factor', 'alpha', '(TNF-alpha)', 'inhibitors', '(PA164713366)']]",increased risk of,
rs10782001,"[['FBXL19', '(PA134911396)']]",belongs to,
rs1042927,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival and progression-free survival when treated with cisplatin and gemcitabine in people with Mesothelioma as compared to,
rs1042927,"[['RRM1', '(PA298)']]",belongs to,
rs2607659,"[['RRM2B', '(PA34866)']]",belongs to,
rs2607659,"[['RRM2B', '(PA34866)']]",belongs to,
rs2254638,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs2254638,"[['N6AMT1', '(PA162396656)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:12,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:12,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:24,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:24,"[['HLA-B', '(PA35056)']]",belongs to,
rs149104283,"[['clozapine', '(PA449061)']]",increased risk of,
rs2032582,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs9554320,"[['sunitinib', '(PA162372840)']]","decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs9554320,"[['FLT1', '(PA28180)']]",belongs to,
rs1127354,"[['ribavirin', '(PA451241)']]",increased likelihood of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs7270101,"[['ribavirin', '(PA451241)']]",increased likelihood of,
rs7270101,"[['ITPA', '(PA29973)']]",belongs to,
rs6051702,"[['ribavirin', '(PA451241)']]",increased likelihood of,
rs6051702,"[['ITPA', '(PA29973)']]",belongs to,
rs727479,"[['CYP19A1', '(PA27091)']]",belongs to,
rs11849538,"[['TCL1A', '(PA36400)']]",belongs to,
rs7159713,"[['TCL1A', '(PA36400)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['anastrozole', '(PA448432)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1008805,"[['CYP19A1', '(PA27091)']]",belongs to,
rs730154,"[['CYP19A1', '(PA27091)']]",belongs to,
rs749292,"[['CYP19A1', '(PA27091)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2274924,"[['Proton', 'pump', 'inhibitors', '(PA164713207)']]",increased risk of,
rs2274924,"[['TRPM6', '(PA38479)']]",belongs to,
rs7187684,"[['capecitabine', '(PA448771)']]",increased risk of,
rs7187684,"[['CES1P1', '(PA134906523)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
HLA-B*15:25:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:25:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:27:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:27:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:32,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:32,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:35,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:35,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*52:01:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*52:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*04:03,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:06,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:07,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*05:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*05:09:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*18:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1127354,"[['ribavirin', '(PA451241)']]",increased likelihood of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet reactivity when treated with aspirin and clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",decreased platelet reactivity when treated with aspirin and clopidogrel as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs2046934,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased risk of,
rs2046934,"[['P2RY12', '(PA134971947)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs7668258,"[['diclofenac', '(PA449293)']]",increased likelihood of,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
"CYP2C8*1A, CYP2C8*3, CYP2C8*4","[['diclofenac', '(PA449293)']]",increased likelihood of,
"CYP2C8*1A, CYP2C8*3, CYP2C8*4","[['CYP2C8', '(PA125)']]",belongs to,
CYP2C8*3,"[['CYP2C8', '(PA125)']]",belongs to,
rs2306283,"[['irinotecan', '(PA450085)']]",increased risk of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
"UGT1A1*1, UGT1A1*93","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*93","[['UGT1A1', '(PA420)']]",belongs to,
rs2244613,"[['capecitabine', '(PA448771)']]",increased risk of,
rs2244613,"[['CES1', '(PA107)']]",belongs to,
rs11861118,"[['capecitabine', '(PA448771)']]",increased risk of,
rs11861118,"[['CES1P1', '(PA134906523)']]",belongs to,
rs2228570,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","decreased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs10741657,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs10741657,"[['CYP2R1', '(PA134986407)']]",belongs to,
rs12117078,"[['CRTC2', '(PA142672073)']]",belongs to,
rs12117078,"[['CRTC2', '(PA142672073)']]",belongs to,
rs8450,"[['CRTC2', '(PA142672073)']]",belongs to,
rs8450,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs8450,"[['CRTC2', '(PA142672073)']]",belongs to,
rs8450,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased Weight gain when treated with cyclosporine or tacrolimus in people with Transplantation as compared to,
rs8450,"[['CRTC2', '(PA142672073)']]",belongs to,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*04:04:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*01:03,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*01:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*08:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*10:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs3892097,"[['haloperidol', '(PA449841)']]",decreased likelihood of,
rs3892097,"[['CYP2D6', '(PA128)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*9","[['efavirenz', '(PA449441)']]",increased likelihood of,
"CYP2B6*1, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,
rs2472677,"[['efavirenz', '(PA449441)']]",decreased likelihood of,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs28399499,"[['efavirenz', '(PA449441)']]",decreased risk of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs4803419,"[['efavirenz', '(PA449441)']]",increased risk of,
rs4803419,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*9","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs9859538,"[['P2RY12', '(PA134971947)']]",belongs to,
rs699517,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs699517,"[['ENOSF1', '(PA134897613)'], ['TYMS', '(PA359)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12050587,"[['PIGB', '(PA33290)']]",belongs to,
rs12050587,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs12050587,"[['PIGB', '(PA33290)']]",belongs to,
rs11636687,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs9514827,"[['TNFSF13B', '(PA434)']]",belongs to,
rs9514827,"[['TNFSF13B', '(PA434)']]",belongs to,
rs4261468,"[['RAB27A', '(PA34117)']]",belongs to,
rs4261468,"[['RAB27A', '(PA34117)']]",belongs to,
rs2290344,"[['PIGB', '(PA33290)']]",belongs to,
rs2290344,"[['PIGB', '(PA33290)']]",belongs to,
rs2290344,"[['PIGB', '(PA33290)']]",belongs to,
rs2231142,"[['sunitinib', '(PA162372840)']]",increased severity of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs8450,"[['cyclosporine', '(PA449167)'], ['tacrolimus', '(PA451578)']]",increased risk of,
rs8450,"[['CRTC2', '(PA142672073)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['capecitabine', '(PA448771)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs2041135,"[['CACNA1C', '(PA83)']]",belongs to,
rs1048977,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs1048977,"[['CDA', '(PA98)']]",belongs to,
rs3212986,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival and progression-free survival when treated with cisplatin and gemcitabine in people with Mesothelioma as compared to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs13181,"[['cisplatin', '(PA449014)'], ['gemcitabine', '(PA449748)']]",decreased overall survival and progression-free survival when treated with cisplatin and gemcitabine in people with Mesothelioma as compared to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs2228000,"[['XPC', '(PA37413)']]",belongs to,
rs2228000,"[['Platinum', 'compounds', '(PA164713176)']]",decreased risk of,
rs2228000,"[['XPC', '(PA37413)']]",belongs to,
rs2228001,"[['XPC', '(PA37413)']]",belongs to,
rs3219489,"[['MUTYH', '(PA31328)']]",belongs to,
rs1800734,"[['MLH1', '(PA240)']]",belongs to,
rs12806698,"[['Platinum', 'compounds', '(PA164713176)']]",increased risk of,
rs12806698,"[['RRM1', '(PA298)']]",belongs to,
rs1799801,"[['ERCC4', '(PA27850)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1047768,"[['ERCC5', '(PA27851)']]",belongs to,
rs17655,"[['ERCC5', '(PA27851)']]",belongs to,
rs1130409,"[['APEX1', '(PA201059)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs2279744,"[['MDM2', '(PA30718)']]",belongs to,
rs1695,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs2916733,"[['MCPH1', '(PA30701)']]",belongs to,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
rs4148323,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs4148323,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased likelihood of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs185346775,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs185346775,"[['MAN1A1', '(PA30570)']]",belongs to,
rs146898897,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs146898897,"[['SSU72', '(PA142670866)']]",belongs to,
rs117484357,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs117484357,"[['ZMIZ1', '(PA162409804)']]",belongs to,
rs77475703,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs77475703,"[['CD96', '(PA437)']]",belongs to,
rs139544515,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs139544515,"[['SPRY2', '(PA36099)']]",belongs to,
rs4958487,"[['SPARC', '(PA36055)']]",belongs to,
rs12153644,"[['SPARC', '(PA36055)']]",belongs to,
rs10065756,"[['SPARC', '(PA36055)']]",belongs to,
rs17718347,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['gemcitabine', '(PA449748)']]","increased progression-free survival when treated with capecitabine, fluorouracil or gemcitabine in people with Pancreatic Neoplasms as compared to",
rs17718347,"[['SPARC', '(PA36055)']]",belongs to,
rs12050885,"[['RAB27A', '(PA34117)']]",belongs to,
rs12050885,"[['RAB27A', '(PA34117)']]",belongs to,
HLA-B*58:01:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs7975232,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",decreased likelihood of,
rs7975232,"[['VDR', '(PA37301)']]",belongs to,
rs10877012,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",decreased likelihood of,
rs10877012,"[['CYP27B1', '(PA27099)'], ['METTL1', '(PA30766)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs6785930,"[['P2RY12', '(PA134971947)']]",belongs to,
rs12979860,"[['boceprevir', '(PA165948902)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]","increased sustained virological response (svr) when treated with boceprevir, peginterferon alfa-2b, ribavirin and telaprevir in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs502046,"[['quetiapine', '(PA451201)']]",decreased likelihood of,
rs502046,"[['RIMS1', '(PA38220)']]",belongs to,
rs116134453,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs116134453,"[['FAT1', '(PA164719952)']]",belongs to,
HLA-B*39:06:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3813928,"[['HTR2C', '(PA194)']]",belongs to,
rs3856806,"[['PPARG', '(PA281)']]",belongs to,
rs1800234,"[['PPARA', '(PA280)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",decreased likelihood of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs5370,"[['bevacizumab', '(PA130232992)']]",decreased overall survival when treated with bevacizumab in women with Breast Neoplasms as compared to,
rs5370,"[['EDN1', '(PA27614)']]",belongs to,
rs3025039,"[['bevacizumab', '(PA130232992)']]",decreased overall survival when treated with bevacizumab in women with Breast Neoplasms as compared to,
rs3025039,"[['VEGFA', '(PA37302)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['CLCN6', '(PA26551)'], ['MTHFR', '(PA245)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs4149117,"[['paclitaxel', '(PA450761)']]",increased severity of,
rs4149117,"[['SLCO1B3', '(PA35844)']]",belongs to,
rs1045642,"[['imatinib', '(PA10804)']]",decreased severity of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['nevirapine', '(PA450616)']]",increased likelihood of,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]",increased likelihood of,
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs117412760,"[['levothyroxine', '(PA450221)'], ['methimazole', '(PA450422)'], ['propylthiouracil', '(PA451156)']]",increased risk of,
rs117412760,"[['NOX3', '(PA31691)']]",belongs to,
rs17036170,"[['diclofenac', '(PA449293)']]",increased likelihood of,
rs17036170,"[['PPARG', '(PA281)']]",belongs to,
rs28714259,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs11124945,"[['atenolol', '(PA448499)'], ['verapamil', '(PA451868)']]",decreased risk of,
rs11124945,"[['PLEKHH2', '(PA134912826)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
CYP2D6 extensive metabolizer and ultra-metabolizer genotypes,"[['amitriptyline', '(PA448385)']]",decreased likelihood of,
CYP2D6 extensive metabolizer and ultra-metabolizer genotypes,"[['CYP2D6', '(PA128)']]",belongs to,
rs141531882,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs141531882,"[['TENM4', '(PA134896466)']]",belongs to,
rs10024471,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs10024471,"[['MIR2054', '(PA164722584)']]",belongs to,
rs72765700,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs1801133,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)']]",increased likelihood of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",increased platelet aggregation when treated with clopidogrel as compared to,['*1/*1.']
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,['*1/*1.']
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs6318,"[['antipsychotics', '(PA452233)']]",increased likelihood of,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a, peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs11125883,"[['XPO1', '(PA37418)']]",belongs to,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs4880,"[['SOD2', '(PA36017)']]",belongs to,
rs4720833,"[['MAFK', '(PA30540)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1041983,"[['isoniazid', '(PA450112)']]",increased risk of,
rs1041983,"[['NAT2', '(PA18)']]",belongs to,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs2298383,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs2298383,"[['ADORA2A', '(PA24584)']]",belongs to,
rs7412,"[['APOE', '(PA55)']]",belongs to,
rs429358,"[['APOE', '(PA55)']]",belongs to,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs699,"[['AGT', '(PA42)']]",belongs to,
rs1978707,"[['SPARC', '(PA36055)']]",belongs to,
rs2347128,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)'], ['gemcitabine', '(PA449748)']]","increased progression-free survival when treated with capecitabine, fluorouracil or gemcitabine in people with Pancreatic Neoplasms as compared to",
rs2347128,"[['SPARC', '(PA36055)']]",belongs to,
rs3210714,"[['SPARC', '(PA36055)']]",belongs to,
rs967527,"[['SPARC', '(PA36055)']]",belongs to,
rs738409,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['mercaptopurine', '(PA450379)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased risk of,
rs738409,"[['PNPLA3', '(PA38592)']]",belongs to,
HLA-B*35:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*39:10:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs6025,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs6025,"[['F5', '(PA159)']]",belongs to,
rs710446,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs710446,"[['KNG1', '(PA225)']]",belongs to,
rs2289252,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs2289252,"[['F11', '(PA27941)']]",belongs to,
rs4379368,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs4379368,"[['SUGCT', '(PA25942)']]",belongs to,
rs56392308,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",decreased risk of,
rs56392308,"[['ABO', '(PA24415)']]",belongs to,
rs8176719,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs8176719,"[['ABO', '(PA24415)']]",belongs to,
rs1799853,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799963,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs1799963,"[['F2', '(PA157)']]",belongs to,
rs9574,"[['hormonal', 'contraceptives', 'for', 'systemic', 'use', '(PA452637)']]",increased risk of,
rs9574,"[['PROCR', '(PA33800)']]",belongs to,
rs27048,"[['SLC6A3', '(PA311)']]",belongs to,
rs37022,"[['SLC6A3', '(PA311)']]",belongs to,
rs37022,"[['SLC6A3', '(PA311)']]",belongs to,
rs37020,"[['SLC6A3', '(PA311)']]",belongs to,
rs37020,"[['SLC6A3', '(PA311)']]",belongs to,
rs464049,"[['SLC6A3', '(PA311)']]",belongs to,
rs464049,"[['SLC6A3', '(PA311)']]",belongs to,
rs460700,"[['SLC6A3', '(PA311)']]",belongs to,
rs460700,"[['SLC6A3', '(PA311)']]",belongs to,
rs460000,"[['SLC6A3', '(PA311)']]",belongs to,
rs460000,"[['SLC6A3', '(PA311)']]",belongs to,
rs403636,"[['SLC6A3', '(PA311)']]",belongs to,
rs403636,"[['SLC6A3', '(PA311)']]",belongs to,
rs1967120,"[['ABCC1', '(PA244)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs16863323,"[['P2RY12', '(PA134971947)']]",belongs to,
rs2317676,"[['ITGB3', '(PA205)']]",belongs to,
rs11871251,"[['ITGB3', '(PA205)']]",belongs to,
rs12979860,"[['boceprevir', '(PA165948902)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['telaprevir', '(PA165958354)']]","increased sustained virological response (svr) when treated with boceprevir, peginterferon alfa-2b, ribavirin or telaprevir in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs73594404,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",increased risk of,
rs2027701,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",decreased risk of,
rs1059698,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",decreased risk of,
rs1829346,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",increased risk of,
rs36080650,"[['Platinum', 'compounds', '(PA164713176)'], ['radiotherapy', '(PA166122986)']]",increased risk of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs699947,"[['sunitinib', '(PA162372840)']]","increased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs2305948,"[['KDR', '(PA30086)']]",belongs to,
rs3025039,"[['VEGFA', '(PA37302)']]",belongs to,
rs762551,"[['deferasirox', '(PA164760843)']]",decreased risk of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2606345,"[['deferasirox', '(PA164760843)']]",decreased risk of,
rs2606345,"[['CYP1A1', '(PA27092)']]",belongs to,
rs3806596,"[['deferasirox', '(PA164760843)']]",decreased risk of,
rs3806596,"[['UGT1A3', '(PA37178)']]",belongs to,
rs887829,"[['deferasirox', '(PA164760843)']]",decreased risk of,
rs887829,"[['UGT1A1', '(PA420)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3, CYP2C19*8","[['CYP2C19', '(PA124)']]",belongs to,
rs1800795,"[['IL6', '(PA198)']]",belongs to,
rs1883112,"[['NCF4', '(PA31465)']]",belongs to,
rs1065852,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs1695,"[['fluorouracil', '(PA128406956)'], ['irinotecan', '(PA450085)'], ['oxaliplatin', '(PA131285527)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
"CYP3A4*1B, CYP3A4*3","[['CYP3A4', '(PA130)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs3087465,"[['irinotecan', '(PA450085)']]",increased risk of,
rs3087465,"[['TGFBR2', '(PA36486)']]",belongs to,
rs1800469,"[['irinotecan', '(PA450085)']]",increased risk of,
rs1800469,"[['TGFB1', '(PA350)']]",belongs to,
"UGT1A1*28, UGT1A1*6","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*28, UGT1A1*6","[['UGT1A1', '(PA420)']]",belongs to,
rs1933437,"[['sunitinib', '(PA162372840)']]",decreased likelihood of,
rs1933437,"[['FLT3', '(PA28181)']]",belongs to,
rs1048943,"[['sunitinib', '(PA162372840)']]",increased likelihood of,
rs1048943,"[['CYP1A1', '(PA27092)']]",belongs to,
"CYP2D6*1, CYP2D6*4","[['risperidone', '(PA451257)']]",increased risk of,
"CYP2D6*1, CYP2D6*4","[['CYP2D6', '(PA128)']]",belongs to,
rs699517,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs699517,"[['ENOSF1', '(PA134897613)'], ['TYMS', '(PA359)']]",belongs to,
rs2279199,"[['capecitabine', '(PA448771)']]",decreased likelihood of,
rs2279199,"[['UMPS', '(PA363)']]",belongs to,
rs147204125,"[['HEATR4', '(PA162390631)']]",belongs to,
rs138741635,"[['FHIT', '(PA28140)']]",belongs to,
rs1495741,"[['isoniazid', '(PA450112)']]",increased risk of,
rs1495741,"[['NAT2', '(PA18)']]",belongs to,
rs3813867,"[['CYP2E1', '(PA129)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs4149014,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1968753,"[['CES1', '(PA107)']]",belongs to,
rs11080344,"[['NOS2', '(PA164724093)']]",belongs to,
rs1053005,"[['STAT3', '(PA337)']]",belongs to,
rs1053004,"[['STAT3', '(PA337)']]",belongs to,
rs2070401,"[['BACH1', '(PA25234)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs6721961,"[['cisplatin', '(PA449014)']]",decreased risk of,
rs6721961,"[['NFE2L2', '(PA31588)']]",belongs to,
rs316019,"[['cisplatin', '(PA449014)']]",decreased risk of,
rs316019,"[['SLC22A2', '(PA331)']]",belongs to,
rs10950831,"[['ABCB5', '(PA24387)']]",belongs to,
rs11646213,"[['CDH13', '(PA26287)']]",belongs to,
rs1051640,"[['ABCC3', '(PA376)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1045642,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)']]",increased likelihood of,
rs8099917,"[['IFNL4', '(PA166049147)']]",belongs to,
rs35112940,"[['gemtuzumab', 'ozogamicin', '(PA164749431)']]","increased overall survival when treated with gemtuzumab ozogamicin in children with Leukemia, Myeloid, Acute as compared to",
rs35112940,"[['CD33', '(PA26210)']]",belongs to,
rs12459419,"[['gemtuzumab', 'ozogamicin', '(PA164749431)']]","increased overall survival when treated with gemtuzumab ozogamicin in children with Leukemia, Myeloid, Acute as compared to",
rs12459419,"[['CD33', '(PA26210)']]",belongs to,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*54:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*55:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2981359,"[['SLC6A3', '(PA311)']]",belongs to,
rs2981359,"[['SLC6A3', '(PA311)']]",belongs to,
rs6350,"[['ethanol', '(PA448073)']]",increased risk of,
rs6350,"[['SLC6A3', '(PA311)']]",belongs to,
rs2975226,"[['SLC6A3', '(PA311)']]",belongs to,
rs2652511,"[['SLC6A3', '(PA311)']]",belongs to,
rs2550948,"[['SLC6A3', '(PA311)']]",belongs to,
rs6318,"[['risperidone', '(PA451257)']]",increased severity of,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs6311,"[['risperidone', '(PA451257)']]",increased severity of,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs1131596,"[['SLC19A1', '(PA327)']]",belongs to,
rs1800038,"[['ADRA2A', '(PA35)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2838958,"[['SLC19A1', '(PA327)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2231137,"[['ABCG2', '(PA390)']]",belongs to,
HLA-B*15:21,"[['carbamazepine', '(PA448785)']]",increased likelihood of,
HLA-B*15:21,"[['HLA-B', '(PA35056)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*5,"[['DPYD', '(PA145)']]",belongs to,
DPYD*9A,"[['DPYD', '(PA145)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
"UGT1A1*1, UGT1A1*28","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*28","[['UGT1A1', '(PA420)']]",belongs to,
rs7668258,"[['ciprofloxacin', '(PA449009)'], ['haloperidol', '(PA449841)']]",adverse events and extrapyramidal symptoms when treated with ciprofloxacin and haloperidol as compared to,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased virological response when treated with efavirenz in people with HIV as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs12979860,"[['sofosbuvir', '(PA166122593)'], ['velpatasvir', '(PA166163415)'], ['voxilaprevir', '(PA166171182)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs9582036,"[['sunitinib', '(PA162372840)']]","decreased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs9582036,"[['FLT1', '(PA28180)']]",belongs to,
rs35626,"[['ABCC1', '(PA244)']]",belongs to,
rs3743527,"[['irinotecan', '(PA450085)']]",decreased severity of,
rs3743527,"[['ABCC1', '(PA244)']]",belongs to,
rs212090,"[['ABCC1', '(PA244)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
HLA-B*55:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:06,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*67:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2B6*1, CYP2B6*2","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*2","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1933437,"[['sunitinib', '(PA162372840)']]",decreased likelihood of,
rs1933437,"[['FLT3', '(PA28181)']]",belongs to,
"UGT1A1*1, UGT1A1*93","[['irinotecan', '(PA450085)']]",increased risk of,
"UGT1A1*1, UGT1A1*93","[['UGT1A1', '(PA420)']]",belongs to,
rs648743,"[['CTH', '(PA27004)']]",belongs to,
rs1021737,"[['busulfan', '(PA448691)'], ['cyclophosphamide', '(PA449165)']]",increased risk of,
rs1021737,"[['CTH', '(PA27004)']]",belongs to,
rs3750625,"[['ADRA2A', '(PA35)']]",belongs to,
rs11195418,"[['ADRA2A', '(PA35)']]",belongs to,
HLA-B*35:05:01,"[['minocycline', '(PA450519)']]",increased risk of,
HLA-B*35:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs41273215,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",high on-treatment platelet reactivity when treated with aspirin and clopidogrel as compared to,
rs41273215,"[['PEAR1', '(PA162399233)']]",belongs to,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2D6 ultra-metabolizer phenotype,"[['risperidone', '(PA451257)']]",decreased severity of,
CYP2D6 ultra-metabolizer phenotype,"[['CYP2D6', '(PA128)']]",belongs to,
rs6265,"[['risperidone', '(PA451257)']]",increased severity of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs833061,"[['sunitinib', '(PA162372840)']]","increased overall survival and progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs7661530,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs7675300,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs16870989,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs145489027,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs1495509,"[['KCNIP4', '(PA134893552)']]",belongs to,
rs62151109,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs62151109,"[['CLASP1', '(PA38436)']]",belongs to,
rs2233006,"[['MAD2L2', '(PA398)']]",belongs to,
rs1047840,"[['EXO1', '(PA27923)']]",belongs to,
rs3776332,"[['ARHGAP26', '(PA134946198)']]",belongs to,
rs1062372,"[['PMS2', '(PA33448)']]",belongs to,
rs1801195,"[['WRN', '(PA367)']]",belongs to,
rs4647554,"[['FANCC', '(PA27997)']]",belongs to,
rs3740615,"[['FANCF', '(PA28001)']]",belongs to,
rs4442551,"[['FANCF', '(PA28001)']]",belongs to,
rs799917,"[['BRCA1', '(PA25411)']]",belongs to,
rs2048718,"[['BRIP1', '(PA134906421)']]",belongs to,
rs1127354,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs3812265,"[['CNOT4', '(PA26675)']]",belongs to,
rs10505168,"[['MIR2053', '(PA164722583)']]",belongs to,
rs2114358,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2114358,"[['MIR1206', '(PA164722363)']]",belongs to,
rs12036333,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]","decreased event-free survival when treated with cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to",
rs10758713,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]","decreased event-free survival when treated with cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to",
rs10758713,"[['KIAA2026', '(PA134907262)']]",belongs to,
rs9883101,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased risk of,
rs6550826,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]",increased risk of,
HLA-B*78:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)'], ['simeprevir', '(PA166122590)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2b, ribavirin and simeprevir in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12979860,"[['ledipasvir', '(PA166128166)'], ['sofosbuvir', '(PA166122593)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs6883259,"[['anthracyclines', 'and', 'related', 'substances', '(PA130620651)']]",increased likelihood of,
rs6883259,"[['ADCY2', '(PA24561)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs4141964,"[['morphine', '(PA450550)']]",increased risk of,
rs4141964,"[['FAAH', '(PA27955)']]",belongs to,
rs4141964,"[['FAAH', '(PA27955)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
rs4124874,"[['UGT1A1', '(PA420)']]",belongs to,
rs738409,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['daunorubicin', '(PA449212)'], ['prednisolone', '(PA451096)'], ['vincristine', '(PA451879)']]",increased risk of,
rs738409,"[['PNPLA3', '(PA38592)']]",belongs to,
rs113993960,"[['CFTR', '(PA109)']]",belongs to,
rs2227983,"[['cetuximab', '(PA10040)']]",decreased progression-free survival when treated with cetuximab in people with Head and Neck Neoplasms as compared to,
rs2227983,"[['EGFR', '(PA7360)']]",belongs to,
"UGT1A1*1, UGT1A1*60","[['UGT1A1', '(PA420)']]",belongs to,
rs2032582,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",decreased platelet reactivity when treated with clopidogrel in people with Coronary Artery Disease as compared to,['*2.']
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,['*2.']
rs2897047,"[['cytarabine', '(PA449177)'], ['idarubicin', '(PA449961)']]","increased overall survival when treated with cytarabine and idarubicin in people with Leukemia, Myeloid, Acute as compared to",
HLA-B*38:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*39:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*39:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*39:09,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:01:01:01,"[['nevirapine', '(PA450616)']]",decreased risk of,
HLA-B*15:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs3813928,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",decreased likelihood of,
rs3813928,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",decreased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs518147,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs1414334,"[['antipsychotics', '(PA452233)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs1414334,"[['HTR2C', '(PA194)']]",belongs to,
rs7566605,"[['INSIG2', '(PA134890284)']]",belongs to,
rs17587100,"[['INSIG2', '(PA134890284)']]",belongs to,
rs10490624,"[['INSIG2', '(PA134890284)']]",belongs to,
rs17047764,"[['INSIG2', '(PA134890284)']]",belongs to,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs498207,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs498207,"[['HTR2C', '(PA194)']]",belongs to,
rs3813928,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs3813928,"[['HTR2C', '(PA194)']]",belongs to,
rs3813929,"[['amisulpride', '(PA162565877)'], ['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs2929183,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)']]",decreased severity of,
rs2929183,"[['CCKBR', '(PA26143)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs10106,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs10106,"[['FPGS', '(PA167)']]",belongs to,
rs2236418,"[['methamphetamine', '(PA450403)']]",increased likelihood of,
rs2236418,"[['GAD2', '(PA28508)']]",belongs to,
rs3766246,"[['morphine', '(PA450550)']]",increased risk of,
rs3766246,"[['FAAH', '(PA27955)']]",belongs to,
rs3766246,"[['FAAH', '(PA27955)']]",belongs to,
rs324420,"[['morphine', '(PA450550)']]",increased risk of,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs2231142,"[['risperidone', '(PA451257)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
CYP2C19 poor metabolizer and intermediate metabolizer genotypes,"[['clopidogrel', '(PA449053)']]",increased risk of,
CYP2C19 poor metabolizer and intermediate metabolizer genotypes,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801320,"[['RAD51', '(PA34176)']]",belongs to,
rs12593359,"[['RAD51', '(PA34176)']]",belongs to,
rs2307486,"[['APEX1', '(PA201059)']]",belongs to,
rs5742933,"[['ORMDL1', '(PA32819)']]",belongs to,
HLA-A*02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*11:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*24:02:01:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*38:01:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-B*38:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-C*15:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*08:01,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1801133,"[['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs1045642,"[['clozapine', '(PA449061)']]",increased Hypertension when treated with clozapine in people with Schizophrenia as compared to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs212090,"[['clozapine', '(PA449061)']]",increased Hypertension when treated with clozapine in men with Schizophrenia as compared to,
rs212090,"[['ABCC1', '(PA244)']]",belongs to,
rs2631372,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs2631372,"[['SLC22A5', '(PA333)']]",belongs to,
rs2631370,"[['sunitinib', '(PA162372840)']]",decreased overall survival when treated with sunitinib in people with Gastrointestinal Stromal Tumors as compared to,
rs2631370,"[['SLC22A5', '(PA333)']]",belongs to,
rs307826,"[['pazopanib', '(PA165291492)']]",decreased progression-free survival when treated with pazopanib in people with Gastrointestinal Neoplasms and Neuroendocrine Tumors as compared to,
rs307826,"[['FLT4', '(PA28183)']]",belongs to,
rs324420,"[['FAAH', '(PA27955)']]",belongs to,
rs2295633,"[['FAAH', '(PA27955)']]",belongs to,
rs11576941,"[['FAAH', '(PA27955)']]",belongs to,
rs2295632,"[['morphine', '(PA450550)']]",increased risk of,
rs2295632,"[['FAAH', '(PA27955)']]",belongs to,
rs2295632,"[['FAAH', '(PA27955)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['methadone', '(PA450401)']]",increased severity of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased likelihood of,
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",decreased likelihood of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs4273729,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
rs8099917,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased sustained virological response (svr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs901865,"[['HRH1', '(PA29456)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased complete early virological response when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs4273729,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased complete early virological response when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased rapid virological response (rvr) when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs12980275,"[['IFNL3', '(PA134952671)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['ribavirin', '(PA451241)']]","increased complete early virological response when treated with peginterferon alfa-2a and ribavirin in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs6318,"[['risperidone', '(PA451257)']]",increased severity of,
rs6318,"[['HTR2C', '(PA194)']]",belongs to,
rs9659997,"[['risperidone', '(PA451257)']]",increased severity of,
rs9659997,"[['HTR6', '(PA29560)']]",belongs to,
rs3813929,"[['HTR2C', '(PA194)']]",belongs to,
rs6277,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs6277,"[['DRD2', '(PA27478)']]",belongs to,
rs1799978,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs1799978,"[['DRD2', '(PA27478)']]",belongs to,
rs1065852,"[['risperidone', '(PA451257)']]",increased likelihood of,
rs1065852,"[['CYP2D6', '(PA128)']]",belongs to,
rs2279343,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs699947,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs699947,"[['pazopanib', '(PA165291492)']]","increased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs699947,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs833061,"[['pazopanib', '(PA165291492)']]","increased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs833061,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['pazopanib', '(PA165291492)']]","increased progression-free survival when treated with pazopanib in people with Carcinoma, Renal Cell as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs2010963,"[['sunitinib', '(PA162372840)']]","increased progression-free survival when treated with sunitinib in people with Carcinoma, Renal Cell as compared to",
rs2010963,"[['VEGFA', '(PA37302)']]",belongs to,
rs924607,"[['vincristine', '(PA451879)']]",increased risk of,
rs924607,"[['CEP72', '(PA142672125)']]",belongs to,
rs6690069,"[['capecitabine', '(PA448771)']]",increased risk of,
rs6690069,"[['CDA', '(PA98)']]",belongs to,
rs532545,"[['capecitabine', '(PA448771)']]",increased risk of,
rs532545,"[['CDA', '(PA98)']]",belongs to,
rs602950,"[['capecitabine', '(PA448771)']]",increased risk of,
rs602950,"[['CDA', '(PA98)']]",belongs to,
rs10916825,"[['capecitabine', '(PA448771)']]",increased risk of,
rs10916825,"[['CDA', '(PA98)']]",belongs to,
rs3217164,"[['capecitabine', '(PA448771)']]",increased risk of,
rs3217164,"[['CES1', '(PA107)']]",belongs to,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
rs12613243,"[['BCL2L11', '(PA25305)']]",belongs to,
rs10932125,"[['NRP2', '(PA31784)']]",belongs to,
rs41423247,"[['NR3C1', '(PA181)']]",belongs to,
rs6190,"[['NR3C1', '(PA181)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
"NAT2*4, NAT2*5B, NAT2*7B","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"NAT2*4, NAT2*5B, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
"NAT2*4, NAT2*6A","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"NAT2*4, NAT2*6A","[['NAT2', '(PA18)']]",belongs to,
"NAT2*4, NAT2*6A, NAT2*7B","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"NAT2*4, NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
"NAT2*4, NAT2*7B","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"NAT2*4, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP2C9*1, CYP2C9*2","[['CYP2C9', '(PA126)']]",belongs to,
rs3758581,"[['phenytoin', '(PA450947)']]",increased risk of,
rs3758581,"[['CYP2C19', '(PA124)']]",belongs to,
rs1061781,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",decreased platelet aggregation when treated with aspirin and clopidogrel as compared to,
rs1061781,"[['B4GALT2', '(PA25224)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet aggregation when treated with aspirin and clopidogrel as compared to,"['*1', '+', '*17.']"
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1', '+', '*17.']"
rs719235,"[['GGH', '(PA432)']]",belongs to,
rs17222723,"[['ABCC2', '(PA116)']]",belongs to,
rs1138272,"[['GSTP1', '(PA29028)']]",belongs to,
rs7115499,"[['NEU3', '(PA31562)']]",belongs to,
rs17028658,"[['ANKS1B', '(PA128394692)']]",belongs to,
rs11075291,"[['ABCC1', '(PA244)']]",belongs to,
rs246240,"[['antineoplastic', 'agents', '(PA452621)'], ['corticosteroids', '(PA10832)']]",increased risk of,
rs246240,"[['ABCC1', '(PA244)']]",belongs to,
rs3784864,"[['ABCC1', '(PA244)']]",belongs to,
rs35592,"[['ABCC1', '(PA244)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs1127354,"[['antineoplastic', 'agents', '(PA452621)'], ['corticosteroids', '(PA10832)']]",increased risk of,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs6990313,"[['GATA4', '(PA28587)']]",belongs to,
rs10105409,"[['GATA4', '(PA28587)']]",belongs to,
rs6601604,"[['GATA4', '(PA28587)']]",belongs to,
rs10112596,"[['GATA4', '(PA28587)']]",belongs to,
rs12550668,"[['GATA4', '(PA28587)']]",belongs to,
rs2898292,"[['GATA4', '(PA28587)']]",belongs to,
rs4840579,"[['GATA4', '(PA28587)']]",belongs to,
rs11250159,"[['GATA4', '(PA28587)']]",belongs to,
rs17153694,"[['GATA4', '(PA28587)']]",belongs to,
rs17153698,"[['GATA4', '(PA28587)']]",belongs to,
rs6983129,"[['GATA4', '(PA28587)']]",belongs to,
rs2898295,"[['GATA4', '(PA28587)']]",belongs to,
rs11250163,"[['GATA4', '(PA28587)']]",belongs to,
rs13275657,"[['GATA4', '(PA28587)']]",belongs to,
rs2029969,"[['GATA4', '(PA28587)']]",belongs to,
rs2173117,"[['GATA4', '(PA28587)']]",belongs to,
rs3779664,"[['GATA4', '(PA28587)']]",belongs to,
rs3735814,"[['GATA4', '(PA28587)']]",belongs to,
rs2740434,"[['GATA4', '(PA28587)']]",belongs to,
rs2645399,"[['GATA4', '(PA28587)']]",belongs to,
rs11784693,"[['GATA4', '(PA28587)']]",belongs to,
rs804283,"[['GATA4', '(PA28587)']]",belongs to,
rs17153747,"[['GATA4', '(PA28587)']]",belongs to,
rs804282,"[['GATA4', '(PA28587)']]",belongs to,
rs13264774,"[['GATA4', '(PA28587)']]",belongs to,
rs13273672,"[['GATA4', '(PA28587)']]",belongs to,
rs804280,"[['GATA4', '(PA28587)']]",belongs to,
rs3729856,"[['GATA4', '(PA28587)']]",belongs to,
rs867858,"[['GATA4', '(PA28587)']]",belongs to,
rs1062219,"[['GATA4', '(PA28587)']]",belongs to,
rs804290,"[['GATA4', '(PA28587)']]",belongs to,
rs6092,"[['SERPINE1', '(PA261)']]",belongs to,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6","[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
"NUDT15*1, NUDT15*2, NUDT15*3, NUDT15*4, NUDT15*5, NUDT15*6","[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs2236624,"[['antineoplastic', 'agents', '(PA452621)'], ['corticosteroids', '(PA10832)']]",increased risk of,
rs2236624,"[['ADORA2A', '(PA24584)']]",belongs to,
"GSTM1 non-null, GSTM1 null","[['GSTM1', '(PA182)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs11785481,"[['GATA4', '(PA28587)']]",belongs to,
rs12458,"[['GATA4', '(PA28587)']]",belongs to,
rs3203358,"[['GATA4', '(PA28587)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
HLA-A*11:01:01,"[['levetiracetam', '(PA450206)']]",increased risk of,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-DQB1*03:03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2072661,"[['CHRNB2', '(PA115)']]",belongs to,
rs142774214,"[['CHRNA5', '(PA26491)']]",belongs to,
rs503464,"[['nicotine', '(PA450626)']]",increased Tobacco Use Disorder when exposed to,
rs503464,"[['CHRNA5', '(PA26491)']]",belongs to,
G6PD deficiency,"[['G6PD', '(PA28469)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased severity of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs7294,"[['acenocoumarol', '(PA452632)']]",decreased likelihood of,
rs7294,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['acenocoumarol', '(PA452632)']]",increased likelihood of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs8099917,"[['ledipasvir', '(PA166128166)'], ['sofosbuvir', '(PA166122593)']]","increased sustained virological response (svr) when treated with ledipasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs12442183,"[['opioids', '(PA452618)']]",increased likelihood of,
rs2108622,"[['Vitamin', 'K', 'antagonists', '(PA164713406)']]",increased risk of,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs61824877,"[['chlorothiazide', '(PA448953)'], ['hydrochlorothiazide', '(PA449899)']]",increased severity of,
rs9943291,"[['chlorothiazide', '(PA448953)'], ['hydrochlorothiazide', '(PA449899)']]",increased severity of,
rs9943291,"[['HMGCS2', '(PA29338)']]",belongs to,
rs8175347,"[['irinotecan', '(PA450085)']]",increased severity of,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs9923231,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased likelihood of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1057910,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased likelihood of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs429358,"[['acenocoumarol', '(PA452632)'], ['warfarin', '(PA451906)']]",increased likelihood of,
rs429358,"[['APOE', '(PA55)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs510769,"[['OPRM1', '(PA31945)']]",belongs to,
rs4870266,"[['OPRM1', '(PA31945)']]",belongs to,
rs3798683,"[['OPRM1', '(PA31945)']]",belongs to,
rs1323042,"[['OPRM1', '(PA31945)']]",belongs to,
rs609623,"[['OPRM1', '(PA31945)']]",belongs to,
rs9397685,"[['fentanyl', '(PA449599)']]",decreased severity of,
rs9397685,"[['OPRM1', '(PA31945)']]",belongs to,
rs644261,"[['OPRM1', '(PA31945)']]",belongs to,
rs9933632,"[['acetaminophen', '(PA448015)'], ['ibuprofen', '(PA449957)'], ['loxoprofen', '(PA166049180)'], ['salicylamide', '(PA165958416)']]",increased risk of,
rs6500265,"[['acetaminophen', '(PA448015)'], ['ibuprofen', '(PA449957)'], ['loxoprofen', '(PA166049180)'], ['salicylamide', '(PA165958416)']]",increased risk of,
"CYP2A6*10, CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",decreased progression-free survival when treated with s 1 (combination) in people with Stomach Neoplasms as compared to,"['*1A/*4A', '+', '*1A/*7', '+', '*1A/*9', '+', '*1A/*10', '+', '*1A/*1A.']"
"CYP2A6*10, CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,"['*1A/*4A', '+', '*1A/*7', '+', '*1A/*9', '+', '*1A/*10', '+', '*1A/*1A.']"
rs869320766,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased severity of,
rs869320766,"[['NUDT15', '(PA134963132)']]",belongs to,
rs45445694,"[['cisplatin', '(PA449014)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]","increased overall survival when treated with cisplatin, epirubicin and fluorouracil in people with Esophageal Neoplasms or Stomach Neoplasms as compared to",
rs45445694,"[['C18orf56', '(PA134956204)'], ['TYMS', '(PA359)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['antineoplastic', 'agents', '(PA452621)']]",increased severity of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs45460698,"[['HTR3B', '(PA29556)']]",belongs to,
rs920829,"[['TRPA1', '(PA24808)']]",belongs to,
rs2165870,"[['CHRM3', '(PA112)']]",belongs to,
rs9371776,"[['OPRM1', '(PA31945)']]",belongs to,
rs558948,"[['OPRM1', '(PA31945)']]",belongs to,
rs558025,"[['OPRM1', '(PA31945)']]",belongs to,
rs645027,"[['OPRM1', '(PA31945)']]",belongs to,
rs2229109,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs186364861,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs186364861,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs3765534,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs3765534,"[['ABCC4', '(PA397)']]",belongs to,
rs2274407,"[['ABCC4', '(PA397)']]",belongs to,
rs11568658,"[['ABCC4', '(PA397)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs3745274,"[['nevirapine', '(PA450616)']]","Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome and dress syndrome when treated with nevirapine in people with HIV as compared to",
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs28399499,"[['nevirapine', '(PA450616)']]","Epidermal Necrolysis, Toxic, Stevens-Johnson Syndrome and dress syndrome when treated with nevirapine in people with HIV as compared to",
rs28399499,"[['CYP2B6', '(PA123)']]",belongs to,
rs113993960,"[['ivacaftor', '(PA165950341)'], ['lumacaftor', '(PA166114483)']]",increased likelihood of,
rs113993960,"[['CFTR', '(PA109)']]",belongs to,
HLA-B*15:02:01,"[['lamotrigine', '(PA450164)']]",increased likelihood of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2229109,"[['dexamethasone', '(PA449247)'], ['lenalidomide', '(PA162363968)']]",increased likelihood of,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs12979860,"[['ribavirin', '(PA451241)'], ['sofosbuvir', '(PA166122593)']]","increased sustained virological response (svr) when treated with ribavirin and sofosbuvir in people with Hepatitis C, Chronic and Liver Cirrhosis as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs869320766,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs869320766,"[['NUDT15', '(PA134963132)']]",belongs to,
rs4244285,"[['iguratimod', '(PA166178387)']]",increased likelihood of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs115457081,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs115457081,"[['IRS1', '(PA203)']]",belongs to,
rs112242273,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs112242273,"[['GNL3', '(PA134952132)']]",belongs to,
rs299293,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs299293,"[['HMMR', '(PA29340)']]",belongs to,
rs299313,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs299313,"[['HMMR', '(PA29340)']]",belongs to,
rs299314,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs299314,"[['HMMR', '(PA29340)']]",belongs to,
rs3805945,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3805945,"[['PPP2R5D', '(PA33676)']]",belongs to,
rs78428806,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs78428806,"[['PERP', '(PA134944221)']]",belongs to,
rs117101815,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs117101815,"[['PERP', '(PA134944221)']]",belongs to,
rs9402944,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs9402944,"[['PERP', '(PA134944221)']]",belongs to,
rs518147,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs518147,"[['HTR2C', '(PA194)']]",belongs to,
rs12836771,"[['clozapine', '(PA449061)'], ['olanzapine', '(PA450688)'], ['quetiapine', '(PA451201)'], ['risperidone', '(PA451257)']]",increased likelihood of,
rs12836771,"[['HTR2C', '(PA194)'], ['MIR1264', '(PA164722409)'], ['MIR1912', '(PA164722546)']]",belongs to,
rs7799039,"[['LEP', '(PA228)']]",belongs to,
rs1137101,"[['LEPR', '(PA229)'], ['LEPROT', '(PA134913422)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['CYP3A5', '(PA131)']]",increased glomerular filtration rate when treated with tacrolimus in people with Kidney Transplantation as compared to,"['*3A/*3A', '+', '*3A/*6', '+', '*3A/*7', '+', '*6/*6', '+', '*6/*7', '+', '*7/*7.']"
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6, CYP3A5*7","[['CYP3A5', '(PA131)']]",belongs to,"['*3A/*3A', '+', '*3A/*6', '+', '*3A/*7', '+', '*6/*6', '+', '*6/*7', '+', '*7/*7.']"
rs9389568,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs9389568,"[['PERP', '(PA134944221)']]",belongs to,
rs117458836,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs117458836,"[['CYP2C8', '(PA125)']]",belongs to,
rs118088833,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs118088833,"[['TP53AIP1', '(PA164726680)']]",belongs to,
rs149212925,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs149212925,"[['NOS1', '(PA252)']]",belongs to,
rs144991623,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs144991623,"[['FOXO1', '(PA28237)']]",belongs to,
rs77769901,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs77769901,"[['CCNK', '(PA26161)']]",belongs to,
rs4968187,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs4968187,"[['TP53', '(PA36679)']]",belongs to,
rs181501757,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs181501757,"[['TOP2A', '(PA354)']]",belongs to,
rs142244113,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs142244113,"[['INSR', '(PA202)']]",belongs to,
rs41412545,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs41412545,"[['INSR', '(PA202)']]",belongs to,
rs118129530,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs118129530,"[['PIK3R2', '(PA33313)']]",belongs to,
rs56022120,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs56022120,"[['PIK3R2', '(PA33313)']]",belongs to,
rs117341846,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs117341846,"[['PIK3R2', '(PA33313)']]",belongs to,
rs117951771,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs117951771,"[['PIK3R2', '(PA33313)']]",belongs to,
rs148235907,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs148235907,"[['PIK3R2', '(PA33313)']]",belongs to,
rs138602176,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs138602176,"[['PIK3R2', '(PA33313)']]",belongs to,
rs150688309,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs150688309,"[['PIK3R2', '(PA33313)']]",belongs to,
rs79430272,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs79430272,"[['PIK3R2', '(PA33313)']]",belongs to,
rs55633228,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs55633228,"[['PIK3R2', '(PA33313)']]",belongs to,
rs148013902,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs148013902,"[['PIK3R2', '(PA33313)']]",belongs to,
rs408626,"[['methotrexate', '(PA450428)']]",decreased event-free survival when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs408626,"[['DHFR', '(PA143)']]",belongs to,
rs442767,"[['methotrexate', '(PA450428)']]",decreased event-free survival when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs442767,"[['DHFR', '(PA143)']]",belongs to,
rs75527207,"[['ivacaftor', '(PA165950341)']]",decreased likelihood of,
rs75527207,"[['CFTR', '(PA109)']]",belongs to,
rs75527207,"[['CFTR', '(PA109)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2737385,"[['clozapine', '(PA449061)']]",decreased severity of,
rs2737385,"[['HNMT', '(PA190)']]",belongs to,
rs17034063,"[['clozapine', '(PA449061)']]",decreased severity of,
rs17034063,"[['HRH1', '(PA29456)']]",belongs to,
rs1552498,"[['clozapine', '(PA449061)']]",increased severity of,
rs1552498,"[['HRH1', '(PA29456)']]",belongs to,
rs6977381,"[['clozapine', '(PA449061)']]",decreased severity of,
rs6977381,"[['AOC1', '(PA24416)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs145623321,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs145623321,"[['PIK3R2', '(PA33313)']]",belongs to,
rs58695150,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs58695150,"[['PIK3R2', '(PA33313)']]",belongs to,
rs8110364,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs8110364,"[['PIK3R2', '(PA33313)']]",belongs to,
rs74743371,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs74743371,"[['CBR3', '(PA26122)']]",belongs to,
rs112783657,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs112783657,"[['CBR3', '(PA26122)']]",belongs to,
rs141084494,"[['cyclophosphamide', '(PA449165)'], ['epirubicin', '(PA449476)'], ['fluorouracil', '(PA128406956)']]",decreased risk of,
rs141084494,"[['RBX1', '(PA34299)']]",belongs to,
rs683369,"[['SLC22A1', '(PA329)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs1056836,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",decreased event-free survival when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801265,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",decreased Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs45589337,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs118192168,"[['halothane', '(PA449845)'], ['succinylcholine', '(PA451522)']]",Malignant Hyperthermia when treated with halothane and succinylcholine as compared to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192176,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['rocuronium', '(PA164754992)'], ['sevoflurane', '(PA451341)']]",increased risk of,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
HLA-B*15:02:01,"[['oxcarbazepine', '(PA450732)']]",increased likelihood of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs193922816,"[['RYR1', '(PA34896)']]",belongs to,
rs727504129,"[['RYR1', '(PA34896)']]",belongs to,
rs121918596,"[['isoflurane', '(PA450106)'], ['sevoflurane', '(PA451341)']]",increased risk of,
rs121918596,"[['RYR1', '(PA34896)']]",belongs to,
rs1801086,"[['sevoflurane', '(PA451341)']]",increased risk of,
rs1801086,"[['RYR1', '(PA34896)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
rs8175347,"[['eltrombopag', '(PA165981594)']]","Oliguria, Unconsciousness and Vomiting when treated with eltrombopag in children with Purpura, Thrombocytopenic, Idiopathic as compared to",
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs4073054,"[['NR1I3', '(PA391)']]",belongs to,
rs2307424,"[['NR1I3', '(PA391)']]",belongs to,
rs380518,"[['RXRG', '(PA34892)']]",belongs to,
rs283695,"[['RXRG', '(PA34892)']]",belongs to,
rs2266780,"[['FMO3', '(PA166)']]",belongs to,
rs111888148,"[['ryanodine', '(PA166176123)']]",Malignant Hyperthermia when exposed to,
rs111888148,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs1800896,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",increased risk of,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['clozapine', '(PA449061)']]",increased likelihood of,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs6011280,"[['OPRL1', '(PA31944)']]",belongs to,
rs6090041,"[['opioids', '(PA452618)']]",increased risk of,
rs6090041,"[['OPRL1', '(PA31944)']]",belongs to,
rs6090041,"[['OPRL1', '(PA31944)']]",belongs to,
rs6090043,"[['opioids', '(PA452618)']]",increased risk of,
rs6090043,"[['OPRL1', '(PA31944)']]",belongs to,
rs6090043,"[['OPRL1', '(PA31944)']]",belongs to,
rs2229205,"[['OPRL1', '(PA31944)']]",belongs to,
rs2295448,"[['OPRL1', '(PA31944)']]",belongs to,
rs12979860,"[['highly', 'active', 'antiretroviral', 'therapy', '(haart)', '(PA166177229)']]",increased immunological response when treated with highly active antiretroviral therapy (haart) in people with HIV as compared to,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs598160,"[['OPRM1', '(PA31945)']]",belongs to,
rs644261,"[['OPRM1', '(PA31945)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs267606617,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606617,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs267606619,"[['aminoglycoside', 'antibacterials', '(PA452167)']]",Ototoxicity when treated with aminoglycoside antibacterials as compared to,
rs267606619,"[['MT-RNR1', '(PA31274)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs193922764,"[['RYR1', '(PA34896)']]",belongs to,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
rs193922764,"[['RYR1', '(PA34896)']]",belongs to,
rs193922764,"[['RYR1', '(PA34896)']]",belongs to,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs193922764,"[['RYR1', '(PA34896)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs4657437,"[['RXRG', '(PA34892)']]",belongs to,
rs3767344,"[['RXRG', '(PA34892)']]",belongs to,
rs157880,"[['RXRG', '(PA34892)']]",belongs to,
rs2972164,"[['PPARG', '(PA281)']]",belongs to,
rs880663,"[['PPARG', '(PA281)']]",belongs to,
rs16830505,"[['NR1I2', '(PA378)']]",belongs to,
rs7643645,"[['NR1I2', '(PA378)']]",belongs to,
rs230539,"[['NFKB1', '(PA248)']]",belongs to,
rs1800630,"[['TNF', '(PA435)']]",belongs to,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs3093662,"[['TNF', '(PA435)']]",belongs to,
rs2076169,"[['PPARD', '(PA33557)']]",belongs to,
rs2076169,"[['PPARD', '(PA33557)']]",belongs to,
rs890293,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs890293,"[['CYP2J2', '(PA27112)']]",belongs to,
rs121918592,"[['sevoflurane', '(PA451341)']]",risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs1650697,"[['methotrexate', '(PA450428)']]",decreased event-free survival when treated with methotrexate in children with Precursor Cell Lymphoblastic Leukemia-Lymphoma as compared to,
rs1650697,"[['DHFR', '(PA143)']]",belongs to,
rs2069840,"[['IL6', '(PA198)']]",belongs to,
rs11574077,"[['VDR', '(PA37301)']]",belongs to,
rs12717991,"[['VDR', '(PA37301)']]",belongs to,
rs2853564,"[['VDR', '(PA37301)']]",belongs to,
rs4760648,"[['VDR', '(PA37301)']]",belongs to,
rs11168287,"[['VDR', '(PA37301)']]",belongs to,
rs11574026,"[['VDR', '(PA37301)']]",belongs to,
rs2069716,"[['IFNG', '(PA29674)']]",belongs to,
rs1053004,"[['STAT3', '(PA337)']]",belongs to,
rs2425637,"[['HNF4A', '(PA29349)']]",belongs to,
rs2425640,"[['HNF4A', '(PA29349)']]",belongs to,
rs2071197,"[['HNF4A', '(PA29349)']]",belongs to,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
GSTT1 null,"[['GSTT1', '(PA183)']]",belongs to,
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",increased glomerular filtration rate when treated with tacrolimus in people with Kidney Transplantation as compared to,['*1A/*1A.']
"CYP2C8*1A, CYP2C8*3","[['CYP2C8', '(PA125)']]",belongs to,['*1A/*1A.']
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]","Binge eating disorder, Constipation, Dystonia, extrapyramidal symptoms, Galactorrhea, Psychomotor Agitation and Weight gain when treated with aripiprazole, quetiapine and risperidone in children with Schizophrenia as compared to",['*1.']
"CYP2D6*1, CYP2D6*4, CYP2D6*41","[['CYP2D6', '(PA128)']]",belongs to,['*1.']
"CYP2D6*1, CYP2D6*1xN","[['haloperidol', '(PA449841)'], ['levomepromazine', '(PA134687942)'], ['risperidone', '(PA451257)']]","extrapyramidal symptoms, hepatic cytolysis and Weight gain when exposed to",
"CYP2D6*1, CYP2D6*1xN","[['CYP2D6', '(PA128)']]",belongs to,
rs2108622,"[['ticagrelor', '(PA165374673)']]",increased platelet aggregation when treated with ticagrelor in people with Angina Pectoris or Myocardial Infarction as compared to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs745975,"[['HNF4A', '(PA29349)']]",belongs to,
rs3212183,"[['HNF4A', '(PA29349)']]",belongs to,
rs6093976,"[['HNF4A', '(PA29349)']]",belongs to,
rs6093976,"[['HNF4A', '(PA29349)']]",belongs to,
rs6031587,"[['HNF4A', '(PA29349)']]",belongs to,
rs6093978,"[['HNF4A', '(PA29349)']]",belongs to,
rs1800961,"[['HNF4A', '(PA29349)']]",belongs to,
rs3212197,"[['HNF4A', '(PA29349)']]",belongs to,
rs6130615,"[['HNF4A', '(PA29349)']]",belongs to,
rs9626736,"[['PPARA', '(PA280)']]",belongs to,
"GSTT1 non-null, GSTT1 null","[['GSTT1', '(PA183)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased platelet aggregation when treated with clopidogrel in people with Angina Pectoris and Myocardial Infarction as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs5746136,"[['heroin', '(PA452619)']]",increased risk of,
rs5746136,"[['SOD2', '(PA36017)']]",belongs to,
rs5746136,"[['SOD2', '(PA36017)']]",belongs to,
rs2758339,"[['heroin', '(PA452619)']]",decreased risk of,
rs2758339,"[['SOD2', '(PA36017)']]",belongs to,
rs2758339,"[['heroin', '(PA452619)']]",decreased risk of,
rs2758339,"[['SOD2', '(PA36017)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1611131,"[['opioids', '(PA452618)']]",decreased risk of,
rs1611131,"[['DBH', '(PA136)']]",belongs to,
rs2070762,"[['opioids', '(PA452618)']]",increased risk of,
rs2070762,"[['TH', '(PA351)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1800566,"[['NQO1', '(PA31744)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased likelihood of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",Sleep Disorders when treated with efavirenz as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*38, CYP2B6*6","[['efavirenz', '(PA449441)']]",increased risk of,
"CYP2B6*1, CYP2B6*38, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",increased risk of,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*6","[['efavirenz', '(PA449441)']]",increased likelihood of,
"CYP2B6*1, CYP2B6*6","[['CYP2B6', '(PA123)']]",belongs to,
rs1799971,"[['remifentanil', '(PA451232)']]",decreased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs186364861,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs186364861,"[['NUDT15', '(PA134963132)']]",belongs to,
rs368234815,"[['direct', 'acting', 'antivirals', '(PA166179660)']]","decreased sustained virological response (svr) when treated with direct acting antivirals in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['direct', 'acting', 'antivirals', '(PA166179660)']]","decreased sustained virological response (svr) when treated with direct acting antivirals in people with Hepatitis C, Chronic as compared to",
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs1076560,"[['heroin', '(PA452619)']]",increased likelihood of,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs121918596,"[['halothane', '(PA449845)'], ['isoflurane', '(PA450106)'], ['succinylcholine', '(PA451522)']]",increased risk of,
rs121918596,"[['RYR1', '(PA34896)']]",belongs to,
"NAT2*4, NAT2*5B, NAT2*6A","[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
"NAT2*4, NAT2*5B, NAT2*6A","[['NAT2', '(PA18)']]",belongs to,
"CYP3A4*1, CYP3A4*18","[['CYP3A4', '(PA130)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased Drug Toxicity when treated with capecitabine or fluorouracil in people with Colorectal Neoplasms as compared to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs2306283,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",increased Blood Coagulation Disorders when treated with warfarin as compared to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs6046,"[['F7', '(PA160)']]",belongs to,
rs1057910,"[['warfarin', '(PA451906)']]",increased Blood Coagulation Disorders when treated with warfarin as compared to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799853,"[['warfarin', '(PA451906)']]",increased Blood Coagulation Disorders when treated with warfarin as compared to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1043550,"[['CALU', '(PA26047)']]",belongs to,
rs12714145,"[['GGCX', '(PA28660)']]",belongs to,
rs699664,"[['GGCX', '(PA28660)']]",belongs to,
rs11676382,"[['GGCX', '(PA28660)']]",belongs to,
rs1051740,"[['EPHX1', '(PA27829)']]",belongs to,
rs1057910,"[['acenocoumarol', '(PA452632)']]",increased risk of,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['heroin', '(PA452619)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs924607,"[['CEP72', '(PA142672125)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs1051266,"[['Platinum', 'compounds', '(PA164713176)']]","decreased progression-free survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
rs2233678,"[['oxaliplatin', '(PA131285527)']]",decreased overall survival and progression-free survival when treated with oxaliplatin in people with Colorectal Neoplasms as compared to,
rs2233678,"[['PIN1', '(PA33320)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs731236,"[['VDR', '(PA37301)']]",belongs to,
rs2228570,"[['VDR', '(PA37301)']]",belongs to,
rs4253728,"[['PPARA', '(PA280)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C19*1, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
CYP2C19*17,"[['clozapine', '(PA449061)']]",decreased likelihood of,
CYP2C19*17,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs17174794,"[['OPRM1', '(PA31945)']]",belongs to,
rs17174801,"[['OPRM1', '(PA31945)']]",belongs to,
rs62638690,"[['cocaine', '(PA449072)'], ['heroin', '(PA452619)']]",decreased likelihood of,
rs62638690,"[['OPRM1', '(PA31945)']]",belongs to,
rs3734704,"[['bevacizumab', '(PA130232992)']]",increased risk of,
rs3734704,"[['HSP90AB1', '(PA29524)']]",belongs to,
rs6929249,"[['bevacizumab', '(PA130232992)']]",increased risk of,
rs6929249,"[['HSP90AB1', '(PA29524)']]",belongs to,
rs834576,"[['bevacizumab', '(PA130232992)']]",increased risk of,
rs834576,"[['HSP90AB1', '(PA29524)']]",belongs to,
rs9381299,"[['bevacizumab', '(PA130232992)']]",increased risk of,
rs9381299,"[['PRKCA', '(PA33759)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",non-response when treated with antidepressants in people with Mood Disorders as compared to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",non-response when treated with antidepressants in people with Mood Disorders as compared to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",non-response when treated with antidepressants in people with Mood Disorders as compared to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
rs9923231,"[['acenocoumarol', '(PA452632)']]",increased risk of,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1801133,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs1801394,"[['methotrexate', '(PA450428)']]",increased likelihood of,
rs1801394,"[['MTRR', '(PA31277)']]",belongs to,
rs2236225,"[['methotrexate', '(PA450428)']]",decreased likelihood of,
rs2236225,"[['MTHFD1', '(PA31236)']]",belongs to,
rs17180982,"[['OPRM1', '(PA31945)']]",belongs to,
rs762551,"[['caffeine', '(PA448710)']]",increased likelihood of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs2233678,"[['irinotecan', '(PA450085)']]",increased progression-free survival when treated with irinotecan in people with Colorectal Neoplasms as compared to,
rs2233678,"[['PIN1', '(PA33320)']]",belongs to,
rs701829,"[['dapsone', '(PA449211)']]",increased risk of,
rs701829,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs201929247,"[['dapsone', '(PA449211)']]",increased risk of,
rs201929247,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs17211071,"[['dapsone', '(PA449211)']]",increased risk of,
rs17211071,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-A*24:02:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-DRB1*16:02:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-DRB1*16:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
CYP2D6 extensive metabolizer and ultra-metabolizer,"[['tramadol', '(PA451735)']]",increased severity of,
CYP2D6 extensive metabolizer and ultra-metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs11568626,"[['SLC22A6', '(PA388)']]",belongs to,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
rs6413432,"[['CYP2E1', '(PA129)']]",belongs to,
rs2070676,"[['CYP2E1', '(PA129)']]",belongs to,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['morphine', '(PA450550)']]",decreased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['morphine', '(PA450550)']]",decreased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs544027339,"[['phenytoin', '(PA450947)']]",increased risk of,
rs544027339,"[['CYP2C9', '(PA126)']]",belongs to,
rs1029359343,"[['phenytoin', '(PA450947)']]",increased risk of,
rs1029359343,"[['CYP2C9', '(PA126)']]",belongs to,
"SLC22A1*1, SLC22A1*2, SLC22A1*3, SLC22A1*4, SLC22A1*5, SLC22A1*6","[['fenoterol', '(PA10079)']]",increased likelihood of,
"SLC22A1*1, SLC22A1*2, SLC22A1*3, SLC22A1*4, SLC22A1*5, SLC22A1*6","[['SLC22A1', '(PA329)']]",belongs to,
"CYP3A4*1, CYP3A4*18B","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs780668,"[['SLC29A3', '(PA134950750)']]",belongs to,
rs2231142,"[['gemcitabine', '(PA449748)']]","increased progression-free survival when treated with gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['gemcitabine', '(PA449748)']]",increased severity of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1022563,"[['opioids', '(PA452618)']]",increased likelihood of,
rs1022563,"[['PDYN', '(PA33163)']]",belongs to,
rs1997794,"[['opioids', '(PA452618)']]",increased likelihood of,
rs1997794,"[['PDYN', '(PA33163)']]",belongs to,
rs7272891,"[['PDYN', '(PA33163)']]",belongs to,
rs1076560,"[['opioids', '(PA452618)']]",increased risk of,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs17174629,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799972,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799972,"[['cocaine', '(PA449072)'], ['ethanol', '(PA448073)'], ['nicotine', '(PA450626)']]",increased risk of,
rs1799972,"[['OPRM1', '(PA31945)']]",belongs to,
rs3745274,"[['efavirenz', '(PA449441)']]",Status Epilepticus when treated with efavirenz as compared to,
rs3745274,"[['CYP2B6', '(PA123)']]",belongs to,
rs6683455,"[['IL23R', '(PA134935109)']]",belongs to,
rs4648310,"[['PTGS2', '(PA293)']]",belongs to,
rs5275,"[['PTGS2', '(PA293)']]",belongs to,
rs5277,"[['PTGS2', '(PA293)']]",belongs to,
rs2745557,"[['PTGS2', '(PA293)']]",belongs to,
rs20417,"[['PTGS2', '(PA293)']]",belongs to,
rs11694911,"[['ODC1', '(PA31897)']]",belongs to,
rs2430420,"[['ODC1', '(PA31897)']]",belongs to,
rs28362380,"[['ODC1', '(PA31897)']]",belongs to,
rs2302615,"[['ODC1', '(PA31897)']]",belongs to,
rs2070959,"[['aspirin', '(PA448497)']]",increased risk of,
rs2070959,"[['UGT1A6', '(PA37181)']]",belongs to,
rs1105879,"[['aspirin', '(PA448497)']]",increased risk of,
rs1105879,"[['UGT1A6', '(PA37181)']]",belongs to,
rs7349744,"[['HPGD', '(PA29424)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs11986055,"[['IKBKB', '(PA29776)']]",belongs to,
rs5029748,"[['IKBKB', '(PA29776)']]",belongs to,
rs10958713,"[['IKBKB', '(PA29776)']]",belongs to,
rs6474387,"[['IKBKB', '(PA29776)']]",belongs to,
rs3842787,"[['PTGS1', '(PA24346)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs7112513,"[['PAFAH1B2', '(PA32906)']]",belongs to,
rs4936367,"[['PAFAH1B2', '(PA32906)']]",belongs to,
rs780668,"[['SLC29A3', '(PA134950750)']]",belongs to,
rs780668,"[['gemcitabine', '(PA449748)']]","increased overall survival when treated with gemcitabine in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs780668,"[['SLC29A3', '(PA134950750)']]",belongs to,
rs3740387,"[['NT5C2', '(PA31801)']]",belongs to,
rs1168312,"[['HELB', '(PA134987279)']]",belongs to,
rs2228130,"[['POLR2A', '(PA33507)']]",belongs to,
rs2279103,"[['CTDP1', '(PA27001)']]",belongs to,
rs3740387,"[['NT5C2', '(PA31801)']]",belongs to,
rs2228130,"[['gemcitabine', '(PA449748)']]",increased severity of,
rs2228130,"[['POLR2A', '(PA33507)']]",belongs to,
rs1168312,"[['HELB', '(PA134987279)']]",belongs to,
rs2228130,"[['POLR2A', '(PA33507)']]",belongs to,
rs2279103,"[['CTDP1', '(PA27001)']]",belongs to,
rs1056836,"[['CYP1B1', '(PA27094)']]",belongs to,
rs3857532,"[['HMG', 'CoA', 'reductase', 'inhibitors,', 'other', 'combinations', '(PA164712781)']]",increased likelihood of,
rs3857532,"[['EYS', '(PA164719488)']]",belongs to,
rs1337512,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased likelihood of,
rs1337512,"[['EYS', '(PA164719488)']]",belongs to,
rs9342288,"[['HMG', 'CoA', 'reductase', 'inhibitors,', 'other', 'combinations', '(PA164712781)']]",increased likelihood of,
rs9342288,"[['EYS', '(PA164719488)']]",belongs to,
rs2306283,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4149056,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs4363657,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased likelihood of,
rs4363657,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs9806699,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",decreased likelihood of,
rs9806699,"[['GATM', '(PA28590)']]",belongs to,
rs2619112,"[['ALOX15', '(PA48)']]",belongs to,
rs5995355,"[['NCF4', '(PA31465)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs11568634,"[['SLC22A6', '(PA388)']]",belongs to,
rs717620,"[['ABCC2', '(PA116)']]",belongs to,
CYP2C9*3,"[['phenytoin', '(PA450947)']]",increased risk of,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-A*02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-A*02:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*24:02:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:03:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:06:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*02:07:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*11:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*29:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*07:05:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:25,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*35:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*38:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*40:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*46:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*51:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*54:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*55:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*56:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:03:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*03:04:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*04:01:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*07:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*08:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*15:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-C*15:05:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs10455872,"[['hmg', 'coa', 'reductase', 'inhibitors', '(PA133950441)']]",increased risk of,
rs10455872,"[['LPA', '(PA30432)']]",belongs to,
rs6785049,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs6785049,"[['NR1I2', '(PA378)']]",belongs to,
rs3814058,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs3814058,"[['NR1I2', '(PA378)']]",belongs to,
rs3732361,"[['methotrexate', '(PA450428)']]",decreased risk of,
rs3732361,"[['GSK3B', '(PA29009)']]",belongs to,
rs2273697,"[['methotrexate', '(PA450428)']]",increased risk of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs1803274,"[['donepezil', '(PA449394)']]",increased likelihood of,
rs1803274,"[['BCHE', '(PA25294)']]",belongs to,
HLA-DRB1*08:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*08:03:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*09:01:02,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*11:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2228145,"[['IL6R', '(PA29835)']]",belongs to,
rs1800871,"[['IL10', '(PA29778)']]",belongs to,
rs1800896,"[['IL10', '(PA29778)']]",belongs to,
rs6853,"[['fentanyl', '(PA449599)']]",decreased risk of,
rs6853,"[['MYD88', '(PA31361)']]",belongs to,
rs2069762,"[['IL2', '(PA195)']]",belongs to,
rs3804100,"[['TLR2', '(PA36550)']]",belongs to,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs10499563,"[['IL6', '(PA198)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2235013,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs11466004,"[['LY96', '(PA134924906)']]",belongs to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs554344,"[['CASP5', '(PA26089)']]",belongs to,
rs580253,"[['CASP1', '(PA26083)']]",belongs to,
rs3024971,"[['STAT6', '(PA339)']]",belongs to,
rs167769,"[['STAT6', '(PA339)']]",belongs to,
rs1800469,"[['TGFB1', '(PA350)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
rs1468412,"[['GRM3', '(PA28992)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs231775,"[['Antiinflammatory', 'agents,', 'non-steroids', '(PA164712462)']]",decreased risk of,
rs231775,"[['CTLA4', '(PA27006)']]",belongs to,
rs2243250,"[['IL4', '(PA197)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs17376848,"[['DPYD', '(PA145)']]",belongs to,
rs1801159,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
HLA-DRB1*12:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*12:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*14:54,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*15:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-DRB1*16:02:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs4978536,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs4978536,"[['SLC31A1', '(PA118)']]",belongs to,
rs4979223,"[['Platinum', 'compounds', '(PA164713176)']]",decreased likelihood of,
rs4979223,"[['SLC31A1', '(PA118)']]",belongs to,
rs4979223,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs4979223,"[['SLC31A1', '(PA118)']]",belongs to,
rs4978536,"[['SLC31A1', '(PA118)']]",belongs to,
rs2233914,"[['Platinum', 'compounds', '(PA164713176)']]",decreased severity of,
rs2233914,"[['SLC31A1', '(PA118)']]",belongs to,
rs2233914,"[['Platinum', 'compounds', '(PA164713176)']]",increased likelihood of,
rs2233914,"[['SLC31A1', '(PA118)']]",belongs to,
rs10817464,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs10817464,"[['SLC31A1', '(PA118)']]",belongs to,
rs10817464,"[['SLC31A1', '(PA118)']]",belongs to,
rs10817465,"[['SLC31A1', '(PA118)']]",belongs to,
rs10513202,"[['SLC31A1', '(PA118)']]",belongs to,
rs1045642,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['fentanyl', '(PA449599)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
CYP2C19 high activity,"[['tamoxifen', '(PA451581)']]",increased risk of,
CYP2C19 high activity,"[['CYP2C19', '(PA124)']]",belongs to,
rs72836345,"[['BCL2L11', '(PA25305)']]",belongs to,
rs72836346,"[['BCL2L11', '(PA25305)']]",belongs to,
rs73954926,"[['BCL2L11', '(PA25305)']]",belongs to,
rs7582030,"[['BCL2L11', '(PA25305)']]",belongs to,
rs2241842,"[['BCL2L11', '(PA25305)']]",belongs to,
rs6750142,"[['BCL2L11', '(PA25305)']]",belongs to,
rs10759637,"[['Platinum', 'compounds', '(PA164713176)']]",decreased likelihood of,
rs10759637,"[['SLC31A1', '(PA118)']]",belongs to,
rs10759637,"[['Platinum', 'compounds', '(PA164713176)']]",increased severity of,
rs10759637,"[['SLC31A1', '(PA118)']]",belongs to,
rs4149056,"[['atorvastatin', '(PA448500)'], ['simvastatin', '(PA451363)']]",increased likelihood of,
rs4149056,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs3828743,"[['abiraterone', '(PA166123407)'], ['prednisolone', '(PA451096)']]",decreased progression-free survival when treated with abiraterone and prednisolone in people with Prostatic Neoplasms as compared to,
rs3828743,"[['TSPYL1', '(PA37050)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs1800498,"[['DRD2', '(PA27478)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
rs2108622,"[['CYP4F2', '(PA27121)']]",belongs to,
CYP2D6 low activity,"[['tamoxifen', '(PA451581)']]",increased risk of,
CYP2D6 low activity,"[['CYP2D6', '(PA128)']]",belongs to,
CYP2C19 poor metabolizer phenotype,"[['CYP2C19', '(PA124)']]",belongs to,
rs714368,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs714368,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs1045642,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs12248560,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs4244285,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs2273697,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs3131003,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3131003,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs3815087,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs3099844,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3099844,"[['CYCSP5', '(PA142672032)']]",belongs to,
rs367398,"[['allopurinol', '(PA448320)']]",decreased risk of,
rs367398,"[['NOTCH4', '(PA31686)']]",belongs to,
rs2010156,"[['allopurinol', '(PA448320)']]",decreased risk of,
rs2010156,"[['TSHZ2', '(PA37589)']]",belongs to,
rs724710,"[['corticosteroids', '(PA10832)']]",increased risk of,
rs724710,"[['BCL2L11', '(PA25305)']]",belongs to,
rs2241843,"[['corticosteroids', '(PA10832)']]",increased risk of,
rs2241843,"[['BCL2L11', '(PA25305)']]",belongs to,
rs2205986,"[['interferon', 'beta-1a', '(PA450037)'], ['interferon', 'beta-1b', '(PA450039)']]",increased risk of,
rs2205986,"[['IRF6', '(PA29920)']]",belongs to,
rs12210856,"[['OPRM1', '(PA31945)']]",belongs to,
rs12190259,"[['OPRM1', '(PA31945)']]",belongs to,
rs12205732,"[['OPRM1', '(PA31945)']]",belongs to,
rs6912029,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs563649,"[['OPRM1', '(PA31945)']]",belongs to,
rs9322446,"[['OPRM1', '(PA31945)']]",belongs to,
rs540825,"[['fentanyl', '(PA449599)']]",increased likelihood of,
rs540825,"[['OPRM1', '(PA31945)']]",belongs to,
rs675026,"[['OPRM1', '(PA31945)']]",belongs to,
rs562859,"[['OPRM1', '(PA31945)']]",belongs to,
rs606545,"[['OPRM1', '(PA31945)']]",belongs to,
rs17181352,"[['OPRM1', '(PA31945)']]",belongs to,
rs671531,"[['OPRM1', '(PA31945)']]",belongs to,
rs583664,"[['OPRM1', '(PA31945)']]",belongs to,
rs658156,"[['OPRM1', '(PA31945)']]",belongs to,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
rs1800498,"[['DRD2', '(PA27478)']]",belongs to,
rs1800498,"[['DRD2', '(PA27478)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
HLA-A*33:03,"[['lamotrigine', '(PA450164)']]",increased likelihood of,
HLA-A*33:03,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*39:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*35:08:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*44:03:01,"[['lamotrigine', '(PA450164)']]",increased likelihood of,
HLA-B*44:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs9263726,"[['allopurinol', '(PA448320)']]",increased risk of,
rs9263726,"[['PSORS1C1', '(PA33919)']]",belongs to,
rs3740066,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs1695,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1801516,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801516,"[['ATM', '(PA61)']]",belongs to,
rs1042522,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1042522,"[['TP53', '(PA36679)']]",belongs to,
rs2228100,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs2228100,"[['ALDH3A1', '(PA24697)']]",belongs to,
rs45445694,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs25487,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs3212986,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs20572,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs20572,"[['CBR1', '(PA26121)']]",belongs to,
rs3740066,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3740066,"[['ABCC2', '(PA116)']]",belongs to,
rs1801516,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801516,"[['ATM', '(PA61)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs4244285,"[['clopidogrel', '(PA449053)']]",increased major adverse cardiac events (mace) when treated with clopidogrel in people with Acute coronary syndrome as compared to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs1799853,"[['CYP2C9', '(PA126)']]",belongs to,
rs1057910,"[['CYP2C9', '(PA126)']]",belongs to,
rs9934438,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4","[['escitalopram', '(PA10074)']]",increased risk of,
"CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*4","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['escitalopram', '(PA10074)']]",increased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP3A4*1, CYP3A4*1G","[['CYP3A4', '(PA130)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP2A6*10, CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",decreased overall survival when treated with s 1 (combination) in people with Stomach Neoplasms as compared to,"['*1A/*4A', '+', '*1A/*7', '+', '*1A/*9', '+', '*1A/*10', '+', '*1A/*1A.']"
"CYP2A6*10, CYP2A6*1A, CYP2A6*4A, CYP2A6*7, CYP2A6*9","[['CYP2A6', '(PA121)']]",belongs to,"['*1A/*4A', '+', '*1A/*7', '+', '*1A/*9', '+', '*1A/*10', '+', '*1A/*1A.']"
rs12402181,"[['vincristine', '(PA451879)']]",decreased risk of,
rs12402181,"[['MIR3117', '(PA165751627)']]",belongs to,
rs7896283,"[['vincristine', '(PA451879)']]",increased risk of,
rs7896283,"[['MIR4481', '(PA166176233)']]",belongs to,
rs35650931,"[['vincristine', '(PA451879)']]",decreased risk of,
rs35650931,"[['MIR6076', '(PA166176239)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2297595,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased likelihood of,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
"TPMT*1, TPMT*6","[['TPMT', '(PA356)']]",belongs to,
"TPMT*1, TPMT*3C","[['TPMT', '(PA356)']]",belongs to,
rs6907567,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs6907567,"[['SLC22A16', '(PA134911502)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs16918482,"[['RRM2B', '(PA34866)']]",belongs to,
rs8187758,"[['SLC28A1', '(PA387)']]",belongs to,
rs8124728,"[['stavudine', '(PA451494)']]",decreased risk of,
rs8124728,"[['SAMHD1', '(PA34938)']]",belongs to,
rs1891643,"[['SAMHD1', '(PA34938)']]",belongs to,
CYP3A haplotype,"[['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)']]",decreased likelihood of,
CYP3A haplotype,"[['CYP3A', '(PA27114)']]",belongs to,
CYP3A poor metabolizer genotype,"[['docetaxel', '(PA449383)'], ['epirubicin', '(PA449476)']]",increased likelihood of,
CYP3A poor metabolizer genotype,"[['CYP3A', '(PA27114)']]",belongs to,
CYP3A5*3A,"[['tacrolimus', '(PA451578)']]",increased risk of,
CYP3A5*3A,"[['CYP3A5', '(PA131)']]",belongs to,
rs193922832,"[['RYR1', '(PA34896)']]",belongs to,
rs193922843,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
GSTM1 null,"[['GSTM1', '(PA182)']]",belongs to,
rs4673,"[['idarubicin', '(PA449961)']]","increased overall survival when treated with idarubicin in people with Leukemia, Myeloid, Acute as compared to",
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
rs4673,"[['idarubicin', '(PA449961)']]",decreased risk of,
rs4673,"[['CYBA', '(PA27075)']]",belongs to,
rs1883112,"[['idarubicin', '(PA449961)']]",increased risk of,
rs1883112,"[['NCF4', '(PA31465)']]",belongs to,
rs13058338,"[['idarubicin', '(PA449961)']]",decreased risk of,
rs13058338,"[['RAC2', '(PA34163)']]",belongs to,
rs67376798,"[['fluorouracil', '(PA128406956)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs45445694,"[['fluorouracil', '(PA128406956)']]",risk of,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs2231142,"[['cyclophosphamide', '(PA449165)'], ['doxorubicin', '(PA449412)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs2231142,"[['ABCG2', '(PA390)']]",belongs to,
rs1801265,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801265,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs118192124,"[['RYR1', '(PA34896)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)']]",increased severity of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs1801158,"[['DPYD', '(PA145)']]",belongs to,
rs75017182,"[['DPYD', '(PA145)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
rs151264360,"[['TYMS', '(PA359)']]",belongs to,
rs4588,"[['bevacizumab', '(PA130232992)']]",decreased overall survival when treated with bevacizumab in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to,
rs4588,"[['GC', '(PA28601)']]",belongs to,
rs116855232,"[['mercaptopurine', '(PA450379)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs1127354,"[['ITPA', '(PA29973)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs193922803,"[['RYR1', '(PA34896)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs193922748,"[['RYR1', '(PA34896)']]",belongs to,
rs193922768,"[['RYR1', '(PA34896)']]",belongs to,
rs193922748,"[['RYR1', '(PA34896)']]",belongs to,
rs193922762,"[['RYR1', '(PA34896)']]",belongs to,
rs144336148,"[['RYR1', '(PA34896)']]",belongs to,
rs118192178,"[['RYR1', '(PA34896)']]",belongs to,
rs193922768,"[['RYR1', '(PA34896)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['tacrolimus', '(PA451578)']]",increased risk of,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs4588,"[['cetuximab', '(PA10040)']]",increased overall survival when treated with cetuximab in people with Colorectal Neoplasms and Neoplasm Metastasis as compared to,
rs4588,"[['GC', '(PA28601)']]",belongs to,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1800497,"[['ethanol', '(PA448073)']]",increased risk of,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['azathioprine', '(PA448515)']]",increased likelihood of,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs1142345,"[['TPMT', '(PA356)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs2236947,"[['cetuximab', '(PA10040)']]",increased overall survival when treated with cetuximab in people with Colorectal Neoplasms as compared to,
rs2236947,"[['RASSF1', '(PA34245)']]",belongs to,
rs274558,"[['imatinib', '(PA10804)']]",decreased risk of,
rs274558,"[['SLC22A5', '(PA333)']]",belongs to,
rs683369,"[['imatinib', '(PA10804)']]",increased risk of,
rs683369,"[['SLC22A1', '(PA329)']]",belongs to,
rs10258429,"[['imatinib', '(PA10804)']]",increased risk of,
rs10258429,"[['EGFR', '(PA7360)']]",belongs to,
rs2235040,"[['imatinib', '(PA10804)']]",decreased risk of,
rs2235040,"[['ABCB1', '(PA267)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs116855232,"[['NUDT15', '(PA134963132)']]",belongs to,
rs1204964501,"[['atorvastatin', '(PA448500)']]",statin-related myopathy when treated with atorvastatin in people with Diabetes Mellitus and Hypertension as compared to,
rs1204964501,"[['CACNA1S', '(PA85)']]",belongs to,
rs768445692,"[['rosuvastatin', '(PA134308647)']]",Rhabdomyolysis and statin-related myopathy when treated with rosuvastatin as compared to,
rs768445692,"[['CACNA1S', '(PA85)']]",belongs to,
rs377474103,"[['pravastatin', '(PA451089)'], ['simvastatin', '(PA451363)']]",statin-related myopathy when treated with pravastatin or simvastatin as compared to,
rs377474103,"[['CACNA1S', '(PA85)']]",belongs to,
rs1225367412,"[['simvastatin', '(PA451363)']]","Rhabdomyolysis and statin-related myopathy when treated with simvastatin in people with Hypertension, Kidney Diseases and Liver Diseases as compared to",
rs1225367412,"[['CACNA1S', '(PA85)']]",belongs to,
rs529038948,"[['atorvastatin', '(PA448500)']]","statin-related myopathy when treated with atorvastatin in people with Diabetes Mellitus, Hypertension and Obesity as compared to",
rs529038948,"[['CACNA1S', '(PA85)']]",belongs to,
rs111364296,"[['atorvastatin', '(PA448500)']]","statin-related myopathy when treated with atorvastatin in people with Coronary Artery Disease, Hypertension and Liver Diseases as compared to",
rs111364296,"[['RYR1', '(PA34896)']]",belongs to,
rs2781377,"[['vincristine', '(PA451879)']]",increased likelihood of,
rs2781377,"[['SYNE2', '(PA128394613)']]",belongs to,
rs10513762,"[['vincristine', '(PA451879)']]",increased likelihood of,
rs10513762,"[['MRPL47', '(PA30979)']]",belongs to,
rs3803357,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs3803357,"[['BAHD1', '(PA128394592)']]",belongs to,
rs1129844,"[['methadone', '(PA450401)']]",increased insomnia due to,
rs1129844,"[['CCL11', '(PA35543)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1801133,"[['azacitidine', '(PA451996)']]",decreased overall survival when treated with azacitidine in people with Myelodysplastic Syndromes as compared to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs11280056,"[['azacitidine', '(PA451996)']]",decreased overall survival when treated with azacitidine in people with Myelodysplastic Syndromes as compared to,
rs11280056,"[['TYMS', '(PA359)']]",belongs to,
rs25487,"[['azacitidine', '(PA451996)']]",decreased overall survival when treated with azacitidine in people with Myelodysplastic Syndromes as compared to,
rs25487,"[['XRCC1', '(PA369)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs193922826,"[['simvastatin', '(PA451363)']]",Rhabdomyolysis and statin-related myopathy when treated with simvastatin in people with Coronary Artery Disease as compared to,
rs193922826,"[['RYR1', '(PA34896)']]",belongs to,
rs141678782,"[['simvastatin', '(PA451363)']]",statin-related myopathy when treated with simvastatin in people with Hypothyroidism as compared to,
rs141678782,"[['RYR1', '(PA34896)']]",belongs to,
rs757284447,"[['atorvastatin', '(PA448500)']]",statin-related myopathy when treated with atorvastatin in people with Diabetes Mellitus as compared to,
rs757284447,"[['RYR1', '(PA34896)']]",belongs to,
rs33389,"[['NR3C1', '(PA181)']]",belongs to,
rs2963155,"[['NR3C1', '(PA181)']]",belongs to,
rs9324918,"[['NR3C1', '(PA181)']]",belongs to,
rs12248560,"[['CYP2C19', '(PA124)']]",belongs to,
rs11568732,"[['clopidogrel', '(PA449053)']]",increased risk of,
rs11568732,"[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*17, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs10929302,"[['risperidone', '(PA451257)']]",increased risk of,
rs10929302,"[['UGT1A1', '(PA420)']]",belongs to,
rs1976391,"[['risperidone', '(PA451257)']]",increased risk of,
rs1976391,"[['UGT1A1', '(PA420)']]",belongs to,
rs887829,"[['risperidone', '(PA451257)']]",increased risk of,
rs887829,"[['UGT1A1', '(PA420)']]",belongs to,
rs2276299,"[['SLC22A8', '(PA389)']]",belongs to,
rs3786362,"[['risperidone', '(PA451257)']]",increased risk of,
rs3786362,"[['TYMS', '(PA359)']]",belongs to,
HLA-B*35:10,"[['HLA-B', '(PA35056)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
"CYP4F2*1, CYP4F2*3","[['warfarin', '(PA451906)']]",time to,
"CYP4F2*1, CYP4F2*3","[['CYP4F2', '(PA27121)']]",belongs to,
rs9923231,"[['warfarin', '(PA451906)']]",time to,
rs9923231,"[['VKORC1', '(PA133787052)']]",belongs to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['warfarin', '(PA451906)']]",time to,
"CYP2C9*1, CYP2C9*2, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A, CYP3A5*6","[['CYP3A5', '(PA131)']]",belongs to,
rs10482672,"[['methadone', '(PA450401)']]",decreased Recurrence in people not taking methadone in people with Heroin Dependence as compared to,
rs10482672,"[['NR3C1', '(PA181)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-B*13:01:01,"[['dapsone', '(PA449211)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
"NAT2*4, NAT2*6A, NAT2*7B","[['NAT2', '(PA18)']]",belongs to,
rs1805087,"[['Platinum', 'compounds', '(PA164713176)']]","decreased progression-free survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1805087,"[['MTR', '(PA31272)']]",belongs to,
rs1690924,"[['Platinum', 'compounds', '(PA164713176)']]","decreased overall survival when treated with Platinum compounds in people with Carcinoma, Non-Small-Cell Lung as compared to",
rs1690924,"[['MDM2', '(PA30718)']]",belongs to,
rs55853698,"[['nicotine', '(PA450626)']]",increased Tobacco Use Disorder when exposed to,
rs55853698,"[['CHRNA5', '(PA26491)']]",belongs to,
rs55781567,"[['nicotine', '(PA450626)']]",increased Tobacco Use Disorder when exposed to,
rs55781567,"[['CHRNA5', '(PA26491)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased Tobacco Use Disorder when exposed to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs2236196,"[['CHRNA4', '(PA26490)']]",belongs to,
rs1801131,"[['MTHFR', '(PA245)']]",belongs to,
rs1801133,"[['MTHFR', '(PA245)']]",belongs to,
rs45445694,"[['TYMS', '(PA359)']]",belongs to,
"DPYD*1, DPYD*2A","[['DPYD', '(PA145)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192177,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192177,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918592,"[['succinylcholine', '(PA451522)'], ['volatile', 'anesthetics', '(PA166131630)']]",increased risk of,
rs121918592,"[['RYR1', '(PA34896)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs118192122,"[['RYR1', '(PA34896)']]",belongs to,
rs118192168,"[['RYR1', '(PA34896)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP3A4*1, CYP3A4*18B","[['CYP3A4', '(PA130)']]",belongs to,
HLA-A*02:07:01,"[['lamotrigine', '(PA450164)']]",increased risk of,
HLA-A*02:07:01,"[['HLA-A', '(PA35055)']]",belongs to,
rs3099844,"[['allopurinol', '(PA448320)']]",increased risk of,
rs3099844,"[['CYCSP5', '(PA142672032)']]",belongs to,
rs2734583,"[['allopurinol', '(PA448320)']]",increased risk of,
rs1799971,"[['alfentanil', '(PA448084)']]",decreased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",non-response when treated with antidepressants in people with Mood Disorders as compared to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,"['HTTLPR', 'long', 'form', '(L', 'allele)/HTTLPR', 'long', 'form', '(L', 'allele).']"
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['antidepressants', '(PA452229)']]",a trend of,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
rs118192172,"[['RYR1', '(PA34896)']]",belongs to,
rs121918593,"[['RYR1', '(PA34896)']]",belongs to,
rs1500,"[['methadone', '(PA450401)']]",decreased Recurrence in people not taking methadone in people with Heroin Dependence as compared to,
rs1500,"[['CRHBP', '(PA26873)']]",belongs to,
rs4234955,"[['methadone', '(PA450401)']]",decreased Recurrence in people not taking methadone in people with Heroin Dependence as compared to,
rs4234955,"[['NPY1R', '(PA258)'], ['NPY5R', '(PA31742)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
HLA-C*06:02:01:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-C*06:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs2472677,"[['efavirenz', '(PA449441)'], ['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased likelihood of,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs2472677,"[['efavirenz', '(PA449441)'], ['ethambutol', '(PA164784021)'], ['isoniazid', '(PA450112)'], ['rifampin', '(PA451250)']]",increased severity of,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs511435,"[['ethanol', '(PA448073)'], ['opioids', '(PA452618)']]",increased risk of,
rs511435,"[['OPRM1', '(PA31945)']]",belongs to,
rs511435,"[['OPRM1', '(PA31945)']]",belongs to,
rs524731,"[['cocaine', '(PA449072)'], ['ethanol', '(PA448073)'], ['opioids', '(PA452618)']]",increased risk of,
rs524731,"[['OPRM1', '(PA31945)']]",belongs to,
rs3823010,"[['cocaine', '(PA449072)'], ['ethanol', '(PA448073)'], ['opioids', '(PA452618)']]",increased risk of,
rs3823010,"[['OPRM1', '(PA31945)']]",belongs to,
rs1381376,"[['OPRM1', '(PA31945)']]",belongs to,
rs1381376,"[['ethanol', '(PA448073)']]",increased risk of,
rs1381376,"[['OPRM1', '(PA31945)']]",belongs to,
HLA-B*51:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*51:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs11969064,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",increased risk of,
rs11503014,"[['cocaine', '(PA449072)']]",increased severity of,
rs11503014,"[['GABRA2', '(PA28490)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs10946737,"[['Drugs', 'For', 'Treatment', 'Of', 'Tuberculosis', '(PA164712708)']]",increased risk of,
rs10946737,"[['RIPOR2', '(PA162387677)']]",belongs to,
rs4149086,"[['gemcitabine', '(PA449748)']]",decreased overall survival when treated with gemcitabine in people with Pancreatic Neoplasms as compared to,
rs4149086,"[['SLCO1B1', '(PA134865839)']]",belongs to,
rs2504938,"[['SLC22A3', '(PA330)']]",belongs to,
rs512077,"[['SLC22A3', '(PA330)']]",belongs to,
rs3778156,"[['cocaine', '(PA449072)'], ['ethanol', '(PA448073)'], ['opioids', '(PA452618)']]",increased risk of,
rs3778156,"[['OPRM1', '(PA31945)']]",belongs to,
rs9322447,"[['OPRM1', '(PA31945)']]",belongs to,
rs609148,"[['OPRM1', '(PA31945)']]",belongs to,
rs609148,"[['opioids', '(PA452618)']]",decreased risk of,
rs609148,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs495491,"[['cocaine', '(PA449072)'], ['ethanol', '(PA448073)'], ['opioids', '(PA452618)']]",increased risk of,
rs495491,"[['OPRM1', '(PA31945)']]",belongs to,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
rs548646,"[['OPRM1', '(PA31945)']]",belongs to,
rs548646,"[['opioids', '(PA452618)']]",decreased risk of,
rs548646,"[['OPRM1', '(PA31945)']]",belongs to,
rs648893,"[['OPRM1', '(PA31945)']]",belongs to,
rs648893,"[['opioids', '(PA452618)']]",decreased risk of,
rs648893,"[['OPRM1', '(PA31945)']]",belongs to,
rs671531,"[['OPRM1', '(PA31945)']]",belongs to,
rs2228226,"[['GLI1', '(PA28720)']]",belongs to,
rs776746,"[['acetaminophen', '(PA448015)']]",increased risk of,
rs776746,"[['CYP3A5', '(PA131)']]",belongs to,
rs1467558,"[['acetaminophen', '(PA448015)']]",increased risk of,
rs1467558,"[['CD44', '(PA26221)']]",belongs to,
"COMTHaplotype high activity, COMTHaplotype low activity","[['COMT', '(PA117)']]",decreased Pain when treated with propranolol in women with Temporomandibular Joint Disorders as compared to,"['Haplotype', 'high', 'activity/Haplotype', 'high', 'activity.']"
"COMTHaplotype high activity, COMTHaplotype low activity","[['COMT', '(PA117)']]",belongs to,"['Haplotype', 'high', 'activity/Haplotype', 'high', 'activity.']"
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs934778,"[['POMC', '(PA33526)']]",belongs to,
rs8099917,"[['asunaprevir', '(PA166128168)'], ['daclatasvir', '(PA166128167)'], ['direct', 'acting', 'antivirals', '(PA166179660)'], ['ledipasvir', '/', 'sofosbuvir', '(PA166163427)'], ['ombitasvir', '/', 'paritaprevir', '/', 'ritonavir', '(PA166163408)']]",increased risk of,
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)']]",increased likelihood of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs368234815,"[['direct', 'acting', 'antivirals', '(PA166179660)'], ['sofosbuvir', '(PA166122593)']]",increased likelihood of,
rs368234815,"[['IFNL4', '(PA166049147)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs671,"[['ethanol', '(PA448073)']]",increased risk of,
rs671,"[['ALDH2', '(PA24696)']]",belongs to,
rs2289487,"[['PLIN1', '(PA33409)']]",belongs to,
rs1052700,"[['PLIN1', '(PA33409)']]",belongs to,
rs1229984,"[['ethanol', '(PA448073)']]",decreased risk of,
rs1229984,"[['ADH1B', '(PA24571)']]",belongs to,
rs2031920,"[['ethanol', '(PA448073)']]",increased risk of,
rs2031920,"[['CYP2E1', '(PA129)']]",belongs to,
"CYP2A6*1A, CYP2A6*1X2A","[['nicotine', '(PA450626)']]",increased severity of,
"CYP2A6*1A, CYP2A6*1X2A","[['CYP2A6', '(PA121)']]",belongs to,
rs28399433,"[['nicotine', '(PA450626)']]",decreased severity of,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
rs1801272,"[['nicotine', '(PA450626)']]",decreased risk of,
rs1801272,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2B6*1, CYP2B6*4","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2D6*2xN, CYP2D6*4, CYP2D6*5","[['nicotine', '(PA450626)']]",increased risk of,
"CYP2D6*2xN, CYP2D6*4, CYP2D6*5","[['CYP2D6', '(PA128)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs148044792,"[['CYP2A13', '(PA27101)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",decreased severity of,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs148044792,"[['CYP2A13', '(PA27101)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1997794,"[['PDYN', '(PA33163)']]",belongs to,
rs2476601,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)']]",increased risk of,
rs2476601,"[['PTPN22', '(PA33995)']]",belongs to,
rs1799752,"[['Ace', 'Inhibitors,', 'Plain', '(PA164712308)']]",increased likelihood of,
rs1799752,"[['ACE', '(PA139)']]",belongs to,
rs1799722,"[['BDKRB2', '(PA80)']]",belongs to,
rs5995653,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs5995653,"[['APOBEC3B', '(PA24892)']]",belongs to,
rs1044394,"[['ethanol', '(PA448073)']]",decreased risk of,
rs1044394,"[['CHRNA4', '(PA26490)']]",belongs to,
rs8175347,"[['UGT1A1', '(PA420)']]",belongs to,
rs200034939,"[['lidocaine', '(PA450226)']]",increased likelihood of,
rs200034939,"[['SCN5A', '(PA304)']]",belongs to,
rs2283265,"[['methylphenidate', '(PA450464)']]",increased adverse events when treated with methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to,
rs2283265,"[['DRD2', '(PA27478)']]",belongs to,
rs10055255,"[['ethanol', '(PA448073)']]",increased severity of,
rs10055255,"[['CRHBP', '(PA26873)']]",belongs to,
"CYP2A6*12, CYP2A6*1A","[['CYP2A6', '(PA121)']]",belongs to,
"CYP2A6*1A, CYP2A6*1X2A","[['CYP2A6', '(PA121)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1709083,"[['nicotine', '(PA450626)']]",increased severity of,
rs1709083,"[['CYP2A13', '(PA27101)']]",belongs to,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
rs8192789,"[['CYP2A13', '(PA27101)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
rs2229109,"[['ABCB1', '(PA267)']]",belongs to,
rs9282564,"[['ABCB1', '(PA267)']]",belongs to,
rs1128503,"[['ABCB1', '(PA267)']]",belongs to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs35599367,"[['CYP3A4', '(PA130)']]",belongs to,
rs2472677,"[['NR1I2', '(PA378)']]",belongs to,
rs2276707,"[['NR1I2', '(PA378)']]",belongs to,
rs1057868,"[['POR', '(PA33532)']]",belongs to,
rs9904341,"[['methotrexate', '(PA450428)']]","increased disease activity score 28 joint in rheumatoid arthritis when treated with methotrexate in people with Arthritis, Rheumatoid as compared to",
rs9904341,"[['BIRC5', '(PA25362)']]",belongs to,
rs12720071,"[['CNR1', '(PA26681)']]",belongs to,
rs12402181,"[['asparaginase', '(PA448492)'], ['cyclophosphamide', '(PA449165)'], ['cytarabine', '(PA449177)'], ['daunorubicin', '(PA449212)'], ['hydrocortisone', '(PA449905)'], ['methotrexate', '(PA450428)'], ['prednisone', '(PA451100)'], ['vincristine', '(PA451879)']]",decreased likelihood of,
rs12402181,"[['MIR3117', '(PA165751627)']]",belongs to,
rs620815,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",increased likelihood of,
rs620815,"[['ATM', '(PA61)']]",belongs to,
rs1800629,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",increased likelihood of,
rs1800629,"[['TNF', '(PA435)']]",belongs to,
rs1800469,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",increased likelihood of,
rs1800469,"[['TGFB1', '(PA350)']]",belongs to,
rs2241716,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",increased likelihood of,
rs2241716,"[['TGFB1', '(PA350)']]",belongs to,
rs11212570,"[['Iodine', '(131I)', 'compounds', '(PA164712848)'], ['radiotherapy', '(PA166122986)']]",increased likelihood of,
rs11212570,"[['ATM', '(PA61)']]",belongs to,
rs1051730,"[['CHRNA3', '(PA113)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
CYP2A6 low activity,"[['nicotine', '(PA450626)']]",decreased risk of,
CYP2A6 low activity,"[['CYP2A6', '(PA121)']]",belongs to,
rs6473797,"[['OPRK1', '(PA31943)']]",belongs to,
rs4148412,"[['morphine', '(PA450550)']]",increased severity of,
rs4148412,"[['ABCC3', '(PA376)']]",belongs to,
rs739923,"[['morphine', '(PA450550)']]",increased severity of,
rs739923,"[['ABCC3', '(PA376)']]",belongs to,
rs733392,"[['morphine', '(PA450550)']]",increased severity of,
rs733392,"[['ABCC3', '(PA376)']]",belongs to,
rs1978153,"[['morphine', '(PA450550)']]",increased severity of,
rs1978153,"[['ABCC3', '(PA376)']]",belongs to,
rs7216383,"[['morphine', '(PA450550)']]",increased severity of,
rs7216383,"[['ABCC3', '(PA376)']]",belongs to,
rs886493,"[['morphine', '(PA450550)']]",increased severity of,
rs886493,"[['ABCC3', '(PA376)']]",belongs to,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1695,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs1050565,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1050565,"[['BLMH', '(PA25370)']]",belongs to,
rs1050565,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1050565,"[['BLMH', '(PA25370)']]",belongs to,
rs13181,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs13181,"[['ERCC2', '(PA27848)']]",belongs to,
rs1799793,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs1051660,"[['heroin', '(PA452619)']]",increased risk of,
rs1051660,"[['OPRK1', '(PA31943)']]",belongs to,
rs1799793,"[['ERCC2', '(PA27848)']]",belongs to,
rs238406,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs238406,"[['ERCC2', '(PA27848)']]",belongs to,
rs238406,"[['ERCC2', '(PA27848)']]",belongs to,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs3212986,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",decreased risk of,
rs3212986,"[['ERCC1', '(PA155)']]",belongs to,
rs11615,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs11615,"[['ERCC1', '(PA155)']]",belongs to,
rs1041983,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1041983,"[['NAT2', '(PA18)']]",belongs to,
rs1801280,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1801280,"[['NAT2', '(PA18)']]",belongs to,
rs1799929,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1799929,"[['NAT2', '(PA18)']]",belongs to,
rs1799930,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1799930,"[['NAT2', '(PA18)']]",belongs to,
rs6357,"[['TH', '(PA351)']]",belongs to,
rs2070762,"[['TH', '(PA351)']]",belongs to,
rs6356,"[['TH', '(PA351)']]",belongs to,
rs1800497,"[['nicotine', '(PA450626)']]",increased severity of,
rs1800497,"[['ANKK1', '(PA134872551)'], ['DRD2', '(PA27478)']]",belongs to,
rs10062367,"[['CRHBP', '(PA26873)']]",belongs to,
rs578776,"[['CHRNA3', '(PA113)']]",belongs to,
"CYP2C19*1, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs3093135,"[['aspirin', '(PA448497)'], ['clopidogrel', '(PA449053)']]",increased likelihood of,
rs3093135,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
CYP2A6 low activity,"[['nicotine', '(PA450626)']]",decreased risk of,
CYP2A6 low activity,"[['CYP2A6', '(PA121)']]",belongs to,
CYP2A6 intermediate activity,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",increased platelet aggregation when treated with clopidogrel as compared to,"['*1/*1', '+', '*1/*17', '+', '*17/*17', '(assigned', 'as', 'extensive', 'metabolizer', 'and', 'ultra-metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,"['*1/*1', '+', '*1/*17', '+', '*17/*17', '(assigned', 'as', 'extensive', 'metabolizer', 'and', 'ultra-metabolizer', 'phenotype)', '.']"
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2","[['CYP2C19', '(PA124)']]",belongs to,
rs78239784,"[['phenytoin', '(PA450947)']]",increased risk of,
rs78239784,"[['CFHR4', '(PA134960382)']]",belongs to,
CYP2C9*3,"[['CYP2C9', '(PA126)']]",belongs to,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*31:01:02,"[['carbamazepine', '(PA448785)']]",increased risk of,
HLA-A*31:01:02,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-A*24:02:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
UGT1A1*28,"[['UGT1A1', '(PA420)']]",belongs to,
DPYD low activity,"[['DPYD', '(PA145)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs2297595,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs599548,"[['OPRM1', '(PA31945)']]",belongs to,
rs598682,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2075572,"[['methamphetamine', '(PA450403)']]",decreased risk of,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
rs1045644,"[['vincristine', '(PA451879)']]",decreased likelihood of,
rs1045644,"[['COCH', '(PA26693)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A4*1, CYP3A4*22","[['CYP3A4', '(PA130)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP3A5*1A, CYP3A5*3A","[['CYP3A5', '(PA131)']]",belongs to,
"CYP2C9*1, CYP2C9*3","[['phenytoin', '(PA450947)']]",increased risk of,
"CYP2C9*1, CYP2C9*3","[['CYP2C9', '(PA126)']]",belongs to,
rs1799972,"[['opioids', '(PA452618)']]",increased likelihood of,
rs1799972,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['opioids', '(PA452618)']]",decreased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"CYP2C19*1, CYP2C19*17","[['clopidogrel', '(PA449053)']]",decreased risk of,
"CYP2C19*1, CYP2C19*17","[['CYP2C19', '(PA124)']]",belongs to,
DPYD*2A,"[['capecitabine', '(PA448771)']]",risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['fluorouracil', '(PA128406956)']]",increased risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
UGT1A1 deficiency,"[['irinotecan', '(PA450085)']]",increased risk of,
UGT1A1 deficiency,"[['UGT1A1', '(PA420)']]",belongs to,
rs698,"[['ADH1C', '(PA24572)']]",belongs to,
rs3758987,"[['heroin', '(PA452619)']]",increased risk of,
rs3758987,"[['HTR3B', '(PA29556)']]",belongs to,
rs2072671,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs2072671,"[['CDA', '(PA98)']]",belongs to,
rs471760,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs471760,"[['CDA', '(PA98)']]",belongs to,
rs12148896,"[['gemcitabine', '(PA449748)']]",decreased risk of,
rs12148896,"[['SLC28A1', '(PA387)']]",belongs to,
rs3825876,"[['gemcitabine', '(PA449748)']]",increased risk of,
rs3825876,"[['SLC28A1', '(PA387)']]",belongs to,
CYP2D6 poor metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
HLA-B*13:01:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*13:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQB1*03:03:02:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DQB1*03:03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs1799836,"[['MAOB', '(PA237)']]",belongs to,
rs1799836,"[['MAOB', '(PA237)']]",belongs to,
rs1799971,"[['heroin', '(PA452619)']]",decreased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
"SLC6A4 HTTLPR long form (L allele), SLC6A4 HTTLPR short form (S allele)","[['SLC6A4', '(PA312)']]",belongs to,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
rs887829,"[['UGT1A1', '(PA420)'], ['UGT1A10', '(PA37174)'], ['UGT1A3', '(PA37178)'], ['UGT1A4', '(PA37179)'], ['UGT1A5', '(PA37180)'], ['UGT1A6', '(PA37181)'], ['UGT1A7', '(PA37182)'], ['UGT1A8', '(PA37183)'], ['UGT1A9', '(PA419)']]",belongs to,
CYP2D6 poor and ultrarapid metabolizers,"[['codeine', '(PA449088)'], ['tramadol', '(PA451735)']]",increased likelihood of,
CYP2D6 poor and ultrarapid metabolizers,"[['CYP2D6', '(PA128)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs1801160,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",increased risk of,
rs1801160,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
CYP2C19 intermediate metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
CYP3A4*22,"[['CYP3A4', '(PA130)']]",belongs to,
CYP3A5*1A,"[['CYP3A5', '(PA131)']]",belongs to,
CYP2C19*2,"[['CYP2C19', '(PA124)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs9479757,"[['OPRM1', '(PA31945)']]",belongs to,
rs2234918,"[['OPRD1', '(PA31942)']]",belongs to,
rs72552266,"[['nicotine', '(PA450626)']]",increased severity of,
rs72552266,"[['CYP2A13', '(PA27101)']]",belongs to,
rs1801272,"[['nicotine', '(PA450626)']]",increased severity of,
rs1801272,"[['CYP2A6', '(PA121)']]",belongs to,
rs3093135,"[['clopidogrel', '(PA449053)'], ['ticagrelor', '(PA165374673)']]",increased likelihood of,
rs3093135,"[['CYP4F2', '(PA27121)']]",belongs to,
rs1042713,"[['ADRB2', '(PA39)']]",belongs to,
rs28399433,"[['CYP2A6', '(PA121)']]",belongs to,
"CYP2A6*12, CYP2A6*1A","[['nicotine', '(PA450626)']]",decreased risk of,
"CYP2A6*12, CYP2A6*1A","[['CYP2A6', '(PA121)']]",belongs to,
"CYP2B6*1, CYP2B6*4","[['nicotine', '(PA450626)']]",increased severity of,
"CYP2B6*1, CYP2B6*4","[['CYP2B6', '(PA123)']]",belongs to,
"CYP2B6*1, CYP2B6*9","[['CYP2B6', '(PA123)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs7903146,"[['TCF7L2', '(PA36394)']]",belongs to,
rs11196205,"[['TCF7L2', '(PA36394)']]",belongs to,
rs12255372,"[['TCF7L2', '(PA36394)']]",belongs to,
rs290487,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs290487,"[['TCF7L2', '(PA36394)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
HLA-B*57:03:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-B*57:03:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs746071566,"[['azathioprine', '(PA448515)'], ['mercaptopurine', '(PA450379)'], ['thioguanine', '(PA451663)']]",increased risk of,
rs746071566,"[['NUDT15', '(PA134963132)']]",belongs to,
HLA-B*59:01:01:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-B*59:01:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-C*01:02:01,"[['methazolamide', '(PA450413)']]",increased risk of,
HLA-C*01:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs3093135,"[['aspirin', '(PA448497)'], ['ticagrelor', '(PA165374673)']]",increased likelihood of,
rs3093135,"[['CYP4F2', '(PA27121)']]",belongs to,
rs35068180,"[['pravastatin', '(PA451089)']]",decreased likelihood of,
rs35068180,"[['MMP3', '(PA30886)']]",belongs to,
rs35068180,"[['lisinopril', '(PA450242)']]",increased risk of,
rs35068180,"[['MMP3', '(PA30886)']]",belongs to,
rs35068180,"[['lisinopril', '(PA450242)']]",decreased risk of,
rs35068180,"[['MMP3', '(PA30886)']]",belongs to,
rs3397,"[['TNFRSF1B', '(PA36610)']]",belongs to,
rs1418553,"[['TGFB2', '(PA36482)']]",belongs to,
rs5744168,"[['TLR5', '(PA36553)']]",belongs to,
rs1208,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1208,"[['NAT2', '(PA18)']]",belongs to,
rs1799931,"[['isoniazid', '(PA450112)'], ['phenytoin', '(PA450947)']]",increased risk of,
rs1799931,"[['NAT2', '(PA18)']]",belongs to,
rs2254638,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs2254638,"[['N6AMT1', '(PA162396656)']]",belongs to,
rs12913988,"[['clopidogrel', '(PA449053)']]",increased likelihood of,
rs12913988,"[['ATP10A', '(PA25097)']]",belongs to,
rs72631546,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
rs3129880,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
rs3129880,"[['HLA-DRA', '(PA35071)']]",belongs to,
HLA-B*57:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQB1*03:03:02:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DQB1*03:03:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
HLA-DRB1*15:01:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DRB1*15:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
HLA-C*06:02:01:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-C*06:02:01:01,"[['HLA-C', '(PA35057)']]",belongs to,
HLA-DQB1*06:02:01,"[['amoxicillin', '(PA448406)'], ['clavulanate', '(PA164742987)'], ['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DQB1*06:02:01,"[['HLA-DQB1', '(PA35068)']]",belongs to,
rs881,"[['TACR1', '(PA36302)']]",belongs to,
rs2160652,"[['TACR1', '(PA36302)']]",belongs to,
rs6443950,"[['HTR3E', '(PA134900226)']]",belongs to,
NAT2*6A,"[['clonazepam', '(PA449050)']]",Fatigue and Paresthesia due to,
NAT2*6A,"[['NAT2', '(PA18)']]",belongs to,
rs12979860,"[['daclatasvir', '(PA166128167)'], ['sofosbuvir', '(PA166122593)']]","increased sustained virological response (svr) when treated with daclatasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to",
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs8099917,"[['daclatasvir', '(PA166128167)'], ['sofosbuvir', '(PA166122593)']]","increased sustained virological response (svr) when treated with daclatasvir and sofosbuvir in people with Hepatitis C, Chronic as compared to",
rs8099917,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
rs1042714,"[['Drugs', 'For', 'Obstructive', 'Airway', 'Diseases', '(PA164712704)']]",increased exacerbation of,
rs1042714,"[['ADRB2', '(PA39)']]",belongs to,
HLA-B*58:01,"[['allopurinol', '(PA448320)']]",increased risk of,
HLA-B*58:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs2069835,"[['IL6', '(PA198)']]",belongs to,
rs2304389,"[['GABBR2', '(PA28896)']]",belongs to,
rs2779562,"[['GABBR2', '(PA28896)']]",belongs to,
rs11195419,"[['ADRA2A', '(PA35)']]",belongs to,
rs553668,"[['ADRA2A', '(PA35)']]",belongs to,
rs6311,"[['HTR2A', '(PA193)']]",belongs to,
CYP2D6 poor metabolizer,"[['codeine', '(PA449088)'], ['tramadol', '(PA451735)']]",increased likelihood of,
CYP2D6 poor metabolizer,"[['CYP2D6', '(PA128)']]",belongs to,
rs7903146,"[['TCF7L2', '(PA36394)']]",belongs to,
rs12255372,"[['TCF7L2', '(PA36394)']]",belongs to,
rs5219,"[['tacrolimus', '(PA451578)']]",increased risk of,
rs5219,"[['KCNJ11', '(PA217)']]",belongs to,
rs2275913,"[['cyclosporine', '(PA449167)']]",increased likelihood of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs694066,"[['heroin', '(PA452619)']]",increased risk of,
rs694066,"[['GAL', '(PA28529)']]",belongs to,
rs6473797,"[['heroin', '(PA452619)']]",decreased risk of,
rs6473797,"[['OPRK1', '(PA31943)']]",belongs to,
rs1534891,"[['heroin', '(PA452619)']]",decreased risk of,
rs1534891,"[['CSNK1E', '(PA26953)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799732,"[['ethanol', '(PA448073)']]",increased severity of,
rs1799732,"[['DRD2', '(PA27478)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased severity of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs11606194,"[['nicotine', '(PA450626)']]",increased severity of,
rs11606194,"[['HTR3B', '(PA29556)']]",belongs to,
rs3758987,"[['nicotine', '(PA450626)']]",increased severity of,
rs3758987,"[['HTR3B', '(PA29556)']]",belongs to,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1076560,"[['DRD2', '(PA27478)']]",belongs to,
rs4244285,"[['CYP2C19', '(PA124)']]",belongs to,
SLC22A1 low activity,"[['codeine', '(PA449088)']]",increased likelihood of,
SLC22A1 low activity,"[['SLC22A1', '(PA329)']]",belongs to,
rs1045642,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs1045642,"[['ABCB1', '(PA267)']]",belongs to,
rs2740574,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs2740574,"[['CYP3A4', '(PA130)']]",belongs to,
rs2740574,"[['CYP3A', '(PA27114)'], ['CYP3A4', '(PA130)']]",belongs to,
rs1695,"[['bleomycin', '(PA448645)'], ['cisplatin', '(PA449014)'], ['etoposide', '(PA449552)']]",increased risk of,
rs1695,"[['GSTP1', '(PA29028)']]",belongs to,
rs2032582,"[['methylphenidate', '(PA450464)']]",increased adverse events when treated with methylphenidate in children with Attention Deficit Disorder with Hyperactivity as compared to,
rs2032582,"[['ABCB1', '(PA267)']]",belongs to,
rs12456693,"[['clopidogrel', '(PA449053)']]",decreased likelihood of,
rs12456693,"[['SLC14A2', '(PA35811)']]",belongs to,
rs16969968,"[['nicotine', '(PA450626)']]",increased risk of,
rs16969968,"[['CHRNA3', '(PA113)'], ['CHRNA5', '(PA26491)']]",belongs to,
rs1948,"[['CHRNB4', '(PA26496)']]",belongs to,
rs4887074,"[['nicotine', '(PA450626)']]",decreased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs4680,"[['COMT', '(PA117)']]",belongs to,
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",increased high on-treatment platelet reactivity when treated with clopidogrel in healthy individuals as compared to,['*1/*1.']
"CYP2C19*1, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,['*1/*1.']
rs1137101,"[['clozapine', '(PA449061)']]",increased likelihood of,
rs1137101,"[['LEPR', '(PA229)']]",belongs to,
rs9282815,"[['OPRM1', '(PA31945)']]",belongs to,
rs6912029,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799972,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2125362,"[['corticosteroids', '(PA10832)']]",increased severity of,
rs2125362,"[['ME3', '(PA30725)']]",belongs to,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['clopidogrel', '(PA449053)']]",increased risk of,
"CYP2C19*1, CYP2C19*17, CYP2C19*2, CYP2C19*3","[['CYP2C19', '(PA124)']]",belongs to,
rs510769,"[['heroin', '(PA452619)']]",increased risk of,
rs510769,"[['OPRM1', '(PA31945)']]",belongs to,
rs3778151,"[['heroin', '(PA452619)']]",increased risk of,
rs3778151,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs12979860,"[['peginterferon', 'alfa-2a', '(PA164749390)'], ['peginterferon', 'alfa-2b', '(PA164784024)'], ['ribavirin', '(PA451241)']]",increased likelihood of,
rs12979860,"[['IFNL3', '(PA134952671)'], ['IFNL4', '(PA166049147)']]",belongs to,
CYP2C19 poor metabolizers,"[['CYP2C19', '(PA124)']]",belongs to,
rs894160,"[['rosiglitazone', '(PA451283)']]",decreased Weight gain due to,
rs894160,"[['PLIN1', '(PA33409)']]",belongs to,
rs2304795,"[['PLIN1', '(PA33409)']]",belongs to,
rs671,"[['ethanol', '(PA448073)']]",decreased risk of,
rs671,"[['ALDH2', '(PA24696)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['heroin', '(PA452619)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs6928499,"[['CNR1', '(PA26681)']]",belongs to,
rs6928499,"[['CNR1', '(PA26681)']]",belongs to,
rs72552266,"[['CYP2A13', '(PA27101)']]",belongs to,
rs8192789,"[['CYP2A13', '(PA27101)']]",belongs to,
rs1709083,"[['CYP2A13', '(PA27101)']]",belongs to,
rs16969968,"[['CHRNA5', '(PA26491)']]",belongs to,
rs1799971,"[['nicotine', '(PA450626)']]",increased smoking due to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1934951,"[['CYP2C8', '(PA125)']]",belongs to,
rs3766951,"[['heroin', '(PA452619)']]",increased risk of,
rs3766951,"[['OPRD1', '(PA31942)']]",belongs to,
rs2236857,"[['heroin', '(PA452619)']]",increased risk of,
rs2236857,"[['OPRD1', '(PA31942)']]",belongs to,
rs2236861,"[['heroin', '(PA452619)']]",increased risk of,
rs2236861,"[['OPRD1', '(PA31942)']]",belongs to,
rs1799971,"[['opioids', '(PA452618)']]",decreased Nausea and Vomiting due to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['opioids', '(PA452618)']]",decreased adverse events due to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs3211371,"[['cyclophosphamide', '(PA449165)']]",increased Recurrence when treated with cyclophosphamide in people with Lymphoma as compared to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs3211371,"[['cyclophosphamide', '(PA449165)']]",decreased overall survival when treated with cyclophosphamide in people with Lymphoma as compared to,
rs3211371,"[['CYP2B6', '(PA123)']]",belongs to,
rs6265,"[['methamphetamine', '(PA450403)']]",decreased severity of,
rs6265,"[['BDNF', '(PA31891)']]",belongs to,
rs1799971,"[['nicotine', '(PA450626)']]",increased smoking due to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2236256,"[['cocaine', '(PA449072)']]",decreased severity of,
rs2236256,"[['OPRM1', '(PA31945)']]",belongs to,
rs598961,"[['ritodrine', '(PA451258)']]",decreased time to,
rs598961,"[['PDE4B', '(PA33129)']]",belongs to,
rs17128809,"[['ritodrine', '(PA451258)']]",increased risk of,
rs17128809,"[['PDE4B', '(PA33129)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
rs3918290,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs3918290,"[['DPYD', '(PA145)']]",belongs to,
rs55886062,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs55886062,"[['DPYD', '(PA145)']]",belongs to,
rs56038477,"[['capecitabine', '(PA448771)'], ['fluorouracil', '(PA128406956)']]",risk of,
rs56038477,"[['DPYD', '(PA145)']]",belongs to,
rs776746,"[['atorvastatin', '(PA448500)'], ['rosuvastatin', '(PA134308647)']]",increased likelihood of,
rs776746,"[['CYP3A', '(PA27114)'], ['CYP3A5', '(PA131)']]",belongs to,
rs35514893,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs35514893,"[['DTNBP1', '(PA27512)']]",belongs to,
rs4897302,"[['corticosteroids', '(PA10832)']]",increased severity of,
rs4897302,"[['TRDN', '(PA36941)']]",belongs to,
rs11121611,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs11121611,"[['ACOT7', '(PA142672655)']]",belongs to,
rs61585310,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs61585310,"[['LHFPL3', '(PA30361)']]",belongs to,
rs7851998,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs7851998,"[['LHX2', '(PA30365)']]",belongs to,
rs450789,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs450789,"[['KL', '(PA30130)']]",belongs to,
rs12959468,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs12959468,"[['ANKRD30B', '(PA134980028)']]",belongs to,
rs2278992,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs2278992,"[['KCNN1', '(PA30070)']]",belongs to,
rs6001366,"[['corticosteroids', '(PA10832)']]",decreased severity of,
rs6001366,"[['APOBEC3B', '(PA24892)']]",belongs to,
HLA-DRB1*07:01:01:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DRB1*07:01:01:01,"[['HLA-DRB1', '(PA35072)']]",belongs to,
rs2234918,"[['OPRD1', '(PA31942)']]",belongs to,
rs11575856,"[['OPRM1', '(PA31945)']]",belongs to,
rs6912029,"[['OPRM1', '(PA31945)']]",belongs to,
rs762551,"[['clozapine', '(PA449061)']]",decreased likelihood of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs762551,"[['clozapine', '(PA449061)']]",increased likelihood of,
rs762551,"[['CYP1A2', '(PA27093)']]",belongs to,
rs924607,"[['vincristine', '(PA451879)']]",increased risk of,
rs924607,"[['CEP72', '(PA142672125)']]",belongs to,
rs3784867,"[['vincristine', '(PA451879)']]",increased risk of,
rs3784867,"[['ABCC1', '(PA244)']]",belongs to,
rs1013940,"[['vincristine', '(PA451879)']]",increased risk of,
rs1013940,"[['SLC5A7', '(PA37838)']]",belongs to,
rs10504361,"[['vincristine', '(PA451879)']]",increased risk of,
rs10504361,"[['NKAIN3', '(PA162397582)']]",belongs to,
HLA-B*15:02:01,"[['phenytoin', '(PA450947)']]",increased risk of,
HLA-B*15:02:01,"[['HLA-B', '(PA35056)']]",belongs to,
rs1799971,"[['ethanol', '(PA448073)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs1800497,"[['DRD2', '(PA27478)']]",belongs to,
HLA-B*57:01:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-B*57:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DQA1*02:01,"[['flucloxacillin', '(PA164781042)']]",increased risk of,
HLA-DQA1*02:01,"[['HLA-DQA1', '(PA35066)']]",belongs to,
HLA-B*58:01:01,"[['amoxicillin', '(PA448406)']]",increased risk of,
HLA-B*58:01:01,"[['HLA-B', '(PA35056)']]",belongs to,
HLA-DPB1*01:01:01,"[['amoxicillin', '(PA448406)']]",increased risk of,
HLA-DPB1*01:01:01,"[['HLA-DPB1', '(PA35064)']]",belongs to,
HLA-A*01:01:01:01,"[['amoxicillin', '(PA448406)']]",increased risk of,
HLA-A*01:01:01:01,"[['HLA-A', '(PA35055)']]",belongs to,
HLA-C*03:02:01,"[['amoxicillin', '(PA448406)']]",increased risk of,
HLA-C*03:02:01,"[['HLA-C', '(PA35057)']]",belongs to,
rs1799971,"[['heroin', '(PA452619)']]",increased risk of,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs2075572,"[['heroin', '(PA452619)']]",increased risk of,
rs2075572,"[['OPRM1', '(PA31945)']]",belongs to,
rs11584174,"[['taxanes', '(PA150481189)']]",decreased likelihood of,
rs11584174,"[['NR1I3', '(PA391)']]",belongs to,
rs7438284,"[['taxanes', '(PA150481189)']]",decreased likelihood of,
rs7438284,"[['UGT2B7', '(PA361)']]",belongs to,
rs7439366,"[['taxanes', '(PA150481189)']]",decreased likelihood of,
rs7439366,"[['UGT2B7', '(PA361)']]",belongs to,
rs7662029,"[['taxanes', '(PA150481189)']]",decreased likelihood of,
rs7662029,"[['UGT2B7', '(PA361)']]",belongs to,
rs7668258,"[['taxanes', '(PA150481189)']]",decreased likelihood of,
rs7668258,"[['UGT2B7', '(PA361)']]",belongs to,
rs1799971,"[['OPRM1', '(PA31945)']]",belongs to,
rs9479757,"[['OPRM1', '(PA31945)']]",belongs to,
rs702764,"[['OPRK1', '(PA31943)']]",belongs to,
rs1051660,"[['OPRK1', '(PA31943)']]",belongs to,
rs67376798,"[['capecitabine', '(PA448771)']]",risk of,
rs67376798,"[['DPYD', '(PA145)']]",belongs to,
DPYD*2A,"[['capecitabine', '(PA448771)']]",risk of,
DPYD*2A,"[['DPYD', '(PA145)']]",belongs to,
DPYD deficiency,"[['capecitabine', '(PA448771)']]",risk of,
DPYD deficiency,"[['DPYD', '(PA145)']]",belongs to,
"DPYD*1, DPYD*2A","[['capecitabine', '(PA448771)']]",risk of,
"DPYD*1, DPYD*2A","[['DPYD', '(PA145)']]",belongs to,
rs11249454,"[['imatinib', '(PA10804)']]",increased risk of,
rs11249454,"[['UGT2A1', '(PA37184)']]",belongs to,
rs628031,"[['imatinib', '(PA10804)']]",increased risk of,
rs628031,"[['SLC22A1', '(PA329)']]",belongs to,
rs1202283,"[['imatinib', '(PA10804)']]",increased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to,
rs1202283,"[['ABCB4', '(PA268)']]",belongs to,
rs2273697,"[['imatinib', '(PA10804)']]",decreased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to,
rs2273697,"[['ABCC2', '(PA116)']]",belongs to,
rs9787901,"[['imatinib', '(PA10804)']]",increased risk of,
rs9787901,"[['CHST1', '(PA26501)']]",belongs to,
rs10517,"[['imatinib', '(PA10804)']]",decreased progression-free survival when treated with imatinib in people with Gastrointestinal Stromal Tumors as compared to,
rs10517,"[['NQO1', '(PA31744)']]",belongs to,
rs305968,"[['imatinib', '(PA10804)']]",increased risk of,
rs305968,"[['CYP2F1', '(PA27109)']]",belongs to,
rs12659,"[['imatinib', '(PA10804)']]",decreased risk of,
rs12659,"[['SLC19A1', '(PA327)']]",belongs to,
rs1051266,"[['imatinib', '(PA10804)']]",increased risk of,
rs1051266,"[['SLC19A1', '(PA327)']]",belongs to,
